code,description,last_updated
   A1,Dressing for one wound,09/11/2025
   A2,Dressing for two wounds,09/11/2025
   A3,Dressing for three wounds,09/11/2025
   A4,Dressing for four wounds,09/11/2025
   A5,Dressing for five wounds,09/11/2025
   A6,Dressing for six wounds,09/11/2025
   A7,Dressing for seven wounds,09/11/2025
   A8,Dressing for eight wounds,09/11/2025
   A9,Dressing for nine or more wounds,09/11/2025
   AA,Anesthesia services performed personally by anesthesiologist,09/11/2025
   AB,"Audiology service furnished personally by an audiologist without a physician/npp order for non-acute hearing assessment unrelated to disequilibrium, or hearing aids, or examinations for the purpose of prescribing, fitting, or changing hearing aids; service may be performed once every 12 months, per beneficiary",09/11/2025
   AD,Medical supervision by a physician: more than four concurrent anesthesia procedures,09/11/2025
   AE,Registered dietician,09/11/2025
   AF,Specialty physician,09/11/2025
   AG,Primary physician,09/11/2025
   AH,Clinical psychologist,09/11/2025
   AI,Principal physician of record,09/11/2025
   AJ,Clinical social worker,09/11/2025
   AK,Non participating physician,09/11/2025
   AM,"Physician, team member service",09/11/2025
   AO,Alternate payment method declined by provider of service,09/11/2025
   AP,Determination of refractive state was not performed in the course of diagnostic ophthalmological examination,09/11/2025
   AQ,Physician providing a service in an unlisted health professional shortage area (hpsa),09/11/2025
   AR,Physician provider services in a physician scarcity area,09/11/2025
   AS,"Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery",09/11/2025
   AT,"Acute treatment (this modifier should be used when reporting service 98940, 98941, 98942)",09/11/2025
   AU,"Item furnished in conjunction with a urological, ostomy, or tracheostomy supply",09/11/2025
   AV,"Item furnished in conjunction with a prosthetic device, prosthetic or orthotic",09/11/2025
   AW,Item furnished in conjunction with a surgical dressing,09/11/2025
   AX,Item furnished in conjunction with dialysis services,09/11/2025
   AY,Item or service furnished to an esrd patient that is not for the treatment of esrd,09/11/2025
   AZ,Physician providing a service in a dental health professional shortage area for the purpose of an electronic health record incentive payment,09/11/2025
   BA,Item furnished in conjunction with parenteral enteral nutrition (pen) services,09/11/2025
   BL,Special acquisition of blood and blood products,09/11/2025
   BO,"Orally administered nutrition, not by feeding tube",09/11/2025
   BP,The beneficiary has been informed of the purchase and rental options and has elected to purchase the item,09/11/2025
   BR,The beneficiary has been informed of the purchase and rental options and has elected to rent the item,09/11/2025
   BU,The beneficiary has been informed of the purchase and rental options and after 30 days has not informed the supplier of his/her decision,09/11/2025
   CA,Procedure payable only in the inpatient setting when performed emergently on an outpatient who expires prior to admission,09/11/2025
   CB,"Service ordered by a renal dialysis facility (rdf) physician as part of the esrd beneficiary's dialysis benefit, is not part of the composite rate, and is separately reimbursable",09/11/2025
   CC,Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed),09/11/2025
   CD,Amcc test has been ordered by an esrd facility or mcp physician that is part of the composite rate and is not separately billable,09/11/2025
   CE,Amcc test has been ordered by an esrd facility or mcp physician that is a composite rate test but is beyond the normal frequency covered under the rate and is separately reimbursable based on medical necessity,09/11/2025
   CF,Amcc test has been ordered by an esrd facility or mcp physician that is not part of the composite rate and is separately billable,09/11/2025
   CG,Policy criteria applied,09/11/2025
   CH,"0 percent impaired, limited or restricted",09/11/2025
   CI,"At least 1 percent but less than 20 percent impaired, limited or restricted",09/11/2025
   CJ,"At least 20 percent but less than 40 percent impaired, limited or restricted",09/11/2025
   CK,"At least 40 percent but less than 60 percent impaired, limited or restricted",09/11/2025
   CL,"At least 60 percent but less than 80 percent impaired, limited or restricted",09/11/2025
   CM,"At least 80 percent but less than 100 percent impaired, limited or restricted",09/11/2025
   CN,"100 percent impaired, limited or restricted",09/11/2025
   CO,Outpatient occupational therapy services furnished in whole or in part by an occupational therapy assistant,09/11/2025
   CP,"Adjunctive service related to a procedure assigned to a comprehensive ambulatory payment classification (c-apc) procedure, but reported on a different claim",09/11/2025
   CQ,Outpatient physical therapy services furnished in whole or in part by a physical therapist assistant,09/11/2025
   CR,Catastrophe/disaster related,09/11/2025
   CS,Cost-sharing waived for specified covid-19 testing-related services that result in and order for or administration of a covid-19 test and/or used for cost-sharing waived preventive services furnished via telehealth in rural health clinics and federally qualified health centers during the covid-19 public health emergency,09/11/2025
   CT,Computed tomography services furnished using equipment that does not meet each of the attributes of the national electrical manufacturers association (nema) xr-29-2013 standard,09/11/2025
   DA,Oral health assessment by a licensed health professional other than a dentist,09/11/2025
   E1,"Upper left, eyelid",09/11/2025
   E2,"Lower left, eyelid",09/11/2025
   E3,"Upper right, eyelid",09/11/2025
   E4,"Lower right, eyelid",09/11/2025
   EA,Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy,09/11/2025
   EB,Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy,09/11/2025
   EC,Erythropoietic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy,09/11/2025
   ED,Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle,09/11/2025
   EE,Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle,09/11/2025
   EJ,"Subsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab",09/11/2025
   EM,Emergency reserve supply (for esrd benefit only),09/11/2025
   EP,Service provided as part of medicaid early periodic screening diagnosis and treatment (epsdt) program,09/11/2025
   ER,"Items and services furnished by a provider-based, off-campus emergency department",09/11/2025
   ET,Emergency services,09/11/2025
   EX,Expatriate beneficiary,09/11/2025
   EY,No physician or other licensed health care provider order for this item or service,09/11/2025
   F1,"Left hand, second digit",09/11/2025
   F2,"Left hand, third digit",09/11/2025
   F3,"Left hand, fourth digit",09/11/2025
   F4,"Left hand, fifth digit",09/11/2025
   F5,"Right hand, thumb",09/11/2025
   F6,"Right hand, second digit",09/11/2025
   F7,"Right hand, third digit",09/11/2025
   F8,"Right hand, fourth digit",09/11/2025
   F9,"Right hand, fifth digit",09/11/2025
   FA,"Left hand, thumb",09/11/2025
   FB,"Item provided without cost to provider, supplier or practitioner, or full credit received for replaced device (examples, but not limited to, covered under warranty, replaced due to defect, free samples)",09/11/2025
   FC,Partial credit received for replaced device,09/11/2025
   FP,Service provided as part of family planning program,09/11/2025
   FQ,The service was furnished using audio-only communication technology,09/11/2025
   FR,"The supervising practitioner was present through two-way, audio/video communication technology",09/11/2025
   FS,Split (or shared) evaluation and management visit,09/11/2025
   FT,"Unrelated evaluation and management (e/m) visit on the same day as another e/m visit or during a global procedure (preoperative, postoperative period, or on the same day as the procedure, as applicable). (report when an e/m visit is furnished within the global period but is unrelated, or when one or more additional e/m visits furnished on the same day are unrelated)",09/11/2025
   FX,X-ray taken using film,09/11/2025
   FY,X-ray taken using computed radiography technology/cassette-based imaging,09/11/2025
   G0,"Telehealth services for diagnosis, evaluation, or treatment, of symptoms of an acute stroke",09/11/2025
   G1,Most recent urr reading of less than 60,09/11/2025
   G2,Most recent urr reading of 60 to 64.9,09/11/2025
   G3,Most recent urr reading of 65 to 69.9,09/11/2025
   G4,Most recent urr reading of 70 to 74.9,09/11/2025
   G5,Most recent urr reading of 75 or greater,09/11/2025
   G6,Esrd patient for whom less than six dialysis sessions have been provided in a month,09/11/2025
   G7,Pregnancy resulted from rape or incest or pregnancy certified by physician as life threatening,09/11/2025
   G8,"Monitored anesthesia care (mac) for deep complex, complicated, or markedly invasive surgical procedure",09/11/2025
   G9,Monitored anesthesia care for patient who has history of severe cardio-pulmonary condition,09/11/2025
   GA,"Waiver of liability statement issued as required by payer policy, individual case",09/11/2025
   GB,Claim being re-submitted for payment because it is no longer covered under a global payment demonstration,09/11/2025
   GC,This service has been performed in part by a resident under the direction of a teaching physician,09/11/2025
   GD,Units of service exceeds medically unlikely edit value and represents reasonable and necessary services,09/11/2025
   GE,This service has been performed by a resident without the presence of a teaching physician under the primary care exception,09/11/2025
   GF,"Non-physician (e.g. nurse practitioner (np), certified registered nurse anesthetist (crna), certified registered nurse (crn), clinical nurse specialist (cns), physician assistant (pa)) services in a critical access hospital",09/11/2025
   GG,"Performance and payment of a screening mammogram and diagnostic mammogram on the same patient, same day",09/11/2025
   GH,Diagnostic mammogram converted from screening mammogram on same day,09/11/2025
   GJ,"""opt out"" physician or practitioner emergency or urgent service",09/11/2025
   GK,Reasonable and necessary item/service associated with a ga or gz modifier,09/11/2025
   GL,"Medically unnecessary upgrade provided instead of non-upgraded item, no charge, no advance beneficiary notice (abn)",09/11/2025
   GM,Multiple patients on one ambulance trip,09/11/2025
   GN,Services delivered under an outpatient speech language pathology plan of care,09/11/2025
   GO,Services delivered under an outpatient occupational therapy plan of care,09/11/2025
   GP,Services delivered under an outpatient physical therapy plan of care,09/11/2025
   GQ,Via asynchronous telecommunications system,09/11/2025
   GR,"This service was performed in whole or in part by a resident in a department of veterans affairs medical center or clinic, supervised in accordance with va policy",09/11/2025
   GS,Dosage of erythropoietin stimulating agent has been reduced and maintained in response to hematocrit or hemoglobin level,09/11/2025
   GT,Via interactive audio and video telecommunication systems,09/11/2025
   GU,"Waiver of liability statement issued as required by payer policy, routine notice",09/11/2025
   GV,Attending physician not employed or paid under arrangement by the patient's hospice provider,09/11/2025
   GW,Service not related to the hospice patient's terminal condition,09/11/2025
   GX,"Notice of liability issued, voluntary under payer policy",09/11/2025
   GY,"Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit",09/11/2025
   GZ,Item or service expected to be denied as not reasonable and necessary,09/11/2025
   H9,Court-ordered,09/11/2025
   HA,Child/adolescent program,09/11/2025
   HB,"Adult program, non geriatric",09/11/2025
   HC,"Adult program, geriatric",09/11/2025
   HD,Pregnant/parenting women's program,09/11/2025
   HE,Mental health program,09/11/2025
   HF,Substance abuse program,09/11/2025
   HG,Opioid addiction treatment program,09/11/2025
   HH,Integrated mental health/substance abuse program,09/11/2025
   HI,Integrated mental health and intellectual disability/developmental disabilities program,09/11/2025
   HJ,Employee assistance program,09/11/2025
   HK,Specialized mental health programs for high-risk populations,09/11/2025
   HL,Intern,09/11/2025
   HM,Less than bachelor degree level,09/11/2025
   HN,Bachelors degree level,09/11/2025
   HO,Masters degree level,09/11/2025
   HP,Doctoral level,09/11/2025
   HQ,Group setting,09/11/2025
   HR,Family/couple with client present,09/11/2025
   HS,Family/couple without client present,09/11/2025
   HT,Multi-disciplinary team,09/11/2025
   HU,Funded by child welfare agency,09/11/2025
   HV,Funded state addictions agency,09/11/2025
   HW,Funded by state mental health agency,09/11/2025
   HX,Funded by county/local agency,09/11/2025
   HY,Funded by juvenile justice agency,09/11/2025
   HZ,Funded by criminal justice agency,09/11/2025
   J1,Competitive acquisition program no-pay submission for a prescription number,09/11/2025
   J2,"Competitive acquisition program, restocking of emergency drugs after emergency administration",09/11/2025
   J3,"Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology",09/11/2025
   J4,Dmepos item subject to dmepos competitive bidding program that is furnished by a hospital upon discharge,09/11/2025
   J5,Off-the-shelf orthotic subject to dmepos competitive bidding program that is furnished as part of a physical therapist or occupational therapist professional service,09/11/2025
   JA,Administered intravenously,09/11/2025
   JB,Administered subcutaneously,09/11/2025
   JC,Skin substitute used as a graft,09/11/2025
   JD,Skin substitute not used as a graft,09/11/2025
   JE,Administered via dialysate,09/11/2025
   JF,Compounded drug,09/11/2025
   JG,"Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes",09/11/2025
   JK,One month supply or less of drug or biological,09/11/2025
   JL,Three month supply of drug or biological,09/11/2025
   JW,Drug amount discarded/not administered to any patient,09/11/2025
   JZ,Zero drug amount discarded/not administered to any patient,09/11/2025
   K0,Lower extremity prosthesis functional level 0 - does not have the ability or potential to ambulate or transfer safely with or without assistance and a prosthesis does not enhance their quality of life or mobility.,09/11/2025
   K1,Lower extremity prosthesis functional level 1 - has the ability or potential to use a prosthesis for transfers or ambulation on level surfaces at fixed cadence. typical of the limited and unlimited household ambulator.,09/11/2025
   K2,"Lower extremity prosthesis functional level 2 - has the ability or potential for ambulation with the ability to traverse low level environmental barriers such as curbs, stairs or uneven surfaces.  typical of the limited community ambulator.",09/11/2025
   K3,"Lower extremity prosthesis functional level 3 - has the ability or potential for ambulation with variable cadence.  typical of the community ambulator who has the ability to transverse most environmental barriers and may have vocational, therapeutic, or exercise activity that demands prosthetic utilization beyond simple locomotion.",09/11/2025
   K4,"Lower extremity prosthesis functional level 4 - has the ability or potential for prosthetic ambulation that exceeds the basic ambulation skills, exhibiting high impact, stress, or energy levels, typical of the prosthetic demands of the child, active adult, or athlete.",09/11/2025
   KA,Add on option/accessory for wheelchair,09/11/2025
   KB,"Beneficiary requested upgrade for abn, more than 4 modifiers identified on claim",09/11/2025
   KC,Replacement of special power wheelchair interface,09/11/2025
   KD,Drug or biological infused through dme,09/11/2025
   KE,Bid under round one of the dmepos competitive bidding program for use with non-competitive bid base equipment,09/11/2025
   KF,Item designated by fda as class iii device,09/11/2025
   KG,Dmepos item subject to dmepos competitive bidding program number 1,09/11/2025
   KH,"Dmepos item, initial claim, purchase or first month rental",09/11/2025
   KI,"Dmepos item, second or third month rental",09/11/2025
   KJ,"Dmepos item, parenteral enteral nutrition (pen) pump or capped rental, months four to fifteen",09/11/2025
   KK,Dmepos item subject to dmepos competitive bidding program number 2,09/11/2025
   KL,Dmepos item delivered via mail,09/11/2025
   KM,Replacement of facial prosthesis including new impression/moulage,09/11/2025
   KN,Replacement of facial prosthesis using previous master model,09/11/2025
   KO,Single drug unit dose formulation,09/11/2025
   KP,First drug of a multiple drug unit dose formulation,09/11/2025
   KQ,Second or subsequent drug of a multiple drug unit dose formulation,09/11/2025
   KR,"Rental item, billing for partial month",09/11/2025
   KS,Glucose monitor supply for diabetic beneficiary not treated with insulin,09/11/2025
   KT,Beneficiary resides in a competitive bidding area and travels outside that competitive bidding area and receives a competitive bid item,09/11/2025
   KU,Dmepos item subject to dmepos competitive bidding program number 3,09/11/2025
   KV,Dmepos item subject to dmepos competitive bidding program that is furnished as part of a professional service,09/11/2025
   KW,Dmepos item subject to dmepos competitive bidding program number 4,09/11/2025
   KX,Requirements specified in the medical policy have been met,09/11/2025
   KY,Dmepos item subject to dmepos competitive bidding program number 5,09/11/2025
   KZ,New coverage not implemented by managed care,09/11/2025
   L1,Provider attestation that the hospital laboratory test(s) is not packaged under the hospital opps,09/11/2025
   LC,Left circumflex coronary artery,09/11/2025
   LD,Left anterior descending coronary artery,09/11/2025
   LL,Lease/rental (use the 'll' modifier when dme equipment rental is to be applied against the purchase price),09/11/2025
   LM,Left main coronary artery,09/11/2025
   LR,Laboratory round trip,09/11/2025
   LS,Fda-monitored intraocular lens implant,09/11/2025
   LT,Left side (used to identify procedures performed on the left side of the body),09/11/2025
   LU,Fractionated payment,09/11/2025
   M2,Medicare secondary payer (msp),09/11/2025
   MA,Ordering professional is not required to consult a clinical decision support mechanism due to service being rendered to a patient with a suspected or confirmed emergency medical condition,09/11/2025
   MB,Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of insufficient internet access,09/11/2025
   MC,Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of electronic health record or clinical decision support mechanism vendor issues,09/11/2025
   MD,Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of extreme and uncontrollable circumstances,09/11/2025
   ME,The order for this service adheres to appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional,09/11/2025
   MF,The order for this service does not adhere to the appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional,09/11/2025
   MG,The order for this service does not have applicable appropriate use criteria in the qualified clinical decision support mechanism consulted by the ordering professional,09/11/2025
   MH,"Unknown if ordering professional consulted a clinical decision support mechanism for this service, related information was not provided to the furnishing professional or provider",09/11/2025
   MS,Six month maintenance and servicing fee for reasonable and necessary parts and labor which are not covered under any manufacturer or supplier warranty,09/11/2025
   N1,Group 1 oxygen coverage criteria met,09/11/2025
   N2,Group 2 oxygen coverage criteria met,09/11/2025
   N3,Group 3 oxygen coverage criteria met,09/11/2025
   NB,"Nebulizer system, any type, fda-cleared for use with specific drug",09/11/2025
   NR,New when rented (use the 'nr' modifier when dme which was new at the time of rental is subsequently purchased),09/11/2025
   NU,New equipment,09/11/2025
   P1,A normal healthy patient,09/11/2025
   P2,A patient with mild systemic disease,09/11/2025
   P3,A patient with severe systemic disease,09/11/2025
   P4,A patient with severe systemic disease that is a constant threat to life,09/11/2025
   P5,A moribund patient who is not expected to survive without the operation,09/11/2025
   P6,A declared brain-dead patient whose organs are being removed for donor purposes,09/11/2025
   PA,Surgical or other invasive procedure on wrong body part,09/11/2025
   PB,Surgical or other invasive procedure on wrong patient,09/11/2025
   PC,Wrong surgery or other invasive procedure on patient,09/11/2025
   PD,Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days,09/11/2025
   PI,Positron emission tomography (pet) or pet/computed tomography (ct) to inform the initial treatment strategy of tumors that are biopsy proven or strongly suspected of being cancerous based on other diagnostic testing,09/11/2025
   PL,Progressive addition lenses,09/11/2025
   PM,Post mortem,09/11/2025
   PN,"Non-excepted service provided at an off-campus, outpatient, provider-based department of a hospital",09/11/2025
   PO,"Excepted service provided at an off-campus, outpatient, provider-based department of a hospital",09/11/2025
   PS,Positron emission tomography (pet) or pet/computed tomography (ct) to inform the subsequent treatment strategy of cancerous tumors when the beneficiary's treating physician determines that the pet study is needed to inform subsequent anti-tumor strategy,09/11/2025
   PT,Colorectal cancer screening test; converted to diagnostic test or other procedure,09/11/2025
   Q0,Investigational clinical service provided in a clinical research study that is in an approved clinical research study,09/11/2025
   Q1,Routine clinical service provided in a clinical research study that is in an approved clinical research study,09/11/2025
   Q2,Demonstration procedure/service,09/11/2025
   Q3,Live kidney donor surgery and related services,09/11/2025
   Q4,Service for ordering/referring physician qualifies as a service exemption,09/11/2025
   Q5,"Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area",09/11/2025
   Q6,"Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area",09/11/2025
   Q7,One class a finding,09/11/2025
   Q8,Two class b findings,09/11/2025
   Q9,One class b and two class c findings,09/11/2025
   QA,Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is less than 1 liter per minute (lpm),09/11/2025
   QB,Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts exceeds 4 liters per minute (lpm) and portable oxygen is prescribed,09/11/2025
   QC,Single channel monitoring,09/11/2025
   QD,Recording and storage in solid state memory by a digital recorder,09/11/2025
   QE,Prescribed amount of stationary oxygen while at rest is less than 1 liter per minute (lpm),09/11/2025
   QF,Prescribed amount of stationary oxygen while at rest exceeds 4 liters per minute (lpm) and portable oxygen is prescribed,09/11/2025
   QG,Prescribed amount of stationary oxygen while at rest is greater than 4 liters per minute (lpm),09/11/2025
   QH,Oxygen conserving device is being used with an oxygen delivery system,09/11/2025
   QJ,"Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b)",09/11/2025
   QK,"Medical direction of two, three, or four concurrent anesthesia procedures involving qualified individuals",09/11/2025
   QL,Patient pronounced dead after ambulance called,09/11/2025
   QM,Ambulance service provided under arrangement by a provider of services,09/11/2025
   QN,Ambulance service furnished directly by a provider of services,09/11/2025
   QP,"Documentation is on file showing that the laboratory test(s) was ordered individually or ordered as a cpt-recognized panel other than automated profile codes 80002-80019, g0058, g0059, and g0060.",09/11/2025
   QQ,Ordering professional consulted a qualified clinical decision support mechanism for this service and the related data was provided to the furnishing professional,09/11/2025
   QR,Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is greater than 4 liters per minute (lpm),09/11/2025
   QS,Monitored anesthesia care service,09/11/2025
   QT,Recording and storage on tape by an analog tape recorder,09/11/2025
   QW,Clia waived test,09/11/2025
   QX,Crna service: with medical direction by a physician,09/11/2025
   QY,Medical direction of one certified registered nurse anesthetist (crna) by an anesthesiologist,09/11/2025
   QZ,Crna service: without medical direction by a physician,09/11/2025
   RA,"Replacement of a dme, orthotic or prosthetic item",09/11/2025
   RB,"Replacement of a part of a dme, orthotic or prosthetic item furnished as part of a repair",09/11/2025
   RC,Right coronary artery,09/11/2025
   RD,"Drug provided to beneficiary, but not administered ""incident-to""",09/11/2025
   RE,Furnished in full compliance with fda-mandated risk evaluation and mitigation strategy (rems),09/11/2025
   RI,Ramus intermedius coronary artery,09/11/2025
   RR,Rental (use the 'rr' modifier when dme is to be rented),09/11/2025
   RT,Right side (used to identify procedures performed on the right side of the body),09/11/2025
   SA,Nurse practitioner rendering service in collaboration with a physician,09/11/2025
   SB,Nurse midwife,09/11/2025
   SC,Medically necessary service or supply,09/11/2025
   SD,"Services provided by registered nurse with specialized, highly technical home infusion training",09/11/2025
   SE,State and/or federally-funded programs/services,09/11/2025
   SF,"Second opinion ordered by a professional review organization (pro) per section 9401, p.l. 99-272 (100% reimbursement - no medicare deductible or coinsurance)",09/11/2025
   SG,Ambulatory surgical center (asc) facility service,09/11/2025
   SH,Second concurrently administered infusion therapy,09/11/2025
   SJ,Third or more concurrently administered infusion therapy,09/11/2025
   SK,Member of high risk population (use only with codes for immunization),09/11/2025
   SL,State supplied vaccine,09/11/2025
   SM,Second surgical opinion,09/11/2025
   SN,Third surgical opinion,09/11/2025
   SQ,Item ordered by home health,09/11/2025
   SS,Home infusion services provided in the infusion suite of the iv therapy provider,09/11/2025
   ST,Related to trauma or injury,09/11/2025
   SU,Procedure performed in physician's office (to denote use of facility and equipment),09/11/2025
   SV,Pharmaceuticals delivered to patient's home but not utilized,09/11/2025
   SW,Services provided by a certified diabetic educator,09/11/2025
   SY,Persons who are in close contact with member of high-risk population (use only with codes for immunization),09/11/2025
   SZ,Habilitative services,09/11/2025
   T1,"Left foot, second digit",09/11/2025
   T2,"Left foot, third digit",09/11/2025
   T3,"Left foot, fourth digit",09/11/2025
   T4,"Left foot, fifth digit",09/11/2025
   T5,"Right foot, great toe",09/11/2025
   T6,"Right foot, second digit",09/11/2025
   T7,"Right foot, third digit",09/11/2025
   T8,"Right foot, fourth digit",09/11/2025
   T9,"Right foot, fifth digit",09/11/2025
   TA,"Left foot, great toe",09/11/2025
   TB,"Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes",09/11/2025
   TC,"Technical component; under certain circumstances, a charge may be made for the technical component alone;  under those circumstances the technical component charge is identified by adding modifier 'tc' to the usual procedure number; technical component charges are institutional charges and not billed separately by physicians; however, portable x-ray suppliers only bill for technical component and should utilize modifier tc; the charge data from portable x-ray suppliers will then be used to build customary and prevailing profiles",09/11/2025
   TD,Rn,09/11/2025
   TE,Lpn/lvn,09/11/2025
   TF,Intermediate level of care,09/11/2025
   TG,Complex/high tech level of care,09/11/2025
   TH,"Obstetrical treatment/services, prenatal or postpartum",09/11/2025
   TJ,"Program group, child and/or adolescent",09/11/2025
   TK,"Extra patient or passenger, non-ambulance",09/11/2025
   TL,Early intervention/individualized family service plan (ifsp),09/11/2025
   TM,Individualized education program (iep),09/11/2025
   TN,Rural/outside providers' customary service area,09/11/2025
   TP,"Medical transport, unloaded vehicle",09/11/2025
   TQ,Basic life support transport by a volunteer ambulance provider,09/11/2025
   TR,School-based individualized education program (iep) services provided outside the public school district responsible for the student,09/11/2025
   TS,Follow-up service,09/11/2025
   TT,Individualized service provided to more than one patient in same setting,09/11/2025
   TU,"Special payment rate, overtime",09/11/2025
   TV,"Special payment rates, holidays/weekends",09/11/2025
   TW,Back-up equipment,09/11/2025
   U1,"Medicaid level of care 1, as defined by each state",09/11/2025
   U2,"Medicaid level of care 2, as defined by each state",09/11/2025
   U3,"Medicaid level of care 3, as defined by each state",09/11/2025
   U4,"Medicaid level of care 4, as defined by each state",09/11/2025
   U5,"Medicaid level of care 5, as defined by each state",09/11/2025
   U6,"Medicaid level of care 6, as defined by each state",09/11/2025
   U7,"Medicaid level of care 7, as defined by each state",09/11/2025
   U8,"Medicaid level of care 8, as defined by each state",09/11/2025
   U9,"Medicaid level of care 9, as defined by each state",09/11/2025
   UA,"Medicaid level of care 10, as defined by each state",09/11/2025
   UB,"Medicaid level of care 11, as defined by each state",09/11/2025
   UC,"Medicaid level of care 12, as defined by each state",09/11/2025
   UD,"Medicaid level of care 13, as defined by each state",09/11/2025
   UE,Used durable medical equipment,09/11/2025
   UF,Services provided in the morning,09/11/2025
   UG,Services provided in the afternoon,09/11/2025
   UH,Services provided in the evening,09/11/2025
   UJ,Services provided at night,09/11/2025
   UK,Services provided on behalf of the client to someone other than the client (collateral relationship),09/11/2025
   UN,Two patients served,09/11/2025
   UP,Three patients served,09/11/2025
   UQ,Four patients served,09/11/2025
   UR,Five patients served,09/11/2025
   US,Six or more patients served,09/11/2025
   V1,Demonstration modifier 1,09/11/2025
   V2,Demonstration modifier 2,09/11/2025
   V3,Demonstration modifier 3,09/11/2025
   V4,Demonstration modifier 4,09/11/2025
   V5,Vascular catheter (alone or with any other vascular access),09/11/2025
   V6,Arteriovenous graft (or other vascular access not including a vascular catheter),09/11/2025
   V7,Arteriovenous fistula only (in use with two needles),09/11/2025
   V8,Infection present,09/11/2025
   V9,No infection present,09/11/2025
   VM,Medicare diabetes prevention program (mdpp) virtual make-up session,09/11/2025
   VP,Aphakic patient,09/11/2025
   X1,"Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care",09/11/2025
   X2,Continuous/focused services: for reporting services by clinicians whose expertise is needed for the ongoing management of a chronic disease or a condition that needs to be managed and followed with no planned endpoint to the relationship; reporting clinician service examples include but are not limited to: a rheumatologist taking care of the patient's rheumatoid arthritis longitudinally but not providing general primary care services,09/11/2025
   X3,Episodic/broad services: for reporting services by clinicians who have broad responsibility for the comprehensive needs of the patient that is limited to a defined period and circumstance such as a hospitalization; reporting clinician service examples include but are not limited to the hospitalist's services rendered providing comprehensive and general care to a patient while admitted to the hospital,09/11/2025
   X4,"Episodic/focused services: for reporting services by clinicians who provide focused care on particular types of treatment limited to a defined period and circumstance; the patient has a problem, acute or chronic, that will be treated with surgery, radiation, or some other type of generally time-limited intervention; reporting clinician service examples include but are not limited to, the orthopedic surgeon performing a knee replacement and seeing the patient through the postoperative period",09/11/2025
   X5,"Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician",09/11/2025
   XE,"Separate encounter, a service that is distinct because it occurred during a separate encounter",09/11/2025
   XP,"Separate practitioner, a service that is distinct because it was performed by a different practitioner",09/11/2025
   XS,"Separate structure, a service that is distinct because it was performed on a separate organ/structure",09/11/2025
   XU,"Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service",09/11/2025
   ZA,Novartis/sandoz,09/11/2025
   ZB,Pfizer/hospira,09/11/2025
   ZC,Merck/samsung bioepis,09/11/2025
A0021,"Ambulance service, outside state per mile, transport (medicaid only)",09/11/2025
A0080,"Non-emergency transportation, per mile - vehicle provided by volunteer (individual or organization), with no vested interest",09/11/2025
A0090,"Non-emergency transportation, per mile - vehicle provided by individual (family member, self, neighbor) with vested interest",09/11/2025
A0100,Non-emergency transportation; taxi,09/11/2025
A0110,"Non-emergency transportation and bus, intra or inter state carrier",09/11/2025
A0120,"Non-emergency transportation: mini-bus, mountain area transports, or other transportation systems",09/11/2025
A0130,Non-emergency transportation: wheelchair van,09/11/2025
A0140,Non-emergency transportation and air travel (private or commercial) intra or inter state,09/11/2025
A0160,Non-emergency transportation: per mile - case worker or social worker,09/11/2025
A0170,"Transportation ancillary: parking fees, tolls, other",09/11/2025
A0180,Non-emergency transportation: ancillary: lodging-recipient,09/11/2025
A0190,Non-emergency transportation: ancillary: meals-recipient,09/11/2025
A0200,Non-emergency transportation: ancillary: lodging escort,09/11/2025
A0210,Non-emergency transportation: ancillary: meals-escort,09/11/2025
A0225,"Ambulance service, neonatal transport, base rate, emergency transport, one way",09/11/2025
A0380,Bls mileage (per mile),09/11/2025
A0382,Bls routine disposable supplies,09/11/2025
A0384,Bls specialized service disposable supplies; defibrillation (used by als ambulances and bls ambulances in jurisdictions where defibrillation is permitted in bls ambulances),09/11/2025
A0390,Als mileage (per mile),09/11/2025
A0392,Als specialized service disposable supplies; defibrillation (to be used only in jurisdictions where defibrillation cannot be performed in bls ambulances),09/11/2025
A0394,Als specialized service disposable supplies; iv drug therapy,09/11/2025
A0396,Als specialized service disposable supplies; esophageal intubation,09/11/2025
A0398,Als routine disposable supplies,09/11/2025
A0420,"Ambulance waiting time (als or bls), one half (1/2) hour increments",09/11/2025
A0422,"Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation",09/11/2025
A0424,"Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review)",09/11/2025
A0425,"Ground mileage, per statute mile",09/11/2025
A0426,"Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)",09/11/2025
A0427,"Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)",09/11/2025
A0428,"Ambulance service, basic life support, non-emergency transport, (bls)",09/11/2025
A0429,"Ambulance service, basic life support, emergency transport (bls-emergency)",09/11/2025
A0430,"Ambulance service, conventional air services, transport, one way (fixed wing)",09/11/2025
A0431,"Ambulance service, conventional air services, transport, one way (rotary wing)",09/11/2025
A0432,"Paramedic intercept (pi), rural area, transport furnished by a volunteer ambulance company which is prohibited by state law from billing third party payers",09/11/2025
A0433,"Advanced life support, level 2 (als 2)",09/11/2025
A0434,Specialty care transport (sct),09/11/2025
A0435,"Fixed wing air mileage, per statute mile",09/11/2025
A0436,"Rotary wing air mileage, per statute mile",09/11/2025
A0888,"Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility)",09/11/2025
A0998,"Ambulance response and treatment, no transport",09/11/2025
A0999,Unlisted ambulance service,09/11/2025
A2001,"Innovamatrix ac, per square centimeter",09/11/2025
A2002,"Mirragen advanced wound matrix, per square centimeter",09/11/2025
A2004,"Xcellistem, 1 mg",09/11/2025
A2005,"Microlyte matrix, per square centimeter",09/11/2025
A2006,"Novosorb synpath dermal matrix, per square centimeter",09/11/2025
A2007,"Restrata, per square centimeter",09/11/2025
A2008,"Theragenesis, per square centimeter",09/11/2025
A2009,"Symphony, per square centimeter",09/11/2025
A2010,"Apis, per square centimeter",09/11/2025
A2011,"Supra sdrm, per square centimeter",09/11/2025
A2012,"Suprathel, per square centimeter",09/11/2025
A2013,"Innovamatrix fs, per square centimeter",09/11/2025
A2014,"Omeza collagen matrix, per 100 mg",09/11/2025
A2015,"Phoenix wound matrix, per square centimeter",09/11/2025
A2016,"Permeaderm b, per square centimeter",09/11/2025
A2017,"Permeaderm glove, each",09/11/2025
A2018,"Permeaderm c, per square centimeter",09/11/2025
A2019,"Kerecis omega3 marigen shield, per square centimeter",09/11/2025
A2020,Ac5 advanced wound system (ac5),09/11/2025
A2021,"Neomatrix, per square centimeter",09/11/2025
A2022,"Innovaburn or innovamatrix xl, per square centimeter",09/11/2025
A2023,"Innovamatrix pd, 1 mg",09/11/2025
A2024,"Resolve matrix or xenopatch, per square centimeter",09/11/2025
A2025,"Miro3d, per cubic centimeter",09/11/2025
A2026,"Restrata minimatrix, 5 mg",09/11/2025
A2027,"Matriderm, per square centimeter",09/11/2025
A2028,"Micromatrix flex, per mg",09/11/2025
A2029,"Mirotract wound matrix sheet, per cubic centimeter",09/11/2025
A2030,"Miro3d fibers, per milligram",09/11/2025
A2031,"Mirodry wound matrix, per square centimeter",09/11/2025
A2032,"Myriad matrix, per square centimeter",09/11/2025
A2033,"Myriad morcells, 4 milligrams",09/11/2025
A2034,"Foundation drs solo, per square centimeter",09/11/2025
A2035,"Corplex p or theracor p or allacor p, per milligram",09/11/2025
A2036,"Cohealyx collagen dermal matrix, per square centimeter",09/11/2025
A2037,"G4derm plus, per milliliter",09/11/2025
A2038,"Marigen pacto, per square centimeter",09/11/2025
A2039,"Innovamatrix fd, per square centimeter",09/11/2025
A4100,"Skin substitute, fda cleared as a device, not otherwise specified",09/11/2025
A4206,"Syringe with needle, sterile, 1 cc or less, each",09/11/2025
A4207,"Syringe with needle, sterile 2 cc, each",09/11/2025
A4208,"Syringe with needle, sterile 3 cc, each",09/11/2025
A4209,"Syringe with needle, sterile 5 cc or greater, each",09/11/2025
A4210,"Needle-free injection device, each",09/11/2025
A4211,Supplies for self-administered injections,09/11/2025
A4212,Non-coring needle or stylet with or without catheter,09/11/2025
A4213,"Syringe, sterile, 20 cc or greater, each",09/11/2025
A4215,"Needle, sterile, any size, each",09/11/2025
A4216,"Sterile water, saline and/or dextrose, diluent/flush, 10 ml",09/11/2025
A4217,"Sterile water/saline, 500 ml",09/11/2025
A4218,"Sterile saline or water, metered dose dispenser, 10 ml",09/11/2025
A4220,Refill kit for implantable infusion pump,09/11/2025
A4221,"Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs  separately)",09/11/2025
A4222,"Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)",09/11/2025
A4223,"Infusion supplies not used with external infusion pump, per cassette or bag (list drugs separately)",09/11/2025
A4224,"Supplies for maintenance of insulin infusion catheter, per week",09/11/2025
A4225,"Supplies for external insulin infusion pump, syringe type cartridge, sterile, each",09/11/2025
A4226,"Supplies for maintenance of insulin infusion pump with dosage rate adjustment using therapeutic continuous glucose sensing, per week",09/11/2025
A4230,"Infusion set for external insulin pump, non needle cannula type",09/11/2025
A4231,"Infusion set for external insulin pump, needle type",09/11/2025
A4232,"Syringe with needle for external insulin pump, sterile, 3 cc",09/11/2025
A4233,"Replacement battery, alkaline (other than j cell), for use with medically necessary home blood glucose monitor owned by patient, each",09/11/2025
A4234,"Replacement battery, alkaline, j cell, for use with medically necessary home blood glucose monitor owned by patient, each",09/11/2025
A4235,"Replacement battery, lithium, for use with medically necessary home blood glucose monitor owned by patient, each",09/11/2025
A4236,"Replacement battery, silver oxide, for use with medically necessary home blood glucose monitor owned by patient, each",09/11/2025
A4238,"Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service",09/11/2025
A4239,"Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service",09/11/2025
A4244,"Alcohol or peroxide, per pint",09/11/2025
A4245,"Alcohol wipes, per box",09/11/2025
A4246,"Betadine or phisohex solution, per pint",09/11/2025
A4247,"Betadine or iodine swabs/wipes, per box",09/11/2025
A4248,"Chlorhexidine containing antiseptic, 1 ml",09/11/2025
A4250,Urine test or reagent strips or tablets (100 tablets or strips),09/11/2025
A4252,"Blood ketone test or reagent strip, each",09/11/2025
A4253,"Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips",09/11/2025
A4255,"Platforms for home blood glucose monitor, 50 per box",09/11/2025
A4256,"Normal, low and high calibrator solution / chips",09/11/2025
A4257,"Replacement lens shield cartridge for use with laser skin piercing device, each",09/11/2025
A4258,"Spring-powered device for lancet, each",09/11/2025
A4259,"Lancets, per box of 100",09/11/2025
A4261,Cervical cap for contraceptive use,09/11/2025
A4262,"Temporary, absorbable lacrimal duct implant, each",09/11/2025
A4263,"Permanent, long term, non-dissolvable lacrimal duct implant, each",09/11/2025
A4264,Permanent implantable contraceptive intratubal occlusion device(s) and delivery system,09/11/2025
A4265,"Paraffin, per pound",09/11/2025
A4266,Diaphragm for contraceptive use,09/11/2025
A4267,"Contraceptive supply, condom, male, each",09/11/2025
A4268,"Contraceptive supply, condom, female, each",09/11/2025
A4269,"Contraceptive supply, spermicide (e.g., foam, gel), each",09/11/2025
A4270,"Disposable endoscope sheath, each",09/11/2025
A4271,"Integrated lancing and blood sample testing cartridges for home blood glucose monitor, per 50 tests",09/11/2025
A4280,"Adhesive skin support attachment for use with external breast prosthesis, each",09/11/2025
A4281,"Tubing for breast pump, replacement",09/11/2025
A4282,"Adapter for breast pump, replacement",09/11/2025
A4283,"Cap for breast pump bottle, replacement",09/11/2025
A4284,"Breast shield and splash protector for use with breast pump, replacement",09/11/2025
A4285,"Polycarbonate bottle for use with breast pump, replacement",09/11/2025
A4286,"Locking ring for breast pump, replacement",09/11/2025
A4287,"Disposable collection and storage bag for breast milk, any size, any type, each",09/11/2025
A4288,"Valve for breast pump, replacement",09/11/2025
A4290,"Sacral nerve stimulation test lead, each",09/11/2025
A4300,"Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access",09/11/2025
A4301,"Implantable access total catheter, port/reservoir (e.g., venous, arterial, epidural, subarachnoid, peritoneal, etc.)",09/11/2025
A4305,"Disposable drug delivery system, flow rate of 50 ml or greater per hour",09/11/2025
A4306,"Disposable drug delivery system, flow rate of less than 50 ml per hour",09/11/2025
A4310,Insertion tray without drainage bag and without catheter (accessories only),09/11/2025
A4311,"Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)",09/11/2025
A4312,"Insertion tray without drainage bag with indwelling catheter, foley type, two-way, all silicone",09/11/2025
A4313,"Insertion tray without drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation",09/11/2025
A4314,"Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)",09/11/2025
A4315,"Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone",09/11/2025
A4316,"Insertion tray with drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation",09/11/2025
A4320,"Irrigation tray with bulb or piston syringe, any purpose",09/11/2025
A4321,Therapeutic agent for urinary catheter irrigation,09/11/2025
A4322,"Irrigation syringe, bulb or piston, each",09/11/2025
A4326,"Male external catheter with integral collection chamber, any type, each",09/11/2025
A4327,"Female external urinary collection device; meatal cup, each",09/11/2025
A4328,"Female external urinary collection device; pouch, each",09/11/2025
A4330,"Perianal fecal collection pouch with adhesive, each",09/11/2025
A4331,"Extension drainage tubing, any type, any length, with connector/adaptor, for use with urinary leg bag or urostomy pouch, each",09/11/2025
A4332,"Lubricant, individual sterile packet, each",09/11/2025
A4333,"Urinary catheter anchoring device, adhesive skin attachment, each",09/11/2025
A4334,"Urinary catheter anchoring device, leg strap, each",09/11/2025
A4335,Incontinence supply; miscellaneous,09/11/2025
A4336,"Incontinence supply, urethral insert, any type, each",09/11/2025
A4337,"Incontinence supply, rectal insert, any type, each",09/11/2025
A4338,"Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each",09/11/2025
A4340,"Indwelling catheter; specialty type, (e.g., coude, mushroom, wing, etc.), each",09/11/2025
A4341,"Indwelling intraurethral drainage device with valve, patient inserted, replacement only, each",09/11/2025
A4342,"Accessories for patient inserted indwelling intraurethral drainage device with valve, replacement only, each",09/11/2025
A4344,"Indwelling catheter, foley type, two-way, all silicone or polyurethane, each",09/11/2025
A4346,"Indwelling catheter; foley type, three way for continuous irrigation, each",09/11/2025
A4349,"Male external catheter, with or without adhesive, disposable, each",09/11/2025
A4351,"Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each",09/11/2025
A4352,"Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each",09/11/2025
A4353,"Intermittent urinary catheter, with insertion supplies",09/11/2025
A4354,Insertion tray with drainage bag but without catheter,09/11/2025
A4355,"Irrigation tubing set for continuous bladder irrigation through a three-way indwelling foley catheter, each",09/11/2025
A4356,"External urethral clamp or compression device (not to be used for catheter clamp), each",09/11/2025
A4357,"Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each",09/11/2025
A4358,"Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each",09/11/2025
A4360,"Disposable external urethral clamp or compression device, with pad and/or pouch, each",09/11/2025
A4361,"Ostomy faceplate, each",09/11/2025
A4362,"Skin barrier; solid, 4 x 4 or equivalent; each",09/11/2025
A4363,"Ostomy clamp, any type, replacement only, each",09/11/2025
A4364,"Adhesive, liquid or equal, any type, per oz",09/11/2025
A4366,"Ostomy vent, any type, each",09/11/2025
A4367,"Ostomy belt, each",09/11/2025
A4368,"Ostomy filter, any type, each",09/11/2025
A4369,"Ostomy skin barrier, liquid (spray, brush, etc.), per oz",09/11/2025
A4371,"Ostomy skin barrier, powder, per oz",09/11/2025
A4372,"Ostomy skin barrier, solid 4 x 4 or equivalent, standard wear, with built-in convexity, each",09/11/2025
A4373,"Ostomy skin barrier, with flange (solid, flexible or accordion), with built-in convexity, any size, each",09/11/2025
A4375,"Ostomy pouch, drainable, with faceplate attached, plastic, each",09/11/2025
A4376,"Ostomy pouch, drainable, with faceplate attached, rubber, each",09/11/2025
A4377,"Ostomy pouch, drainable, for use on faceplate, plastic, each",09/11/2025
A4378,"Ostomy pouch, drainable, for use on faceplate, rubber, each",09/11/2025
A4379,"Ostomy pouch, urinary, with faceplate attached, plastic, each",09/11/2025
A4380,"Ostomy pouch, urinary, with faceplate attached, rubber, each",09/11/2025
A4381,"Ostomy pouch, urinary, for use on faceplate, plastic, each",09/11/2025
A4382,"Ostomy pouch, urinary, for use on faceplate, heavy plastic, each",09/11/2025
A4383,"Ostomy pouch, urinary, for use on faceplate, rubber, each",09/11/2025
A4384,"Ostomy faceplate equivalent, silicone ring, each",09/11/2025
A4385,"Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each",09/11/2025
A4387,"Ostomy pouch, closed, with barrier attached, with built-in convexity (1 piece), each",09/11/2025
A4388,"Ostomy pouch, drainable, with extended wear barrier attached, (1 piece), each",09/11/2025
A4389,"Ostomy pouch, drainable, with barrier attached, with built-in convexity (1 piece), each",09/11/2025
A4390,"Ostomy pouch, drainable, with extended wear barrier attached, with built-in convexity (1 piece), each",09/11/2025
A4391,"Ostomy pouch, urinary, with extended wear barrier attached (1 piece), each",09/11/2025
A4392,"Ostomy pouch, urinary, with standard wear barrier attached, with built-in convexity (1 piece), each",09/11/2025
A4393,"Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity (1 piece), each",09/11/2025
A4394,"Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce",09/11/2025
A4395,"Ostomy deodorant for use in ostomy pouch, solid, per tablet",09/11/2025
A4396,Ostomy belt with peristomal hernia support,09/11/2025
A4397,"Irrigation supply; sleeve, each",09/11/2025
A4398,"Ostomy irrigation supply; bag, each",09/11/2025
A4399,"Ostomy irrigation supply; cone/catheter, with or without brush",09/11/2025
A4400,Ostomy irrigation set,09/11/2025
A4402,"Lubricant, per ounce",09/11/2025
A4404,"Ostomy ring, each",09/11/2025
A4405,"Ostomy skin barrier, non-pectin based, paste, per ounce",09/11/2025
A4406,"Ostomy skin barrier, pectin-based, paste, per ounce",09/11/2025
A4407,"Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each",09/11/2025
A4408,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, with built-in convexity, larger than 4 x 4 inches, each",09/11/2025
A4409,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each",09/11/2025
A4410,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, larger than 4 x 4 inches, each",09/11/2025
A4411,"Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, with built-in convexity, each",09/11/2025
A4412,"Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), without filter, each",09/11/2025
A4413,"Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), with filter, each",09/11/2025
A4414,"Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, 4 x 4 inches or smaller, each",09/11/2025
A4415,"Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, larger than 4 x 4 inches, each",09/11/2025
A4416,"Ostomy pouch, closed, with barrier attached, with filter (1 piece), each",09/11/2025
A4417,"Ostomy pouch, closed, with barrier attached, with built-in convexity, with filter (1 piece), each",09/11/2025
A4418,"Ostomy pouch, closed; without barrier attached, with filter (1 piece), each",09/11/2025
A4419,"Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each",09/11/2025
A4420,"Ostomy pouch, closed; for use on barrier with locking flange (2 piece), each",09/11/2025
A4421,Ostomy supply; miscellaneous,09/11/2025
A4422,"Ostomy absorbent material (sheet/pad/crystal packet) for use in ostomy pouch to thicken liquid stomal output, each",09/11/2025
A4423,"Ostomy pouch, closed; for use on barrier with locking flange, with filter (2 piece), each",09/11/2025
A4424,"Ostomy pouch, drainable, with barrier attached, with filter (1 piece), each",09/11/2025
A4425,"Ostomy pouch, drainable; for use on barrier with non-locking flange, with filter (2 piece system), each",09/11/2025
A4426,"Ostomy pouch, drainable; for use on barrier with locking flange (2 piece system), each",09/11/2025
A4427,"Ostomy pouch, drainable; for use on barrier with locking flange, with filter (2 piece system), each",09/11/2025
A4428,"Ostomy pouch, urinary, with extended wear barrier attached, with faucet-type tap with valve (1 piece), each",09/11/2025
A4429,"Ostomy pouch, urinary, with barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each",09/11/2025
A4430,"Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each",09/11/2025
A4431,"Ostomy pouch, urinary; with barrier attached, with faucet-type tap with valve (1 piece), each",09/11/2025
A4432,"Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each",09/11/2025
A4433,"Ostomy pouch, urinary; for use on barrier with locking flange (2 piece), each",09/11/2025
A4434,"Ostomy pouch, urinary; for use on barrier with locking flange, with faucet-type tap with valve (2 piece), each",09/11/2025
A4435,"Ostomy pouch, drainable, high output, with extended wear barrier (one-piece system), with or without filter, each",09/11/2025
A4436,"Irrigation supply; sleeve, reusable, per month",09/11/2025
A4437,"Irrigation supply; sleeve, disposable, per month",09/11/2025
A4438,"Adhesive clip applied to the skin to secure external electrical nerve stimulator controller, each",09/11/2025
A4450,"Tape, non-waterproof, per 18 square inches",09/11/2025
A4452,"Tape, waterproof, per 18 square inches",09/11/2025
A4453,"Rectal catheter with or without balloon, for use with any type transanal irrigation system, each",09/11/2025
A4455,"Adhesive remover or solvent (for tape, cement or other adhesive), per ounce",09/11/2025
A4456,"Adhesive remover, wipes, any type, each",09/11/2025
A4457,"Enema tube, with or without adapter, any type, replacement only, each",09/11/2025
A4458,"Enema bag with tubing, reusable",09/11/2025
A4459,"Manual transanal irrigation system, includes water reservoir, pump, tubing, and accessories, without catheter, any type",09/11/2025
A4461,"Surgical dressing holder, non-reusable, each",09/11/2025
A4463,"Surgical dressing holder, reusable, each",09/11/2025
A4465,Non-elastic binder for extremity,09/11/2025
A4466,"Garment, belt, sleeve or other covering, elastic or similar stretchable material, any type, each",09/11/2025
A4467,"Belt, strap, sleeve, garment, or covering, any type",09/11/2025
A4468,"Exsufflation belt, includes all supplies and accessories",09/11/2025
A4470,Gravlee jet washer,09/11/2025
A4480,Vabra aspirator,09/11/2025
A4481,"Tracheostoma filter, any type, any size, each",09/11/2025
A4483,"Moisture exchanger, disposable, for use with invasive mechanical ventilation",09/11/2025
A4490,"Surgical stockings above knee length, each",09/11/2025
A4495,"Surgical stockings thigh length, each",09/11/2025
A4500,"Surgical stockings below knee length, each",09/11/2025
A4510,"Surgical stockings full length, each",09/11/2025
A4520,"Incontinence garment, any type, (e.g., brief, diaper), each",09/11/2025
A4540,"Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves of the upper arm",09/11/2025
A4541,Monthly supplies for use of device coded at e0733,09/11/2025
A4542,Supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist,09/11/2025
A4543,"Supplies for transcutaneous electrical nerve stimulator, for nerves in the auricular region, per month",09/11/2025
A4544,Electrode for external lower extremity nerve stimulator for restless legs syndrome,09/11/2025
A4545,"Supplies and accessories for external tibial nerve stimulator (e.g., socks, gel pads, electrodes, etc.), needed for one month",09/11/2025
A4550,Surgical trays,09/11/2025
A4553,"Non-disposable underpads, all sizes",09/11/2025
A4554,"Disposable underpads, all sizes",09/11/2025
A4555,"Electrode/transducer for use with electrical stimulation device used for cancer treatment, replacement only",09/11/2025
A4556,"Electrodes, (e.g., apnea monitor), per pair",09/11/2025
A4557,"Lead wires, (e.g., apnea monitor), per pair",09/11/2025
A4558,"Conductive gel or paste, for use with electrical device (e.g., tens, nmes), per oz",09/11/2025
A4559,"Coupling gel or paste, for use with ultrasound device, per oz",09/11/2025
A4560,"Neuromuscular electrical stimulator (nmes), disposable, replacement only",09/11/2025
A4561,"Pessary, reusable, rubber, any type",09/11/2025
A4562,"Pessary, reusable, non rubber, any type",09/11/2025
A4563,"Rectal control system for vaginal insertion, for long term use, includes pump and all supplies and accessories, any type each",09/11/2025
A4564,"Pessary, disposable, any type",09/11/2025
A4565,Slings,09/11/2025
A4566,"Shoulder sling or vest design, abduction restrainer, with or without swathe control, prefabricated, includes fitting and adjustment",09/11/2025
A4570,Splint,09/11/2025
A4575,"Topical hyperbaric oxygen chamber, disposable",09/11/2025
A4580,"Cast supplies (e.g., plaster)",09/11/2025
A4590,"Special casting material (e.g., fiberglass)",09/11/2025
A4593,"Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, controller",09/11/2025
A4594,"Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each",09/11/2025
A4595,"Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)",09/11/2025
A4596,"Cranial electrotherapy stimulation (ces) system supplies and accessories, per month",09/11/2025
A4600,"Sleeve for intermittent limb compression device, replacement only, each",09/11/2025
A4601,"Lithium ion battery, rechargeable, for non-prosthetic use, replacement",09/11/2025
A4602,"Replacement battery for external infusion pump owned by patient, lithium, 1.5 volt, each",09/11/2025
A4604,Tubing with integrated heating element for use with positive airway pressure device,09/11/2025
A4605,"Tracheal suction catheter, closed system, each",09/11/2025
A4606,"Oxygen probe for use with oximeter device, replacement",09/11/2025
A4608,"Transtracheal oxygen catheter, each",09/11/2025
A4611,"Battery, heavy duty; replacement for patient owned ventilator",09/11/2025
A4612,Battery cables; replacement for patient-owned ventilator,09/11/2025
A4613,Battery charger; replacement for patient-owned ventilator,09/11/2025
A4614,"Peak expiratory flow rate meter, hand held",09/11/2025
A4615,"Cannula, nasal",09/11/2025
A4616,"Tubing (oxygen), per foot",09/11/2025
A4617,Mouth piece,09/11/2025
A4618,Breathing circuits,09/11/2025
A4619,Face tent,09/11/2025
A4620,Variable concentration mask,09/11/2025
A4623,"Tracheostomy, inner cannula",09/11/2025
A4624,"Tracheal suction catheter, any type other than closed system, each",09/11/2025
A4625,Tracheostomy care kit for new tracheostomy,09/11/2025
A4626,"Tracheostomy cleaning brush, each",09/11/2025
A4627,"Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler",09/11/2025
A4628,"Oral and/or oropharyngeal suction catheter, each",09/11/2025
A4629,Tracheostomy care kit for established tracheostomy,09/11/2025
A4630,"Replacement batteries, medically necessary, transcutaneous electrical stimulator, owned by patient",09/11/2025
A4633,"Replacement bulb/lamp for ultraviolet light therapy system, each",09/11/2025
A4634,"Replacement bulb for therapeutic light box, tabletop model",09/11/2025
A4635,"Underarm pad, crutch, replacement, each",09/11/2025
A4636,"Replacement, handgrip, cane, crutch, or walker, each",09/11/2025
A4637,"Replacement, tip, cane, crutch, walker, each.",09/11/2025
A4638,"Replacement battery for patient-owned ear pulse generator, each",09/11/2025
A4639,"Replacement pad for infrared heating pad system, each",09/11/2025
A4640,Replacement pad for use with medically necessary alternating pressure pad owned by patient,09/11/2025
A4641,"Radiopharmaceutical, diagnostic, not otherwise classified",09/11/2025
A4642,"Indium in-111 satumomab pendetide, diagnostic, per study dose, up to 6 millicuries",09/11/2025
A4648,"Tissue marker, implantable, any type, each",09/11/2025
A4649,Surgical supply; miscellaneous,09/11/2025
A4650,"Implantable radiation dosimeter, each",09/11/2025
A4651,"Calibrated microcapillary tube, each",09/11/2025
A4652,Microcapillary tube sealant,09/11/2025
A4653,"Peritoneal dialysis catheter anchoring device, belt, each",09/11/2025
A4657,"Syringe, with or without needle, each",09/11/2025
A4660,Sphygmomanometer/blood pressure apparatus with cuff and stethoscope,09/11/2025
A4663,Blood pressure cuff only,09/11/2025
A4670,Automatic blood pressure monitor,09/11/2025
A4671,"Disposable cycler set used with cycler dialysis machine, each",09/11/2025
A4672,"Drainage extension line, sterile, for dialysis, each",09/11/2025
A4673,"Extension line with easy lock connectors, used with dialysis",09/11/2025
A4674,"Chemicals/antiseptics solution used to clean/sterilize dialysis equipment, per 8 oz",09/11/2025
A4680,"Activated carbon filter for hemodialysis, each",09/11/2025
A4690,"Dialyzer (artificial kidneys), all types, all sizes, for hemodialysis, each",09/11/2025
A4706,"Bicarbonate concentrate, solution, for hemodialysis, per gallon",09/11/2025
A4707,"Bicarbonate concentrate, powder, for hemodialysis, per packet",09/11/2025
A4708,"Acetate concentrate solution, for hemodialysis, per gallon",09/11/2025
A4709,"Acid concentrate, solution, for hemodialysis, per gallon",09/11/2025
A4714,"Treated water (deionized, distilled, or reverse osmosis) for peritoneal dialysis, per gallon",09/11/2025
A4719,"""y set"" tubing for peritoneal dialysis",09/11/2025
A4720,"Dialysate solution, any concentration of dextrose, fluid volume greater than 249 cc, but less than or equal to 999 cc, for peritoneal dialysis",09/11/2025
A4721,"Dialysate solution, any concentration of dextrose, fluid volume greater than 999 cc but less than or equal to 1999 cc, for peritoneal dialysis",09/11/2025
A4722,"Dialysate solution, any concentration of dextrose, fluid volume greater than 1999 cc but less than or equal to 2999 cc, for peritoneal dialysis",09/11/2025
A4723,"Dialysate solution, any concentration of dextrose, fluid volume greater than 2999 cc but less than or equal to 3999 cc, for peritoneal dialysis",09/11/2025
A4724,"Dialysate solution, any concentration of dextrose, fluid volume greater than 3999 cc but less than or equal to 4999 cc, for peritoneal dialysis",09/11/2025
A4725,"Dialysate solution, any concentration of dextrose, fluid volume greater than 4999 cc but less than or equal to 5999 cc, for peritoneal dialysis",09/11/2025
A4726,"Dialysate solution, any concentration of dextrose, fluid volume greater than 5999 cc, for peritoneal dialysis",09/11/2025
A4728,"Dialysate solution, non-dextrose containing, 500 ml",09/11/2025
A4730,"Fistula cannulation set for hemodialysis, each",09/11/2025
A4736,"Topical anesthetic, for dialysis, per gram",09/11/2025
A4737,"Injectable anesthetic, for dialysis, per 10 ml",09/11/2025
A4740,"Shunt accessory, for hemodialysis, any type, each",09/11/2025
A4750,"Blood tubing, arterial or venous, for hemodialysis, each",09/11/2025
A4755,"Blood tubing, arterial and venous combined, for hemodialysis, each",09/11/2025
A4760,"Dialysate solution test kit, for peritoneal dialysis, any type, each",09/11/2025
A4765,"Dialysate concentrate, powder, additive for peritoneal dialysis, per packet",09/11/2025
A4766,"Dialysate concentrate, solution, additive for peritoneal dialysis, per 10 ml",09/11/2025
A4770,"Blood collection tube, vacuum, for dialysis, per 50",09/11/2025
A4771,"Serum clotting time tube, for dialysis, per 50",09/11/2025
A4772,"Blood glucose test strips, for dialysis, per 50",09/11/2025
A4773,"Occult blood test strips, for dialysis, per 50",09/11/2025
A4774,"Ammonia test strips, for dialysis, per 50",09/11/2025
A4802,"Protamine sulfate, for hemodialysis, per 50 mg",09/11/2025
A4860,"Disposable catheter tips for peritoneal dialysis, per 10",09/11/2025
A4870,Plumbing and/or electrical work for home hemodialysis equipment,09/11/2025
A4890,"Contracts, repair and maintenance, for hemodialysis equipment",09/11/2025
A4911,"Drain bag/bottle, for dialysis, each",09/11/2025
A4913,"Miscellaneous dialysis supplies, not otherwise specified",09/11/2025
A4918,"Venous pressure clamp, for hemodialysis, each",09/11/2025
A4927,"Gloves, non-sterile, per 100",09/11/2025
A4928,"Surgical mask, per 20",09/11/2025
A4929,"Tourniquet for dialysis, each",09/11/2025
A4930,"Gloves, sterile, per pair",09/11/2025
A4931,"Oral thermometer, reusable, any type, each",09/11/2025
A4932,"Rectal thermometer, reusable, any type, each",09/11/2025
A5051,"Ostomy pouch, closed; with barrier attached (1 piece), each",09/11/2025
A5052,"Ostomy pouch, closed; without barrier attached (1 piece), each",09/11/2025
A5053,"Ostomy pouch, closed; for use on faceplate, each",09/11/2025
A5054,"Ostomy pouch, closed; for use on barrier with flange (2 piece), each",09/11/2025
A5055,Stoma cap,09/11/2025
A5056,"Ostomy pouch, drainable, with extended wear barrier attached, with filter, (1 piece), each",09/11/2025
A5057,"Ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), each",09/11/2025
A5061,"Ostomy pouch, drainable; with barrier attached, (1 piece), each",09/11/2025
A5062,"Ostomy pouch, drainable; without barrier attached (1 piece), each",09/11/2025
A5063,"Ostomy pouch, drainable; for use on barrier with flange (2 piece system), each",09/11/2025
A5071,"Ostomy pouch, urinary; with barrier attached (1 piece), each",09/11/2025
A5072,"Ostomy pouch, urinary; without barrier attached (1 piece), each",09/11/2025
A5073,"Ostomy pouch, urinary; for use on barrier with flange (2 piece), each",09/11/2025
A5081,"Stoma plug or seal, any type",09/11/2025
A5082,Continent device; catheter for continent stoma,09/11/2025
A5083,"Continent device, stoma absorptive cover for continent stoma",09/11/2025
A5093,Ostomy accessory; convex insert,09/11/2025
A5102,"Bedside drainage bottle with or without tubing, rigid or expandable, each",09/11/2025
A5105,"Urinary suspensory with leg bag, with or without tube, each",09/11/2025
A5112,"Urinary drainage bag, leg or abdomen, latex, with or without tube, with straps, each",09/11/2025
A5113,"Leg strap; latex, replacement only, per set",09/11/2025
A5114,"Leg strap; foam or fabric, replacement only, per set",09/11/2025
A5120,"Skin barrier, wipes or swabs, each",09/11/2025
A5121,"Skin barrier; solid, 6 x 6 or equivalent, each",09/11/2025
A5122,"Skin barrier; solid, 8 x 8 or equivalent, each",09/11/2025
A5126,Adhesive or non-adhesive; disk or foam pad,09/11/2025
A5131,"Appliance cleaner, incontinence and ostomy appliances, per 16 oz.",09/11/2025
A5200,"Percutaneous catheter/tube anchoring device, adhesive skin attachment",09/11/2025
A5500,"For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe",09/11/2025
A5501,"For diabetics only, fitting (including follow-up), custom preparation and supply of shoe molded from cast(s) of patient's foot (custom molded shoe), per shoe",09/11/2025
A5503,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with roller or rigid rocker bottom, per shoe",09/11/2025
A5504,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with wedge(s), per shoe",09/11/2025
A5505,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with metatarsal bar, per shoe",09/11/2025
A5506,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with off-set heel(s), per shoe",09/11/2025
A5507,"For diabetics only, not otherwise specified modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe",09/11/2025
A5508,"For diabetics only, deluxe feature of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe",09/11/2025
A5510,"For diabetics only, direct formed, compression molded to patient's foot without external heat source, multiple-density insert(s) prefabricated, per shoe",09/11/2025
A5512,"For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each",09/11/2025
A5513,"For diabetics only, multiple density insert, custom molded from model of patient's foot, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each",09/11/2025
A5514,"For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each",09/11/2025
A6000,Non-contact wound warming wound cover for use with the non-contact wound warming device and warming card,09/11/2025
A6010,"Collagen based wound filler, dry form, sterile, per gram of collagen",09/11/2025
A6011,"Collagen based wound filler, gel/paste, per gram of collagen",09/11/2025
A6021,"Collagen dressing, sterile, size 16 sq. in. or less, each",09/11/2025
A6022,"Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each",09/11/2025
A6023,"Collagen dressing, sterile, size more than 48 sq. in., each",09/11/2025
A6024,"Collagen dressing wound filler, sterile, per 6 inches",09/11/2025
A6025,"Gel sheet for dermal or epidermal application, (e.g., silicone, hydrogel, other), each",09/11/2025
A6154,"Wound pouch, each",09/11/2025
A6196,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing",09/11/2025
A6197,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing",09/11/2025
A6198,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 48 sq. in., each dressing",09/11/2025
A6199,"Alginate or other fiber gelling dressing, wound filler, sterile, per 6 inches",09/11/2025
A6203,"Composite dressing, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",09/11/2025
A6204,"Composite dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6205,"Composite dressing, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6206,"Contact layer, sterile, 16 sq. in. or less, each dressing",09/11/2025
A6207,"Contact layer, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing",09/11/2025
A6208,"Contact layer, sterile, more than 48 sq. in., each dressing",09/11/2025
A6209,"Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",09/11/2025
A6210,"Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",09/11/2025
A6211,"Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",09/11/2025
A6212,"Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",09/11/2025
A6213,"Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6214,"Foam dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6215,"Foam dressing, wound filler, sterile, per gram",09/11/2025
A6216,"Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",09/11/2025
A6217,"Gauze, non-impregnated, non-sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",09/11/2025
A6218,"Gauze, non-impregnated, non-sterile, pad size more than 48 sq. in., without adhesive border, each dressing",09/11/2025
A6219,"Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",09/11/2025
A6220,"Gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6221,"Gauze, non-impregnated, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6222,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",09/11/2025
A6223,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing",09/11/2025
A6224,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",09/11/2025
A6228,"Gauze, impregnated, water or normal saline, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",09/11/2025
A6229,"Gauze, impregnated, water or normal saline, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",09/11/2025
A6230,"Gauze, impregnated, water or normal saline, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",09/11/2025
A6231,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size 16 sq. in. or less, each dressing",09/11/2025
A6232,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size greater than 16 sq. in., but less than or equal to 48 sq. in., each dressing",09/11/2025
A6233,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size more than 48 sq. in., each dressing",09/11/2025
A6234,"Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",09/11/2025
A6235,"Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",09/11/2025
A6236,"Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",09/11/2025
A6237,"Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",09/11/2025
A6238,"Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6239,"Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6240,"Hydrocolloid dressing, wound filler, paste, sterile, per ounce",09/11/2025
A6241,"Hydrocolloid dressing, wound filler, dry form, sterile, per gram",09/11/2025
A6242,"Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",09/11/2025
A6243,"Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",09/11/2025
A6244,"Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",09/11/2025
A6245,"Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",09/11/2025
A6246,"Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6247,"Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6248,"Hydrogel dressing, wound filler, gel, per fluid ounce",09/11/2025
A6250,"Skin sealants, protectants, moisturizers, ointments, any type, any size",09/11/2025
A6251,"Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",09/11/2025
A6252,"Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",09/11/2025
A6253,"Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",09/11/2025
A6254,"Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",09/11/2025
A6255,"Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6256,"Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",09/11/2025
A6257,"Transparent film, sterile, 16 sq. in. or less, each dressing",09/11/2025
A6258,"Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing",09/11/2025
A6259,"Transparent film, sterile, more than 48 sq. in., each dressing",09/11/2025
A6260,"Wound cleansers, any type, any size",09/11/2025
A6261,"Wound filler, gel/paste, per fluid ounce, not otherwise specified",09/11/2025
A6262,"Wound filler, dry form, per gram, not otherwise specified",09/11/2025
A6266,"Gauze, impregnated, other than water, normal saline, or zinc paste, sterile, any width, per linear yard",09/11/2025
A6402,"Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",09/11/2025
A6403,"Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing",09/11/2025
A6404,"Gauze, non-impregnated, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",09/11/2025
A6407,"Packing strips, non-impregnated, sterile, up to 2 inches in width, per linear yard",09/11/2025
A6410,"Eye pad, sterile, each",09/11/2025
A6411,"Eye pad, non-sterile, each",09/11/2025
A6412,"Eye patch, occlusive, each",09/11/2025
A6413,"Adhesive bandage, first-aid type, any size, each",09/11/2025
A6441,"Padding bandage, non-elastic, non-woven/non-knitted, width greater than or equal to three inches and less than five inches, per yard",09/11/2025
A6442,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width less than three inches, per yard",09/11/2025
A6443,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to three inches and less than five inches, per yard",09/11/2025
A6444,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to 5 inches, per yard",09/11/2025
A6445,"Conforming bandage, non-elastic, knitted/woven, sterile, width less than three inches, per yard",09/11/2025
A6446,"Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard",09/11/2025
A6447,"Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to five inches, per yard",09/11/2025
A6448,"Light compression bandage, elastic, knitted/woven, width less than three inches, per yard",09/11/2025
A6449,"Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard",09/11/2025
A6450,"Light compression bandage, elastic, knitted/woven, width greater than or equal to five inches, per yard",09/11/2025
A6451,"Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard",09/11/2025
A6452,"High compression bandage, elastic, knitted/woven, load resistance greater than or equal to 1.35 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard",09/11/2025
A6453,"Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard",09/11/2025
A6454,"Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard",09/11/2025
A6455,"Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to five inches, per yard",09/11/2025
A6456,"Zinc paste impregnated bandage, non-elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard",09/11/2025
A6457,"Tubular dressing with or without elastic, any width, per linear yard",09/11/2025
A6460,"Synthetic resorbable wound dressing, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",09/11/2025
A6461,"Synthetic resorbable wound dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",09/11/2025
A6501,"Compression burn garment, bodysuit (head to foot), custom fabricated",09/11/2025
A6502,"Compression burn garment, chin strap, custom fabricated",09/11/2025
A6503,"Compression burn garment, facial hood, custom fabricated",09/11/2025
A6504,"Compression burn garment, glove to wrist, custom fabricated",09/11/2025
A6505,"Compression burn garment, glove to elbow, custom fabricated",09/11/2025
A6506,"Compression burn garment, glove to axilla, custom fabricated",09/11/2025
A6507,"Compression burn garment, foot to knee length, custom fabricated",09/11/2025
A6508,"Compression burn garment, foot to thigh length, custom fabricated",09/11/2025
A6509,"Compression burn garment, upper trunk to waist including arm openings (vest), custom fabricated",09/11/2025
A6510,"Compression burn garment, trunk, including arms down to leg openings (leotard), custom fabricated",09/11/2025
A6511,"Compression burn garment, lower trunk including leg openings (panty), custom fabricated",09/11/2025
A6512,"Compression burn garment, not otherwise classified",09/11/2025
A6513,"Compression burn mask, face and/or neck, plastic or equal, custom fabricated",09/11/2025
A6515,"Gradient compression wrap with adjustable straps, full leg, each, custom",09/11/2025
A6516,"Gradient compression wrap with adjustable straps, foot, each, custom",09/11/2025
A6517,"Gradient compression wrap with adjustable straps, below knee, each, custom",09/11/2025
A6518,"Gradient compression wrap with adjustable straps, arm, each, custom",09/11/2025
A6519,"Gradient compression garment, not otherwise specified, for nighttime use, each",09/11/2025
A6520,"Gradient compression garment, glove, padded, for nighttime use, each",09/11/2025
A6521,"Gradient compression garment, glove, padded, for nighttime use, custom, each",09/11/2025
A6522,"Gradient compression garment, arm, padded, for nighttime use, each",09/11/2025
A6523,"Gradient compression garment, arm, padded, for nighttime use, custom, each",09/11/2025
A6524,"Gradient compression garment, lower leg and foot, padded, for nighttime use, each",09/11/2025
A6525,"Gradient compression garment, lower leg and foot, padded, for nighttime use, custom, each",09/11/2025
A6526,"Gradient compression garment, full leg and foot, padded, for nighttime use, each",09/11/2025
A6527,"Gradient compression garment, full leg and foot, padded, for nighttime use, custom, each",09/11/2025
A6528,"Gradient compression garment, bra, for nighttime use, each",09/11/2025
A6529,"Gradient compression garment, bra, for nighttime use, custom, each",09/11/2025
A6530,"Gradient compression stocking, below knee, 18-30 mmhg, each",09/11/2025
A6531,"Gradient compression stocking, below knee, 30-40 mmhg, used as a surgical dressing, each",09/11/2025
A6532,"Gradient compression stocking, below knee, 40-50 mmhg, used as a surgical dressing, each",09/11/2025
A6533,"Gradient compression stocking, thigh length, 18-30 mmhg, each",09/11/2025
A6534,"Gradient compression stocking, thigh length, 30-40 mmhg, each",09/11/2025
A6535,"Gradient compression stocking, thigh length, 40 mmhg or greater, each",09/11/2025
A6536,"Gradient compression stocking, full length/chap style, 18-30 mmhg, each",09/11/2025
A6537,"Gradient compression stocking, full length/chap style, 30-40 mmhg, each",09/11/2025
A6538,"Gradient compression stocking, full length/chap style, 40 mmhg or greater, each",09/11/2025
A6539,"Gradient compression stocking, waist length, 18-30 mmhg, each",09/11/2025
A6540,"Gradient compression stocking, waist length, 30-40 mmhg, each",09/11/2025
A6541,"Gradient compression stocking, waist length, 40 mmhg or greater, each",09/11/2025
A6544,"Gradient compression stocking, garter belt",09/11/2025
A6545,"Gradient compression wrap, non-elastic, below knee, 30-50 mmhg, used as a surgical dressing, each",09/11/2025
A6549,"Gradient compression garment, not otherwise specified, for daytime use, each",09/11/2025
A6550,"Wound care set, for negative pressure wound therapy electrical pump, includes all supplies and accessories",09/11/2025
A6552,"Gradient compression stocking, below knee, 30-40 mmhg, each",09/11/2025
A6553,"Gradient compression stocking, below knee, 30-40 mmhg, custom, each",09/11/2025
A6554,"Gradient compression stocking, below knee, 40 mmhg or greater, each",09/11/2025
A6555,"Gradient compression stocking, below knee, 40 mmhg or greater, custom, each",09/11/2025
A6556,"Gradient compression stocking, thigh length, 18-30 mmhg, custom, each",09/11/2025
A6557,"Gradient compression stocking, thigh length, 30-40 mmhg, custom, each",09/11/2025
A6558,"Gradient compression stocking, thigh length, 40 mmhg or greater, custom, each",09/11/2025
A6559,"Gradient compression stocking, full length/chap style, 18-30 mmhg, custom, each",09/11/2025
A6560,"Gradient compression stocking, full length/chap style, 30-40 mmhg, custom, each",09/11/2025
A6561,"Gradient compression stocking, full length/chap style, 40 mmhg or greater, custom, each",09/11/2025
A6562,"Gradient compression stocking, waist length, 18-30 mmhg, custom, each",09/11/2025
A6563,"Gradient compression stocking, waist length, 30-40 mmhg, custom, each",09/11/2025
A6564,"Gradient compression stocking, waist length, 40 mmhg or greater, custom, each",09/11/2025
A6565,"Gradient compression gauntlet, custom, each",09/11/2025
A6566,"Gradient compression garment, neck/head, each",09/11/2025
A6567,"Gradient compression garment, neck/head, custom, each",09/11/2025
A6568,"Gradient compression garment, torso and shoulder, each",09/11/2025
A6569,"Gradient compression garment, torso/shoulder, custom, each",09/11/2025
A6570,"Gradient compression garment, genital region, each",09/11/2025
A6571,"Gradient compression garment, genital region, custom, each",09/11/2025
A6572,"Gradient compression garment, toe caps, each",09/11/2025
A6573,"Gradient compression garment, toe caps, custom, each",09/11/2025
A6574,"Gradient compression arm sleeve and glove combination, custom, each",09/11/2025
A6575,"Gradient  compression arm sleeve and glove combination, each",09/11/2025
A6576,"Gradient  compression arm sleeve, custom, medium weight, each",09/11/2025
A6577,"Gradient  compression arm sleeve, custom, heavy weight, each",09/11/2025
A6578,"Gradient  compression arm sleeve, each",09/11/2025
A6579,"Gradient compression glove, custom, medium weight, each",09/11/2025
A6580,"Gradient  compression glove, custom, heavy weight, each",09/11/2025
A6581,"Gradient compression glove, each",09/11/2025
A6582,"Gradient compression gauntlet, each",09/11/2025
A6583,"Gradient compression wrap with adjustable straps, below knee, each",09/11/2025
A6584,"Gradient compression wrap with adjustable straps, not otherwise specified",09/11/2025
A6585,"Gradient compression wrap with adjustable straps, above knee, each",09/11/2025
A6586,"Gradient compression wrap with adjustable straps, full leg, each",09/11/2025
A6587,"Gradient compression wrap with adjustable straps, foot, each",09/11/2025
A6588,"Gradient compression wrap with adjustable straps, arm, each",09/11/2025
A6589,"Gradient pressure wrap with adjustable straps, bra, each",09/11/2025
A6590,"External urinary catheters; disposable, with wicking material, for use with suction pump, per month",09/11/2025
A6591,"External urinary catheter; non-disposable, for use with suction pump, per month",09/11/2025
A6593,"Accessory for gradient compression garment or wrap with adjustable straps, not-otherwise specified",09/11/2025
A6594,"Gradient compression bandaging supply, bandage liner, lower extremity, any size or length, each",09/11/2025
A6595,"Gradient compression bandaging supply, bandage liner, upper extremity, any size or length, each",09/11/2025
A6596,"Gradient compression bandaging supply, conforming gauze, per linear yard, any width, each",09/11/2025
A6597,"Gradient compression bandage roll, elastic long stretch, linear yard, any width, each",09/11/2025
A6598,"Gradient compression bandage roll, elastic medium stretch, per linear yard, any width, each",09/11/2025
A6599,"Gradient compression bandage roll, inelastic short stretch, per linear yard, any width, each",09/11/2025
A6600,"Gradient compression bandaging supply, high density foam sheet, per 250 square centimeters, each",09/11/2025
A6601,"Gradient compression bandaging supply, high density foam pad, any size or shape, each",09/11/2025
A6602,"Gradient compression bandaging supply, high density foam roll for bandage, per linear yard, any width, each",09/11/2025
A6603,"Gradient compression bandaging supply, low density channel foam sheet, per 250 square centimeters, each",09/11/2025
A6604,"Gradient compression bandaging supply, low density flat foam sheet, per 250 square centimeters, each",09/11/2025
A6605,"Gradient compression bandaging supply, padded foam, per linear yard, any width, each",09/11/2025
A6606,"Gradient compression bandaging supply, padded textile, per linear yard, any width, each",09/11/2025
A6607,"Gradient compression bandaging supply, tubular protective absorption layer, per linear yard, any width, each",09/11/2025
A6608,"Gradient compression bandaging supply, tubular protective absorption padded layer, per linear yard, any width, each",09/11/2025
A6609,"Gradient compression bandaging supply, not otherwise specified",09/11/2025
A6610,"Gradient compression stocking, below knee, 18-30 mmhg, custom, each",09/11/2025
A6611,"Gradient compression wrap with adjustable straps, above knee, each, custom",09/11/2025
A7000,"Canister, disposable, used with suction pump, each",09/11/2025
A7001,"Canister, non-disposable, used with suction pump, each",09/11/2025
A7002,"Tubing, used with suction pump, each",09/11/2025
A7003,"Administration set, with small volume nonfiltered pneumatic nebulizer, disposable",09/11/2025
A7004,"Small volume nonfiltered pneumatic nebulizer, disposable",09/11/2025
A7005,"Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable",09/11/2025
A7006,"Administration set, with small volume filtered pneumatic nebulizer",09/11/2025
A7007,"Large volume nebulizer, disposable, unfilled, used with aerosol compressor",09/11/2025
A7008,"Large volume nebulizer, disposable, prefilled, used with aerosol compressor",09/11/2025
A7009,"Reservoir bottle, non-disposable, used with large volume ultrasonic nebulizer",09/11/2025
A7010,"Corrugated tubing, disposable, used with large volume nebulizer, 100 feet",09/11/2025
A7011,"Corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet",09/11/2025
A7012,"Water collection device, used with large volume nebulizer",09/11/2025
A7013,"Filter, disposable, used with aerosol compressor or ultrasonic generator",09/11/2025
A7014,"Filter, nondisposable, used with aerosol compressor or ultrasonic generator",09/11/2025
A7015,"Aerosol mask, used with dme nebulizer",09/11/2025
A7016,"Dome and mouthpiece, used with small volume ultrasonic nebulizer",09/11/2025
A7017,"Nebulizer, durable, glass or autoclavable plastic, bottle type, not used with oxygen",09/11/2025
A7018,"Water, distilled, used with large volume nebulizer, 1000 ml",09/11/2025
A7020,"Interface for cough stimulating device, includes all components, replacement only",09/11/2025
A7021,"Supplies and accessories for lung expansion airway clearance, continuous high frequency oscillation, and nebulization device (e.g., handset, nebulizer kit, biofilter)",09/11/2025
A7023,"Mechanical allergen particle barrier/inhalation filter, cream, nasal, topical",09/11/2025
A7025,"High frequency chest wall oscillation system vest, replacement for use with patient owned equipment, each",09/11/2025
A7026,"High frequency chest wall oscillation system hose, replacement for use with patient owned equipment, each",09/11/2025
A7027,"Combination oral/nasal mask, used with continuous positive airway pressure device, each",09/11/2025
A7028,"Oral cushion for combination oral/nasal mask, replacement only, each",09/11/2025
A7029,"Nasal pillows for combination oral/nasal mask, replacement only, pair",09/11/2025
A7030,"Full face mask used with positive airway pressure device, each",09/11/2025
A7031,"Face mask interface, replacement for full face mask, each",09/11/2025
A7032,"Cushion for use on nasal mask interface, replacement only, each",09/11/2025
A7033,"Pillow for use on nasal cannula type interface, replacement only, pair",09/11/2025
A7034,"Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap",09/11/2025
A7035,Headgear used with positive airway pressure device,09/11/2025
A7036,Chinstrap used with positive airway pressure device,09/11/2025
A7037,Tubing used with positive airway pressure device,09/11/2025
A7038,"Filter, disposable, used with positive airway pressure device",09/11/2025
A7039,"Filter, non disposable, used with positive airway pressure device",09/11/2025
A7040,One way chest drain valve,09/11/2025
A7041,Water seal drainage container and tubing for use with implanted chest tube,09/11/2025
A7042,"Implanted pleural catheter, each",09/11/2025
A7043,Vacuum drainage bottle and tubing for use with implanted catheter,09/11/2025
A7044,"Oral interface used with positive airway pressure device, each",09/11/2025
A7045,"Exhalation port with or without swivel used with accessories for positive airway devices, replacement only",09/11/2025
A7046,"Water chamber for humidifier, used with positive airway pressure device, replacement, each",09/11/2025
A7047,"Oral interface used with respiratory suction pump, each",09/11/2025
A7048,"Vacuum drainage collection unit and tubing kit, including all supplies needed for collection unit change, for use with implanted catheter, each",09/11/2025
A7049,Expiratory positive airway pressure intranasal resistance valve,09/11/2025
A7501,"Tracheostoma valve, including diaphragm, each",09/11/2025
A7502,"Replacement diaphragm/faceplate for tracheostoma valve, each",09/11/2025
A7503,"Filter holder or filter cap, reusable, for use in a tracheostoma heat and moisture exchange system, each",09/11/2025
A7504,"Filter for use in a tracheostoma heat and moisture exchange system, each",09/11/2025
A7505,"Housing, reusable without adhesive, for use in a heat and moisture exchange system and/or with a tracheostoma valve, each",09/11/2025
A7506,"Adhesive disc for use in a heat and moisture exchange system and/or with tracheostoma valve, any type each",09/11/2025
A7507,"Filter holder and integrated filter without adhesive, for use in a tracheostoma heat and moisture exchange system, each",09/11/2025
A7508,"Housing and integrated adhesive, for use in a tracheostoma heat and moisture exchange system and/or with a tracheostoma valve, each",09/11/2025
A7509,"Filter holder and integrated filter housing, and adhesive, for use as a tracheostoma heat and moisture exchange system, each",09/11/2025
A7520,"Tracheostomy/laryngectomy tube, non-cuffed, polyvinylchloride (pvc), silicone or equal, each",09/11/2025
A7521,"Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each",09/11/2025
A7522,"Tracheostomy/laryngectomy tube, stainless steel or equal (sterilizable and reusable), each",09/11/2025
A7523,"Tracheostomy shower protector, each",09/11/2025
A7524,"Tracheostoma stent/stud/button, each",09/11/2025
A7525,"Tracheostomy mask, each",09/11/2025
A7526,"Tracheostomy tube collar/holder, each",09/11/2025
A7527,"Tracheostomy/laryngectomy tube plug/stop, each",09/11/2025
A8000,"Helmet, protective, soft, prefabricated, includes all components and accessories",09/11/2025
A8001,"Helmet, protective, hard, prefabricated, includes all components and accessories",09/11/2025
A8002,"Helmet, protective, soft, custom fabricated, includes all components and accessories",09/11/2025
A8003,"Helmet, protective, hard, custom fabricated, includes all components and accessories",09/11/2025
A8004,"Soft interface for helmet, replacement only",09/11/2025
A9150,Non-prescription drugs,09/11/2025
A9152,"Single vitamin/mineral/trace element, oral, per dose, not otherwise specified",09/11/2025
A9153,"Multiple vitamins, with or without minerals and trace elements, oral, per dose, not otherwise specified",09/11/2025
A9154,"Artificial saliva, 1 ml",09/11/2025
A9155,"Artificial saliva, 30 ml",09/11/2025
A9156,"Oral mucoadhesive, any type (liquid, gel, paste, etc.), per 1 ml",09/11/2025
A9180,"Pediculosis (lice infestation) treatment, topical, for administration by patient/caretaker",09/11/2025
A9268,"Programmer for transient, orally ingested capsule",09/11/2025
A9269,"Programable, transient, orally ingested capsule, for use with external programmer, per month",09/11/2025
A9270,Non-covered item or service,09/11/2025
A9272,"Wound suction, disposable, includes dressing, all accessories and components, any type, each",09/11/2025
A9273,"Cold or hot fluid bottle, ice cap or collar, heat and/or cold wrap, any type",09/11/2025
A9274,"External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories",09/11/2025
A9275,"Home glucose disposable monitor, includes test strips",09/11/2025
A9276,"Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply",09/11/2025
A9277,"Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system",09/11/2025
A9278,"Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system",09/11/2025
A9279,"Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified",09/11/2025
A9280,"Alert or alarm device, not otherwise classified",09/11/2025
A9281,"Reaching/grabbing device, any type, any length, each",09/11/2025
A9282,"Wig, any type, each",09/11/2025
A9283,"Foot pressure off loading/supportive device, any type, each",09/11/2025
A9284,"Spirometer, non-electronic, includes all accessories",09/11/2025
A9285,Inversion/eversion correction device,09/11/2025
A9286,"Hygienic item or device, disposable or non-disposable, any type, each",09/11/2025
A9291,"Prescription digital cognitive and/or behavioral therapy, fda cleared, per course of treatment",09/11/2025
A9292,"Prescription digital visual therapy, software-only, fda cleared, per course of treatment",09/11/2025
A9293,"Fertility cycle (contraception & conception) tracking software application, fda cleared, per month, includes accessories (e.g., thermometer)",09/11/2025
A9300,Exercise equipment,09/11/2025
A9500,"Technetium tc-99m sestamibi, diagnostic, per study dose",09/11/2025
A9501,"Technetium tc-99m teboroxime, diagnostic, per study dose",09/11/2025
A9502,"Technetium tc-99m tetrofosmin, diagnostic, per study dose",09/11/2025
A9503,"Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries",09/11/2025
A9504,"Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries",09/11/2025
A9505,"Thallium tl-201 thallous chloride, diagnostic, per millicurie",09/11/2025
A9506,"Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible",09/11/2025
A9507,"Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries",09/11/2025
A9508,"Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie",09/11/2025
A9509,"Iodine i-123 sodium iodide, diagnostic, per millicurie",09/11/2025
A9510,"Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries",09/11/2025
A9512,"Technetium tc-99m pertechnetate, diagnostic, per millicurie",09/11/2025
A9513,"Lutetium lu 177, dotatate, therapeutic, 1 millicurie",09/11/2025
A9515,"Choline c-11, diagnostic, per study dose up to 20 millicuries",09/11/2025
A9516,"Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries",09/11/2025
A9517,"Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie",09/11/2025
A9520,"Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries",09/11/2025
A9521,"Technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries",09/11/2025
A9524,"Iodine i-131 iodinated serum albumin, diagnostic, per 5 microcuries",09/11/2025
A9526,"Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries",09/11/2025
A9527,"Iodine i-125, sodium iodide solution, therapeutic, per millicurie",09/11/2025
A9528,"Iodine i-131 sodium iodide capsule(s), diagnostic, per millicurie",09/11/2025
A9529,"Iodine i-131 sodium iodide solution, diagnostic, per millicurie",09/11/2025
A9530,"Iodine i-131 sodium iodide solution, therapeutic, per millicurie",09/11/2025
A9531,"Iodine i-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries)",09/11/2025
A9532,"Iodine i-125 serum albumin, diagnostic, per 5 microcuries",09/11/2025
A9536,"Technetium tc-99m depreotide, diagnostic, per study dose, up to 35 millicuries",09/11/2025
A9537,"Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries",09/11/2025
A9538,"Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries",09/11/2025
A9539,"Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries",09/11/2025
A9540,"Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries",09/11/2025
A9541,"Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries",09/11/2025
A9542,"Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries",09/11/2025
A9543,"Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries",09/11/2025
A9544,"Iodine i-131 tositumomab, diagnostic, per study dose",09/11/2025
A9545,"Iodine i-131 tositumomab, therapeutic, per treatment dose",09/11/2025
A9546,"Cobalt co-57/58, cyanocobalamin, diagnostic, per study dose, up to 1 microcurie",09/11/2025
A9547,"Indium in-111 oxyquinoline, diagnostic, per 0.5 millicurie",09/11/2025
A9548,"Indium in-111 pentetate, diagnostic, per 0.5 millicurie",09/11/2025
A9550,"Technetium tc-99m sodium gluceptate, diagnostic, per study dose, up to 25 millicurie",09/11/2025
A9551,"Technetium tc-99m succimer, diagnostic, per study dose, up to 10 millicuries",09/11/2025
A9552,"Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries",09/11/2025
A9553,"Chromium cr-51 sodium chromate, diagnostic, per study dose, up to 250 microcuries",09/11/2025
A9554,"Iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries",09/11/2025
A9555,"Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries",09/11/2025
A9556,"Gallium ga-67 citrate, diagnostic, per millicurie",09/11/2025
A9557,"Technetium tc-99m bicisate, diagnostic, per study dose, up to 25 millicuries",09/11/2025
A9558,"Xenon xe-133 gas, diagnostic, per 10 millicuries",09/11/2025
A9559,"Cobalt co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 microcurie",09/11/2025
A9560,"Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries",09/11/2025
A9561,"Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries",09/11/2025
A9562,"Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries",09/11/2025
A9563,"Sodium phosphate p-32, therapeutic, per millicurie",09/11/2025
A9564,"Chromic phosphate p-32 suspension, therapeutic, per millicurie",09/11/2025
A9566,"Technetium tc-99m fanolesomab, diagnostic, per study dose, up to 25 millicuries",09/11/2025
A9567,"Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries",09/11/2025
A9568,"Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries",09/11/2025
A9569,"Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose",09/11/2025
A9570,"Indium in-111 labeled autologous white blood cells, diagnostic, per study dose",09/11/2025
A9571,"Indium in-111 labeled autologous platelets, diagnostic, per study dose",09/11/2025
A9572,"Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuries",09/11/2025
A9573,"Injection, gadopiclenol, 1 ml",09/11/2025
A9575,"Injection, gadoterate meglumine, 0.1 ml",09/11/2025
A9576,"Injection, gadoteridol, (prohance multipack), per ml",09/11/2025
A9577,"Injection, gadobenate dimeglumine (multihance), per ml",09/11/2025
A9578,"Injection, gadobenate dimeglumine (multihance multipack), per ml",09/11/2025
A9579,"Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml",09/11/2025
A9580,"Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries",09/11/2025
A9581,"Injection, gadoxetate disodium, 1 ml",09/11/2025
A9582,"Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries",09/11/2025
A9583,"Injection, gadofosveset trisodium, 1 ml",09/11/2025
A9584,"Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries",09/11/2025
A9585,"Injection, gadobutrol, 0.1 ml",09/11/2025
A9586,"Florbetapir f18, diagnostic, per study dose, up to 10 millicuries",09/11/2025
A9587,"Gallium ga-68, dotatate, diagnostic, 0.1 millicurie",09/11/2025
A9588,"Fluciclovine f-18, diagnostic, 1 millicurie",09/11/2025
A9589,"Instillation, hexaminolevulinate hydrochloride, 100 mg",09/11/2025
A9590,"Iodine i-131, iobenguane, 1 millicurie",09/11/2025
A9591,"Fluoroestradiol f 18, diagnostic, 1 millicurie",09/11/2025
A9592,"Copper cu-64, dotatate, diagnostic, 1 millicurie",09/11/2025
A9593,"Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie",09/11/2025
A9594,"Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie",09/11/2025
A9595,"Piflufolastat f-18, diagnostic, 1 millicurie",09/11/2025
A9596,"Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie",09/11/2025
A9597,"Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified",09/11/2025
A9598,"Positron emission tomography radiopharmaceutical, diagnostic, for non-tumor identification, not otherwise classified",09/11/2025
A9599,"Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified",09/11/2025
A9600,"Strontium sr-89 chloride, therapeutic, per millicurie",09/11/2025
A9601,"Flortaucipir f 18 injection, diagnostic, 1 millicurie",09/11/2025
A9602,"Fluorodopa f-18, diagnostic, per millicurie",09/11/2025
A9603,"Injection, pafolacianine, 0.1 mg",09/11/2025
A9604,"Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries",09/11/2025
A9606,"Radium ra-223 dichloride, therapeutic, per microcurie",09/11/2025
A9607,"Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie",09/11/2025
A9608,"Flotufolastat f 18, diagnostic, 1 millicurie",09/11/2025
A9609,Fludeoxyglucose f18 up to 15 millicuries,09/11/2025
A9610,"Xenon xe-129 hyperpolarized gas, diagnostic, per study dose",09/11/2025
A9611,"Flurpiridaz f 18, diagnostic, 1 millicurie",09/11/2025
A9612,"Injection, fluorescein, 1 mg",09/11/2025
A9615,"Injection, pegulicianine, 1 mg",09/11/2025
A9616,"Gallium ga-68 gozetotide (gozellix), diagnostic, 1 millicurie",09/11/2025
A9697,"Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose",09/11/2025
A9698,"Non-radioactive contrast imaging material, not otherwise classified, per study",09/11/2025
A9699,"Radiopharmaceutical, therapeutic, not otherwise classified",09/11/2025
A9700,"Supply of injectable contrast material for use in echocardiography, per study",09/11/2025
A9800,"Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie",09/11/2025
A9900,"Miscellaneous dme supply, accessory, and/or service component of another hcpcs code",09/11/2025
A9901,"Dme delivery, set up, and/or dispensing service component of another hcpcs code",09/11/2025
A9999,"Miscellaneous dme supply or accessory, not otherwise specified",09/11/2025
B4034,"Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape",09/11/2025
B4035,"Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape",09/11/2025
B4036,"Enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape",09/11/2025
B4081,Nasogastric tubing with stylet,09/11/2025
B4082,Nasogastric tubing without stylet,09/11/2025
B4083,Stomach tube - levine type,09/11/2025
B4087,"Gastrostomy/jejunostomy tube, standard, any material, any type, each",09/11/2025
B4088,"Gastrostomy/jejunostomy tube, low-profile, any material, any type, each",09/11/2025
B4100,"Food thickener, administered orally, per ounce",09/11/2025
B4102,"Enteral formula, for adults, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit",09/11/2025
B4103,"Enteral formula, for pediatrics, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit",09/11/2025
B4104,"Additive for enteral formula (e.g., fiber)",09/11/2025
B4105,"In-line cartridge containing digestive enzyme(s) for enteral feeding, each",09/11/2025
B4148,"Enteral feeding supply kit; elastomeric control fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape",09/11/2025
B4149,"Enteral formula, manufactured blenderized natural foods with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4150,"Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4152,"Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4153,"Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and peptide chain), includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4154,"Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4155,"Enteral formula, nutritionally incomplete/modular nutrients, includes specific nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g., glutamine, arginine), fat (e.g., medium chain triglycerides) or combination, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4157,"Enteral formula, nutritionally complete, for special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4158,"Enteral formula, for pediatrics, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4159,"Enteral formula, for pediatrics, nutritionally complete soy based with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4160,"Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4161,"Enteral formula, for pediatrics, hydrolyzed/amino acids and peptide chain proteins, includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4162,"Enteral formula, for pediatrics, special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",09/11/2025
B4164,"Parenteral nutrition solution: carbohydrates (dextrose), 50% or less (500 ml = 1 unit) - home mix",09/11/2025
B4168,"Parenteral nutrition solution; amino acid, 3.5%, (500 ml = 1 unit) - home mix",09/11/2025
B4172,"Parenteral nutrition solution; amino acid, 5.5% through 7%, (500 ml = 1 unit) - home mix",09/11/2025
B4176,"Parenteral nutrition solution; amino acid, 7% through 8.5%, (500 ml = 1 unit) - home mix",09/11/2025
B4178,"Parenteral nutrition solution: amino acid, greater than 8.5% (500 ml = 1 unit) - home mix",09/11/2025
B4180,"Parenteral nutrition solution; carbohydrates (dextrose), greater than 50% (500 ml = 1 unit) - home mix",09/11/2025
B4185,"Parenteral nutrition solution, not otherwise specified, 10 grams lipids",09/11/2025
B4187,"Omegaven, 10 grams lipids",09/11/2025
B4189,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 10 to 51 grams of protein - premix",09/11/2025
B4193,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix",09/11/2025
B4197,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix",09/11/2025
B4199,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, over 100 grams of protein - premix",09/11/2025
B4216,"Parenteral nutrition; additives (vitamins, trace elements, heparin, electrolytes), home mix, per day",09/11/2025
B4220,"Parenteral nutrition supply kit; premix, per day",09/11/2025
B4222,"Parenteral nutrition supply kit; home mix, per day",09/11/2025
B4224,"Parenteral nutrition administration kit, per day",09/11/2025
B5000,"Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, renal-aminosyn-rf, nephramine, renamine-premix",09/11/2025
B5100,"Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, hepatic, hepatamine-premix",09/11/2025
B5200,"Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, stress-branch chain amino acids-freamine-hbc-premix",09/11/2025
B9000,Enteral nutrition infusion pump - without alarm,09/11/2025
B9002,"Enteral nutrition infusion pump, any type",09/11/2025
B9004,"Parenteral nutrition infusion pump, portable",09/11/2025
B9006,"Parenteral nutrition infusion pump, stationary",09/11/2025
B9998,Noc for enteral supplies,09/11/2025
B9999,Noc for parenteral supplies,09/11/2025
C1052,"Hemostatic agent, gastrointestinal, topical",09/11/2025
C1062,"Intravertebral body fracture augmentation with implant (e.g., metal, polymer)",09/11/2025
C1300,"Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval",09/11/2025
C1600,"Catheter, transluminal intravascular lesion preparation device, bladed, sheathed (insertable)",09/11/2025
C1601,"Endoscope, single-use (i.e. disposable), pulmonary, imaging/illumination device (insertable)",09/11/2025
C1602,"Orthopedic/device/drug matrix/absorbable bone void filler, antimicrobial-eluting (implantable)",09/11/2025
C1603,"Retrieval device, insertable, laser (used to retrieve intravascular inferior vena cava filter)",09/11/2025
C1604,"Graft, transmural transvenous arterial bypass (implantable), with all delivery system components",09/11/2025
C1605,"Pacemaker, leadless, dual chamber (right atrial and right ventricular implantable components), rate-responsive, including all necessary components for implantation",09/11/2025
C1606,"Adapter, single-use (i.e. disposable), for attaching ultrasound system to upper gastrointestinal endoscope",09/11/2025
C1713,Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable),09/11/2025
C1714,"Catheter, transluminal atherectomy, directional",09/11/2025
C1715,Brachytherapy needle,09/11/2025
C1716,"Brachytherapy source, non-stranded, gold-198, per source",09/11/2025
C1717,"Brachytherapy source, non-stranded, high dose rate iridium-192, per source",09/11/2025
C1719,"Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source",09/11/2025
C1721,"Cardioverter-defibrillator, dual chamber (implantable)",09/11/2025
C1722,"Cardioverter-defibrillator, single chamber (implantable)",09/11/2025
C1724,"Catheter, transluminal atherectomy, rotational",09/11/2025
C1725,"Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)",09/11/2025
C1726,"Catheter, balloon dilatation, non-vascular",09/11/2025
C1727,"Catheter, balloon tissue dissector, non-vascular (insertable)",09/11/2025
C1728,"Catheter, brachytherapy seed administration",09/11/2025
C1729,"Catheter, drainage",09/11/2025
C1730,"Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)",09/11/2025
C1731,"Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes)",09/11/2025
C1732,"Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping",09/11/2025
C1733,"Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip",09/11/2025
C1734,Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable),09/11/2025
C1735,"Catheter(s), intravascular for renal denervation, radiofrequency, including all single use system components",09/11/2025
C1736,"Catheter(s), intravascular for renal denervation, ultrasound, including all single use system components",09/11/2025
C1737,"Joint fusion and fixation device(s), sacroiliac and pelvis, including all system components (implantable)",09/11/2025
C1738,"Powered, single-use (i.e. disposable) endoscopic ultrasound-guided biopsy device",09/11/2025
C1739,"Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system",09/11/2025
C1740,"Leadless electrode, transmitter, battery (all implantable), for sequential left ventricular pacing",09/11/2025
C1741,"Anchor/screw for bone fixation, absorbable (implantable)",09/11/2025
C1742,"Pressure monitoring system, compartmental intramuscular (implantable), continuous, including all components (e.g., introducer, sensor), excludes mobile (wireless) software application",09/11/2025
C1747,"Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable)",09/11/2025
C1748,"Endoscope, single-use (i.e. disposable), upper gi, imaging/illumination device (insertable)",09/11/2025
C1749,"Endoscope, retrograde imaging/illumination colonoscope device (implantable)",09/11/2025
C1750,"Catheter, hemodialysis/peritoneal, long-term",09/11/2025
C1751,"Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)",09/11/2025
C1752,"Catheter, hemodialysis/peritoneal, short-term",09/11/2025
C1753,"Catheter, intravascular ultrasound",09/11/2025
C1754,"Catheter, intradiscal",09/11/2025
C1755,"Catheter, intraspinal",09/11/2025
C1756,"Catheter, pacing, transesophageal",09/11/2025
C1757,"Catheter, thrombectomy/embolectomy",09/11/2025
C1758,"Catheter, ureteral",09/11/2025
C1759,"Catheter, intracardiac echocardiography",09/11/2025
C1760,"Closure device, vascular (implantable/insertable)",09/11/2025
C1761,"Catheter, transluminal intravascular lithotripsy, coronary",09/11/2025
C1762,"Connective tissue, human (includes fascia lata)",09/11/2025
C1763,"Connective tissue, non-human (includes synthetic)",09/11/2025
C1764,"Event recorder, cardiac (implantable)",09/11/2025
C1765,Adhesion barrier,09/11/2025
C1766,"Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away",09/11/2025
C1767,"Generator, neurostimulator (implantable), non-rechargeable",09/11/2025
C1768,"Graft, vascular",09/11/2025
C1769,Guide wire,09/11/2025
C1770,"Imaging coil, magnetic resonance (insertable)",09/11/2025
C1771,"Repair device, urinary, incontinence, with sling graft",09/11/2025
C1772,"Infusion pump, programmable (implantable)",09/11/2025
C1773,"Retrieval device, insertable (used to retrieve fractured medical devices)",09/11/2025
C1776,Joint device (implantable),09/11/2025
C1777,"Lead, cardioverter-defibrillator, endocardial single coil (implantable)",09/11/2025
C1778,"Lead, neurostimulator (implantable)",09/11/2025
C1779,"Lead, pacemaker, transvenous vdd single pass",09/11/2025
C1780,"Lens, intraocular (new technology)",09/11/2025
C1781,Mesh (implantable),09/11/2025
C1782,Morcellator,09/11/2025
C1783,"Ocular implant, aqueous drainage assist device",09/11/2025
C1784,"Ocular device, intraoperative, detached retina",09/11/2025
C1785,"Pacemaker, dual chamber, rate-responsive (implantable)",09/11/2025
C1786,"Pacemaker, single chamber, rate-responsive (implantable)",09/11/2025
C1787,"Patient programmer, neurostimulator",09/11/2025
C1788,"Port, indwelling (implantable)",09/11/2025
C1789,"Prosthesis, breast (implantable)",09/11/2025
C1813,"Prosthesis, penile, inflatable",09/11/2025
C1814,"Retinal tamponade device, silicone oil",09/11/2025
C1815,"Prosthesis, urinary sphincter (implantable)",09/11/2025
C1816,"Receiver and/or transmitter, neurostimulator (implantable)",09/11/2025
C1817,"Septal defect implant system, intracardiac",09/11/2025
C1818,Integrated keratoprosthesis,09/11/2025
C1819,Surgical tissue localization and excision device (implantable),09/11/2025
C1820,"Generator, neurostimulator (implantable), with rechargeable battery and charging system",09/11/2025
C1821,Interspinous process distraction device (implantable),09/11/2025
C1822,"Generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging system",09/11/2025
C1823,"Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads",09/11/2025
C1824,"Generator, cardiac contractility modulation (implantable)",09/11/2025
C1825,"Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)",09/11/2025
C1826,"Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system",09/11/2025
C1827,"Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controller",09/11/2025
C1830,Powered bone marrow biopsy needle,09/11/2025
C1831,"Interbody cage, anterior, lateral or posterior, personalized (implantable)",09/11/2025
C1832,"Autograft suspension, including cell processing and application, and all system components",09/11/2025
C1833,"Monitor, cardiac, including intracardiac lead and all system components (implantable)",09/11/2025
C1834,"Pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software application",09/11/2025
C1839,Iris prosthesis,09/11/2025
C1840,"Lens, intraocular (telescopic)",09/11/2025
C1841,"Retinal prosthesis, includes all internal and external components",09/11/2025
C1842,"Retinal prosthesis, includes all internal and external components; add-on to c1841",09/11/2025
C1849,"Skin substitute, synthetic, resorbable, per square centimeter",09/11/2025
C1874,"Stent, coated/covered, with delivery system",09/11/2025
C1875,"Stent, coated/covered, without delivery system",09/11/2025
C1876,"Stent, non-coated/non-covered, with delivery system",09/11/2025
C1877,"Stent, non-coated/non-covered, without delivery system",09/11/2025
C1878,"Material for vocal cord medialization, synthetic (implantable)",09/11/2025
C1880,Vena cava filter,09/11/2025
C1881,Dialysis access system (implantable),09/11/2025
C1882,"Cardioverter-defibrillator, other than single or dual chamber (implantable)",09/11/2025
C1883,"Adapter/extension, pacing lead or neurostimulator lead (implantable)",09/11/2025
C1884,Embolization protective system,09/11/2025
C1885,"Catheter, transluminal angioplasty, laser",09/11/2025
C1886,"Catheter, extravascular tissue ablation, any modality (insertable)",09/11/2025
C1887,"Catheter, guiding (may include infusion/perfusion capability)",09/11/2025
C1888,"Catheter, ablation, non-cardiac, endovascular (implantable)",09/11/2025
C1889,"Implantable/insertable device, not otherwise classified",09/11/2025
C1890,No implantable/insertable device used with device-intensive procedures,09/11/2025
C1891,"Infusion pump, non-programmable, permanent (implantable)",09/11/2025
C1892,"Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away",09/11/2025
C1893,"Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away",09/11/2025
C1894,"Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser",09/11/2025
C1895,"Lead, cardioverter-defibrillator, endocardial dual coil (implantable)",09/11/2025
C1896,"Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable)",09/11/2025
C1897,"Lead, neurostimulator test kit (implantable)",09/11/2025
C1898,"Lead, pacemaker, other than transvenous vdd single pass",09/11/2025
C1899,"Lead, pacemaker/cardioverter-defibrillator combination (implantable)",09/11/2025
C1900,"Lead, left ventricular coronary venous system",09/11/2025
C1982,"Catheter, pressure-generating, (e.g., one-way valve, intermittently occlusive)",09/11/2025
C2596,"Probe, image-guided, robotic, waterjet ablation",09/11/2025
C2613,Lung biopsy plug with delivery system,09/11/2025
C2614,"Probe, percutaneous lumbar discectomy",09/11/2025
C2615,"Sealant, pulmonary, liquid",09/11/2025
C2616,"Brachytherapy source, non-stranded, yttrium-90, per source",09/11/2025
C2617,"Stent, non-coronary, temporary, without delivery system",09/11/2025
C2618,"Probe/needle, cryoablation",09/11/2025
C2619,"Pacemaker, dual chamber, non rate-responsive (implantable)",09/11/2025
C2620,"Pacemaker, single chamber, non rate-responsive (implantable)",09/11/2025
C2621,"Pacemaker, other than single or dual chamber (implantable)",09/11/2025
C2622,"Prosthesis, penile, non-inflatable",09/11/2025
C2623,"Catheter, transluminal angioplasty, drug-coated, non-laser",09/11/2025
C2624,"Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components",09/11/2025
C2625,"Stent, non-coronary, temporary, with delivery system",09/11/2025
C2626,"Infusion pump, non-programmable, temporary (implantable)",09/11/2025
C2627,"Catheter, suprapubic/cystoscopic",09/11/2025
C2628,"Catheter, occlusion",09/11/2025
C2629,"Introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser",09/11/2025
C2630,"Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, cool-tip",09/11/2025
C2631,"Repair device, urinary, incontinence, without sling graft",09/11/2025
C2634,"Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source",09/11/2025
C2635,"Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source",09/11/2025
C2636,"Brachytherapy linear source, non-stranded, palladium-103, per 1 mm",09/11/2025
C2637,"Brachytherapy source, non-stranded, ytterbium-169, per source",09/11/2025
C2638,"Brachytherapy source, stranded, iodine-125, per source",09/11/2025
C2639,"Brachytherapy source, non-stranded, iodine-125, per source",09/11/2025
C2640,"Brachytherapy source, stranded, palladium-103, per source",09/11/2025
C2641,"Brachytherapy source, non-stranded, palladium-103, per source",09/11/2025
C2642,"Brachytherapy source, stranded, cesium-131, per source",09/11/2025
C2643,"Brachytherapy source, non-stranded, cesium-131, per source",09/11/2025
C2644,"Brachytherapy source, cesium-131 chloride solution, per millicurie",09/11/2025
C2645,"Brachytherapy planar source, palladium-103, per square millimeter",09/11/2025
C2698,"Brachytherapy source, stranded, not otherwise specified, per source",09/11/2025
C2699,"Brachytherapy source, non-stranded, not otherwise specified, per source",09/11/2025
C5271,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area",09/11/2025
C5272,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)",09/11/2025
C5273,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children",09/11/2025
C5274,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)",09/11/2025
C5275,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area",09/11/2025
C5276,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)",09/11/2025
C5277,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children",09/11/2025
C5278,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)",09/11/2025
C7500,"Debridement, bone including epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed, first 20 sq cm or less with manual preparation and insertion of deep (e.g., subfacial) drug-delivery device(s)",09/11/2025
C7501,"Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code)",09/11/2025
C7502,"Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)",09/11/2025
C7503,"Open biopsy or excision of deep cervical node(s) with intraoperative identification (e.g., mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed",09/11/2025
C7504,"Percutaneous vertebroplasties (bone biopsies included when performed), first cervicothoracic and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance",09/11/2025
C7505,"Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance",09/11/2025
C7506,"Arthrodesis, interphalangeal joints, with or without internal fixation",09/11/2025
C7507,"Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance",09/11/2025
C7508,"Percutaneous vertebral augmentations, first lumbar and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance",09/11/2025
C7509,"Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed",09/11/2025
C7510,"Bronchoscopy, rigid or flexible, with bronchial alveolar lavage(s), with computer-assisted image-guided navigation, including fluoroscopic guidance when performed",09/11/2025
C7511,"Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed",09/11/2025
C7512,"Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance when performed",09/11/2025
C7513,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report",09/11/2025
C7514,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with all angioplasty in the central dialysis segment, and transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report",09/11/2025
C7515,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with dialysis circuit permanent endovascular embolization or occlusion of main circuit or any accessory veins, including all required imaging, radiological supervision and interpretation, image documentation and report",09/11/2025
C7516,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report",09/11/2025
C7517,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation",09/11/2025
C7518,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, interpretation and report",09/11/2025
C7519,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",09/11/2025
C7520,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) includes intraprocedural injection(s) for bypass graft angiography with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation",09/11/2025
C7521,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report",09/11/2025
C7522,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right heart catheterization, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",09/11/2025
C7523,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report",09/11/2025
C7524,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",09/11/2025
C7525,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report",09/11/2025
C7526,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",09/11/2025
C7527,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report",09/11/2025
C7528,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",09/11/2025
C7529,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",09/11/2025
C7530,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty and all angioplasty in the central dialysis segment, with transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging, radiological supervision and interpretation, documentation and report",09/11/2025
C7531,"Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation",09/11/2025
C7532,"Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation",09/11/2025
C7533,"Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy",09/11/2025
C7534,"Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation",09/11/2025
C7535,"Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal stent placement(s), includes angioplasty within the same vessel, when performed, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation",09/11/2025
C7537,"Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)",09/11/2025
C7538,"Insertion of new or replacement of permanent pacemaker with ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)",09/11/2025
C7539,"Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)",09/11/2025
C7540,"Removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator, dual lead system, with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)",09/11/2025
C7541,"Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)",09/11/2025
C7542,"Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)",09/11/2025
C7543,"Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)",09/11/2025
C7544,"Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)",09/11/2025
C7545,"Percutaneous exchange of biliary drainage catheter (eg, external, internal-external, or conversion of internal-external to external only), with removal of calculi/debris from biliary duct(s) and/or gallbladder, including destruction of calculi by any method (eg, mechanical, electrohydraulic, lithotripsy) when performed, including diagnostic cholangiography(ies) when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation",09/11/2025
C7546,"Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation",09/11/2025
C7547,"Convert nephrostomy catheter to nephroureteral catheter, percutaneous via pre-existing nephrostomy tract, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation",09/11/2025
C7548,"Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation",09/11/2025
C7549,"Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation",09/11/2025
C7550,"Cystourethroscopy, with biopsy(ies) with adjunctive blue light cystoscopy with fluorescent imaging agent",09/11/2025
C7551,"Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle",09/11/2025
C7552,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress, initial vessel",09/11/2025
C7553,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed",09/11/2025
C7554,Cystourethroscopy with adjunctive blue light cystoscopy with fluorescent imaging agent,09/11/2025
C7555,"Thyroidectomy, total or complete with parathyroid autotransplantation",09/11/2025
C7556,"Bronchoscopy, rigid or flexible, with bronchial alveolar lavage and transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance, when performed",09/11/2025
C7557,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed and intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention",09/11/2025
C7558,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed",09/11/2025
C7560,Endoscopic retrograde cholangiopancreatography (ercp) with removal of foreign body(s) or stent(s) from biliary/pancreatic duct(s) and endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s),09/11/2025
C7562,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed with intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention",09/11/2025
C7563,"Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the  angioplasty within the same artery, initial artery and all additional arteries",09/11/2025
C7564,"Percutaneous transluminal mechanical thrombectomy, vein(s), including intraprocedural pharmacological thrombolytic injections and fluoroscopic guidance with intravascular ultrasound (noncoronary vessel(s)) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation",09/11/2025
C7565,"Repair of anterior abdominal hernia(s) (ie, epigastric, incisional, ventral, umbilical, spigelian), any approach (i.e., open, laparoscopic, robotic), recurrent, including implantation of mesh or other prosthesis when performed, total length of defect(s) less than 3 cm, reducible with removal of total or near total non-infected mesh or other prosthesis at the time of initial or recurrent anterior abdominal hernia repair or parastomal hernia repair",09/11/2025
C7900,"Service for diagnosis, evaluation, or treatment of a mental health  or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service",09/11/2025
C7901,"Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service",09/11/2025
C7902,"Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)",09/11/2025
C7903,"Group psychotherapy service for diagnosis, evaluation, or treatment of a mental health or substance use disorder provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service",09/11/2025
C8000,"Support device, extravascular, for arteriovenous fistula (implantable)",09/11/2025
C8001,"3d anatomical segmentation imaging for preoperative planning, data preparation and transmission, obtained from previous diagnostic computed tomographic or magnetic resonance examination of the same anatomy",09/11/2025
C8002,"Preparation of skin cell suspension autograft, automated, including all enzymatic processing and device components (do not report with manual suspension preparation)",09/11/2025
C8003,"Implantation of medial knee extraarticular implantable shock absorber spanning the knee joint from distal femur to proximal tibia, open, includes measurements, positioning and adjustments, with imaging guidance (e.g., fluoroscopy)",09/11/2025
C8004,"Simulation angiogram with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the angiogram, for subsequent therapeutic radioembolization of tumors",09/11/2025
C8005,"Bronchoscopy, rigid or flexible, non-thermal transbronchial ablation of lesion(s) by pulsed electric field (pef) energy, including fluoroscopic and/or ultrasound guidance, when performed, with computed tomography acquisition(s) and 3d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) of lung(s) and all mediastinal and/or hilar lymph node stations or structures, and therapeutic intervention(s)",09/11/2025
C8006,"Insertion of pleural-peritoneal shunt with intercostal pump chamber, including imaging, injection(s) of contrast with radiological supervision and interpretation, when performed",09/11/2025
C8900,"Magnetic resonance angiography with contrast, abdomen",09/11/2025
C8901,"Magnetic resonance angiography without contrast, abdomen",09/11/2025
C8902,"Magnetic resonance angiography without contrast followed by with contrast, abdomen",09/11/2025
C8903,"Magnetic resonance imaging with contrast, breast; unilateral",09/11/2025
C8904,"Magnetic resonance imaging without contrast, breast; unilateral",09/11/2025
C8905,"Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral",09/11/2025
C8906,"Magnetic resonance imaging with contrast, breast; bilateral",09/11/2025
C8907,"Magnetic resonance imaging without contrast, breast; bilateral",09/11/2025
C8908,"Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral",09/11/2025
C8909,"Magnetic resonance angiography with contrast, chest (excluding myocardium)",09/11/2025
C8910,"Magnetic resonance angiography without contrast, chest (excluding myocardium)",09/11/2025
C8911,"Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)",09/11/2025
C8912,"Magnetic resonance angiography with contrast, lower extremity",09/11/2025
C8913,"Magnetic resonance angiography without contrast, lower extremity",09/11/2025
C8914,"Magnetic resonance angiography without contrast followed by with contrast, lower extremity",09/11/2025
C8918,"Magnetic resonance angiography with contrast, pelvis",09/11/2025
C8919,"Magnetic resonance angiography without contrast, pelvis",09/11/2025
C8920,"Magnetic resonance angiography without contrast followed by with contrast, pelvis",09/11/2025
C8921,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete",09/11/2025
C8922,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study",09/11/2025
C8923,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography",09/11/2025
C8924,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study",09/11/2025
C8925,"Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report",09/11/2025
C8926,"Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report",09/11/2025
C8927,"Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis",09/11/2025
C8928,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report",09/11/2025
C8929,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography",09/11/2025
C8930,"Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision",09/11/2025
C8931,"Magnetic resonance angiography with contrast, spinal canal and contents",09/11/2025
C8932,"Magnetic resonance angiography without contrast, spinal canal and contents",09/11/2025
C8933,"Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents",09/11/2025
C8934,"Magnetic resonance angiography with contrast, upper extremity",09/11/2025
C8935,"Magnetic resonance angiography without contrast, upper extremity",09/11/2025
C8936,"Magnetic resonance angiography without contrast followed by with contrast, upper extremity",09/11/2025
C8937,"Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)",09/11/2025
C8957,"Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump",09/11/2025
C9014,"Injection, cerliponase alfa, 1 mg",09/11/2025
C9015,"Injection, c-1 esterase inhibitor (human), haegarda, 10 units",09/11/2025
C9016,"Injection, triptorelin extended release, 3.75 mg",09/11/2025
C9021,"Injection, obinutuzumab, 10 mg",09/11/2025
C9022,"Injection, elosulfase alfa, 1mg",09/11/2025
C9023,"Injection, testosterone undecanoate, 1 mg",09/11/2025
C9024,"Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine",09/11/2025
C9025,"Injection, ramucirumab, 5 mg",09/11/2025
C9026,"Injection, vedolizumab, 1 mg",09/11/2025
C9027,"Injection, pembrolizumab, 1 mg",09/11/2025
C9028,"Injection, inotuzumab ozogamicin, 0.1 mg",09/11/2025
C9029,"Injection, guselkumab, 1 mg",09/11/2025
C9030,"Injection, copanlisib, 1 mg",09/11/2025
C9031,"Lutetium lu 177, dotatate, therapeutic, 1 mci",09/11/2025
C9032,"Injection, voretigene neparvovec-rzyl, 1 billion vector genome",09/11/2025
C9033,"Injection, fosnetupitant 235 mg and palonosetron 0.25 mg",09/11/2025
C9034,"Injection, dexamethasone 9%, intraocular, 1 mcg",09/11/2025
C9035,"Injection, aripiprazole lauroxil (aristada initio), 1 mg",09/11/2025
C9036,"Injection, patisiran, 0.1 mg",09/11/2025
C9037,"Injection, risperidone (perseris), 0.5 mg",09/11/2025
C9038,"Injection, mogamulizumab-kpkc, 1 mg",09/11/2025
C9039,"Injection, plazomicin, 5 mg",09/11/2025
C9040,"Injection, fremanezumab-vfrm, 1mg",09/11/2025
C9041,"Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg",09/11/2025
C9042,"Injection, bendamustine hcl (belrapzo), 1 mg",09/11/2025
C9043,"Injection, levoleucovorin, 1 mg",09/11/2025
C9044,"Injection, cemiplimab-rwlc, 1 mg",09/11/2025
C9045,"Injection, moxetumomab pasudotox-tdfk, 0.01 mg",09/11/2025
C9046,"Cocaine hydrochloride nasal solution (goprelto), 1 mg",09/11/2025
C9047,"Injection, caplacizumab-yhdp, 1 mg",09/11/2025
C9048,"Dexamethasone, lacrimal ophthalmic insert, 0.1 mg",09/11/2025
C9049,"Injection, tagraxofusp-erzs, 10 mcg",09/11/2025
C9050,"Injection, emapalumab-lzsg, 1 mg",09/11/2025
C9051,"Injection, omadacycline, 1 mg",09/11/2025
C9052,"Injection, ravulizumab-cwvz, 10 mg",09/11/2025
C9053,"Injection,  crizanlizumab-tmca, 1 mg",09/11/2025
C9054,"Injection, lefamulin (xenleta), 1 mg",09/11/2025
C9055,"Injection, brexanolone, 1mg",09/11/2025
C9056,"Injection, givosiran, 0.5 mg",09/11/2025
C9057,"Injection, cetirizine hydrochloride, 1 mg",09/11/2025
C9058,"Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg",09/11/2025
C9059,"Injection, meloxicam, 1 mg",09/11/2025
C9060,"Fluoroestradiol f18, diagnostic, 1 mci",09/11/2025
C9061,"Injection, teprotumumab-trbw, 10 mg",09/11/2025
C9062,"Injection, daratumumab 10 mg and hyaluronidase-fihj",09/11/2025
C9063,"Injection, eptinezumab-jjmr, 1 mg",09/11/2025
C9064,"Mitomycin pyelocalyceal instillation, 1 mg",09/11/2025
C9065,"Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg",09/11/2025
C9066,"Injection, sacituzumab govitecan-hziy, 2.5 mg",09/11/2025
C9067,"Gallium ga-68, dotatoc, diagnostic, 0.01 mci",09/11/2025
C9068,"Copper cu-64, dotatate, diagnostic, 1 millicurie",09/11/2025
C9069,"Injection, belantamab mafodontin-blmf, 0.5 mg",09/11/2025
C9070,"Injection, tafasitamab-cxix, 2 mg",09/11/2025
C9071,"Injection, viltolarsen, 10 mg",09/11/2025
C9072,"Injection, immune globulin (asceniv), 500 mg",09/11/2025
C9073,"Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
C9074,"Injection, lumasiran, 0.5 mg",09/11/2025
C9075,"Injection, casimersen, 10 mg",09/11/2025
C9076,"Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
C9077,"Injection, cabotegravir and rilpivirine, 2mg/3mg",09/11/2025
C9078,"Injection, trilaciclib, 1 mg",09/11/2025
C9079,"Injection, evinacumab-dgnb, 5 mg",09/11/2025
C9080,"Injection, melphalan flufenamide hydrochloride, 1 mg",09/11/2025
C9081,"Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
C9082,"Injection, dostarlimab-gxly, 100 mg",09/11/2025
C9083,"Injection, amivantamab-vmjw, 10 mg",09/11/2025
C9084,"Injection, loncastuximab tesirine-lpyl, 0.1 mg",09/11/2025
C9085,"Injection, avalglucosidase alfa-ngpt, 4 mg",09/11/2025
C9086,"Injection, anifrolumab-fnia, 1 mg",09/11/2025
C9087,"Injection, cyclophosphamide, (auromedics), 10 mg",09/11/2025
C9088,"Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg",09/11/2025
C9089,"Bupivacaine, collagen-matrix implant, 1 mg",09/11/2025
C9090,"Injection, plasminogen, human-tvmh, 1 mg",09/11/2025
C9091,"Injection, sirolimus protein-bound particles, 1 mg",09/11/2025
C9092,"Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg",09/11/2025
C9093,"Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg",09/11/2025
C9094,"Inj, sutimlimab-jome, 10 mg",09/11/2025
C9095,"Inj, tebentafusp-tebn, 1 mcg",09/11/2025
C9096,"Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram",09/11/2025
C9097,"Inj, faricimab-svoa, 0.1 mg",09/11/2025
C9098,"Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
C9101,"Injection, oliceridine, 0.1 mg",09/11/2025
C9113,"Injection, pantoprazole sodium, per vial",09/11/2025
C9121,"Injection, argatroban, per 5 mg",09/11/2025
C9122,"Mometasone furoate sinus implant, 10 micrograms (sinuva)",09/11/2025
C9132,"Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity",09/11/2025
C9133,"Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.",09/11/2025
C9134,"Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.",09/11/2025
C9135,"Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.",09/11/2025
C9136,"Injection, factor viii, fc fusion protein, (recombinant), per i.u.",09/11/2025
C9137,"Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.",09/11/2025
C9138,"Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.",09/11/2025
C9139,"Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.",09/11/2025
C9140,"Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.",09/11/2025
C9141,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.",09/11/2025
C9142,"Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg",09/11/2025
C9143,"Cocaine hydrochloride nasal solution (numbrino), 1 mg",09/11/2025
C9144,"Injection, bupivacaine (posimir), 1 mg",09/11/2025
C9145,"Injection, aprepitant, (aponvie), 1 mg",09/11/2025
C9146,"Injection, mirvetuximab soravtansine-gynx, 1 mg",09/11/2025
C9147,"Injection, tremelimumab-actl, 1 mg",09/11/2025
C9148,"Injection, teclistamab-cqyv, 0.5 mg",09/11/2025
C9149,"Injection, teplizumab-mzwv, 5 mcg",09/11/2025
C9150,"Xenon xe-129 hyperpolarized gas, diagnostic, per study dose",09/11/2025
C9151,"Injection, pegcetacoplan, 1 mg",09/11/2025
C9152,"Injection, aripiprazole, (abilify asimtufii), 1 mg",09/11/2025
C9153,"Injection, amisulpride, 1 mg",09/11/2025
C9154,"Injection, buprenorphine extended-release (brixadi), 1 mg",09/11/2025
C9155,"Injection, epcoritamab-bysp, 0.16 mg",09/11/2025
C9156,"Flotufolastat f 18, diagnostic, 1 millicurie",09/11/2025
C9157,"Injection, tofersen, 1 mg",09/11/2025
C9158,"Injection, risperidone, (uzedy), 1 mg",09/11/2025
C9159,"Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity",09/11/2025
C9160,"Injection, daxibotulinumtoxina-lanm, 1 unit",09/11/2025
C9161,"Injection, aflibercept hd, 1 mg",09/11/2025
C9162,"Injection, avacincaptad pegol, 0.1 mg",09/11/2025
C9163,"Injection, talquetamab-tgvs, 0.25 mg",09/11/2025
C9164,"Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)",09/11/2025
C9165,"Injection, elranatamab-bcmm, 1 mg",09/11/2025
C9166,"Injection, secukinumab, intravenous, 1 mg",09/11/2025
C9167,"Injection, adamts13, recombinant-krhn, 10 iu",09/11/2025
C9168,"Injection, mirikizumab-mrkz, 1 mg",09/11/2025
C9169,"Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram",09/11/2025
C9170,"Injection, tarlatamab-dlle, 1 mg",09/11/2025
C9171,"Injection, pegulicianine, 1 mg",09/11/2025
C9172,"Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose",09/11/2025
C9173,"Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram",09/11/2025
C9174,"Injection, datopotamab deruxtecan-dlnk, 1 mg",09/11/2025
C9175,"Injection, treosulfan, 50 mg",09/11/2025
C9248,"Injection, clevidipine butyrate, 1 mg",09/11/2025
C9250,"Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml",09/11/2025
C9254,"Injection, lacosamide, 1 mg",09/11/2025
C9257,"Injection, bevacizumab, 0.25 mg",09/11/2025
C9275,"Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose",09/11/2025
C9285,"Lidocaine 70 mg/tetracaine 70 mg, per patch",09/11/2025
C9290,"Injection, bupivacaine liposome, 1 mg",09/11/2025
C9293,"Injection, glucarpidase, 10 units",09/11/2025
C9300,"Injection, indigotindisulfonate sodium, 1 mg",09/11/2025
C9301,"Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
C9302,"Injection, zanidatamab-hrii, 2 mg",09/11/2025
C9303,"Injection, zolbetuximab-clzb, 1 mg",09/11/2025
C9304,"Injection, marstacimab-hncq, 0.5 mg",09/11/2025
C9305,"Injection, nipocalimab-aahu, 3 mg",09/11/2025
C9306,"Injection, telisotuzumab vedotin-tllv, 1 mg",09/11/2025
C9349,"Puraply, and puraply antimicrobial, any type, per square centimeter",09/11/2025
C9352,"Microporous collagen implantable tube (neuragen nerve guide), per centimeter length",09/11/2025
C9353,"Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length",09/11/2025
C9354,"Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter",09/11/2025
C9355,"Collagen nerve cuff (neuromatrix), per 0.5 centimeter length",09/11/2025
C9356,"Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter",09/11/2025
C9358,"Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters",09/11/2025
C9359,"Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc",09/11/2025
C9360,"Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters",09/11/2025
C9361,"Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length",09/11/2025
C9362,"Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc",09/11/2025
C9363,"Skin substitute, integra meshed bilayer wound matrix, per square centimeter",09/11/2025
C9364,"Porcine implant, permacol, per square centimeter",09/11/2025
C9399,Unclassified drugs or biologicals,09/11/2025
C9407,"Iodine i-131 iobenguane, diagnostic, 1 millicurie",09/11/2025
C9408,"Iodine i-131 iobenguane, therapeutic, 1 millicurie",09/11/2025
C9441,"Injection, ferric carboxymaltose, 1 mg",09/11/2025
C9442,"Injection, belinostat, 10 mg",09/11/2025
C9443,"Injection, dalbavancin, 10 mg",09/11/2025
C9444,"Injection, oritavancin, 10 mg",09/11/2025
C9445,"Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units",09/11/2025
C9446,"Injection, tedizolid phosphate, 1 mg",09/11/2025
C9447,"Injection, phenylephrine and ketorolac, 4 ml vial",09/11/2025
C9448,"Netupitant 300 mg and palonosetron 0.5 mg, oral",09/11/2025
C9449,"Injection, blinatumomab, 1 mcg",09/11/2025
C9450,"Injection, fluocinolone acetonide intravitreal implant, 0.01 mg",09/11/2025
C9451,"Injection, peramivir, 1 mg",09/11/2025
C9452,"Injection, ceftolozane 50 mg and tazobactam 25 mg",09/11/2025
C9453,"Injection, nivolumab, 1 mg",09/11/2025
C9454,"Injection, pasireotide long acting, 1 mg",09/11/2025
C9455,"Injection, siltuximab, 10 mg",09/11/2025
C9456,"Injection, isavuconazonium sulfate, 1 mg",09/11/2025
C9457,"Injection, sulfur hexafluoride lipid microsphere, per ml",09/11/2025
C9458,"Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries",09/11/2025
C9459,"Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries",09/11/2025
C9460,"Injection, cangrelor, 1 mg",09/11/2025
C9461,"Choline c 11, diagnostic, per study dose",09/11/2025
C9462,"Injection, delafloxacin, 1 mg",09/11/2025
C9463,"Injection, aprepitant, 1 mg",09/11/2025
C9464,"Injection, rolapitant, 0.5 mg",09/11/2025
C9465,"Hyaluronan or derivative, durolane, for intra-articular injection, per dose",09/11/2025
C9466,"Injection, benralizumab, 1 mg",09/11/2025
C9467,"Injection, rituximab and hyaluronidase, 10 mg",09/11/2025
C9468,"Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.",09/11/2025
C9469,"Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg",09/11/2025
C9470,"Injection, aripiprazole lauroxil, 1 mg",09/11/2025
C9471,"Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg",09/11/2025
C9472,"Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)",09/11/2025
C9473,"Injection, mepolizumab, 1 mg",09/11/2025
C9474,"Injection, irinotecan liposome, 1 mg",09/11/2025
C9475,"Injection, necitumumab, 1 mg",09/11/2025
C9476,"Injection, daratumumab, 10 mg",09/11/2025
C9477,"Injection, elotuzumab, 1 mg",09/11/2025
C9478,"Injection, sebelipase alfa, 1 mg",09/11/2025
C9479,"Instillation, ciprofloxacin otic suspension, 6 mg",09/11/2025
C9480,"Injection, trabectedin, 0.1 mg",09/11/2025
C9481,"Injection, reslizumab, 1 mg",09/11/2025
C9482,"Injection, sotalol hydrochloride, 1 mg",09/11/2025
C9483,"Injection, atezolizumab, 10 mg",09/11/2025
C9484,"Injection, eteplirsen, 10 mg",09/11/2025
C9485,"Injection, olaratumab, 10 mg",09/11/2025
C9486,"Injection, granisetron extended release, 0.1 mg",09/11/2025
C9487,"Ustekinumab, for intravenous injection, 1 mg",09/11/2025
C9488,"Injection, conivaptan hydrochloride, 1 mg",09/11/2025
C9489,"Injection, nusinersen, 0.1 mg",09/11/2025
C9490,"Injection, bezlotoxumab, 10 mg",09/11/2025
C9491,"Injection, avelumab, 10 mg",09/11/2025
C9492,"Injection, durvalumab, 10 mg",09/11/2025
C9493,"Injection, edaravone, 1 mg",09/11/2025
C9494,"Injection, ocrelizumab, 1 mg",09/11/2025
C9497,"Loxapine, inhalation powder, 10 mg",09/11/2025
C9507,"Plasma, high titer covid-19 convalescent, each unit",09/11/2025
C9600,"Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch",09/11/2025
C9601,"Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)",09/11/2025
C9602,"Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch",09/11/2025
C9603,"Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)",09/11/2025
C9604,"Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel",09/11/2025
C9605,"Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)",09/11/2025
C9606,"Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel",09/11/2025
C9607,"Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel",09/11/2025
C9608,"Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)",09/11/2025
C9610,"Catheter, transluminal drug delivery with or without angioplasty, coronary, non-laser (insertable)",09/11/2025
C9724,Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy,09/11/2025
C9725,Placement of endorectal intracavitary applicator for high intensity brachytherapy,09/11/2025
C9726,"Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure",09/11/2025
C9727,Insertion of implants into the soft palate; minimum of three implants,09/11/2025
C9728,"Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple",09/11/2025
C9733,Non-ophthalmic fluorescent vascular angiography,09/11/2025
C9734,"Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance",09/11/2025
C9735,"Anoscopy; with directed submucosal injection(s), any substance",09/11/2025
C9737,"Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)",09/11/2025
C9738,Adjunctive blue light cystoscopy with fluorescent imaging agent  (list separately in addition to code for primary procedure),09/11/2025
C9739,"Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants",09/11/2025
C9740,"Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants",09/11/2025
C9741,"Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report",09/11/2025
C9742,"Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed",09/11/2025
C9743,Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies),09/11/2025
C9744,"Ultrasound, abdominal, with contrast",09/11/2025
C9745,"Nasal endoscopy, surgical; balloon dilation of eustachian tube",09/11/2025
C9746,"Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed",09/11/2025
C9747,"Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance",09/11/2025
C9748,Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy,09/11/2025
C9749,Repair of nasal vestibular lateral wall stenosis with implant(s),09/11/2025
C9750,Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode),09/11/2025
C9751,"Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including  fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s)",09/11/2025
C9752,"Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum",09/11/2025
C9753,"Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)",09/11/2025
C9754,"Creation of arteriovenous fistula,  percutaneous; direct, any site, including  all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed)",09/11/2025
C9755,"Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed",09/11/2025
C9756,Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure),09/11/2025
C9757,"Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect  measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar",09/11/2025
C9758,"Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study",09/11/2025
C9759,"Transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal, vascular wall and/or perivascular) therapy, any vessel, including radiological supervision and interpretation, when performed",09/11/2025
C9760,"Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study",09/11/2025
C9761,"Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and ureteral catheterization for steerable vacuum aspiration of the kidney, collecting system, ureter, bladder, and urethra if applicable (must use a steerable ureteral catheter)",09/11/2025
C9762,"Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging",09/11/2025
C9763,"Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging",09/11/2025
C9764,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel(s), when performed",09/11/2025
C9765,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed",09/11/2025
C9766,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel(s), when performed",09/11/2025
C9767,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed",09/11/2025
C9768,Endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method (list separately in addition to code for primary procedure),09/11/2025
C9769,"Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional struts",09/11/2025
C9770,"Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent",09/11/2025
C9771,"Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral",09/11/2025
C9772,"Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed",09/11/2025
C9773,"Revascularization, endovascular, open or percutaneous,  tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty  within the same vessel(s), when performed",09/11/2025
C9774,"Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel (s), when performed",09/11/2025
C9775,"Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel (s), when performed",09/11/2025
C9776,"Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure)",09/11/2025
C9777,"Esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy",09/11/2025
C9778,"Colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous)",09/11/2025
C9779,"Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed",09/11/2025
C9780,"Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance",09/11/2025
C9781,"Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed",09/11/2025
C9782,"Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study",09/11/2025
C9783,"Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study",09/11/2025
C9784,"Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components",09/11/2025
C9785,"Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components",09/11/2025
C9786,"Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report",09/11/2025
C9787,Gastric electrophysiology mapping with simultaneous patient symptom profiling,09/11/2025
C9788,"Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examination",09/11/2025
C9789,"Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed",09/11/2025
C9790,"Histotripsy (i.e., non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance",09/11/2025
C9791,"Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent",09/11/2025
C9792,"Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study)",09/11/2025
C9793,"3d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography and/or magnetic resonance imaging with report",09/11/2025
C9794,"Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)",09/11/2025
C9795,"Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions",09/11/2025
C9796,"Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (e.g., porcine small intestine submucosa [sis])",09/11/2025
C9797,"Vascular embolization or occlusion procedure with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction",09/11/2025
C9800,"Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies",09/11/2025
C9803,"Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source",09/11/2025
C9804,"Elastomeric infusion pump (e.g., on-q* pump with bolus), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",09/11/2025
C9806,"Rotary peristaltic infusion pump (e.g., ambit pump), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",09/11/2025
C9807,"Nerve stimulator, percutaneous, peripheral (e.g., sprint peripheral nerve stimulation system), including electrode and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",09/11/2025
C9808,"Nerve cryoablation probe (e.g., cryoice, cryosphere, cryosphere max, cryoice cryosphere, cryoice cryo2), including probe and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",09/11/2025
C9809,"Cryoablation needle (e.g., iovera system), including needle/tip and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",09/11/2025
C9898,Radiolabeled product provided during a hospital inpatient stay,09/11/2025
C9899,"Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage",09/11/2025
C9901,"Endoscopic defect closure within the entire gastrointestinal tract, including upper endoscopy (including diagnostic, if performed) or colonoscopy (including diagnostic, if performed), with all system and tissue anchoring components",09/11/2025
E0100,"Cane, includes canes of all materials, adjustable or fixed, with tip",09/11/2025
E0105,"Cane, quad or three prong, includes canes of all materials, adjustable or fixed, with tips",09/11/2025
E0110,"Crutches, forearm, includes crutches of various materials, adjustable or fixed, pair, complete with tips and handgrips",09/11/2025
E0111,"Crutch forearm, includes crutches of various materials, adjustable or fixed, each, with tip and handgrips",09/11/2025
E0112,"Crutches underarm, wood, adjustable or fixed, pair, with pads, tips and handgrips",09/11/2025
E0113,"Crutch underarm, wood, adjustable or fixed, each, with pad, tip and handgrip",09/11/2025
E0114,"Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips",09/11/2025
E0116,"Crutch, underarm, other than wood, adjustable or fixed, with pad, tip, handgrip, with or without shock absorber, each",09/11/2025
E0117,"Crutch, underarm, articulating, spring assisted, each",09/11/2025
E0118,"Crutch substitute, lower leg platform, with or without wheels, each",09/11/2025
E0130,"Walker, rigid (pickup), adjustable or fixed height",09/11/2025
E0135,"Walker, folding (pickup), adjustable or fixed height",09/11/2025
E0140,"Walker, with trunk support, adjustable or fixed height, any type",09/11/2025
E0141,"Walker, rigid, wheeled, adjustable or fixed height",09/11/2025
E0143,"Walker, folding, wheeled, adjustable or fixed height",09/11/2025
E0144,"Walker, enclosed, four sided framed, rigid or folding, wheeled with posterior seat",09/11/2025
E0147,"Walker, heavy duty, multiple braking system, variable wheel resistance",09/11/2025
E0148,"Walker, heavy duty, without wheels, rigid or folding, any type, each",09/11/2025
E0149,"Walker, heavy duty, wheeled, rigid or folding, any type",09/11/2025
E0150,"Combination wheeled walker with seat and transport chair, folding, adjustable or fixed height",09/11/2025
E0152,"Walker, battery powered, wheeled, folding, adjustable or fixed height",09/11/2025
E0153,"Platform attachment, forearm crutch, each",09/11/2025
E0154,"Platform attachment, walker, each",09/11/2025
E0155,"Wheel attachment, rigid pick-up walker, per pair",09/11/2025
E0156,"Seat attachment, walker",09/11/2025
E0157,"Crutch attachment, walker, each",09/11/2025
E0158,"Leg extensions for walker, per set of four (4)",09/11/2025
E0159,"Brake attachment for wheeled walker, replacement, each",09/11/2025
E0160,"Sitz type bath or equipment, portable, used with or without commode",09/11/2025
E0161,"Sitz type bath or equipment, portable, used with or without commode, with faucet attachment/s",09/11/2025
E0162,Sitz bath chair,09/11/2025
E0163,"Commode chair, mobile or stationary, with fixed arms",09/11/2025
E0165,"Commode chair, mobile or stationary, with detachable arms",09/11/2025
E0167,"Pail or pan for use with commode chair, replacement only",09/11/2025
E0168,"Commode chair, extra wide and/or heavy duty, stationary or mobile, with or without arms, any type, each",09/11/2025
E0170,"Commode chair with integrated seat lift mechanism, electric, any type",09/11/2025
E0171,"Commode chair with integrated seat lift mechanism, non-electric, any type",09/11/2025
E0172,"Seat lift mechanism placed over or on top of toilet, any type",09/11/2025
E0175,"Foot rest, for use with commode chair, each",09/11/2025
E0181,"Powered pressure reducing mattress overlay/pad, alternating, with pump, includes heavy duty",09/11/2025
E0182,"Pump for alternating pressure pad, for replacement only",09/11/2025
E0183,"Powered pressure reducing underlay/pad, alternating, with pump, includes heavy duty",09/11/2025
E0184,Dry pressure mattress,09/11/2025
E0185,"Gel or gel-like pressure pad for mattress, standard mattress length and width",09/11/2025
E0186,Air pressure mattress,09/11/2025
E0187,Water pressure mattress,09/11/2025
E0188,Synthetic sheepskin pad,09/11/2025
E0189,"Lambswool sheepskin pad, any size",09/11/2025
E0190,"Positioning cushion/pillow/wedge, any shape or size, includes all components and accessories",09/11/2025
E0191,"Heel or elbow protector, each",09/11/2025
E0193,Powered air flotation bed (low air loss therapy),09/11/2025
E0194,Air fluidized bed,09/11/2025
E0196,Gel pressure mattress,09/11/2025
E0197,"Air pressure pad for mattress, standard mattress length and width",09/11/2025
E0198,"Water pressure pad for mattress, standard mattress length and width",09/11/2025
E0199,"Dry pressure pad for mattress, standard mattress length and width",09/11/2025
E0200,"Heat lamp, without stand (table model), includes bulb, or infrared element",09/11/2025
E0201,"Penile contracture device, manual, greater than 3 lbs traction force",09/11/2025
E0202,Phototherapy (bilirubin) light with photometer,09/11/2025
E0203,"Therapeutic lightbox, minimum 10,000 lux, table top model",09/11/2025
E0205,"Heat lamp, with stand, includes bulb, or infrared element",09/11/2025
E0210,"Electric heat pad, standard",09/11/2025
E0215,"Electric heat pad, moist",09/11/2025
E0217,Water circulating heat pad with pump,09/11/2025
E0218,"Fluid circulating cold pad with pump, any type",09/11/2025
E0221,Infrared heating pad system,09/11/2025
E0225,"Hydrocollator unit, includes pads",09/11/2025
E0231,"Non-contact wound warming device (temperature control unit, ac adapter and power cord) for use with warming card and wound cover",09/11/2025
E0232,Warming card for use with the non contact wound warming device and non contact wound warming wound cover,09/11/2025
E0235,"Paraffin bath unit, portable (see medical supply code a4265 for paraffin)",09/11/2025
E0236,Pump for water circulating pad,09/11/2025
E0239,"Hydrocollator unit, portable",09/11/2025
E0240,"Bath/shower chair, with or without wheels, any size",09/11/2025
E0241,"Bath tub wall rail, each",09/11/2025
E0242,"Bath tub rail, floor base",09/11/2025
E0243,"Toilet rail, each",09/11/2025
E0244,Raised toilet seat,09/11/2025
E0245,Tub stool or bench,09/11/2025
E0246,Transfer tub rail attachment,09/11/2025
E0247,Transfer bench for tub or toilet with or without commode opening,09/11/2025
E0248,"Transfer bench, heavy duty, for tub or toilet with or without commode opening",09/11/2025
E0249,"Pad for water circulating heat unit, for replacement only",09/11/2025
E0250,"Hospital bed, fixed height, with any type side rails, with mattress",09/11/2025
E0251,"Hospital bed, fixed height, with any type side rails, without mattress",09/11/2025
E0255,"Hospital bed, variable height, hi-lo, with any type side rails, with mattress",09/11/2025
E0256,"Hospital bed, variable height, hi-lo, with any type side rails, without mattress",09/11/2025
E0260,"Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress",09/11/2025
E0261,"Hospital bed, semi-electric (head and foot adjustment), with any type side rails, without mattress",09/11/2025
E0265,"Hospital bed, total electric (head, foot and height adjustments), with any type side rails, with mattress",09/11/2025
E0266,"Hospital bed, total electric (head, foot and height adjustments), with any type side rails, without mattress",09/11/2025
E0270,"Hospital bed, institutional type includes: oscillating, circulating and stryker frame, with mattress",09/11/2025
E0271,"Mattress, innerspring",09/11/2025
E0272,"Mattress, foam rubber",09/11/2025
E0273,Bed board,09/11/2025
E0274,Over-bed table,09/11/2025
E0275,"Bed pan, standard, metal or plastic",09/11/2025
E0276,"Bed pan, fracture, metal or plastic",09/11/2025
E0277,Powered pressure-reducing air mattress,09/11/2025
E0280,"Bed cradle, any type",09/11/2025
E0290,"Hospital bed, fixed height, without side rails, with mattress",09/11/2025
E0291,"Hospital bed, fixed height, without side rails, without mattress",09/11/2025
E0292,"Hospital bed, variable height, hi-lo, without side rails, with mattress",09/11/2025
E0293,"Hospital bed, variable height, hi-lo, without side rails, without mattress",09/11/2025
E0294,"Hospital bed, semi-electric (head and foot adjustment), without side rails, with mattress",09/11/2025
E0295,"Hospital bed, semi-electric (head and foot adjustment), without side rails, without mattress",09/11/2025
E0296,"Hospital bed, total electric (head, foot and height adjustments), without side rails, with mattress",09/11/2025
E0297,"Hospital bed, total electric (head, foot and height adjustments), without side rails, without mattress",09/11/2025
E0300,"Pediatric crib, hospital grade, fully enclosed, with or without top enclosure",09/11/2025
E0301,"Hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, without mattress",09/11/2025
E0302,"Hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, without mattress",09/11/2025
E0303,"Hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, with mattress",09/11/2025
E0304,"Hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, with mattress",09/11/2025
E0305,"Bed side rails, half length",09/11/2025
E0310,"Bed side rails, full length",09/11/2025
E0315,"Bed accessory: board, table, or support device, any type",09/11/2025
E0316,"Safety enclosure frame/canopy for use with hospital bed, any type",09/11/2025
E0325,"Urinal; male, jug-type, any material",09/11/2025
E0326,"Urinal; female, jug-type, any material",09/11/2025
E0328,"Hospital bed, pediatric, manual, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress",09/11/2025
E0329,"Hospital bed, pediatric, electric or semi-electric, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress",09/11/2025
E0350,Control unit for electronic bowel irrigation/evacuation system,09/11/2025
E0352,"Disposable pack (water reservoir bag, speculum, valving mechanism and collection bag/box) for use with the electronic bowel irrigation/evacuation system",09/11/2025
E0370,Air pressure elevator for heel,09/11/2025
E0371,"Nonpowered advanced pressure reducing overlay for mattress, standard mattress length and width",09/11/2025
E0372,"Powered air overlay for mattress, standard mattress length and width",09/11/2025
E0373,Nonpowered advanced pressure reducing mattress,09/11/2025
E0424,"Stationary compressed gaseous oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing",09/11/2025
E0425,"Stationary compressed gas system, purchase; includes regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing",09/11/2025
E0430,"Portable gaseous oxygen system, purchase; includes regulator, flowmeter, humidifier, cannula or mask, and tubing",09/11/2025
E0431,"Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing",09/11/2025
E0433,"Portable liquid oxygen system, rental; home liquefier used to fill portable liquid oxygen containers, includes portable containers, regulator, flowmeter, humidifier, cannula or mask and tubing, with or without supply reservoir and contents gauge",09/11/2025
E0434,"Portable liquid oxygen system, rental; includes portable container, supply reservoir, humidifier, flowmeter, refill adaptor, contents gauge, cannula or mask, and tubing",09/11/2025
E0435,"Portable liquid oxygen system, purchase; includes portable container, supply reservoir, flowmeter, humidifier, contents gauge, cannula or mask, tubing and refill adaptor",09/11/2025
E0439,"Stationary liquid oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, & tubing",09/11/2025
E0440,"Stationary liquid oxygen system, purchase; includes use of reservoir, contents indicator, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing",09/11/2025
E0441,"Stationary oxygen contents, gaseous, 1 month's supply = 1 unit",09/11/2025
E0442,"Stationary oxygen contents, liquid, 1 month's supply = 1 unit",09/11/2025
E0443,"Portable oxygen contents, gaseous, 1 month's supply = 1 unit",09/11/2025
E0444,"Portable oxygen contents, liquid, 1 month's supply = 1 unit",09/11/2025
E0445,Oximeter device for measuring blood oxygen levels non-invasively,09/11/2025
E0446,"Topical oxygen delivery system, not otherwise specified, includes all supplies and accessories",09/11/2025
E0447,"Portable oxygen contents, liquid, 1 month's supply = 1 unit, prescribed amount at rest or nighttime exceeds 4 liters per minute (lpm)",09/11/2025
E0450,"Volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)",09/11/2025
E0455,"Oxygen tent, excluding croup or pediatric tents",09/11/2025
E0457,Chest shell (cuirass),09/11/2025
E0459,Chest wrap,09/11/2025
E0460,Negative pressure ventilator; portable or stationary,09/11/2025
E0461,"Volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask)",09/11/2025
E0462,Rocking bed with or without side rails,09/11/2025
E0463,"Pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)",09/11/2025
E0464,"Pressure support ventilator with volume control mode, may include pressure control mode, used with non-invasive interface (e.g., mask)",09/11/2025
E0465,"Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)",09/11/2025
E0466,"Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)",09/11/2025
E0467,"Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation, includes all accessories, components and supplies for all functions",09/11/2025
E0468,"Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation, includes all accessories, components and supplies for all functions",09/11/2025
E0469,"Lung expansion airway clearance, continuous high frequency oscillation, and nebulization device",09/11/2025
E0470,"Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)",09/11/2025
E0471,"Respiratory assist device, bi-level pressure capability, with back-up rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)",09/11/2025
E0472,"Respiratory assist device, bi-level pressure capability, with backup rate feature, used with invasive interface, e.g., tracheostomy tube (intermittent assist device with continuous positive airway pressure device)",09/11/2025
E0480,"Percussor, electric or pneumatic, home model",09/11/2025
E0481,Intrapulmonary percussive ventilation system and related accessories,09/11/2025
E0482,"Cough stimulating device, alternating positive and negative airway pressure",09/11/2025
E0483,"High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each",09/11/2025
E0484,"Oscillatory positive expiratory pressure device, non-electric, any type, each",09/11/2025
E0485,"Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, prefabricated, includes fitting and adjustment",09/11/2025
E0486,"Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, custom fabricated, includes fitting and adjustment",09/11/2025
E0487,"Spirometer, electronic, includes all accessories",09/11/2025
E0490,"Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by hardware remote",09/11/2025
E0491,"Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by hardware remote, 90-day supply",09/11/2025
E0492,"Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application",09/11/2025
E0493,"Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply",09/11/2025
E0500,"Ippb machine, all types, with built-in nebulization; manual or automatic valves; internal or external power source",09/11/2025
E0530,"Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type",09/11/2025
E0550,"Humidifier, durable for extensive supplemental humidification during ippb treatments or oxygen delivery",09/11/2025
E0555,"Humidifier, durable, glass or autoclavable plastic bottle type, for use with regulator or flowmeter",09/11/2025
E0560,"Humidifier, durable for supplemental humidification during ippb treatment or oxygen delivery",09/11/2025
E0561,"Humidifier, non-heated, used with positive airway pressure device",09/11/2025
E0562,"Humidifier, heated, used with positive airway pressure device",09/11/2025
E0565,"Compressor, air power source for equipment which is not self-contained or cylinder driven",09/11/2025
E0570,"Nebulizer, with compressor",09/11/2025
E0572,"Aerosol compressor, adjustable pressure, light duty for intermittent use",09/11/2025
E0574,Ultrasonic/electronic aerosol generator with small volume nebulizer,09/11/2025
E0575,"Nebulizer, ultrasonic, large volume",09/11/2025
E0580,"Nebulizer, durable, glass or autoclavable plastic, bottle type, for use with regulator or flowmeter",09/11/2025
E0585,"Nebulizer, with compressor and heater",09/11/2025
E0600,"Respiratory suction pump, home model, portable or stationary, electric",09/11/2025
E0601,Continuous positive airway pressure (cpap) device,09/11/2025
E0602,"Breast pump, manual, any type",09/11/2025
E0603,"Breast pump, electric (ac and/or dc), any type",09/11/2025
E0604,"Breast pump, hospital grade, electric (ac and / or dc), any type",09/11/2025
E0605,"Vaporizer, room type",09/11/2025
E0606,Postural drainage board,09/11/2025
E0607,Home blood glucose monitor,09/11/2025
E0610,"Pacemaker monitor, self-contained, (checks battery depletion, includes audible and visible check systems)",09/11/2025
E0615,"Pacemaker monitor, self contained, checks battery depletion and other pacemaker components, includes digital/visible check systems",09/11/2025
E0616,"Implantable cardiac event recorder with memory, activator and programmer",09/11/2025
E0617,External defibrillator with integrated electrocardiogram analysis,09/11/2025
E0618,"Apnea monitor, without recording feature",09/11/2025
E0619,"Apnea monitor, with recording feature",09/11/2025
E0620,"Skin piercing device for collection of capillary blood, laser, each",09/11/2025
E0621,"Sling or seat, patient lift, canvas or nylon",09/11/2025
E0625,"Patient lift, bathroom or toilet, not otherwise classified",09/11/2025
E0627,"Seat lift mechanism, electric, any type",09/11/2025
E0628,Separate seat lift mechanism for use with patient owned furniture-electric,09/11/2025
E0629,"Seat lift mechanism, non-electric, any type",09/11/2025
E0630,"Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)",09/11/2025
E0635,"Patient lift, electric with seat or sling",09/11/2025
E0636,"Multipositional patient support system, with integrated lift, patient accessible controls",09/11/2025
E0637,"Combination sit to stand frame/table system, any size including pediatric, with seat lift feature, with or without wheels",09/11/2025
E0638,"Standing frame/table system, one position (e.g., upright, supine or prone stander), any size including pediatric, with or without wheels",09/11/2025
E0639,"Patient lift, moveable from room to room with disassembly and reassembly, includes all components/accessories",09/11/2025
E0640,"Patient lift, fixed system, includes all components/accessories",09/11/2025
E0641,"Standing frame/table system, multi-position (e.g., three-way stander), any size including pediatric, with or without wheels",09/11/2025
E0642,"Standing frame/table system, mobile (dynamic stander), any size including pediatric",09/11/2025
E0650,"Pneumatic compressor, non-segmental home model",09/11/2025
E0651,"Pneumatic compressor, segmental home model without calibrated gradient pressure",09/11/2025
E0652,"Pneumatic compressor, segmental home model with calibrated gradient pressure",09/11/2025
E0655,"Non-segmental pneumatic appliance for use with pneumatic compressor, half arm",09/11/2025
E0656,"Segmental pneumatic appliance for use with pneumatic compressor, trunk",09/11/2025
E0657,"Segmental pneumatic appliance for use with pneumatic compressor, chest",09/11/2025
E0658,"Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest",09/11/2025
E0659,"Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest",09/11/2025
E0660,"Non-segmental pneumatic appliance for use with pneumatic compressor, full leg",09/11/2025
E0665,"Non-segmental pneumatic appliance for use with pneumatic compressor, full arm",09/11/2025
E0666,"Non-segmental pneumatic appliance for use with pneumatic compressor, half leg",09/11/2025
E0667,"Segmental pneumatic appliance for use with pneumatic compressor, full leg",09/11/2025
E0668,"Segmental pneumatic appliance for use with pneumatic compressor, full arm",09/11/2025
E0669,"Segmental pneumatic appliance for use with pneumatic compressor, half leg",09/11/2025
E0670,"Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full legs and trunk",09/11/2025
E0671,"Segmental gradient pressure pneumatic appliance, full leg",09/11/2025
E0672,"Segmental gradient pressure pneumatic appliance, full arm",09/11/2025
E0673,"Segmental gradient pressure pneumatic appliance, half leg",09/11/2025
E0675,"Pneumatic compression device, high pressure, rapid inflation/deflation cycle, for arterial insufficiency (unilateral or bilateral system)",09/11/2025
E0676,"Intermittent limb compression device (includes all accessories), not otherwise specified",09/11/2025
E0677,"Non-pneumatic sequential compression garment, trunk",09/11/2025
E0678,"Non-pneumatic sequential compression garment, full leg",09/11/2025
E0679,"Non-pneumatic sequential compression garment, half leg",09/11/2025
E0680,Non-pneumatic compression controller with sequential calibrated gradient pressure,09/11/2025
E0681,Non-pneumatic compression controller without calibrated gradient pressure,09/11/2025
E0682,"Non-pneumatic sequential compression garment, full arm",09/11/2025
E0683,"Non-pneumatic, non-sequential, peristaltic wave compression pump",09/11/2025
E0691,"Ultraviolet light therapy system, includes bulbs/lamps, timer and eye protection; treatment area 2 square feet or less",09/11/2025
E0692,"Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 4 foot panel",09/11/2025
E0693,"Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 6 foot panel",09/11/2025
E0694,"Ultraviolet multidirectional light therapy system in 6 foot cabinet, includes bulbs/lamps, timer and eye protection",09/11/2025
E0700,"Safety equipment, device or accessory, any type",09/11/2025
E0705,"Transfer device, any type, each",09/11/2025
E0710,"Restraints, any type (body, chest, wrist or ankle)",09/11/2025
E0711,"Upper extremity medical tubing/lines enclosure or covering device, restricts elbow range of motion",09/11/2025
E0715,Intravaginal device intended to strengthen pelvic floor muscles during kegel exercises,09/11/2025
E0716,Supplies and accessories for intravaginal device intended to strengthen pelvic floor muscles during kegel exercises,09/11/2025
E0720,"Transcutaneous electrical nerve stimulation (tens) device, two lead, localized stimulation",09/11/2025
E0721,Transcutaneous electrical nerve stimulator for nerves in the auricular region,09/11/2025
E0730,"Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation",09/11/2025
E0731,Form fitting conductive garment for delivery of tens or nmes (with conductive fibers separated from the patient's skin by layers of fabric),09/11/2025
E0732,"Cranial electrotherapy stimulation (ces) system, any type",09/11/2025
E0733,Transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerve,09/11/2025
E0734,External upper limb tremor stimulator of the peripheral nerves of the wrist,09/11/2025
E0735,Non-invasive vagus nerve stimulator,09/11/2025
E0736,Transcutaneous tibial nerve stimulator,09/11/2025
E0737,"Transcutaneous tibial nerve stimulator, controlled by phone application",09/11/2025
E0738,"Upper extremity rehabilitation system providing active assistance to facilitate muscle re-education, include microprocessor, all components and accessories",09/11/2025
E0739,"Rehabilitation system with interactive interface providing active assistance in rehabilitation therapy, includes all components and accessories, motors, microprocessors, sensors",09/11/2025
E0740,"Non-implanted pelvic floor electrical stimulator, complete system",09/11/2025
E0743,"External lower extremity nerve stimulator for restless legs syndrome, each",09/11/2025
E0744,Neuromuscular stimulator for scoliosis,09/11/2025
E0745,"Neuromuscular stimulator, electronic shock unit",09/11/2025
E0746,"Electromyography (emg), biofeedback device",09/11/2025
E0747,"Osteogenesis stimulator, electrical, non-invasive, other than spinal applications",09/11/2025
E0748,"Osteogenesis stimulator, electrical, non-invasive, spinal applications",09/11/2025
E0749,"Osteogenesis stimulator, electrical, surgically implanted",09/11/2025
E0755,Electronic salivary reflex stimulator (intra-oral/non-invasive),09/11/2025
E0760,"Osteogenesis stimulator, low intensity ultrasound, non-invasive",09/11/2025
E0761,"Non-thermal pulsed high frequency radiowaves, high peak power electromagnetic energy treatment device",09/11/2025
E0762,"Transcutaneous electrical joint stimulation device system, includes all accessories",09/11/2025
E0764,"Functional neuromuscular stimulation, transcutaneous stimulation of sequential muscle groups of ambulation with computer control, used for walking by spinal cord injured, entire system, after completion of training program",09/11/2025
E0765,"Fda approved nerve stimulator, for treatment of nausea and vomiting",09/11/2025
E0766,"Electrical stimulation device used for cancer treatment, includes all accessories, any type",09/11/2025
E0767,"Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories",09/11/2025
E0769,"Electrical stimulation or electromagnetic wound treatment device, not otherwise classified",09/11/2025
E0770,"Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specified",09/11/2025
E0776,Iv pole,09/11/2025
E0779,"Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater",09/11/2025
E0780,"Ambulatory infusion pump, mechanical, reusable, for infusion less than 8 hours",09/11/2025
E0781,"Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient",09/11/2025
E0782,"Infusion pump, implantable, non-programmable (includes all components, e.g., pump, catheter, connectors, etc.)",09/11/2025
E0783,"Infusion pump system, implantable, programmable (includes all components, e.g., pump, catheter, connectors, etc.)",09/11/2025
E0784,"External ambulatory infusion pump, insulin",09/11/2025
E0785,"Implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement",09/11/2025
E0786,"Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter)",09/11/2025
E0787,"External ambulatory infusion pump, insulin, dosage rate adjustment using therapeutic continuous glucose sensing",09/11/2025
E0791,"Parenteral infusion pump, stationary, single or multi-channel",09/11/2025
E0830,"Ambulatory traction device, all types, each",09/11/2025
E0840,"Traction frame, attached to headboard, cervical traction",09/11/2025
E0849,"Traction equipment, cervical, free-standing stand/frame, pneumatic, applying traction force to other than mandible",09/11/2025
E0850,"Traction stand, free standing, cervical traction",09/11/2025
E0855,Cervical traction equipment not requiring additional stand or frame,09/11/2025
E0856,"Cervical traction device, with inflatable air bladder(s)",09/11/2025
E0860,"Traction equipment, overdoor, cervical",09/11/2025
E0870,"Traction frame, attached to footboard, extremity traction, (e.g., buck's)",09/11/2025
E0880,"Traction stand, free standing, extremity traction",09/11/2025
E0890,"Traction frame, attached to footboard, pelvic traction",09/11/2025
E0900,"Traction stand, free standing, pelvic traction, (e.g., buck's)",09/11/2025
E0910,"Trapeze bars, a/k/a patient helper, attached to bed, with grab bar",09/11/2025
E0911,"Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, attached to bed, with grab bar",09/11/2025
E0912,"Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, free standing, complete with grab bar",09/11/2025
E0920,"Fracture frame, attached to bed, includes weights",09/11/2025
E0930,"Fracture frame, free standing, includes weights",09/11/2025
E0935,Continuous passive motion exercise device for use on knee only,09/11/2025
E0936,Continuous passive motion exercise device for use other than knee,09/11/2025
E0940,"Trapeze bar, free standing, complete with grab bar",09/11/2025
E0941,"Gravity assisted traction device, any type",09/11/2025
E0942,Cervical head harness/halter,09/11/2025
E0944,Pelvic belt/harness/boot,09/11/2025
E0945,Extremity belt/harness,09/11/2025
E0946,"Fracture, frame, dual with cross bars, attached to bed, (e.g., balken, 4 poster)",09/11/2025
E0947,"Fracture frame, attachments for complex pelvic traction",09/11/2025
E0948,"Fracture frame, attachments for complex cervical traction",09/11/2025
E0950,"Wheelchair accessory, tray, each",09/11/2025
E0951,"Heel loop/holder, any type, with or without ankle strap, each",09/11/2025
E0952,"Toe loop/holder, any type, each",09/11/2025
E0953,"Wheelchair accessory, lateral thigh or knee support, any type including fixed mounting hardware, each",09/11/2025
E0954,"Wheelchair accessory, foot box, any type, includes attachment and mounting hardware, each foot",09/11/2025
E0955,"Wheelchair accessory, headrest, cushioned, any type, including fixed mounting hardware, each",09/11/2025
E0956,"Wheelchair accessory, lateral trunk or hip support, any type, including fixed mounting hardware, each",09/11/2025
E0957,"Wheelchair accessory, medial thigh support, any type, including fixed mounting hardware, each",09/11/2025
E0958,"Manual wheelchair accessory, one-arm drive attachment, each",09/11/2025
E0959,"Manual wheelchair accessory, adapter for amputee, each",09/11/2025
E0960,"Wheelchair accessory, shoulder harness/straps or chest strap, including any type mounting hardware",09/11/2025
E0961,"Manual wheelchair accessory, wheel lock brake extension (handle), each",09/11/2025
E0966,"Manual wheelchair accessory, headrest extension, each",09/11/2025
E0967,"Manual wheelchair accessory, hand rim with projections, any type, replacement only, each",09/11/2025
E0968,"Commode seat, wheelchair",09/11/2025
E0969,"Narrowing device, wheelchair",09/11/2025
E0970,"No. 2 footplates, except for elevating leg rest",09/11/2025
E0971,"Manual wheelchair accessory, anti-tipping device, each",09/11/2025
E0973,"Wheelchair accessory, adjustable height, detachable armrest, complete assembly, each",09/11/2025
E0974,"Manual wheelchair accessory, anti-rollback device, each",09/11/2025
E0978,"Wheelchair accessory, positioning belt/safety belt/pelvic strap, each",09/11/2025
E0980,"Safety vest, wheelchair",09/11/2025
E0981,"Wheelchair accessory, seat upholstery, replacement only, each",09/11/2025
E0982,"Wheelchair accessory, back upholstery, replacement only, each",09/11/2025
E0983,"Manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, joystick control",09/11/2025
E0984,"Manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, tiller control",09/11/2025
E0985,"Wheelchair accessory, seat lift mechanism",09/11/2025
E0986,"Manual wheelchair accessory, power assist system",09/11/2025
E0988,"Manual wheelchair accessory, lever-activated, wheel drive, pair",09/11/2025
E0990,"Wheelchair accessory, elevating leg rest, complete assembly, each",09/11/2025
E0992,"Manual wheelchair accessory, solid seat insert",09/11/2025
E0994,"Arm rest, each",09/11/2025
E0995,"Wheelchair accessory, calf rest/pad, replacement only, each",09/11/2025
E1002,"Wheelchair accessory, power seating system, tilt only",09/11/2025
E1003,"Wheelchair accessory, power seating system, recline only, without shear reduction",09/11/2025
E1004,"Wheelchair accessory, power seating system, recline only, with mechanical shear reduction",09/11/2025
E1005,"Wheelchair accessory, power seating system, recline only, with power shear reduction",09/11/2025
E1006,"Wheelchair accessory, power seating system, combination tilt and recline, without shear reduction",09/11/2025
E1007,"Wheelchair accessory, power seating system, combination tilt and recline, with mechanical shear reduction",09/11/2025
E1008,"Wheelchair accessory, power seating system, combination tilt and recline, with power shear reduction",09/11/2025
E1009,"Wheelchair accessory, addition to power seating system, mechanically linked leg elevation system, including pushrod and leg rest, each",09/11/2025
E1010,"Wheelchair accessory, addition to power seating system, power leg elevation system, including leg rest, pair",09/11/2025
E1011,"Modification to pediatric size wheelchair, width adjustment package (not to be dispensed with initial chair)",09/11/2025
E1012,"Wheelchair accessory, addition to power seating system, center mount power elevating leg rest/platform, complete system, any type, each",09/11/2025
E1014,"Reclining back, addition to pediatric size wheelchair",09/11/2025
E1015,"Shock absorber for manual wheelchair, each",09/11/2025
E1016,"Shock absorber for power wheelchair, each",09/11/2025
E1017,"Heavy duty shock absorber for heavy duty or extra heavy duty manual wheelchair, each",09/11/2025
E1018,"Heavy duty shock absorber for heavy duty or extra heavy duty power wheelchair, each",09/11/2025
E1020,"Residual limb support system for wheelchair, any type",09/11/2025
E1022,"Wheelchair transportation securement system, any type includes all components and accessories",09/11/2025
E1023,"Wheelchair transit securement system, includes all components and accessories",09/11/2025
E1028,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware, other",09/11/2025
E1029,"Wheelchair accessory, ventilator tray, fixed",09/11/2025
E1030,"Wheelchair accessory, ventilator tray, gimbaled",09/11/2025
E1031,"Rollabout chair, any and all types with casters 5"" or greater",09/11/2025
E1032,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware used with joystick or other drive control interface",09/11/2025
E1033,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for headrest, cushioned, any type",09/11/2025
E1034,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for lateral trunk or hip support, any type",09/11/2025
E1035,"Multi-positional patient transfer system, with integrated seat, operated by care giver, patient weight capacity up to and including 300 lbs",09/11/2025
E1036,"Multi-positional patient transfer system, extra-wide, with integrated seat, operated by caregiver, patient weight capacity greater than 300 lbs",09/11/2025
E1037,"Transport chair, pediatric size",09/11/2025
E1038,"Transport chair, adult size, patient weight capacity up to and including 300 pounds",09/11/2025
E1039,"Transport chair, adult size, heavy duty, patient weight capacity greater than 300 pounds",09/11/2025
E1050,"Fully-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests",09/11/2025
E1060,"Fully-reclining wheelchair, detachable arms, desk or full length, swing away detachable elevating legrests",09/11/2025
E1070,"Fully-reclining wheelchair, detachable arms (desk or full length) swing away detachable footrest",09/11/2025
E1083,"Hemi-wheelchair, fixed full length arms, swing away detachable elevating leg rest",09/11/2025
E1084,"Hemi-wheelchair, detachable arms desk or full length arms, swing away detachable elevating leg rests",09/11/2025
E1085,"Hemi-wheelchair, fixed full length arms, swing away detachable foot rests",09/11/2025
E1086,"Hemi-wheelchair detachable arms desk or full length, swing away detachable footrests",09/11/2025
E1087,"High strength lightweight wheelchair, fixed full length arms, swing away detachable elevating leg rests",09/11/2025
E1088,"High strength lightweight wheelchair, detachable arms desk or full length, swing away detachable elevating leg rests",09/11/2025
E1089,"High strength lightweight wheelchair, fixed length arms, swing away detachable footrest",09/11/2025
E1090,"High strength lightweight wheelchair, detachable arms desk or full length, swing away detachable foot rests",09/11/2025
E1092,"Wide heavy duty wheel chair, detachable arms (desk or full length), swing away detachable elevating leg rests",09/11/2025
E1093,"Wide heavy duty wheelchair, detachable arms desk or full length arms, swing away detachable footrests",09/11/2025
E1100,"Semi-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests",09/11/2025
E1110,"Semi-reclining wheelchair, detachable arms (desk or full length) elevating leg rest",09/11/2025
E1130,"Standard wheelchair, fixed full length arms, fixed or swing away detachable footrests",09/11/2025
E1140,"Wheelchair, detachable arms, desk or full length, swing away detachable footrests",09/11/2025
E1150,"Wheelchair, detachable arms, desk or full length swing away detachable elevating legrests",09/11/2025
E1160,"Wheelchair, fixed full length arms, swing away detachable elevating legrests",09/11/2025
E1161,"Manual adult size wheelchair, includes tilt in space",09/11/2025
E1170,"Amputee wheelchair, fixed full length arms, swing away detachable elevating legrests",09/11/2025
E1171,"Amputee wheelchair, fixed full length arms, without footrests or legrest",09/11/2025
E1172,"Amputee wheelchair, detachable arms (desk or full length) without footrests or legrest",09/11/2025
E1180,"Amputee wheelchair, detachable arms (desk or full length) swing away detachable footrests",09/11/2025
E1190,"Amputee wheelchair, detachable arms (desk or full length) swing away detachable elevating legrests",09/11/2025
E1195,"Heavy duty wheelchair, fixed full length arms, swing away detachable elevating legrests",09/11/2025
E1200,"Amputee wheelchair, fixed full length arms, swing away detachable footrest",09/11/2025
E1220,"Wheelchair; specially sized or constructed, (indicate brand name, model number, if any) and justification",09/11/2025
E1221,"Wheelchair with fixed arm, footrests",09/11/2025
E1222,"Wheelchair with fixed arm, elevating legrests",09/11/2025
E1223,"Wheelchair with detachable arms, footrests",09/11/2025
E1224,"Wheelchair with detachable arms, elevating legrests",09/11/2025
E1225,"Wheelchair accessory, manual semi-reclining back, (recline greater than 15 degrees, but less than 80 degrees), each",09/11/2025
E1226,"Wheelchair accessory, manual fully reclining back, (recline greater than 80 degrees), each",09/11/2025
E1227,Special height arms for wheelchair,09/11/2025
E1228,Special back height for wheelchair,09/11/2025
E1229,"Wheelchair, pediatric size, not otherwise specified",09/11/2025
E1230,Power operated vehicle (three or four wheel nonhighway) specify brand name and model number,09/11/2025
E1231,"Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, with seating system",09/11/2025
E1232,"Wheelchair, pediatric size, tilt-in-space, folding, adjustable, with seating system",09/11/2025
E1233,"Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, without seating system",09/11/2025
E1234,"Wheelchair, pediatric size, tilt-in-space, folding, adjustable, without seating system",09/11/2025
E1235,"Wheelchair, pediatric size, rigid, adjustable, with seating system",09/11/2025
E1236,"Wheelchair, pediatric size, folding, adjustable, with seating system",09/11/2025
E1237,"Wheelchair, pediatric size, rigid, adjustable, without seating system",09/11/2025
E1238,"Wheelchair, pediatric size, folding, adjustable, without seating system",09/11/2025
E1239,"Power wheelchair, pediatric size, not otherwise specified",09/11/2025
E1240,"Lightweight wheelchair, detachable arms, (desk or full length) swing away detachable, elevating legrest",09/11/2025
E1250,"Lightweight wheelchair, fixed full length arms, swing away detachable footrest",09/11/2025
E1260,"Lightweight wheelchair, detachable arms (desk or full length) swing away detachable footrest",09/11/2025
E1270,"Lightweight wheelchair, fixed full length arms, swing away detachable elevating legrests",09/11/2025
E1280,"Heavy duty wheelchair, detachable arms (desk or full length) elevating legrests",09/11/2025
E1285,"Heavy duty wheelchair, fixed full length arms, swing away detachable footrest",09/11/2025
E1290,"Heavy duty wheelchair, detachable arms (desk or full length) swing away detachable footrest",09/11/2025
E1295,"Heavy duty wheelchair, fixed full length arms, elevating legrest",09/11/2025
E1296,Special wheelchair seat height from floor,09/11/2025
E1297,"Special wheelchair seat depth, by upholstery",09/11/2025
E1298,"Special wheelchair seat depth and/or width, by construction",09/11/2025
E1300,"Whirlpool, portable (overtub type)",09/11/2025
E1301,"Whirlpool tub, walk-in, portable",09/11/2025
E1310,"Whirlpool, non-portable (built-in type)",09/11/2025
E1352,"Oxygen accessory, flow regulator capable of positive inspiratory pressure",09/11/2025
E1353,Regulator,09/11/2025
E1354,"Oxygen accessory, wheeled cart for portable cylinder or portable concentrator, any type, replacement only, each",09/11/2025
E1355,Stand/rack,09/11/2025
E1356,"Oxygen accessory, battery pack/cartridge for portable concentrator, any type, replacement only, each",09/11/2025
E1357,"Oxygen accessory, battery charger for portable concentrator, any type, replacement only, each",09/11/2025
E1358,"Oxygen accessory, dc power adapter for portable concentrator, any type, replacement only, each",09/11/2025
E1372,Immersion external heater for nebulizer,09/11/2025
E1390,"Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate",09/11/2025
E1391,"Oxygen concentrator, dual delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate, each",09/11/2025
E1392,"Portable oxygen concentrator, rental",09/11/2025
E1399,"Durable medical equipment, miscellaneous",09/11/2025
E1405,Oxygen and water vapor enriching system with heated delivery,09/11/2025
E1406,Oxygen and water vapor enriching system without heated delivery,09/11/2025
E1500,"Centrifuge, for dialysis",09/11/2025
E1510,"Kidney, dialysate delivery syst kidney machine, pump recirculating, air removal syst, flowrate meter, power off, heater and temperature control with alarm, i.v. poles, pressure gauge, concentrate container",09/11/2025
E1520,Heparin infusion pump for hemodialysis,09/11/2025
E1530,"Air bubble detector for hemodialysis, each, replacement",09/11/2025
E1540,"Pressure alarm for hemodialysis, each, replacement",09/11/2025
E1550,"Bath conductivity meter for hemodialysis, each",09/11/2025
E1560,"Blood leak detector for hemodialysis, each, replacement",09/11/2025
E1570,"Adjustable chair, for esrd patients",09/11/2025
E1575,"Transducer protectors/fluid barriers, for hemodialysis, any size, per 10",09/11/2025
E1580,Unipuncture control system for hemodialysis,09/11/2025
E1590,Hemodialysis machine,09/11/2025
E1592,Automatic intermittent peritoneal dialysis system,09/11/2025
E1594,Cycler dialysis machine for peritoneal dialysis,09/11/2025
E1600,Delivery and/or installation charges for hemodialysis equipment,09/11/2025
E1610,"Reverse osmosis water purification system, for hemodialysis",09/11/2025
E1615,"Deionizer water purification system, for hemodialysis",09/11/2025
E1620,"Blood pump for hemodialysis, replacement",09/11/2025
E1625,"Water softening system, for hemodialysis",09/11/2025
E1629,Tablo hemodialysis system for the billable dialysis service,09/11/2025
E1630,Reciprocating peritoneal dialysis system,09/11/2025
E1632,"Wearable artificial kidney, each",09/11/2025
E1634,"Peritoneal dialysis clamps, each",09/11/2025
E1635,Compact (portable) travel hemodialyzer system,09/11/2025
E1636,"Sorbent cartridges, for hemodialysis, per 10",09/11/2025
E1637,"Hemostats, each",09/11/2025
E1639,"Scale, each",09/11/2025
E1699,"Dialysis equipment, not otherwise specified",09/11/2025
E1700,Jaw motion rehabilitation system,09/11/2025
E1701,"Replacement cushions for jaw motion rehabilitation system, pkg. of 6",09/11/2025
E1702,"Replacement measuring scales for jaw motion rehabilitation system, pkg. of 200",09/11/2025
E1800,"Dynamic adjustable elbow extension and flexion device, includes soft interface material",09/11/2025
E1801,"Static progressive stretch/patient actualized serial stretch elbow device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories",09/11/2025
E1802,"Dynamic adjustable forearm pronation/supination device, includes soft interface material",09/11/2025
E1803,"Dynamic adjustable elbow extension only device, includes soft interface material",09/11/2025
E1804,"Dynamic adjustable elbow flexion only device, includes soft interface material",09/11/2025
E1805,"Dynamic adjustable wrist extension and flexion device, includes soft interface material",09/11/2025
E1806,"Static progressive stretch wrist device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories",09/11/2025
E1807,"Dynamic adjustable wrist extension only device, includes soft interface material",09/11/2025
E1808,"Dynamic adjustable wrist flexion only device, includes soft interface material",09/11/2025
E1810,"Dynamic adjustable knee extension and flexion device, includes soft interface material",09/11/2025
E1811,"Static progressive stretch/patient actualized serial stretch knee device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories",09/11/2025
E1812,"Dynamic knee, extension/flexion device with active resistance control",09/11/2025
E1813,"Dynamic adjustable knee extension only device, includes soft interface material",09/11/2025
E1814,"Dynamic adjustable knee flexion only device, includes soft interface material",09/11/2025
E1815,"Dynamic adjustable ankle extension and flexion device, includes soft interface material",09/11/2025
E1816,"Static progressive stretch/patient actualized serial stretch ankle device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories",09/11/2025
E1818,"Static progressive stretch/patient actualized serial stretch forearm pronation / supination device, with or without range of motion adjustment, includes all components and accessories",09/11/2025
E1820,"Replacement soft interface material, dynamic adjustable extension/flexion device",09/11/2025
E1821,Replacement soft interface material/cuffs for bi-directional static progressive stretch device,09/11/2025
E1822,"Dynamic adjustable ankle extension only device, includes soft interface material",09/11/2025
E1823,"Dynamic adjustable ankle flexion only device, includes soft interface material",09/11/2025
E1825,"Dynamic adjustable finger extension and flexion device, includes soft interface material",09/11/2025
E1826,"Dynamic adjustable finger extension only device, includes soft interface material",09/11/2025
E1827,"Dynamic adjustable finger flexion only device, includes soft interface material",09/11/2025
E1828,"Dynamic adjustable toe extension only device, includes soft interface material",09/11/2025
E1829,"Dynamic adjustable toe flexion only device, includes soft interface material",09/11/2025
E1830,"Dynamic adjustable toe extension and flexion device, includes soft interface material",09/11/2025
E1831,"Static progressive stretch toe device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories",09/11/2025
E1832,"Static progressive stretch finger device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories",09/11/2025
E1840,"Dynamic adjustable shoulder flexion / abduction / rotation device, includes soft interface material",09/11/2025
E1841,"Static progressive stretch/patient actualized serial stretch shoulder device, with or without range of motion adjustment, includes all components and accessories",09/11/2025
E1902,"Communication board, non-electronic augmentative or alternative communication device",09/11/2025
E1905,"Virtual reality cognitive behavioral therapy device (cbt), including pre-programmed therapy software",09/11/2025
E2000,"Gastric suction pump, home model, portable or stationary, electric",09/11/2025
E2001,"Suction pump, home model, portable or stationary, electric, any type, for use with external urine and/or fecal management system",09/11/2025
E2100,Blood glucose monitor with integrated voice synthesizer,09/11/2025
E2101,Blood glucose monitor with integrated lancing/blood sample,09/11/2025
E2102,"Adjunctive, non-implanted continuous glucose monitor or receiver",09/11/2025
E2103,"Non-adjunctive, non-implanted continuous glucose monitor or receiver",09/11/2025
E2104,Home blood glucose monitor for use with integrated lancing/blood sample testing cartridge,09/11/2025
E2120,Pulse generator system for tympanic treatment of inner ear endolymphatic fluid,09/11/2025
E2201,"Manual wheelchair accessory, nonstandard seat frame, width greater than or equal to 20 inches and less than 24 inches",09/11/2025
E2202,"Manual wheelchair accessory, nonstandard seat frame width, 24-27 inches",09/11/2025
E2203,"Manual wheelchair accessory, nonstandard seat frame depth, 20 to less than 22 inches",09/11/2025
E2204,"Manual wheelchair accessory, nonstandard seat frame depth, 22 to 25 inches",09/11/2025
E2205,"Manual wheelchair accessory, handrim without projections (includes ergonomic or contoured), any type, replacement only, each",09/11/2025
E2206,"Manual wheelchair accessory, wheel lock assembly, complete, replacement only, each",09/11/2025
E2207,"Wheelchair accessory, crutch and cane holder, each",09/11/2025
E2208,"Wheelchair accessory, cylinder tank carrier, each",09/11/2025
E2209,"Accessory, arm trough, with or without hand support, each",09/11/2025
E2210,"Wheelchair accessory, bearings, any type, replacement only, each",09/11/2025
E2211,"Manual wheelchair accessory, pneumatic propulsion tire, any size, each",09/11/2025
E2212,"Manual wheelchair accessory, tube for pneumatic propulsion tire, any size, each",09/11/2025
E2213,"Manual wheelchair accessory, insert for pneumatic propulsion tire (removable), any type, any size, each",09/11/2025
E2214,"Manual wheelchair accessory, pneumatic caster tire, any size, each",09/11/2025
E2215,"Manual wheelchair accessory, tube for pneumatic caster tire, any size, each",09/11/2025
E2216,"Manual wheelchair accessory, foam filled propulsion tire, any size, each",09/11/2025
E2217,"Manual wheelchair accessory, foam filled caster tire, any size, each",09/11/2025
E2218,"Manual wheelchair accessory, foam propulsion tire, any size, each",09/11/2025
E2219,"Manual wheelchair accessory, foam caster tire, any size, each",09/11/2025
E2220,"Manual wheelchair accessory, solid (rubber/plastic) propulsion tire, any size, replacement only, each",09/11/2025
E2221,"Manual wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each",09/11/2025
E2222,"Manual wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each",09/11/2025
E2224,"Manual wheelchair accessory, propulsion wheel excludes tire, any size, replacement only, each",09/11/2025
E2225,"Manual wheelchair accessory, caster wheel excludes tire, any size, replacement only, each",09/11/2025
E2226,"Manual wheelchair accessory, caster fork, any size, replacement only, each",09/11/2025
E2227,"Manual wheelchair accessory, gear reduction drive wheel, each",09/11/2025
E2228,"Manual wheelchair accessory, wheel braking system and lock, complete, each",09/11/2025
E2230,"Manual wheelchair accessory, manual standing system",09/11/2025
E2231,"Manual wheelchair accessory, solid seat support base (replaces sling seat), includes any type mounting hardware",09/11/2025
E2291,"Back, planar, for pediatric size wheelchair including fixed attaching hardware",09/11/2025
E2292,"Seat, planar, for pediatric size wheelchair including fixed attaching hardware",09/11/2025
E2293,"Back, contoured, for pediatric size wheelchair including fixed attaching hardware",09/11/2025
E2294,"Seat, contoured, for pediatric size wheelchair including fixed attaching hardware",09/11/2025
E2295,"Manual wheelchair accessory, for pediatric size wheelchair, dynamic seating frame, allows coordinated movement of multiple positioning features",09/11/2025
E2298,"Complex rehabilitative power wheelchair accessory, power seat elevation system, any type",09/11/2025
E2300,"Wheelchair accessory, power seat elevation system, any type",09/11/2025
E2301,"Wheelchair accessory, power standing system, any type",09/11/2025
E2310,"Power wheelchair accessory, electronic connection between wheelchair controller and one power seating system motor, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware",09/11/2025
E2311,"Power wheelchair accessory, electronic connection between wheelchair controller and two or more power seating system motors, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware",09/11/2025
E2312,"Power wheelchair accessory, hand or chin control interface, mini-proportional remote joystick, proportional, including fixed mounting hardware",09/11/2025
E2313,"Power wheelchair accessory, harness for upgrade to expandable controller, including all fasteners, connectors and mounting hardware, each",09/11/2025
E2321,"Power wheelchair accessory, hand control interface, remote joystick, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware",09/11/2025
E2322,"Power wheelchair accessory, hand control interface, multiple mechanical switches, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware",09/11/2025
E2323,"Power wheelchair accessory, specialty joystick handle for hand control interface, prefabricated",09/11/2025
E2324,"Power wheelchair accessory, chin cup for chin control interface",09/11/2025
E2325,"Power wheelchair accessory, sip and puff interface, nonproportional, including all related electronics, mechanical stop switch, and manual swingaway mounting hardware",09/11/2025
E2326,"Power wheelchair accessory, breath tube kit for sip and puff interface",09/11/2025
E2327,"Power wheelchair accessory, head control interface, mechanical, proportional, including all related electronics, mechanical direction change switch, and fixed mounting hardware",09/11/2025
E2328,"Power wheelchair accessory, head control or extremity control interface, electronic, proportional, including all related electronics and fixed mounting hardware",09/11/2025
E2329,"Power wheelchair accessory, head control interface, contact switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware",09/11/2025
E2330,"Power wheelchair accessory, head control interface, proximity switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware",09/11/2025
E2331,"Power wheelchair accessory, attendant control, proportional, including all related electronics and fixed mounting hardware",09/11/2025
E2340,"Power wheelchair accessory, nonstandard seat frame width, 20-23 inches",09/11/2025
E2341,"Power wheelchair accessory, nonstandard seat frame width, 24-27 inches",09/11/2025
E2342,"Power wheelchair accessory, nonstandard seat frame depth, 20 or 21 inches",09/11/2025
E2343,"Power wheelchair accessory, nonstandard seat frame depth, 22-25 inches",09/11/2025
E2351,"Power wheelchair accessory, electronic interface to operate speech generating device using power wheelchair control interface",09/11/2025
E2358,"Power wheelchair accessory, group 34 non-sealed lead acid battery, each",09/11/2025
E2359,"Power wheelchair accessory, group 34 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)",09/11/2025
E2360,"Power wheelchair accessory, 22nf non-sealed lead acid battery, each",09/11/2025
E2361,"Power wheelchair accessory, 22nf sealed lead acid battery, each, (e.g., gel cell, absorbed glassmat)",09/11/2025
E2362,"Power wheelchair accessory, group 24 non-sealed lead acid battery, each",09/11/2025
E2363,"Power wheelchair accessory, group 24 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)",09/11/2025
E2364,"Power wheelchair accessory, u-1 non-sealed lead acid battery, each",09/11/2025
E2365,"Power wheelchair accessory, u-1 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)",09/11/2025
E2366,"Power wheelchair accessory, battery charger, single mode, for use with only one battery type, sealed or non-sealed, each",09/11/2025
E2367,"Power wheelchair accessory, battery charger, dual mode, for use with either battery type, sealed or non-sealed, each",09/11/2025
E2368,"Power wheelchair component, drive wheel motor, replacement only",09/11/2025
E2369,"Power wheelchair component, drive wheel gear box, replacement only",09/11/2025
E2370,"Power wheelchair component, integrated drive wheel motor and gear box combination, replacement only",09/11/2025
E2371,"Power wheelchair accessory, group 27 sealed lead acid battery, (e.g., gel cell, absorbed glassmat), each",09/11/2025
E2372,"Power wheelchair accessory, group 27 non-sealed lead acid battery, each",09/11/2025
E2373,"Power wheelchair accessory, hand or chin control interface, compact remote joystick, proportional, including fixed mounting hardware",09/11/2025
E2374,"Power wheelchair accessory, hand or chin control interface, standard remote joystick (not including controller), proportional, including all related electronics and fixed mounting hardware, replacement only",09/11/2025
E2375,"Power wheelchair accessory, non-expandable controller, including all related electronics and mounting hardware, replacement only",09/11/2025
E2376,"Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, replacement only",09/11/2025
E2377,"Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, upgrade provided at initial issue",09/11/2025
E2378,"Power wheelchair component, actuator, replacement only",09/11/2025
E2381,"Power wheelchair accessory, pneumatic drive wheel tire, any size, replacement only, each",09/11/2025
E2382,"Power wheelchair accessory, tube for pneumatic drive wheel tire, any size, replacement only, each",09/11/2025
E2383,"Power wheelchair accessory, insert for pneumatic drive wheel tire (removable), any type, any size, replacement only, each",09/11/2025
E2384,"Power wheelchair accessory, pneumatic caster tire, any size, replacement only, each",09/11/2025
E2385,"Power wheelchair accessory, tube for pneumatic caster tire, any size, replacement only, each",09/11/2025
E2386,"Power wheelchair accessory, foam filled drive wheel tire, any size, replacement only, each",09/11/2025
E2387,"Power wheelchair accessory, foam filled caster tire, any size, replacement only, each",09/11/2025
E2388,"Power wheelchair accessory, foam drive wheel tire, any size, replacement only, each",09/11/2025
E2389,"Power wheelchair accessory, foam caster tire, any size, replacement only, each",09/11/2025
E2390,"Power wheelchair accessory, solid (rubber/plastic) drive wheel tire, any size, replacement only, each",09/11/2025
E2391,"Power wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each",09/11/2025
E2392,"Power wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each",09/11/2025
E2394,"Power wheelchair accessory, drive wheel excludes tire, any size, replacement only, each",09/11/2025
E2395,"Power wheelchair accessory, caster wheel excludes tire, any size, replacement only, each",09/11/2025
E2396,"Power wheelchair accessory, caster fork, any size, replacement only, each",09/11/2025
E2397,"Power wheelchair accessory, lithium-based battery, each",09/11/2025
E2398,"Wheelchair accessory, dynamic positioning hardware for back",09/11/2025
E2402,"Negative pressure wound therapy electrical pump, stationary or portable",09/11/2025
E2500,"Speech generating device, digitized speech, using pre-recorded messages, less than or equal to 8 minutes recording time",09/11/2025
E2502,"Speech generating device, digitized speech, using pre-recorded messages, greater than 8 minutes but less than or equal to 20 minutes recording time",09/11/2025
E2504,"Speech generating device, digitized speech, using pre-recorded messages, greater than 20 minutes but less than or equal to 40 minutes recording time",09/11/2025
E2506,"Speech generating device, digitized speech, using pre-recorded messages, greater than 40 minutes recording time",09/11/2025
E2508,"Speech generating device, synthesized speech, requiring message formulation by spelling and access by physical contact with the device",09/11/2025
E2510,"Speech generating device, synthesized speech, permitting multiple methods of message formulation and multiple methods of device access",09/11/2025
E2511,"Speech generating software program, for personal computer or personal digital assistant",09/11/2025
E2512,"Accessory for speech generating device, mounting system",09/11/2025
E2513,"Accessory for speech generating device, electromyographic sensor",09/11/2025
E2599,"Accessory for speech generating device, not otherwise classified",09/11/2025
E2601,"General use wheelchair seat cushion, width less than 22 inches, any depth",09/11/2025
E2602,"General use wheelchair seat cushion, width 22 inches or greater, any depth",09/11/2025
E2603,"Skin protection wheelchair seat cushion, width less than 22 inches, any depth",09/11/2025
E2604,"Skin protection wheelchair seat cushion, width 22 inches or greater, any depth",09/11/2025
E2605,"Positioning wheelchair seat cushion, width less than 22 inches, any depth",09/11/2025
E2606,"Positioning wheelchair seat cushion, width 22 inches or greater, any depth",09/11/2025
E2607,"Skin protection and positioning wheelchair seat cushion, width less than 22 inches, any depth",09/11/2025
E2608,"Skin protection and positioning wheelchair seat cushion, width 22 inches or greater, any depth",09/11/2025
E2609,"Custom fabricated wheelchair seat cushion, any size",09/11/2025
E2610,"Wheelchair seat cushion, powered",09/11/2025
E2611,"General use wheelchair back cushion, width less than 22 inches, any height, including any type mounting hardware",09/11/2025
E2612,"General use wheelchair back cushion, width 22 inches or greater, any height, including any type mounting hardware",09/11/2025
E2613,"Positioning wheelchair back cushion, posterior, width less than 22 inches, any height, including any type mounting hardware",09/11/2025
E2614,"Positioning wheelchair back cushion, posterior, width 22 inches or greater, any height, including any type mounting hardware",09/11/2025
E2615,"Positioning wheelchair back cushion, posterior-lateral, width less than 22 inches, any height, including any type mounting hardware",09/11/2025
E2616,"Positioning wheelchair back cushion, posterior-lateral, width 22 inches or greater, any height, including any type mounting hardware",09/11/2025
E2617,"Custom fabricated wheelchair back cushion, any size, including any type mounting hardware",09/11/2025
E2619,"Replacement cover for wheelchair seat cushion or back cushion, each",09/11/2025
E2620,"Positioning wheelchair back cushion, planar back with lateral supports, width less than 22 inches, any height, including any type mounting hardware",09/11/2025
E2621,"Positioning wheelchair back cushion, planar back with lateral supports, width 22 inches or greater, any height, including any type mounting hardware",09/11/2025
E2622,"Skin protection wheelchair seat cushion, adjustable, width less than 22 inches, any depth",09/11/2025
E2623,"Skin protection wheelchair seat cushion, adjustable, width 22 inches or greater, any depth",09/11/2025
E2624,"Skin protection and positioning wheelchair seat cushion, adjustable, width less than 22 inches, any depth",09/11/2025
E2625,"Skin protection and positioning wheelchair seat cushion, adjustable, width 22 inches or greater, any depth",09/11/2025
E2626,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable",09/11/2025
E2627,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable rancho type",09/11/2025
E2628,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, reclining",09/11/2025
E2629,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, friction arm support (friction dampening to proximal and distal joints)",09/11/2025
E2630,"Wheelchair accessory, shoulder elbow, mobile arm support, monosuspension arm and hand support, overhead elbow forearm hand sling support, yoke type suspension support",09/11/2025
E2631,"Wheelchair accessory, addition to mobile arm support, elevating proximal arm",09/11/2025
E2632,"Wheelchair accessory, addition to mobile arm support, offset or lateral rocker arm with elastic balance control",09/11/2025
E2633,"Wheelchair accessory, addition to mobile arm support, supinator",09/11/2025
E3000,"Speech volume modulation system, any type, including all components and accessories",09/11/2025
E3200,"Gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components and accessories, prescription only",09/11/2025
E8000,"Gait trainer, pediatric size, posterior support, includes all accessories and components",09/11/2025
E8001,"Gait trainer, pediatric size, upright support, includes all accessories and components",09/11/2025
E8002,"Gait trainer, pediatric size, anterior support, includes all accessories and components",09/11/2025
G0008,Administration of influenza virus vaccine,09/11/2025
G0009,Administration of pneumococcal vaccine,09/11/2025
G0010,Administration of hepatitis b vaccine,09/11/2025
G0011,"Individual counseling for pre-exposure prophylaxis (prep) by physician or qualified health care professional (qhp) to prevent human immunodeficiency virus (hiv), includes hiv risk assessment (initial or continued assessment of risk), hiv risk reduction and medication adherence, 15-30 minutes",09/11/2025
G0012,"Injection of pre-exposure prophylaxis (prep) drug for hiv prevention, under skin or into muscle",09/11/2025
G0013,"Individual counseling for pre-exposure prophylaxis (prep) by clinical staff to prevent human immunodeficiency virus (hiv), includes: hiv risk assessment (initial or continued assessment of risk), hiv risk reduction and medication adherence",09/11/2025
G0017,"Psychotherapy for crisis furnished in an applicable site of service (any place of service at which the non-facility rate for psychotherapy for crisis services applies, other than the office setting); first 60 minutes",09/11/2025
G0018,"Psychotherapy for crisis furnished in an applicable site of service (any place of service at which the non-facility rate for psychotherapy for crisis services applies, other than the office setting); each additional 30 minutes (list separately in addition to code for primary service)",09/11/2025
G0019,"Community health integration services performed by certified or trained auxiliary personnel, including a community health worker, under the direction of a physician or other practitioner; 60 minutes per calendar month, in the following activities to address social determinants of health (sdoh) need(s) that are significantly limiting the ability to diagnose or treat problem(s) addressed in an initiating visit: person-centered assessment, performed to better understand the individualized context of the intersection between the sdoh need(s) and the problem(s) addressed in the initiating visit. ++ conducting a person-centered assessment to understand patient's life story, strengths, needs, goals, preferences and desired outcomes, including understanding cultural and linguistic factors and including unmet sdoh needs (that are not separately billed). ++ facilitating patient-driven goal-setting and establishing an action plan. ++ providing tailored support to the patient as needed to accomplish the practitioner's treatment plan. practitioner, home-, and community-based care coordination. ++ coordinating receipt of needed services from healthcare practitioners, providers, and facilities; and from home- and community-based service providers, social service providers, and caregiver (if applicable). ++ communication with practitioners, home- and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ coordination of care transitions between and among health care practitioners and settings, including transitions involving referral to other clinicians; follow-up after an emergency department visit; or follow-up after discharges from hospitals, skilled nursing facilities or other health care facilities. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) to address the sdoh need(s). health education- helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, and preferences, in the context of the sdoh need(s), and educating the patient on how to best participate in medical decision-making. building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services addressing the sdoh need(s), in ways that are more likely to promote personalized and effective diagnosis or treatment. health care access / health system navigation. ++ helping the patient access healthcare, including identifying appropriate practitioners or providers for clinical care and helping secure appointments with them. facilitating behavioral change as necessary for meeting diagnosis and treatment goals, including promoting patient motivation to participate in care and reach person-centered diagnosis or treatment goals. facilitating and providing social and emotional support to help the patient cope with the problem(s) addressed in the initiating visit, the sdoh need(s), and adjust daily routines to better meet diagnosis and treatment goals. leveraging lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals",09/11/2025
G0022,"Community health integration services, each additional 30 minutes per calendar month (list separately in addition to g0019)",09/11/2025
G0023,"Principal illness navigation services by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a patient navigator; 60 minutes per calendar month, in the following activities:  person-centered assessment, performed to better understand the individual context of the serious, high-risk condition. ++ conducting a person-centered assessment to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes, including understanding cultural and linguistic factors and including unmet sdoh needs (that are not separately billed). ++ facilitating patient-driven goal setting and establishing an action plan. ++ providing tailored support as needed to accomplish the practitioner's treatment plan.  identifying or referring patient (and caregiver or family, if applicable) to appropriate supportive services.  practitioner, home, and community-based care coordination. ++ coordinating receipt of needed services from healthcare practitioners, providers, and facilities; home- and community-based service providers; and caregiver (if applicable). ++ communication with practitioners, home-, and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ coordination of care transitions between and among health care practitioners and settings, including transitions involving referral to other clinicians; follow-up after an emergency department visit; or follow-up after discharges from hospitals, skilled nursing facilities or other health care facilities. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) as needed to address sdoh need(s).  health education- helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, preferences, and sdoh need(s), and educating the patient (and caregiver if applicable) on how to best participate in medical decision-making.  building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services (as needed), in ways that are more likely to promote personalized and effective treatment of their condition.  health care access / health system navigation. ++ helping the patient access healthcare, including identifying appropriate practitioners or providers for clinical care,  and helping secure appointments with them. ++ providing the patient with information/resources to consider participation in clinical trials or clinical research as applicable.  facilitating behavioral change as necessary for meeting diagnosis and treatment goals, including promoting patient motivation to participate in care and reach person-centered diagnosis or treatment goals.  facilitating and providing social and emotional support to help the patient cope with the condition, sdoh need(s), and adjust daily routines to better meet diagnosis and treatment goals.  leverage knowledge of the serious, high-risk condition and/or lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals",09/11/2025
G0024,"Principal illness navigation services, additional 30 minutes per calendar month (list separately in addition to g0023)",09/11/2025
G0027,Semen analysis; presence and/or motility of sperm excluding huhner,09/11/2025
G0028,"Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)",09/11/2025
G0029,Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period,09/11/2025
G0030,"Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user",09/11/2025
G0031,Palliative care services given to patient any time during the measurement period,09/11/2025
G0032,"Two or more antipsychotic prescriptions ordered for patients who had a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder on or between january 1 of the year prior to the measurement period and the index prescription start date (ipsd) for antipsychotics",09/11/2025
G0033,"Two or more benzodiazepine prescriptions ordered for patients who had a diagnosis of seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder on or between january 1 of the year prior to the measurement period and the ipsd for benzodiazepines",09/11/2025
G0034,Patients receiving palliative care during the measurement period,09/11/2025
G0035,Patient has any emergency department encounter during the performance period with place of service indicator 23,09/11/2025
G0036,Patient or care partner decline assessment,09/11/2025
G0037,"On date of encounter, patient is not able to participate in assessment or screening, including non-verbal patients, delirious, severely aphasic, severely developmentally delayed, severe visual or hearing impairment and for those patients, no knowledgeable informant available",09/11/2025
G0038,Clinician determines patient does not require referral,09/11/2025
G0039,"Patient not referred, reason not otherwise specified",09/11/2025
G0040,Patient already receiving physical/occupational/speech/recreational therapy during the measurement period,09/11/2025
G0041,Patient and/or care partner decline referral,09/11/2025
G0042,"Referral to physical, occupational, speech, or recreational therapy",09/11/2025
G0043,Patients with mechanical prosthetic heart valve,09/11/2025
G0044,Patients with moderate or severe mitral stenosis,09/11/2025
G0045,Clinical follow-up and mrs score assessed at 90 days following endovascular stroke intervention,09/11/2025
G0046,Clinical follow-up and mrs score not assessed at 90 days following endovascular stroke intervention,09/11/2025
G0047,Pediatric patient with minor blunt head trauma and pecarn prediction criteria are not assessed,09/11/2025
G0048,Patients who receive palliative care services any time during the intake period through the end of the measurement year,09/11/2025
G0049,With maintenance hemodialysis (in-center and home hd) for the complete reporting month,09/11/2025
G0050,Patients with a catheter that have limited life expectancy,09/11/2025
G0051,Patients under hospice care in the current reporting month,09/11/2025
G0052,Patients on peritoneal dialysis for any portion of the reporting month,09/11/2025
G0053,Advancing rheumatology patient care mips value pathways,09/11/2025
G0054,Coordinating stroke care to promote prevention and cultivate positive outcomes mips value pathways,09/11/2025
G0055,Advancing care for heart disease mips value pathways,09/11/2025
G0056,Optimizing chronic disease management mips value pathways,09/11/2025
G0057,Proposed adopting best practices and promoting patient safety within emergency medicine mips value pathways,09/11/2025
G0058,Improving care for lower extremity joint repair mips value pathways,09/11/2025
G0059,Patient safety and support of positive experiences with anesthesia mips value pathways,09/11/2025
G0060,Allergy/immunology mips specialty set,09/11/2025
G0061,Anesthesiology mips specialty set,09/11/2025
G0062,Audiology mips specialty set,09/11/2025
G0063,Cardiology mips specialty set,09/11/2025
G0064,Certified nurse midwife mips specialty set,09/11/2025
G0065,Chiropractic medicine mips specialty set,09/11/2025
G0066,Clinical social work mips specialty set,09/11/2025
G0067,Dentistry mips specialty set,09/11/2025
G0068,"Professional services for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each infusion drug administration calendar day in the individual's home, each 15 minutes",09/11/2025
G0069,"Professional services for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes",09/11/2025
G0070,"Professional services for the administration of intravenous chemotherapy or other intravenous highly complex drug or biological infusion for each infusion drug administration calendar day in the individual's home, each 15 minutes",09/11/2025
G0071,"Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only",09/11/2025
G0076,"Brief (20 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0077,"Limited (30 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0078,"Moderate (45 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0079,"Comprehensive (60 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0080,"Extensive (75 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0081,"Brief (20 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0082,"Limited (30 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0083,"Moderate (45 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0084,"Comprehensive (60 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0085,"Extensive (75 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0086,"Limited (30 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0087,"Comprehensive (60 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",09/11/2025
G0088,"Professional services, initial visit, for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each infusion drug administration calendar day in the individual's home, each 15 minutes",09/11/2025
G0089,"Professional services, initial visit, for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes",09/11/2025
G0090,"Professional services, initial visit, for the administration of intravenous chemotherapy or other highly complex infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes",09/11/2025
G0101,Cervical or vaginal cancer screening; pelvic and clinical breast examination,09/11/2025
G0102,Prostate cancer screening; digital rectal examination,09/11/2025
G0103,Prostate cancer screening; prostate specific antigen test (psa),09/11/2025
G0104,Colorectal cancer screening; flexible sigmoidoscopy,09/11/2025
G0105,Colorectal cancer screening; colonoscopy on individual at high risk,09/11/2025
G0106,"Colorectal cancer screening; alternative to g0104, screening sigmoidoscopy, barium enema",09/11/2025
G0108,"Diabetes outpatient self-management training services, individual, per 30 minutes",09/11/2025
G0109,"Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes",09/11/2025
G0117,Glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist,09/11/2025
G0118,Glaucoma screening for high risk patient furnished under the direct supervision of an optometrist or ophthalmologist,09/11/2025
G0120,"Colorectal cancer screening; alternative to g0105, screening colonoscopy, barium enema.",09/11/2025
G0121,Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk,09/11/2025
G0122,Colorectal cancer screening; barium enema,09/11/2025
G0123,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision",09/11/2025
G0124,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician",09/11/2025
G0127,"Trimming of dystrophic nails, any number",09/11/2025
G0128,"Direct (face-to-face with patient) skilled nursing services of a registered nurse provided in a comprehensive outpatient rehabilitation facility, each 10 minutes beyond the first 5 minutes",09/11/2025
G0129,"Occupational therapy services requiring the skills of a qualified occupational therapist, furnished as a component of a partial hospitalization or intensive outpatient treatment program, per session (45 minutes or more)",09/11/2025
G0130,"Single energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)",09/11/2025
G0136,"Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes",09/11/2025
G0137,"Intensive outpatient services; weekly bundle, minimum of 9 services over a 7 contiguous day period, which can include individual and group therapy with physicians or psychologists (or other mental health professionals to the extent authorized under state law); occupational therapy requiring the skills of a qualified occupational therapist; services of social workers, trained psychiatric nurses, and other staff trained to work with psychiatric patients; individualized activity therapies that are not primarily recreational or diversionary; family counseling (the primary purpose of which is treatment of the individual's condition); patient training and education (to the extent that training and educational activities are closely and clearly related to individual's care and treatment); diagnostic services; and such other items and services (excluding meals and transportation) that are reasonable and necessary for the diagnosis or active treatment of the individual's condition, reasonably expected to improve or maintain the individual's condition and functional level and to prevent relapse or hospitalization, and furnished pursuant to such guidelines relating to frequency and duration of services in accordance with a physician certification and plan of treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure",09/11/2025
G0138,"Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga",09/11/2025
G0140,"Principal illness navigation - peer support by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a certified peer specialist; 60 minutes per calendar month, in the following activities:  person-centered interview, performed to better understand the individual context of the serious, high-risk condition. ++ conducting a person-centered interview to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes, including understanding cultural and linguistic factors, and including unmet sdoh needs (that are not billed separately). ++ facilitating patient-driven goal setting and establishing an action plan. ++ providing tailored support as needed to accomplish the person-centered goals in the practitioner's treatment plan. identifying or referring patient (and caregiver or family, if applicable) to appropriate supportive services. practitioner, home, and community-based care communication. ++ assist the patient in communicating with their practitioners, home-, and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) as needed to address sdoh need(s). health education. helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, preferences, and sdoh need(s), and educating the patient (and caregiver if applicable) on how to best participate in medical decision-making. building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services (as needed), in ways that are more likely to promote personalized and effective treatment of their condition. developing and proposing strategies to help meet person-centered treatment goals and supporting the patient in using chosen strategies to reach person-centered treatment goals. facilitating and providing social and emotional support to help the patient cope with the condition, sdoh need(s), and adjust daily routines to better meet person-centered diagnosis and treatment goals. leverage knowledge of the serious, high-risk condition and/or lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals",09/11/2025
G0141,"Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician",09/11/2025
G0143,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision",09/11/2025
G0144,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision",09/11/2025
G0145,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision",09/11/2025
G0146,"Principal illness navigation - peer support, additional 30 minutes per calendar month (list separately in addition to g0140)",09/11/2025
G0147,"Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision",09/11/2025
G0148,"Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening",09/11/2025
G0151,"Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes",09/11/2025
G0152,"Services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes",09/11/2025
G0153,"Services performed by a qualified speech-language pathologist in the home health or hospice setting, each 15 minutes",09/11/2025
G0154,"Direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes",09/11/2025
G0155,"Services of clinical social worker in home health or hospice settings, each 15 minutes",09/11/2025
G0156,"Services of home health/hospice aide in home health or hospice settings, each 15 minutes",09/11/2025
G0157,"Services performed by a qualified physical therapist assistant in the home health or hospice setting, each 15 minutes",09/11/2025
G0158,"Services performed by a qualified occupational therapist assistant in the home health or hospice setting, each 15 minutes",09/11/2025
G0159,"Services performed by a qualified physical therapist, in the home health setting, in the establishment or delivery of a safe and effective physical therapy maintenance program, each 15 minutes",09/11/2025
G0160,"Services performed by a qualified occupational therapist, in the home health setting, in the establishment or delivery of a safe and effective occupational therapy maintenance program, each 15 minutes",09/11/2025
G0161,"Services performed by a qualified speech-language pathologist, in the home health setting, in the establishment or delivery of a safe and effective speech-language pathology maintenance program, each 15 minutes",09/11/2025
G0162,Skilled services by a registered nurse (rn) for management and evaluation of the plan of care; each 15 minutes (the patient's underlying condition or complication requires an rn to ensure that essential non-skilled care achieves its purpose in the home health or hospice setting),09/11/2025
G0163,"Skilled services of a licensed nurse (lpn or rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)",09/11/2025
G0164,"Skilled services of a licensed nurse (lpn or rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes",09/11/2025
G0166,"External counterpulsation, per treatment session",09/11/2025
G0168,Wound closure utilizing tissue adhesive(s) only,09/11/2025
G0173,"Linear accelerator based stereotactic radiosurgery, complete course of therapy in one session",09/11/2025
G0175,Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present,09/11/2025
G0176,"Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more)",09/11/2025
G0177,Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more),09/11/2025
G0179,"Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care",09/11/2025
G0180,"Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care",09/11/2025
G0181,Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans,09/11/2025
G0182,"Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of laboratory and other studies, communication (including telephone calls) with other health care professionals involved in the patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month, 30 minutes or more",09/11/2025
G0183,"Quantitative software measurements of cardiac volume, cardiac chambers volumes and left ventricular wall mass derived from ct scan(s) data of the chest/heart (with or without contrast)",09/11/2025
G0186,"Destruction of localized lesion of choroid (for example, choroidal neovascularization); photocoagulation, feeder vessel technique (one or more sessions)",09/11/2025
G0202,"Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed",09/11/2025
G0204,"Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral",09/11/2025
G0206,"Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral",09/11/2025
G0219,Pet imaging whole body; melanoma for non-covered indications,09/11/2025
G0235,"Pet imaging, any site, not otherwise specified",09/11/2025
G0237,"Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring)",09/11/2025
G0238,"Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring)",09/11/2025
G0239,"Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring)",09/11/2025
G0245,"Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education",09/11/2025
G0246,"Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education",09/11/2025
G0247,"Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails",09/11/2025
G0248,"Demonstration, prior to initiation of home inr monitoring, for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria, under the direction of a physician; includes: face-to-face demonstration of use and care of the inr monitor, obtaining at least one blood sample, provision of instructions for reporting home inr test results, and documentation of patient's ability to perform testing and report results",09/11/2025
G0249,"Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests",09/11/2025
G0250,"Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests",09/11/2025
G0251,"Linear accelerator based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatment",09/11/2025
G0252,"Pet imaging, full and partial-ring pet scanners only, for initial diagnosis of breast cancer and/or surgical planning for breast cancer (e.g., initial staging of axillary lymph nodes)",09/11/2025
G0255,"Current perception threshold/sensory nerve conduction test, (snct) per limb, any nerve",09/11/2025
G0257,Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility,09/11/2025
G0259,Injection procedure for sacroiliac joint; arthrography,09/11/2025
G0260,"Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography",09/11/2025
G0268,Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing,09/11/2025
G0269,"Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug)",09/11/2025
G0270,"Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes",09/11/2025
G0271,"Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes",09/11/2025
G0276,"Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (pild) or placebo-control, performed in an approved coverage with evidence development (ced) clinical trial",09/11/2025
G0277,"Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval",09/11/2025
G0278,"Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation (list separately in addition to primary procedure)",09/11/2025
G0279,"Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)",09/11/2025
G0281,"Electrical stimulation, (unattended), to one or more areas, for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care",09/11/2025
G0282,"Electrical stimulation, (unattended), to one or more areas, for wound care other than described in g0281",09/11/2025
G0283,"Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care",09/11/2025
G0288,"Reconstruction, computed tomographic angiography of aorta for surgical planning for vascular surgery",09/11/2025
G0289,"Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee",09/11/2025
G0293,"Noncovered surgical procedure(s) using conscious sedation, regional, general or spinal anesthesia in a medicare qualifying clinical trial, per day",09/11/2025
G0294,"Noncovered procedure(s) using either no anesthesia or local anesthesia only, in a medicare qualifying clinical trial, per day",09/11/2025
G0295,"Electromagnetic therapy, to one or more areas, for wound care other than described in g0329 or for other uses",09/11/2025
G0296,Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making),09/11/2025
G0297,Low dose ct scan (ldct) for lung cancer screening,09/11/2025
G0299,"Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes",09/11/2025
G0300,"Direct skilled nursing services of a licensed practical nurse (lpn) in the home health or hospice setting, each 15 minutes",09/11/2025
G0302,"Pre-operative pulmonary surgery services for preparation for lvrs, complete course of services, to include a minimum of 16 days of services",09/11/2025
G0303,"Pre-operative pulmonary surgery services for preparation for lvrs, 10 to 15 days of services",09/11/2025
G0304,"Pre-operative pulmonary surgery services for preparation for lvrs, 1 to 9 days of services",09/11/2025
G0305,"Post-discharge pulmonary surgery services after lvrs, minimum of 6 days of services",09/11/2025
G0306,"Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count",09/11/2025
G0307,"Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count)",09/11/2025
G0308,"Creation of subcutaneous pocket with insertion of 180 day implantable interstitial glucose sensor, including system activation and patient training",09/11/2025
G0309,"Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 180 day implantable sensor, including system activation",09/11/2025
G0310,"Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 5 to 15 mins time (this code is used for medicaid billing purposes)",09/11/2025
G0311,"Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service,  16-30 mins time (this code is used for medicaid billing purposes)",09/11/2025
G0312,"Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes)",09/11/2025
G0313,"Immunization counseling by a physician or other qualified health care professional when  the vaccine(s) is not administered on the same date of service for ages under 21, 16-30 mins time (this code is used for medicaid billing purposes)",09/11/2025
G0314,"Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 16-30 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)",09/11/2025
G0315,"Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)",09/11/2025
G0316,"Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes)",09/11/2025
G0317,"Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99306, 99310 for nursing facility evaluation and management services). (do not report g0317 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418). (do not report g0317 for any time unit less than 15 minutes)",09/11/2025
G0318,"Prolonged home or residence evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99345, 99350 for home or residence evaluation and management services). (do not report g0318 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99417). (do not report g0318 for any time unit less than 15 minutes)",09/11/2025
G0320,Home health services furnished using synchronous telemedicine rendered via a real-time two-way audio and video telecommunications system,09/11/2025
G0321,Home health services furnished using synchronous telemedicine rendered via telephone or other real-time interactive audio-only telecommunications system,09/11/2025
G0322,"The collection of physiologic data digitally stored and/or transmitted by the patient to the home health agency (i.e., remote patient monitoring)",09/11/2025
G0323,"Care management services for behavioral health conditions, at least 20 minutes of clinical psychologist, clinical social worker, mental health counselor, or marriage and family therapist time, per calendar month. (these services include the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, coordination with and/or referral to physicians and practitioners who are authorized by medicare to prescribe medications and furnish e/m services, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team)",09/11/2025
G0327,Colorectal cancer screening; blood-based biomarker,09/11/2025
G0328,"Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous",09/11/2025
G0329,"Electromagnetic therapy, to one or more areas for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care as part of a therapy plan of care",09/11/2025
G0330,"Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room",09/11/2025
G0333,Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary,09/11/2025
G0337,"Hospice evaluation and counseling services, pre-election",09/11/2025
G0339,"Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment",09/11/2025
G0340,"Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment",09/11/2025
G0341,"Percutaneous islet cell transplant, includes portal vein catheterization and infusion",09/11/2025
G0342,"Laparoscopy for islet cell transplant, includes portal vein catheterization and infusion",09/11/2025
G0343,"Laparotomy for islet cell transplant, includes portal vein catheterization and infusion",09/11/2025
G0364,Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service,09/11/2025
G0365,"Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow)",09/11/2025
G0372,Physician service required to establish and document the need for a power mobility device,09/11/2025
G0378,"Hospital observation service, per hour",09/11/2025
G0379,Direct admission of patient for hospital observation care,09/11/2025
G0380,"Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)",09/11/2025
G0381,"Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)",09/11/2025
G0382,"Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)",09/11/2025
G0383,"Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)",09/11/2025
G0384,"Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)",09/11/2025
G0389,Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening,09/11/2025
G0390,Trauma response team associated with hospital critical care service,09/11/2025
G0396,"Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes",09/11/2025
G0397,"Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes",09/11/2025
G0398,"Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation",09/11/2025
G0399,"Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation",09/11/2025
G0400,"Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels",09/11/2025
G0402,"Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment",09/11/2025
G0403,"Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report",09/11/2025
G0404,"Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination",09/11/2025
G0405,"Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination",09/11/2025
G0406,"Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth",09/11/2025
G0407,"Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth",09/11/2025
G0408,"Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth",09/11/2025
G0409,"Social work and psychological services, directly relating to and/or furthering the patient's rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)",09/11/2025
G0410,"Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes",09/11/2025
G0411,"Interactive group psychotherapy, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes",09/11/2025
G0412,"Open treatment of iliac spine(s), tuberosity avulsion, or iliac wing fracture(s), unilateral or bilateral for pelvic bone fracture patterns which do not disrupt the pelvic ring includes internal fixation, when performed",09/11/2025
G0413,"Percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, (includes ilium, sacroiliac joint and/or sacrum)",09/11/2025
G0414,"Open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami)",09/11/2025
G0415,"Open treatment of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation, when performed (includes ilium, sacroiliac joint and/or sacrum)",09/11/2025
G0416,"Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method",09/11/2025
G0417,"Surgical pathology, gross and microscopic examination, for prostate needle  biopsy, any method, 21-40 specimens",09/11/2025
G0418,"Surgical pathology, gross and microscopic examination, for prostate needle  biopsy, any method, 41-60 specimens",09/11/2025
G0419,"Surgical pathology, gross and microscopic examination, for prostate needle  biopsy, any method, >60 specimens",09/11/2025
G0420,"Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour",09/11/2025
G0421,"Face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour",09/11/2025
G0422,"Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session",09/11/2025
G0423,"Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session",09/11/2025
G0424,"Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day",09/11/2025
G0425,"Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth",09/11/2025
G0426,"Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth",09/11/2025
G0427,"Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth",09/11/2025
G0428,"Collagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)",09/11/2025
G0429,"Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)",09/11/2025
G0431,"Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter",09/11/2025
G0432,"Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening",09/11/2025
G0433,"Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening",09/11/2025
G0434,"Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter",09/11/2025
G0435,"Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening",09/11/2025
G0436,"Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes",09/11/2025
G0437,"Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes",09/11/2025
G0438,"Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit",09/11/2025
G0439,"Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit",09/11/2025
G0442,"Annual alcohol misuse screening, 5 to 15 minutes",09/11/2025
G0443,"Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes",09/11/2025
G0444,"Annual depression screening, 5 to 15 minutes",09/11/2025
G0445,"High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes",09/11/2025
G0446,"Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes",09/11/2025
G0447,"Face-to-face behavioral counseling for obesity, 15 minutes",09/11/2025
G0448,"Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing",09/11/2025
G0451,"Development testing, with interpretation and report, per standardized instrument form",09/11/2025
G0452,Molecular pathology procedure; physician interpretation and report,09/11/2025
G0453,"Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)",09/11/2025
G0454,"Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist",09/11/2025
G0455,"Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen",09/11/2025
G0456,"Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimeters",09/11/2025
G0457,"Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimeters",09/11/2025
G0458,"Low dose rate (ldr) prostate brachytherapy services, composite rate",09/11/2025
G0459,"Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy",09/11/2025
G0460,"Autologous platelet rich plasma or other blood-derived product for non-diabetic chronic wounds/ulcers, including as applicable phlebotomy, centrifugation or mixing, and all other preparatory procedures, administration and dressings, per treatment",09/11/2025
G0461,"Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain",09/11/2025
G0462,"Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)",09/11/2025
G0463,Hospital outpatient clinic visit for assessment and management of a patient,09/11/2025
G0464,"Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3)",09/11/2025
G0465,"Autologous platelet rich plasma (prp) or other blood-derived product for diabetic chronic wounds/ulcers, using an fda-cleared device for this indication, (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other preparatory procedures, per treatment)",09/11/2025
G0466,"Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit",09/11/2025
G0467,"Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit",09/11/2025
G0468,"Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv",09/11/2025
G0469,"Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit",09/11/2025
G0470,"Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit",09/11/2025
G0471,Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha),09/11/2025
G0472,"Hepatitis c antibody screening, for individual at high risk and other covered indication(s)",09/11/2025
G0473,"Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes",09/11/2025
G0475,"Hiv antigen/antibody, combination assay, screening",09/11/2025
G0476,"Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test",09/11/2025
G0477,"Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service",09/11/2025
G0478,"Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) read by instrument-assisted direct optical observation (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service",09/11/2025
G0479,"Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi, ldtd, desi, dart, ghpc, gc mass spectrometry), includes sample validation when performed, per date of service",09/11/2025
G0480,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed",09/11/2025
G0481,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed",09/11/2025
G0482,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed",09/11/2025
G0483,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed",09/11/2025
G0490,Face-to-face home health nursing visit by a rural health clinic (rhc) or federally qualified health center (fqhc) in an area with a shortage of home health agencies;  (services limited to rn or lpn only),09/11/2025
G0491,Dialysis procedure at a medicare certified esrd facility for acute kidney injury without esrd,09/11/2025
G0492,Dialysis procedure with single evaluation by a physician or other qualified health care professional  for acute kidney injury without esrd,09/11/2025
G0493,"Skilled services of a registered nurse (rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)",09/11/2025
G0494,"Skilled services of a licensed practical nurse (lpn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)",09/11/2025
G0495,"Skilled services of a registered nurse (rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes",09/11/2025
G0496,"Skilled services of a licensed practical nurse (lpn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes",09/11/2025
G0498,"Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion",09/11/2025
G0499,"Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result",09/11/2025
G0500,"Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)",09/11/2025
G0501,"Resource-intensive services for patients for whom the use of specialized mobility-assistive technology (such as adjustable height chairs or tables, patient lift, and adjustable padded leg supports) is medically necessary and used during the provision of an office/outpatient, evaluation and management  visit (list separately in addition to primary service)",09/11/2025
G0502,"Initial psychiatric collaborative care management, first 70 minutes in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional; initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan;  review by the psychiatric consultant with modifications of the plan if recommended;  entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant; and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies",09/11/2025
G0503,"Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements:  tracking patient follow-up and progress using the registry, with appropriate documentation;  participation in weekly caseload consultation with the psychiatric consultant;  ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers;  additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant;  provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies;  monitoring of patient outcomes using validated rating scales; and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment",09/11/2025
G0504,"Initial or subsequent psychiatric collaborative care management, each additional 30 minutes in a calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional (list separately in addition to code for primary procedure);  (use g0504 in conjunction with g0502, g0503)",09/11/2025
G0505,"Cognition and functional assessment using standardized instruments with development of recorded care plan for the patient with cognitive impairment, history obtained from patient and/or caregiver, in office or other outpatient setting or home or domiciliary or rest home",09/11/2025
G0506,Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service),09/11/2025
G0507,"Care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team",09/11/2025
G0508,"Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth",09/11/2025
G0509,"Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth",09/11/2025
G0511,"Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month",09/11/2025
G0512,"Rural health clinic or federally qualified health center (rhc/fqhc) only, psychiatric collaborative care model (psychiatric cocm), 60 minutes or more of clinical staff time for psychiatric cocm services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm) and including services furnished by a behavioral health care manager and consultation with a psychiatric consultant, per calendar month",09/11/2025
G0513,"Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service)",09/11/2025
G0514,"Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service)",09/11/2025
G0515,"Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes",09/11/2025
G0516,"Insertion of non-biodegradable drug delivery implants, 4 or more (services for subdermal rod implant)",09/11/2025
G0517,"Removal of non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)",09/11/2025
G0518,"Removal with reinsertion, non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)",09/11/2025
G0519,"Management of new patient-caregiver dyad with dementia, low complexity, for use in cmmi model",09/11/2025
G0520,"Management of new patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model",09/11/2025
G0521,"Management of new patient-caregiver dyad with dementia, high complexity, for use in cmmi model",09/11/2025
G0522,"Management of a new patient with dementia, low complexity, for use in cmmi model",09/11/2025
G0523,"Management of a new patient with dementia, moderate to high complexity, for use in cmmi model",09/11/2025
G0524,"Management of established patient-caregiver dyad with dementia, low complexity, for use in cmmi model",09/11/2025
G0525,"Management of established patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model",09/11/2025
G0526,"Management of established patient-caregiver dyad with dementia, high complexity, for use in cmmi model",09/11/2025
G0527,"Management of established patient with dementia, low complexity, for use in cmmi model",09/11/2025
G0528,"Management of established patient with dementia, moderate to high complexity, for use in cmmi model",09/11/2025
G0529,"In-home respite care, 4-hour unit, for use in cmmi model",09/11/2025
G0530,"Adult day center, 8-hour unit, for use in cmmi model",09/11/2025
G0531,"Facility-based respite, 24-hour unit, for use in cmmi model",09/11/2025
G0532,"Take-home supply of nasal nalmefene hydrochloride; one carton of two, 2.7 mg per 0.1 ml nasal sprays (provision of the services by a medicare-enrolled opioid treatment program);( list separately in addition to each primary code)",09/11/2025
G0533,"Medication assisted treatment, buprenorphine (injectable) administered on a weekly basis; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",09/11/2025
G0534,"Coordinated care and/or referral services, such as to adequate and accessible community resources to address unmet health-related social needs, including harm reduction interventions and recovery support services a patient needs and wishes to pursue, which significantly limit the ability to diagnose or treat an opioid use disorder; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)",09/11/2025
G0535,"Patient navigational services, provided directly or by referral; including helping the patient to navigate health systems and identify care providers and supportive services, to build patient self-advocacy and communication skills with care providers, and to promote patient-driven action plans and goals; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)",09/11/2025
G0536,"Peer recovery support services, provided directly or by referral; including leveraging knowledge of the condition or lived experience to provide support, mentorship, or inspiration to meet oud treatment and recovery goals; conducting a person-centered interview to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes; developing and proposing strategies to help meet person-centered treatment goals; assisting the patient in locating or navigating recovery support services; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)",09/11/2025
G0537,"Administration of a standardized, evidence-based atherosclerotic cardiovascular disease (ascvd) risk assessment, 5-15 minutes, not more often than every 12 months",09/11/2025
G0538,Atherosclerotic cardiovascular disease (ascvd) risk management services; clinical staff time; per calendar month,09/11/2025
G0539,"Caregiver training in behavior management/modification for caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face; initial 30 minutes",09/11/2025
G0540,"Caregiver training in behavior management/modification for parent(s)/guardian(s)/caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face; each additional 15 minutes",09/11/2025
G0541,"Caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face; initial 30 minutes",09/11/2025
G0542,"Caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face; each additional 15 minutes (list separately in addition to code for primary service) (use g0542 in conjunction with g0541)",09/11/2025
G0543,"Group caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face with multiple sets of caregivers",09/11/2025
G0544,"Post discharge telephonic follow-up contacts performed in conjunction with a discharge from the emergency department for behavioral health or other crisis encounter, 4 calls per calendar month",09/11/2025
G0545,"Visit complexity inherent to hospital inpatient or observation care associated with a confirmed or suspected infectious disease by an infectious diseases specialist, including disease transmission risk assessment and mitigation, public health investigation, analysis, and testing, and complex antimicrobial therapy counseling and treatment (add-on code, list separately in addition to hospital inpatient or observation evaluation and management visit, initial, same day discharge, subsequent or discharge)",09/11/2025
G0546,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty   whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 5-10 minutes of medical consultative discussion and review",09/11/2025
G0547,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 11-20 minutes of medical consultative discussion and review",09/11/2025
G0548,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 21-30 minutes of medical consultative discussion and review",09/11/2025
G0549,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 31 or more minutes of medical consultative discussion and review",09/11/2025
G0550,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a written report to the patient's treating/requesting practitioner, 5 minutes or more of medical consultative time",09/11/2025
G0551,"Interprofessional telephone/internet/electronic health record referral service(s) provided by a treating/requesting practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, 30 minutes",09/11/2025
G0552,"Supply of digital mental health treatment device and initial education and onboarding, per course of treatment that augments a behavioral therapy plan",09/11/2025
G0553,"First 20 minutes of monthly treatment management services directly related to the patient's therapeutic use of the digital mental health treatment (dmht) device that augments a behavioral therapy plan, physician/other qualified health care professional time reviewing information related to the use of the dmht device, including patient observations and patient specific inputs in a calendar month and requiring at least one interactive communication with the patient/caregiver during the calendar month",09/11/2025
G0554,"Each additional 20 minutes of monthly treatment management services directly related to the patient's therapeutic use of the digital mental health treatment (dmht) device that augments a behavioral therapy plan, physician/other qualified health care professional time reviewing data generated from the dmht device from patient observations and patient specific inputs in a calendar month and requiring at least one interactive communication with the patient/caregiver during the calendar month",09/11/2025
G0555,"Provision of replacement patient electronics system (e.g., system pillow, handheld reader) for home pulmonary artery pressure monitoring",09/11/2025
G0556,"Advanced primary care management services for a patient with one chronic condition [expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline], or fewer, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate: consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained. initiation during a qualifying visit for new patients or patients not seen within 3 years; provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week; continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments; deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours; overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++  system-based approaches to ensure receipt of preventive services. ++  medication reconciliation, management and oversight of self-management. development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan with typical care plan elements when clinically relevant; ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver; coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated. ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record; enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits). analyze patient population data to identify gaps in care and offer additional interventions, as appropriate; risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients; be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology",09/11/2025
G0557,"Advanced primary care management services for a patient with multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate: consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained. initiation during a qualifying visit for new patients or patients not seen within 3 years; provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week; continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments; deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours; overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++  system-based approaches to ensure receipt of preventive services. ++  medication reconciliation, management and oversight of self-management. development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan; ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver; coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated. ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record; enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits). analyze patient population data to identify gaps in care and offer additional interventions, as appropriate; risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients; be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology",09/11/2025
G0558,"Advanced primary care management services for a patient that is a qualified medicare beneficiary with multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate:   consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained. initiation during a qualifying visit for new patients or patients not seen within 3 years; provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week; continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments; deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours; overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++  system-based approaches to ensure receipt of preventive services. ++  medication reconciliation, management and oversight of self-management. development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan; ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver; coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated. ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record; enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits). analyze patient population data to identify gaps in care and offer additional interventions, as appropriate; risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients; be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology",09/11/2025
G0559,"Post-operative follow-up visit complexity inherent to evaluation and management services addressing surgical procedure(s), provided by a physician or qualified health care professional who is not the practitioner who performed the procedure (or in the same group practice) and is of the same or of a different specialty than the practitioner who performed the procedure, within the 90-day global period of the procedure(s), once per 90-day global period, when there has not been a formal transfer of care and requires the following required elements, when possible and applicable:    reading available surgical note to understand the relative success of the procedure, the anatomy that was affected, and potential complications that could have arisen due to the unique circumstances of the patient's operation.    research the procedure to determine expected post-operative course and potential complications (in the case of doing a post-op for a procedure outside the specialty).    evaluate and physically examine the patient to determine whether the post-operative course is progressing appropriately.    communicate with the practitioner who performed the procedure if any questions or concerns arise. (list separately in addition to office/outpatient evaluation and management visit, new or established)",09/11/2025
G0560,"Safety planning interventions, each 20 minutes personally performed by the billing practitioner, including assisting the patient in the identification of the following personalized elements of a safety plan: recognizing warning signs of an impending suicidal or substance use-related crisis; employing internal coping strategies; utilizing social contacts and social settings as a means of distraction from suicidal thoughts or risky substance use; utilizing family members, significant others, caregivers, and/or friends to help resolve the crisis; contacting mental health or substance use disorder professionals or agencies; and making the environment safe",09/11/2025
G0561,"Tympanostomy with local or topical anesthesia and insertion of a ventilating tube when performed with tympanostomy tube delivery device, unilateral (list separately in addition to 69433) (do not use in conjunction with 0583t)",09/11/2025
G0562,"Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)",09/11/2025
G0563,"Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions",09/11/2025
G0564,"Creation of subcutaneous pocket with insertion of 365 day implantable interstitial glucose sensor, including system activation and patient training",09/11/2025
G0565,"Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 365 day implantable sensor, including system activation",09/11/2025
G0566,"3d radiodensity-value bone imaging, algorithm derived, from previous magnetic resonance examination of the same anatomy",09/11/2025
G0567,"Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique",09/11/2025
G0659,"Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes",09/11/2025
G0908,Most recent hemoglobin (hgb) level > 12.0 g/dl,09/11/2025
G0909,"Hemoglobin level measurement not documented, reason not given",09/11/2025
G0910,Most recent hemoglobin level <= 12.0 g/dl,09/11/2025
G0913,Improvement in visual function achieved within 90 days following cataract surgery,09/11/2025
G0914,Patient care survey was not completed by patient,09/11/2025
G0915,Improvement in visual function not achieved within 90 days following cataract surgery,09/11/2025
G0916,Satisfaction with care achieved within 90 days following cataract surgery,09/11/2025
G0917,Patient care survey was not completed by patient,09/11/2025
G0918,Satisfaction with care not achieved within 90 days following cataract surgery,09/11/2025
G0919,Influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit,09/11/2025
G0920,"Type, anatomic location, and activity all documented",09/11/2025
G0921,"Documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment)",09/11/2025
G0922,"No documentation of disease type, anatomic location, and activity, reason not given",09/11/2025
G1000,"Clinical decision support mechanism applied pathways, as defined by the medicare appropriate use criteria program",09/11/2025
G1001,"Clinical decision support mechanism evicore, as defined by the medicare appropriate use criteria program",09/11/2025
G1002,"Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program",09/11/2025
G1003,"Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program",09/11/2025
G1004,"Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program",09/11/2025
G1005,"Clinical decision support mechanism national imaging associates, as defined by the medicare appropriate use criteria program",09/11/2025
G1006,"Clinical decision support mechanism test appropriate, as defined by the medicare appropriate use criteria program",09/11/2025
G1007,"Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program",09/11/2025
G1008,"Clinical decision support mechanism cranberry peak, as defined by the medicare appropriate use criteria program",09/11/2025
G1009,"Clinical decision support mechanism sage health management solutions, as defined by the medicare appropriate use criteria program",09/11/2025
G1010,"Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program",09/11/2025
G1011,"Clinical decision support mechanism, qualified tool not otherwise specified, as defined by the medicare appropriate use criteria program",09/11/2025
G1012,"Clinical decision support mechanism agilemd, as defined by the medicare appropriate use criteria program",09/11/2025
G1013,"Clinical decision support mechanism evidencecare imagingcare, as defined by the medicare appropriate use criteria program",09/11/2025
G1014,"Clinical decision support mechanism inveniqa semantic answers in medicine, as defined by the medicare appropriate use criteria program",09/11/2025
G1015,"Clinical decision support mechanism reliant medical group, as defined by the medicare appropriate use criteria program",09/11/2025
G1016,"Clinical decision support mechanism speed of care, as defined by the medicare appropriate use criteria program",09/11/2025
G1017,"Clinical decision support mechanism healthhelp, as defined by the medicare appropriate use criteria program",09/11/2025
G1018,"Clinical decision support mechanism infinx, as defined by the medicare appropriate use criteria program",09/11/2025
G1019,"Clinical decision support mechanism logicnets, as defined by the medicare appropriate use criteria program",09/11/2025
G1020,"Clinical decision support mechanism curbside clinical augmented workflow, as defined by the medicare appropriate use criteria program",09/11/2025
G1021,"Clinical decision support mechanism ehealthline clinical decision support mechanism, as defined by the medicare appropriate use criteria program",09/11/2025
G1022,"Clinical decision support mechanism intermountain clinical decision support mechanism, as defined by the medicare appropriate use criteria program",09/11/2025
G1023,"Clinical decision support mechanism persivia clinical decision support, as defined by the medicare appropriate use criteria program",09/11/2025
G1024,"Clinical decision support mechanism radrite, as defined by the medicare appropriate use criteria program",09/11/2025
G1025,Patient-months where there are more than one medicare capitated payment (mcp) provider listed for the month,09/11/2025
G1026,The number of adult patient-months in the denominator who were on maintenance hemodialysis using a catheter continuously for three months or longer under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month,09/11/2025
G1027,The number of adult patient-months in the denominator who were on maintenance hemodialysis under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month using a catheter continuously for less than three months,09/11/2025
G1028,Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure,09/11/2025
G2000,"Blinded administration of convulsive therapy procedure, either electroconvulsive therapy (ect, current covered gold standard) or magnetic seizure therapy (mst, non-covered experimental therapy), performed in an approved ide-based clinical trial, per treatment session",09/11/2025
G2001,"Brief (20 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",09/11/2025
G2002,"Limited (30 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",09/11/2025
G2003,"Moderate (45 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",09/11/2025
G2004,"Comprehensive (60 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",09/11/2025
G2005,"Extensive (75 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",09/11/2025
G2006,"Brief (20 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",09/11/2025
G2007,"Limited (30 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",09/11/2025
G2008,"Moderate (45 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",09/11/2025
G2009,"Comprehensive (60 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",09/11/2025
G2010,"Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment",09/11/2025
G2011,"Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes",09/11/2025
G2012,"Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion",09/11/2025
G2013,"Extensive (75 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",09/11/2025
G2014,"Limited (30 minutes) care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",09/11/2025
G2015,"Comprehensive (60 mins) home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility.)",09/11/2025
G2020,Services for high intensity clinical services associated with the initial engagement and outreach of beneficiaries assigned to the sip component of the pcf model (do not bill with chronic care management codes),09/11/2025
G2021,Health care practitioners rendering treatment in place (tip),09/11/2025
G2022,"A model participant (ambulance supplier/provider), the beneficiary refuses services covered under the model (transport to an alternate destination/treatment in place)",09/11/2025
G2023,"Specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source",09/11/2025
G2024,"Specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a  snf or by a laboratory on behalf of a hha, any specimen source",09/11/2025
G2025,Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only,09/11/2025
G2058,"Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)).",09/11/2025
G2061,"Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutes",09/11/2025
G2062,"Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 11-20 minutes",09/11/2025
G2063,"Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 21 or more minutes",09/11/2025
G2064,"Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician  or other qualified health care professional  time per calendar month with the following elements: one complex chronic condition lasting  at least 3 months,  which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities",09/11/2025
G2065,"Comprehensive care management for a single high-risk disease services, e.g. principal care management, at least 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities",09/11/2025
G2066,"Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results",09/11/2025
G2067,"Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)",09/11/2025
G2068,"Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",09/11/2025
G2069,"Medication assisted treatment, buprenorphine (injectable) administered on a monthly basis; bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",09/11/2025
G2070,"Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",09/11/2025
G2071,"Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",09/11/2025
G2072,"Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",09/11/2025
G2073,"Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",09/11/2025
G2074,"Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",09/11/2025
G2075,"Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)",09/11/2025
G2076,"Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a standardized, evidence-based social determinants of health risk assessment to identify unmet health-related social needs, and that includes the patient's goals and mutually agreed-upon actions for the patient to meet those goals, including harm reduction interventions; the patient's needs and goals in the areas of education, vocational training, and employment; and the medical and psychiatric, psychosocial, economic, legal, housing, and other recovery support services that a patient needs and wishes to pursue, conducted by an appropriately licensed/credentialed personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code",09/11/2025
G2077,"Periodic assessment; assessing periodically by an otp practitioner and includes a  review of moud dosing, treatment response, other substance use disorder treatment needs, responses and patient-identified goals, and other relevant physical and psychiatric treatment needs and goals; assessment may be informed by administration of a standardized, evidence-based social determinants of health risk assessment to identify unmet health-related social needs, or the need and interest for harm reduction interventions and recovery support services (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code",09/11/2025
G2078,Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure,09/11/2025
G2079,Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure,09/11/2025
G2080,"Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure",09/11/2025
G2081,"Patients age 66 and older in institutional special needs plans (snp) or residing in long-term care with a pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period",09/11/2025
G2082,"Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of up to 56 mg of esketamine nasal self-administration, includes 2 hours post-administration observation",09/11/2025
G2083,"Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of  greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation",09/11/2025
G2086,"Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month",09/11/2025
G2087,"Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month",09/11/2025
G2088,"Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; each additional 30 minutes beyond the first 120 minutes (list separately in addition to code for primary procedure)",09/11/2025
G2089,Most recent hemoglobin a1c (hba1c) level 7.0 to 9.0%,09/11/2025
G2090,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,09/11/2025
G2091,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,09/11/2025
G2092,Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy prescribed or currently being taken,09/11/2025
G2093,"Documentation of medical reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., hypotensive patients who are at immediate risk of cardiogenic shock, hospitalized patients who have experienced marked azotemia, allergy, intolerance, other medical reasons)",09/11/2025
G2094,"Documentation of patient reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., patient declined, other patient reasons)",09/11/2025
G2095,"Documentation of system reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., other system reasons)",09/11/2025
G2096,"Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy was not prescribed, reason not given",09/11/2025
G2097,"Episodes where the patient had a competing diagnosis on or within three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, chronic sinusitis, infection of the adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti)",09/11/2025
G2098,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,09/11/2025
G2099,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,09/11/2025
G2100,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,09/11/2025
G2101,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,09/11/2025
G2102,Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed,09/11/2025
G2103,Seven standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewed,09/11/2025
G2104,Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed,09/11/2025
G2105,"Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period",09/11/2025
G2106,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,09/11/2025
G2107,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,09/11/2025
G2108,"Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period",09/11/2025
G2109,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,09/11/2025
G2110,"Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period",09/11/2025
G2112,"Patient receiving <=5 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months",09/11/2025
G2113,"Patient receiving >5 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity",09/11/2025
G2114,Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,09/11/2025
G2115,Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,09/11/2025
G2116,Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,09/11/2025
G2117,"Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period",09/11/2025
G2118,Patients 81 years of age and older with at least one claim/encounter for frailty during the measurement period,09/11/2025
G2119,"Within the past 2 years, calcium and/or vitamin d optimization has been ordered or performed",09/11/2025
G2120,"Within the past 2 years, calcium and/or vitamin d optimization has not been ordered or performed",09/11/2025
G2121,"Depression, anxiety, apathy, and psychosis assessed",09/11/2025
G2122,"Depression, anxiety, apathy, and psychosis not assessed",09/11/2025
G2123,"Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period",09/11/2025
G2124,Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and a dispensed dementia medication,09/11/2025
G2125,Patients 81 years of age and older with at least one claim/encounter for frailty during the six months prior to the measurement period through  december 31 of the measurement period,09/11/2025
G2126,Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,09/11/2025
G2127,Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,09/11/2025
G2128,"Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed, intra-cranial bleed, blood disorders, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)",09/11/2025
G2129,"Procedure-related bp's not taken during an outpatient visit. examples include same day surgery, ambulatory service center, g.i. lab, dialysis, infusion center, chemotherapy",09/11/2025
G2130,"Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement period",09/11/2025
G2131,Patients 81 years and older with a diagnosis of frailty,09/11/2025
G2132,Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,09/11/2025
G2133,"Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period",09/11/2025
G2134,Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,09/11/2025
G2135,"Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period",09/11/2025
G2136,Back pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater,09/11/2025
G2137,Back pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated improvement of less than 5.0 points,09/11/2025
G2138,Back pain as measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater,09/11/2025
G2139,Back pain measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated improvement of less than 5.0 points,09/11/2025
G2140,Leg pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater,09/11/2025
G2141,Leg pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated improvement of less than 5.0 points,09/11/2025
G2142,Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 30 points or greater,09/11/2025
G2143,Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of less than 30 points,09/11/2025
G2144,Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6-20 weeks) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at three months (6-20 weeks) postoperatively demonstrated an improvement of 30 points or greater,09/11/2025
G2145,Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of less than 30 points,09/11/2025
G2146,Leg pain as measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater,09/11/2025
G2147,Leg pain measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated improvement of less than 5.0 points,09/11/2025
G2148,Multimodal pain management was used,09/11/2025
G2149,"Documentation of medical reason(s) for not using multimodal pain management (e.g., allergy to multiple classes of analgesics, intubated patient, hepatic failure, patient reports no pain during pacu stay, other medical reason(s))",09/11/2025
G2150,Multimodal pain management was not used,09/11/2025
G2151,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",09/11/2025
G2152,Residual score for the neck impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0),09/11/2025
G2153,In hospice or using hospice services during the measurement period,09/11/2025
G2154,Patient received at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period,09/11/2025
G2155,"Patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)",09/11/2025
G2156,"Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)",09/11/2025
G2157,"Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period",09/11/2025
G2158,Patient had prior pneumococcal vaccine adverse reaction any time during or before the measurement period,09/11/2025
G2159,"Patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement period",09/11/2025
G2160,Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period,09/11/2025
G2161,Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period,09/11/2025
G2162,Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period,09/11/2025
G2163,Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period,09/11/2025
G2164,Patient had a prior influenza virus vaccine adverse reaction any time before or during the measurement period,09/11/2025
G2165,Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period; or did not have a prior influenza virus vaccine adverse reaction any time before or during the measurement period,09/11/2025
G2166,"Patient refused to participate at admission and/or discharge; patient unable to complete the neck fs prom at admission or discharge due to cognitive deficit, visual deficit, motor deficit, language barrier, or low reading level, and a suitable proxy/recorder is not available; patient self-discharged early; medical reason",09/11/2025
G2167,Residual score for the neck impairment successfully calculated and the score was less than zero (< 0),09/11/2025
G2168,"Services performed by a physical therapist assistant in the home health setting in the delivery of a safe and effective physical therapy maintenance program, each 15 minutes",09/11/2025
G2169,"Services performed by an occupational therapist assistant in the home health setting in the delivery of a safe and effective occupational therapy maintenance program, each 15 minutes",09/11/2025
G2170,"Percutaneous arteriovenous fistula creation (avf), direct, any site, by tissue approximation using thermal resistance energy, and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization) when performed, and includes all imaging and radiologic guidance, supervision and interpretation, when performed",09/11/2025
G2171,"Percutaneous arteriovenous fistula creation (avf), direct, any site, using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, wen performed) and fistulogram(s), angiography, enography, and/or ultrasound, with radiologic supervision and interpretation, when performed",09/11/2025
G2172,All inclusive payment for services related to highly coordinated and integrated opioid use disorder (oud) treatment services furnished for the demonstration project,09/11/2025
G2173,"Uri episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)",09/11/2025
G2174,Uri episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date,09/11/2025
G2175,"Episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)",09/11/2025
G2176,"Outpatient, ed, or observation visits that result in an inpatient admission",09/11/2025
G2177,Acute bronchitis/bronchiolitis episodes when the patient had a new or refill prescription of antibiotics (table 1) in the 30 days prior to the episode date,09/11/2025
G2178,"Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure, for example patient bilateral amputee; patient has condition that would not allow them to accurately respond to a neurological exam (dementia, alzheimer's, etc.); patient has previously documented diabetic peripheral neuropathy with loss of protective sensation",09/11/2025
G2179,Clinician documented that patient had medical reason for not performing lower extremity neurological exam,09/11/2025
G2180,Clinician documented that patient was not an eligible candidate for evaluation of footwear as patient is bilateral lower extremity amputee,09/11/2025
G2181,Bmi not documented due to medical reason or patient refusal of height or weight measurement,09/11/2025
G2182,Patient receiving first-time biologic and/or immune response modifier therapy,09/11/2025
G2183,Documentation patient unable to communicate and informant not available,09/11/2025
G2184,Patient does not have a caregiver,09/11/2025
G2185,Documentation caregiver is trained and certified in dementia care,09/11/2025
G2186,Patient /caregiver dyad has been referred to appropriate resources and connection to those resources is confirmed,09/11/2025
G2187,Patients with clinical indications for imaging of the head: head trauma,09/11/2025
G2188,Patients with clinical indications for imaging of the head: new or change in headache above 50 years of age,09/11/2025
G2189,Patients with clinical indications for imaging of the head: abnormal neurologic exam,09/11/2025
G2190,Patients with clinical indications for imaging of the head: headache radiating to the neck,09/11/2025
G2191,Patients with clinical indications for imaging of the head: positional headaches,09/11/2025
G2192,Patients with clinical indications for imaging of the head: temporal headaches in patients over 55 years of age,09/11/2025
G2193,Patients with clinical indications for imaging of the head: new onset headache in pre-school children or younger (<6 years of age),09/11/2025
G2194,Patients with clinical indications for imaging of the head: new onset headache in pediatric patients with disabilities for which headache is a concern as inferred from behavior,09/11/2025
G2195,Patients with clinical indications for imaging of the head: occipital headache in children,09/11/2025
G2196,Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method,09/11/2025
G2197,Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user,09/11/2025
G2198,"Documentation of medical reason(s) for not screening for unhealthy alcohol use using a systematic screening method (e.g., limited life expectancy, other medical reasons)",09/11/2025
G2199,Patient not screened for unhealthy alcohol use using a systematic screening method,09/11/2025
G2200,Patient identified as an unhealthy alcohol user received brief counseling,09/11/2025
G2201,"Documentation of medical reason(s) for not providing brief counseling (e.g., limited life expectancy, other medical reasons)",09/11/2025
G2202,Patient did not receive brief counseling if identified as an unhealthy alcohol user,09/11/2025
G2203,"Documentation of medical reason(s) for not providing brief counseling if identified as an unhealthy alcohol user (e.g., limited life expectancy, other medical reasons)",09/11/2025
G2204,Patients between 45 and 85 years of age who received a screening colonoscopy during the performance period,09/11/2025
G2205,Patients with pregnancy during adjuvant treatment course,09/11/2025
G2206,Patient received adjuvant treatment course including both chemotherapy and her2-targeted therapy,09/11/2025
G2207,"Reason for not administering adjuvant treatment course including both chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4; karnofsky <=50), cardiac contraindications, insufficient renal function, insufficient hepatic function, other active or secondary cancer diagnoses, other medical contraindications, patients who died during initial treatment course or transferred during or after initial treatment course)",09/11/2025
G2208,Patient did not receive adjuvant treatment course including both chemotherapy and her2-targeted therapy,09/11/2025
G2209,Patient refused to participate,09/11/2025
G2210,"Residual score for the neck impairment not measured because the patient did not complete the neck fs prom at initial evaluation and/or near discharge, reason not given",09/11/2025
G2211,"Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition.  (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)",09/11/2025
G2212,"Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)",09/11/2025
G2213,"Initiation of medication for the treatment of opioid use disorder in the emergency department setting, including assessment, referral to ongoing care, and arranging access to supportive services (list separately in addition to code for primary procedure)",09/11/2025
G2214,"Initial or subsequent psychiatric collaborative care management, first 30 minutes in a month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional",09/11/2025
G2215,Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure,09/11/2025
G2216,Take-home supply of injectable naloxone (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure,09/11/2025
G2250,"Remote assessment of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment",09/11/2025
G2251,"Brief communication technology-based service, e.g. virtual check-in, by a qualified health care professional who cannot report evaluation and management services, provided to an established patient, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of clinical discussion",09/11/2025
G2252,"Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion",09/11/2025
G3001,"Administration and supply of tositumomab, 450 mg",09/11/2025
G3002,"Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.)",09/11/2025
G3003,"Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.)",09/11/2025
G4000,Dermatology mips specialty set,09/11/2025
G4001,Diagnostic radiology mips specialty set,09/11/2025
G4002,Electrophysiology cardiac specialist mips specialty set,09/11/2025
G4003,Emergency medicine mips specialty set,09/11/2025
G4004,Endocrinology mips specialty set,09/11/2025
G4005,Family medicine mips specialty set,09/11/2025
G4006,Gastro-enterology mips specialty set,09/11/2025
G4007,General surgery mips specialty set,09/11/2025
G4008,Geriatrics mips specialty set,09/11/2025
G4009,Hospitalists mips specialty set,09/11/2025
G4010,Infectious disease mips specialty set,09/11/2025
G4011,Internal medicine mips specialty set,09/11/2025
G4012,Interventional radiology mips specialty set,09/11/2025
G4013,Mental/behavioral and psychiatry mips specialty set,09/11/2025
G4014,Nephrology mips specialty set,09/11/2025
G4015,Neurology mips specialty set,09/11/2025
G4016,Neurosurgical mips specialty set,09/11/2025
G4017,Nutrition/dietician mips specialty set,09/11/2025
G4018,Obstetrics/gynecology mips specialty set,09/11/2025
G4019,Oncology/hematology mips specialty set,09/11/2025
G4020,Ophthalmology/optometry mips specialty set,09/11/2025
G4021,Orthopedic surgery mips specialty set,09/11/2025
G4022,Otolaryngology mips specialty set,09/11/2025
G4023,Pathology mips specialty set,09/11/2025
G4024,Pediatrics mips specialty set,09/11/2025
G4025,Physical medicine mips specialty set,09/11/2025
G4026,Physical therapy/occupational therapy mips specialty set,09/11/2025
G4027,Plastic surgery mips specialty set,09/11/2025
G4028,Podiatry mips specialty set,09/11/2025
G4029,Preventive medicine mips specialty set,09/11/2025
G4030,Pulmonology mips specialty set,09/11/2025
G4031,Radiation oncology mips specialty set,09/11/2025
G4032,Rheumatology mips specialty set,09/11/2025
G4033,Skilled nursing facility mips specialty set,09/11/2025
G4034,Speech language pathology mips specialty set,09/11/2025
G4035,Thoracic surgery mips specialty set,09/11/2025
G4036,Urgent care mips specialty set,09/11/2025
G4037,Urology mips specialty set,09/11/2025
G4038,Vascular surgery mips specialty set,09/11/2025
G6001,Ultrasonic guidance for placement of radiation therapy fields,09/11/2025
G6002,Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy,09/11/2025
G6003,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: up to 5 mev",09/11/2025
G6004,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 6-10 mev",09/11/2025
G6005,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 11-19 mev",09/11/2025
G6006,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 20 mev or greater",09/11/2025
G6007,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5 mev",09/11/2025
G6008,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10 mev",09/11/2025
G6009,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19 mev",09/11/2025
G6010,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater",09/11/2025
G6011,"Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5 mev",09/11/2025
G6012,"Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev",09/11/2025
G6013,"Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev",09/11/2025
G6014,"Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater",09/11/2025
G6015,"Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session",09/11/2025
G6016,"Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session",09/11/2025
G6017,"Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment",09/11/2025
G6018,"Ileoscopy, through stoma; with transendoscopic stent placement (includes predilation)",09/11/2025
G6019,"Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique",09/11/2025
G6020,Colonoscopy through stoma; with transendoscopic stent placement (includes predilation),09/11/2025
G6021,"Unlisted procedure, intestine",09/11/2025
G6022,"Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique",09/11/2025
G6023,"Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation)",09/11/2025
G6024,"Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique",09/11/2025
G6025,"Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation)",09/11/2025
G6027,"Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed",09/11/2025
G6028,"Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies)",09/11/2025
G6030,Amitriptyline,09/11/2025
G6031,Benzodiazepines,09/11/2025
G6032,Desipramine,09/11/2025
G6034,Doxepin,09/11/2025
G6035,Gold,09/11/2025
G6036,Assay of imipramine,09/11/2025
G6037,Nortriptyline,09/11/2025
G6038,Salicylate,09/11/2025
G6039,Acetaminophen,09/11/2025
G6040,Alcohol (ethanol); any specimen except breath,09/11/2025
G6041,"Alkaloids, urine, quantitative",09/11/2025
G6042,Amphetamine or methamphetamine,09/11/2025
G6043,"Barbiturates, not elsewhere specified",09/11/2025
G6044,Cocaine or metabolite,09/11/2025
G6045,Dihydrocodeinone,09/11/2025
G6046,Dihydromorphinone,09/11/2025
G6047,Dihydrotestosterone,09/11/2025
G6048,Dimethadione,09/11/2025
G6049,Epiandrosterone,09/11/2025
G6050,Ethchlorvynol,09/11/2025
G6051,Flurazepam,09/11/2025
G6052,Meprobamate,09/11/2025
G6053,Methadone,09/11/2025
G6054,Methsuximide,09/11/2025
G6055,Nicotine,09/11/2025
G6056,"Opiate(s), drug and metabolites, each procedure",09/11/2025
G6057,Phenothiazine,09/11/2025
G6058,"Drug confirmation, each procedure",09/11/2025
G8126,Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week)  acute treatment phase,09/11/2025
G8127,Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase,09/11/2025
G8128,Clinician documented that patient was not an eligible candidate for antidepressant medication during the entire 12 week acute treatment phase measure,09/11/2025
G8395,Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function,09/11/2025
G8396,Left ventricular ejection fraction (lvef) not performed or documented,09/11/2025
G8397,"Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy",09/11/2025
G8398,Dilated macular or fundus exam not performed,09/11/2025
G8399,Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed,09/11/2025
G8400,"Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given",09/11/2025
G8401,Clinician documented that patient was not an eligible candidate for screening,09/11/2025
G8404,Lower extremity neurological exam performed and documented,09/11/2025
G8405,Lower extremity neurological exam not performed,09/11/2025
G8406,Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure,09/11/2025
G8410,Footwear evaluation performed and documented,09/11/2025
G8415,Footwear evaluation was not performed,09/11/2025
G8416,Clinician documented that patient was not an eligible candidate for footwear evaluation measure,09/11/2025
G8417,Bmi is documented above normal parameters and a follow-up plan is documented,09/11/2025
G8418,Bmi is documented below normal parameters and a follow-up plan is documented,09/11/2025
G8419,"Bmi documented outside normal parameters, no follow-up plan documented, no reason given",09/11/2025
G8420,Bmi is documented within normal parameters and no follow-up plan is required,09/11/2025
G8421,Bmi not documented and no reason is given,09/11/2025
G8422,"Bmi not documented, documentation the patient is not eligible for bmi calculation",09/11/2025
G8427,"Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications",09/11/2025
G8428,"Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given",09/11/2025
G8430,"Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an urgent or emergent medical situation)",09/11/2025
G8431,Screening for depression is documented as being positive and a follow-up plan is documented,09/11/2025
G8432,"Depression screening not documented, reason not given",09/11/2025
G8433,"Screening for depression not completed, documented patient or medical reason",09/11/2025
G8442,"Pain assessment not documented as being performed, documentation the patient is not eligible for a pain assessment using a standardized tool at the time of the encounter",09/11/2025
G8450,Beta-blocker therapy prescribed,09/11/2025
G8451,"Beta-blocker therapy for lvef <=40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons, patient declined, other patient reasons)",09/11/2025
G8452,Beta-blocker therapy not prescribed,09/11/2025
G8458,"Clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for hepatitis c during the measurement period (e.g. genotype test done prior to the reporting period, patient declines, patient not a candidate for antiviral treatment)",09/11/2025
G8460,Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis c,09/11/2025
G8461,Patient receiving antiviral treatment for hepatitis c during the measurement period,09/11/2025
G8464,Clinician documented that prostate cancer patient is not an eligible candidate for adjuvant hormonal therapy; low or intermediate risk of recurrence or risk of recurrence not determined,09/11/2025
G8465,High or very high risk of recurrence of prostate cancer,09/11/2025
G8473,Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed,09/11/2025
G8474,"Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (e.g., allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (e.g., patient declined, other patient reasons)",09/11/2025
G8475,"Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not given",09/11/2025
G8476,Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg,09/11/2025
G8477,Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg,09/11/2025
G8478,"Blood pressure measurement not performed or documented, reason not given",09/11/2025
G8482,Influenza immunization administered or previously received,09/11/2025
G8483,"Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)",09/11/2025
G8484,"Influenza immunization was not administered, reason not given",09/11/2025
G8485,I intend to report the diabetes mellitus (dm) measures group,09/11/2025
G8486,I intend to report the preventive care measures group,09/11/2025
G8487,I intend to report the chronic kidney disease (ckd) measures group,09/11/2025
G8489,I intend to report the coronary artery disease (cad) measures group,09/11/2025
G8490,I intend to report the rheumatoid arthritis (ra) measures group,09/11/2025
G8491,I intend to report the hiv/aids measures group,09/11/2025
G8492,I intend to report the perioperative care measures group,09/11/2025
G8493,I intend to report the back pain measures group,09/11/2025
G8494,All quality actions for the applicable measures in the diabetes mellitus (dm) measures group have been performed for this patient,09/11/2025
G8495,All quality actions for the applicable measures in the chronic kidney disease (ckd) measures group have been performed for this patient,09/11/2025
G8496,All quality actions for the applicable measures in the preventive care measures group have been performed for this patient,09/11/2025
G8497,All quality actions for the applicable measures in the coronary artery bypass graft (cabg) measures group have been performed for this patient,09/11/2025
G8498,All quality actions for the applicable measures in the coronary artery disease (cad) measures group have been performed for this patient,09/11/2025
G8499,All quality actions for the applicable measures in the rheumatoid arthritis (ra) measures group have been performed for this patient,09/11/2025
G8500,All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient,09/11/2025
G8501,All quality actions for the applicable measures in the perioperative care measures group have been performed for this patient,09/11/2025
G8502,All quality actions for the applicable measures in the back pain measures group have been performed for this patient,09/11/2025
G8506,Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy,09/11/2025
G8509,"Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given",09/11/2025
G8510,"Screening for depression is documented as negative, a follow-up plan is not required",09/11/2025
G8511,"Screening for depression documented as positive, follow-up plan not documented, reason not given",09/11/2025
G8530,Autogenous av fistula received,09/11/2025
G8531,Clinician documented that patient was not an eligible candidate for autogenous av fistula,09/11/2025
G8532,"Clinician documented that patient received vascular access other than autogenous av fistula, reason not given",09/11/2025
G8535,"Elder maltreatment screen not documented; documentation that patient is not eligible for the elder maltreatment screen at the time of the encounter related to one of the following reasons: (1) patient refuses to participate in the screening and has reasonable decisional capacity for self-protection, or (2) patient is in an urgent or emergent situation where time is of the essence and to delay treatment to perform the screening would jeopardize the patient's health status",09/11/2025
G8536,"No documentation of an elder maltreatment screen, reason not given",09/11/2025
G8539,Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment,09/11/2025
G8540,"Functional outcome assessment not documented as being performed, documentation the patient is not eligible for a functional outcome assessment using a standardized tool at the time of the encounter",09/11/2025
G8541,"Functional outcome assessment using a standardized tool not documented, reason not given",09/11/2025
G8542,"Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required",09/11/2025
G8543,"Documentation of a positive functional outcome assessment using a standardized tool; care plan not documented within two days of assessment, reason not given",09/11/2025
G8544,I intend to report the coronary artery bypass graft (cabg) measures group,09/11/2025
G8545,I intend to report the hepatitis c measures group,09/11/2025
G8547,I intend to report the ischemic vascular disease (ivd) measures group,09/11/2025
G8548,I intend to report the heart failure (hf) measures group,09/11/2025
G8549,All quality actions for the applicable measures in the hepatitis c measures group have been performed for this patient,09/11/2025
G8551,All quality actions for the applicable measures in the heart failure (hf) measures group have been performed for this patient,09/11/2025
G8552,All quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient,09/11/2025
G8559,Patient referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation,09/11/2025
G8560,Patient has a history of active drainage from the ear within the previous 90 days,09/11/2025
G8561,Patient is not eligible for the referral for otologic evaluation for patients with a history of active drainage measure,09/11/2025
G8562,Patient does not have a history of active drainage from the ear within the previous 90 days,09/11/2025
G8563,"Patient not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given",09/11/2025
G8564,"Patient was referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not specified)",09/11/2025
G8565,Verification and documentation of sudden or rapidly progressive hearing loss,09/11/2025
G8566,"Patient is not eligible for the ""referral for otologic evaluation for sudden or rapidly progressive hearing loss"" measure",09/11/2025
G8567,Patient does not have verification and documentation of sudden or rapidly progressive hearing loss,09/11/2025
G8568,"Patient was not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given",09/11/2025
G8569,Prolonged postoperative intubation (> 24 hrs) required,09/11/2025
G8570,Prolonged postoperative intubation (> 24 hrs) not required,09/11/2025
G8571,Development of deep sternal wound infection/mediastinitis within 30 days postoperatively,09/11/2025
G8572,No deep sternal wound infection/mediastinitis,09/11/2025
G8573,Stroke following isolated cabg surgery,09/11/2025
G8574,No stroke following isolated cabg surgery,09/11/2025
G8575,Developed postoperative renal failure or required dialysis,09/11/2025
G8576,No postoperative renal failure/dialysis not required,09/11/2025
G8577,"Re-exploration required due to mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native, vessel, graft, or both), valve dysfunction, aortic reintervention, or other cardiac reason",09/11/2025
G8578,"Re-exploration not required due to mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native, vessel, graft, or both), valve dysfunction, aortic reintervention, or other cardiac reason",09/11/2025
G8579,Antiplatelet medication at discharge,09/11/2025
G8580,Antiplatelet medication contraindicated,09/11/2025
G8581,No antiplatelet medication at discharge,09/11/2025
G8582,Beta-blocker at discharge,09/11/2025
G8583,Beta-blocker contraindicated,09/11/2025
G8584,No beta-blocker at discharge,09/11/2025
G8585,Anti-lipid treatment at discharge,09/11/2025
G8586,Anti-lipid treatment contraindicated,09/11/2025
G8587,No anti-lipid treatment at discharge,09/11/2025
G8593,"Lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)",09/11/2025
G8594,"Lipid profile not performed, reason not given",09/11/2025
G8595,Most recent ldl-c < 100 mg/dl,09/11/2025
G8597,Most recent ldl-c >= 100 mg/dl,09/11/2025
G8598,Aspirin or another antiplatelet therapy used,09/11/2025
G8599,"Aspirin or another antiplatelet therapy not used, reason not given",09/11/2025
G8600,Iv thrombolytic therapy initiated within 4.5 hours (<= 270 minutes) of time last known well,09/11/2025
G8601,"Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time last known well for reasons documented by clinician (e.g. patient enrolled in clinical trial for stroke, patient admitted for elective carotid intervention)",09/11/2025
G8602,"Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time last known well, reason not given",09/11/2025
G8627,"Surgical procedure performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)",09/11/2025
G8628,"Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)",09/11/2025
G8629,"Documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)",09/11/2025
G8630,"Documentation that administration of prophylactic parenteral antibiotics was initiated within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required), as ordered",09/11/2025
G8631,"Clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)",09/11/2025
G8632,"Prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given",09/11/2025
G8633,Pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed,09/11/2025
G8634,Clinician documented patient not an eligible candidate to receive pharmacologic therapy for osteoporosis,09/11/2025
G8635,"Pharmacologic therapy for osteoporosis was not prescribed, reason not given",09/11/2025
G8645,I intend to report the asthma measures group,09/11/2025
G8646,All quality actions for the applicable measures in the asthma measures group have been performed for this patient,09/11/2025
G8647,Residual score for the knee impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0),09/11/2025
G8648,Residual score for the knee impairment successfully calculated and the score was less than zero (< 0),09/11/2025
G8649,"Risk-adjusted functional status change residual score for the knee impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",09/11/2025
G8650,"Residual score for the knee impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given",09/11/2025
G8651,Residual score for the hip impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0),09/11/2025
G8652,Residual score for the hip impairment successfully calculated and the score was less than zero (< 0),09/11/2025
G8653,"Risk-adjusted functional status change residual scores for the hip impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",09/11/2025
G8654,"Residual score for the hip impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given",09/11/2025
G8655,"Residual score for the lower leg, foot or ankle impairment successfully calculated and the score was equal to zero (0) or greater than zero ( > 0)",09/11/2025
G8656,"Residual score for the lower leg, foot or ankle impairment successfully calculated and the score was less than zero (< 0)",09/11/2025
G8657,"Risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",09/11/2025
G8658,"Residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given",09/11/2025
G8659,Residual score for the low back impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0),09/11/2025
G8660,Residual score for the low back impairment successfully calculated and the score was less than zero (< 0),09/11/2025
G8661,"Risk-adjusted functional status change residual score for the low back impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",09/11/2025
G8662,"Residual score for the low back impairment not measured because the patient did not complete the low back fs prom at initial evaluation and/or near discharge, reason not given",09/11/2025
G8663,Residual score for the shoulder impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0),09/11/2025
G8664,Residual score for the shoulder impairment successfully calculated and the score was less than zero (< 0),09/11/2025
G8665,"Risk-adjusted functional status change residual score for the shoulder impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",09/11/2025
G8666,"Residual score for the shoulder impairment not measured because the patient did not complete the shoulder fs prom at initial evaluation and/or near discharge, reason not given",09/11/2025
G8667,"Residual score for the elbow, wrist or hand impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)",09/11/2025
G8668,"Residual score for the elbow, wrist or hand impairment successfully calculated and the score was less than zero (< 0)",09/11/2025
G8669,"Risk-adjusted functional status change residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",09/11/2025
G8670,"Residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the elbow/wrist/hand fs prom at initial evaluation and/or near discharge, reason not given",09/11/2025
G8671,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)",09/11/2025
G8672,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was less than zero (< 0)",09/11/2025
G8673,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",09/11/2025
G8674,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the general orthopedic fs prom at initial evaluation and/or near discharge, reason not given",09/11/2025
G8682,Lvf testing documented as being performed prior to discharge or in the previous 12 months,09/11/2025
G8683,Lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason,09/11/2025
G8685,"Lvf testing not documented as being performed prior to discharge or in the previous 12 months, reason not given",09/11/2025
G8694,Current or prior left ventricular ejection fraction (lvef) < = 40% or documentation of moderate or severe lvsd,09/11/2025
G8696,Antithrombotic therapy prescribed at discharge,09/11/2025
G8697,"Antithrombotic therapy not prescribed for documented reasons (e.g., patient had stroke during hospital stay, patient expired during inpatient stay, other medical reason(s)); (e.g., patient left against medical advice, other patient reason(s))",09/11/2025
G8698,"Antithrombotic therapy was not prescribed at discharge, reason not given",09/11/2025
G8699,"Rehabilitation services (occupational, physical or speech) ordered at or prior to discharge",09/11/2025
G8700,"Rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge",09/11/2025
G8701,"Rehabilitation services were not ordered, reason not otherwise specified",09/11/2025
G8702,Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or intraoperatively,09/11/2025
G8703,Documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively,09/11/2025
G8704,12-lead electrocardiogram (ecg) performed,09/11/2025
G8705,Documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg),09/11/2025
G8706,Documentation of patient reason(s) for not performing a 12-lead electrocardiogram (ecg),09/11/2025
G8707,"12-lead electrocardiogram (ecg) not performed, reason not given",09/11/2025
G8708,Patient not prescribed antibiotic,09/11/2025
G8709,"Uri episodes when the patient had competing diagnoses on or three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti, and acne)",09/11/2025
G8710,Patient prescribed antibiotic,09/11/2025
G8711,Prescribed antibiotic on or within 3 days after the episode date,09/11/2025
G8712,Antibiotic not prescribed or dispensed,09/11/2025
G8713,Spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]),09/11/2025
G8714,Hemodialysis treatment performed exactly three times per week for > 90 days,09/11/2025
G8717,"Spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given",09/11/2025
G8718,Total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt] / volume [v]),09/11/2025
G8720,Total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]),09/11/2025
G8721,"Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documented in pathology report",09/11/2025
G8722,"Documentation of medical reason(s) for not including the pt category, the pn category or the histologic grade in the pathology report (e.g., re-excision without residual tumor; non-carcinomasanal canal)",09/11/2025
G8723,Specimen site is other than anatomic location of primary tumor,09/11/2025
G8724,"Pt category, pn category and histologic grade were not documented in the pathology report, reason not given",09/11/2025
G8725,"Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol)",09/11/2025
G8726,"Clinician has documented reason for not performing fasting lipid profile (e.g., patient declined, other patient reasons)",09/11/2025
G8728,"Fasting lipid profile not performed, reason not given",09/11/2025
G8730,Pain assessment documented as positive using a standardized tool and a follow-up plan is documented,09/11/2025
G8731,"Pain assessment using a standardized tool is documented as negative, no follow-up plan required",09/11/2025
G8732,"No documentation of pain assessment, reason not given",09/11/2025
G8733,Elder maltreatment screen documented as positive and a follow-up plan is documented,09/11/2025
G8734,"Elder maltreatment screen documented as negative, follow-up is not required",09/11/2025
G8735,"Elder maltreatment screen documented as positive, follow-up plan not documented, reason not given",09/11/2025
G8736,Most current ldl-c <100mg/dl,09/11/2025
G8737,Most current ldl-c >=100mg/dl,09/11/2025
G8738,Left ventricular ejection fraction (lvef) < 40% or documentation of severely or moderately depressed left ventricular systolic function,09/11/2025
G8739,Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function,09/11/2025
G8740,"Left ventricular ejection fraction (lvef) not performed or assessed, reason not given",09/11/2025
G8749,"Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or any other sign suggesting systemic spread) or absence of symptoms of melanoma (cough, dyspnea, pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma)",09/11/2025
G8751,"Smoking status and exposure to second hand smoke in the home not assessed, reason not given",09/11/2025
G8752,Most recent systolic blood pressure < 140 mmhg,09/11/2025
G8753,Most recent systolic blood pressure >= 140 mmhg,09/11/2025
G8754,Most recent diastolic blood pressure < 90 mmhg,09/11/2025
G8755,Most recent diastolic blood pressure >= 90 mmhg,09/11/2025
G8756,"No documentation of blood pressure measurement, reason not given",09/11/2025
G8757,All quality actions for the applicable measures in the chronic obstructive pulmonary disease (copd) measures group have been performed for this patient,09/11/2025
G8758,All quality actions for the applicable measures in the inflammatory bowel disease (ibd) measures group have been performed for this patient,09/11/2025
G8759,All quality actions for the applicable measures in the sleep apnea measures group have been performed for this patient,09/11/2025
G8761,All quality actions for the applicable measures in the dementia measures group have been performed for this patient,09/11/2025
G8762,All quality actions for the applicable measures in the parkinson's disease measures group have been performed for this patient,09/11/2025
G8763,All quality actions for the applicable measures in the hypertension (htn) measures group have been performed for this patient,09/11/2025
G8764,All quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient,09/11/2025
G8765,All quality actions for the applicable measures in the cataract measures group have been performed for this patient,09/11/2025
G8767,"Lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)",09/11/2025
G8768,"Documentation of medical reason(s) for not performing lipid profile (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",09/11/2025
G8769,"Lipid profile not performed, reason not given",09/11/2025
G8770,Urine protein test result documented and reviewed,09/11/2025
G8771,Documentation of diagnosis of chronic kidney disease,09/11/2025
G8772,"Documentation of medical reason(s) for not performing urine protein test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not cllinically appropriate)",09/11/2025
G8773,"Urine protein test was not performed, reason not given",09/11/2025
G8774,Serum creatinine test result documented and reviewed,09/11/2025
G8775,"Documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",09/11/2025
G8776,"Serum creatinine test not performed, reason not given",09/11/2025
G8777,Diabetes screening test performed,09/11/2025
G8778,"Documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",09/11/2025
G8779,"Diabetes screening test not performed, reason not given",09/11/2025
G8780,Counseling for diet and physical activity performed,09/11/2025
G8781,"Documentation of medical reason(s) for patient not receiving counseling for diet and physical activity (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",09/11/2025
G8782,"Counseling for diet and physical activity not performed, reason not given",09/11/2025
G8783,"Normal blood pressure reading documented, follow-up not required",09/11/2025
G8784,"Patient not eligible (e.g., documentation the patient is not eligible due to active diagnosis of hypertension, patient refuses, urgent or emergent situation)",09/11/2025
G8785,"Blood pressure reading not documented, reason not given",09/11/2025
G8797,Specimen site other than anatomic location of esophagus,09/11/2025
G8798,Specimen site other than anatomic location of prostate,09/11/2025
G8806,Performance of trans-abdominal or trans-vaginal ultrasound and pregnancy location documented,09/11/2025
G8807,"Trans-abdominal or trans-vaginal ultrasound not performed for reasons documented by clinician (e.g., patient has a documented intrauterine pregnancy [iup])",09/11/2025
G8808,"Trans-abdominal or trans-vaginal ultrasound not performed, reason not given",09/11/2025
G8809,Rh-immunoglobulin (rhogam) ordered,09/11/2025
G8810,"Rh-immunoglobulin (rhogam) not ordered for reasons documented by clinician (e.g., patient had prior documented receipt of rhogam within 12 weeks, patient refusal)",09/11/2025
G8811,"Documentation rh-immunoglobulin (rhogam) was not ordered, reason not given",09/11/2025
G8815,"Documented reason in the medical records for why the statin therapy was not prescribed (i.e., lower extremity bypass was for a patient with non-artherosclerotic disease)",09/11/2025
G8816,Statin medication prescribed at discharge,09/11/2025
G8817,"Statin therapy not prescribed at discharge, reason not given",09/11/2025
G8818,Patient discharge to home no later than post-operative day #7,09/11/2025
G8825,Patient not discharged to home by post-operative day #7,09/11/2025
G8826,Patient discharged to home no later than post-operative day #2 following evar,09/11/2025
G8833,Patient not discharged to home by post-operative day #2 following evar,09/11/2025
G8834,Patient discharged to home no later than post-operative day #2 following cea,09/11/2025
G8838,Patient not discharged to home by post-operative day #2 following cea,09/11/2025
G8839,"Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness",09/11/2025
G8840,"Documentation of reason(s) for not documenting an assessment of sleep symptoms (e.g., patient didn't have initial daytime sleepiness, patient visited between initial testing and initiation of therapy)",09/11/2025
G8841,"Sleep apnea symptoms not assessed, reason not given",09/11/2025
G8842,"Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory event index (rei) documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea",09/11/2025
G8843,"Documentation of reason(s) for not measuring an apnea hypopnea index (ahi), a respiratory disturbance index (rdi), or a respiratory event index (rei) within 2 months after initial evaluation for suspected obstructive sleep apnea (e.g., medical, neurological, or psychiatric disease that prohibits successful completion of a sleep study, patients for whom a sleep study would present a bigger risk than benefit or would pose an undue burden, dementia, patients previously diagnosed with osa and severity assessed by another provider, patients who decline ahi/rdi/rei measurement, patients who had a financial reason for not completing testing, test was ordered but not completed, patients decline because their insurance (payer) does not cover the expense)",09/11/2025
G8844,"Apnea hypopnea index (ahi), respiratory disturbance index (rdi), or respiratory event index (rei) not documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea, reason not given",09/11/2025
G8845,Positive airway pressure therapy prescribed,09/11/2025
G8846,Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater),09/11/2025
G8848,Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15),09/11/2025
G8849,"Documentation of reason(s) for not prescribing positive airway pressure therapy (e.g., patient unable to tolerate, alternative therapies use, patient declined, financial, insurance coverage)",09/11/2025
G8850,"Positive airway pressure therapy not prescribed, reason not given",09/11/2025
G8851,"Adherence to therapy was assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available, documented)",09/11/2025
G8852,Positive airway pressure therapy was prescribed,09/11/2025
G8853,Positive airway pressure therapy not prescribed,09/11/2025
G8854,"Documentation of reason(s) for not objectively reporting adherence to evidence-based therapy (e.g., patients who have been diagnosed with a terminal or advanced disease with an expected life span of less than 6 months, patients who decline therapy, patients who do not return for follow-up at least annually, patients unable to access/afford therapy, patient's insurance will not cover therapy)",09/11/2025
G8855,"Adherence to therapy was not assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available), reason not given",09/11/2025
G8856,Referral to a physician for an otologic evaluation performed,09/11/2025
G8857,"Patient is not eligible for the referral for otologic evaluation measure (e.g., patients who are already under the care of a physician for acute or chronic dizziness)",09/11/2025
G8858,"Referral to a physician for an otologic evaluation not performed, reason not given",09/11/2025
G8859,Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days,09/11/2025
G8860,Patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days,09/11/2025
G8861,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered and documented, review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed",09/11/2025
G8862,Patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days,09/11/2025
G8863,"Patients not assessed for risk of bone loss, reason not given",09/11/2025
G8864,Pneumococcal vaccine administered or previously received,09/11/2025
G8865,"Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)",09/11/2025
G8866,"Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)",09/11/2025
G8867,"Pneumococcal vaccine not administered or previously received, reason not given",09/11/2025
G8868,Patients receiving a first course of anti-tnf therapy,09/11/2025
G8869,Patient has documented immunity to hepatitis b and initiating anti-tnf therapy,09/11/2025
G8870,Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy,09/11/2025
G8871,Patient not receiving a first course of anti-tnf therapy,09/11/2025
G8872,Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion,09/11/2025
G8873,"Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)",09/11/2025
G8874,Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion,09/11/2025
G8875,Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method,09/11/2025
G8876,"Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prevents needle biopsy [weight, breast thickness, etc.], duct excision without imaging abnormality, prophylactic mastectomy, reduction mammoplasty, excisional biopsy performed by another physician)",09/11/2025
G8877,"Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not given",09/11/2025
G8878,Sentinel lymph node biopsy procedure performed,09/11/2025
G8879,Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer,09/11/2025
G8880,"Documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node (ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer, recurrent invasive breast cancer, clinically node positive after neoadjuvant systemic therapy, patient refusal after informed consent, patient with significant age, comorbidities, or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change)",09/11/2025
G8881,Stage of breast cancer is greater than t1n0m0 or t2n0m0,09/11/2025
G8882,"Sentinel lymph node biopsy procedure not performed, reason not given",09/11/2025
G8883,"Biopsy results reviewed, communicated, tracked and documented",09/11/2025
G8884,Clinician documented reason that patient's biopsy results were not reviewed,09/11/2025
G8885,"Biopsy results not reviewed, communicated, tracked or documented",09/11/2025
G8886,Most recent blood pressure under control,09/11/2025
G8887,"Documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",09/11/2025
G8888,"Most recent blood pressure not under control, results documented and reviewed",09/11/2025
G8889,"No documentation of blood pressure measurement, reason not given",09/11/2025
G8890,"Most recent ldl-c under control, results documented and reviewed",09/11/2025
G8891,"Documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",09/11/2025
G8892,Documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate),09/11/2025
G8893,"Most recent ldl-c not under control, results documented and reviewed",09/11/2025
G8894,"Ldl-c not performed, reason not given",09/11/2025
G8895,Oral aspirin or other antithrombotic therapy prescribed,09/11/2025
G8896,"Documentation of medical reason(s) for not prescribing oral aspirin or other antithrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appropriate, or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled)",09/11/2025
G8897,"Oral aspirin or other antithrombotic therapy was not prescribed, reason not given",09/11/2025
G8898,I intend to report the chronic obstructive pulmonary disease (copd) measures group,09/11/2025
G8899,I intend to report the inflammatory bowel disease (ibd) measures group,09/11/2025
G8900,I intend to report the sleep apnea measures group,09/11/2025
G8902,I intend to report the dementia measures group,09/11/2025
G8903,I intend to report the parkinson's disease measures group,09/11/2025
G8904,I intend to report the hypertension (htn) measures group,09/11/2025
G8905,I intend to report the cardiovascular prevention measures group,09/11/2025
G8906,I intend to report the cataract measures group,09/11/2025
G8907,Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility,09/11/2025
G8908,Patient documented to have received a burn prior to discharge,09/11/2025
G8909,Patient documented not to have received a burn prior to discharge,09/11/2025
G8910,Patient documented to have experienced a fall within asc,09/11/2025
G8911,Patient documented not to have experienced a fall within ambulatory surgical center,09/11/2025
G8912,"Patient documented to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event",09/11/2025
G8913,"Patient documented not to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event",09/11/2025
G8914,Patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc,09/11/2025
G8915,Patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc,09/11/2025
G8916,"Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time",09/11/2025
G8917,"Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time",09/11/2025
G8918,Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis,09/11/2025
G8923,Current or prior left ventricular ejection fraction (lvef) <= 40% or documentation of moderately or severely depressed left ventricular systolic function,09/11/2025
G8924,Spirometry results documented (fev1/fvc < 70%),09/11/2025
G8925,"Spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70%, predicted or patient does not have copd symptoms",09/11/2025
G8926,"Spirometry test not performed or documented, reason not given",09/11/2025
G8927,"Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer",09/11/2025
G8928,"Adjuvant chemotherapy not prescribed or previously received, for documented reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient's diagnosis date is within 120 days of the end of the 12 month reporting period, patient's cancer has metastasized, medical contraindication/allergy, poor performance status, other medical reasons, patient refusal, other patient reasons, patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy, other system reasons)",09/11/2025
G8929,"Adjuvant chemotherapy not prescribed or previously received, reason not given",09/11/2025
G8930,Assessment of depression severity at the initial evaluation,09/11/2025
G8931,"Assessment of depression severity not documented, reason not given",09/11/2025
G8932,Suicide risk assessed at the initial evaluation,09/11/2025
G8933,"Suicide risk not assessed at the initial evaluation, reason not given",09/11/2025
G8934,Current or prior left ventricular ejection fraction (lvef) <=40% or documentation of moderately or severely depressed left ventricular systolic function,09/11/2025
G8935,Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy,09/11/2025
G8936,"Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (eg, patient declined, other patient reasons)",09/11/2025
G8937,"Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given",09/11/2025
G8938,"Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible",09/11/2025
G8939,"Pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible at the time of the encounter",09/11/2025
G8940,"Screening for depression documented as positive, a follow-up plan not completed, documented reason",09/11/2025
G8941,"Elder maltreatment screen documented as positive, follow-up plan not documented, documentation the patient is not eligible for follow-up plan at the time of the encounter",09/11/2025
G8942,"Functional outcome assessment using a standardized tool is documented within the previous 30 days and a care plan, based on identified deficiencies is documented within two days of the functional outcome assessment",09/11/2025
G8943,Ldl-c result not present or not within 12 months prior,09/11/2025
G8944,Ajcc melanoma cancer stage 0 through iic melanoma,09/11/2025
G8946,"Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g., high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular hyperplasia, lobular carcinoma in situ, atypical columnar hyperplasia, flat epithelial atypia, radial scar, complex sclerosing lesion, papillary lesion, or any lesion with spindle cells)",09/11/2025
G8947,One or more neuropsychiatric symptoms,09/11/2025
G8948,No neuropsychiatric symptoms,09/11/2025
G8949,"Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes)",09/11/2025
G8950,"Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented",09/11/2025
G8951,"Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, documentation the patient is not eligible",09/11/2025
G8952,"Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given",09/11/2025
G8953,All quality actions for the applicable measures in the oncology measures group have been performed for this patient,09/11/2025
G8955,Most recent assessment of adequacy of volume management documented,09/11/2025
G8956,Patient receiving maintenance hemodialysis in an outpatient dialysis facility,09/11/2025
G8957,Patient not receiving maintenance hemodialysis in an outpatient dialysis facility,09/11/2025
G8958,"Assessment of adequacy of volume management not documented, reason not given",09/11/2025
G8959,Clinician treating major depressive disorder communicates to clinician treating comorbid condition,09/11/2025
G8960,"Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given",09/11/2025
G8961,Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery,09/11/2025
G8962,Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery,09/11/2025
G8963,Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years,09/11/2025
G8964,"Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g., symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)",09/11/2025
G8965,Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment,09/11/2025
G8966,Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment,09/11/2025
G8967,Fda approved oral anticoagulant is prescribed,09/11/2025
G8968,"Documentation of medical reason(s) for not prescribing an fda-approved anticoagulant (e.g., present or planned atrial appendage occlusion or ligation or patient being currently enrolled in a clinical trial related to af/atrial flutter treatment)",09/11/2025
G8969,"Documentation of patient reason(s) for not prescribing an oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient preference for not receiving anticoagulation)",09/11/2025
G8970,No risk factors or one moderate risk factor for thromboembolism,09/11/2025
G8971,"Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given",09/11/2025
G8972,One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism,09/11/2025
G8973,Most recent hemoglobin (hgb) level < 10 g/dl,09/11/2025
G8974,"Hemoglobin level measurement not documented, reason not given",09/11/2025
G8975,"Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)",09/11/2025
G8976,Most recent hemoglobin (hgb) level >= 10 g/dl,09/11/2025
G8977,I intend to report the oncology measures group,09/11/2025
G8978,"Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals",09/11/2025
G8979,"Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G8980,"Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting",09/11/2025
G8981,"Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals",09/11/2025
G8982,"Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G8983,"Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting",09/11/2025
G8984,"Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals",09/11/2025
G8985,"Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G8986,"Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting",09/11/2025
G8987,"Self care functional limitation, current status, at therapy episode outset and at reporting intervals",09/11/2025
G8988,"Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G8989,"Self care functional limitation, discharge status, at discharge from therapy or to end reporting",09/11/2025
G8990,"Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals",09/11/2025
G8991,"Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G8992,"Other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reporting",09/11/2025
G8993,"Other physical or occupational therapy subsequent functional limitation, current status, at therapy episode outset and at reporting intervals",09/11/2025
G8994,"Other physical or occupational therapy subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G8995,"Other physical or occupational therapy subsequent functional limitation, discharge status, at discharge from therapy or to end reporting",09/11/2025
G8996,"Swallowing functional limitation, current status at therapy episode outset and at reporting intervals",09/11/2025
G8997,"Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G8998,"Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting",09/11/2025
G8999,"Motor speech functional limitation, current status at therapy episode outset and at reporting intervals",09/11/2025
G9001,"Coordinated care fee, initial rate",09/11/2025
G9002,"Coordinated care fee, maintenance rate",09/11/2025
G9003,"Coordinated care fee, risk adjusted high, initial",09/11/2025
G9004,"Coordinated care fee, risk adjusted low, initial",09/11/2025
G9005,"Coordinated care fee, risk adjusted maintenance",09/11/2025
G9006,"Coordinated care fee, home monitoring",09/11/2025
G9007,"Coordinated care fee, scheduled team conference",09/11/2025
G9008,"Coordinated care fee, physician coordinated care oversight services",09/11/2025
G9009,"Coordinated care fee, risk adjusted maintenance, level 3",09/11/2025
G9010,"Coordinated care fee, risk adjusted maintenance, level 4",09/11/2025
G9011,"Coordinated care fee, risk adjusted maintenance, level 5",09/11/2025
G9012,Other specified case management service not elsewhere classified,09/11/2025
G9013,Esrd demo basic bundle level i,09/11/2025
G9014,Esrd demo expanded bundle including venous access and related services,09/11/2025
G9016,"Smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only]",09/11/2025
G9017,"Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)",09/11/2025
G9018,"Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)",09/11/2025
G9019,"Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project)",09/11/2025
G9020,"Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)",09/11/2025
G9033,"Amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project)",09/11/2025
G9034,"Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project)",09/11/2025
G9035,"Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project)",09/11/2025
G9036,"Rimantadine hydrochloride, oral, brand, per 100 mg (for use in a medicare-approved demonstration project)",09/11/2025
G9037,Interprofessional telephone/internet/electronic health record clinical question/request for specialty recommendations by a treating/requesting physician or other qualified health care professional for the care of the patient (i.e. not for professional education or scheduling) and may include subsequent follow up on the specialist's recommendations; 30 minutes,09/11/2025
G9038,"Co-management services with the following elements: new diagnosis or acute exacerbation and stabilization of existing condition; condition which may benefit from joint care planning; condition for which specialist is taking a co-management role; condition expected to last at least 3 months; comprehensive care plan established, implemented, revised or monitored in partnership with co-managing clinicians; ongoing communication and care coordination between co-managing clinicians furnishing care",09/11/2025
G9050,"Oncology; primary focus of visit; work-up, evaluation, or staging at the time of cancer diagnosis or recurrence (for use in a medicare-approved demonstration project)",09/11/2025
G9051,"Oncology; primary focus of visit; treatment decision-making after disease is staged or restaged, discussion of treatment options, supervising/coordinating active cancer directed therapy or managing consequences of cancer directed therapy (for use in a medicare-approved demonstration project)",09/11/2025
G9052,Oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project),09/11/2025
G9053,Oncology; primary focus of visit; expectant management of patient with evidence of cancer for whom no cancer directed therapy is being administered or arranged at present; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project),09/11/2025
G9054,"Oncology; primary focus of visit; supervising, coordinating or managing care of patient with terminal cancer or for whom other medical illness prevents further cancer treatment; includes symptom management, end-of-life care planning, management of palliative therapies (for use in a medicare-approved demonstration project)",09/11/2025
G9055,"Oncology; primary focus of visit; other, unspecified service not otherwise listed (for use in a medicare-approved demonstration project)",09/11/2025
G9056,Oncology; practice guidelines; management adheres to guidelines (for use in a medicare-approved demonstration project),09/11/2025
G9057,Oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial (for use in a medicare-approved demonstration project),09/11/2025
G9058,Oncology; practice guidelines; management differs from guidelines because the treating physician disagrees with guideline recommendations (for use in a medicare-approved demonstration project),09/11/2025
G9059,"Oncology; practice guidelines; management differs from guidelines because the patient, after being offered treatment consistent with guidelines, has opted for alternative treatment or management, including no treatment (for use in a medicare-approved demonstration project)",09/11/2025
G9060,Oncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a medicare-approved demonstration project),09/11/2025
G9061,Oncology; practice guidelines; patient's condition not addressed by available guidelines (for use in a medicare-approved demonstration project),09/11/2025
G9062,Oncology; practice guidelines; management differs from guidelines for other reason(s) not listed (for use in a medicare-approved demonstration project),09/11/2025
G9063,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9064,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9065,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9066,"Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",09/11/2025
G9067,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9068,"Oncology; disease status; limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9069,"Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",09/11/2025
G9070,"Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9071,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9072,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9073,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9074,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9075,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",09/11/2025
G9077,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9078,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9079,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9080,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project)",09/11/2025
G9083,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9084,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9085,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9086,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9087,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive with current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)",09/11/2025
G9088,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive without current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)",09/11/2025
G9089,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9090,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9091,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t3, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9092,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9093,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9094,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",09/11/2025
G9095,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9096,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9097,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9098,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",09/11/2025
G9099,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9100,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r0 resection (with or without neoadjuvant therapy) with no evidence of disease recurrence, progression, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9101,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9102,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m0, unresectable with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9103,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",09/11/2025
G9104,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9105,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9106,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9107,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",09/11/2025
G9108,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9109,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9110,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9111,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",09/11/2025
G9112,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9113,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9114,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 2-3); or stage ic (all grades); or stage ii; without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9115,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9116,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; evidence of disease progression, or recurrence, and/or platinum resistance (for use in a medicare-approved demonstration project)",09/11/2025
G9117,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9123,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)",09/11/2025
G9124,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)",09/11/2025
G9125,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)",09/11/2025
G9126,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)",09/11/2025
G9128,"Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project)",09/11/2025
G9129,"Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project)",09/11/2025
G9130,"Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9131,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9132,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)",09/11/2025
G9133,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)",09/11/2025
G9134,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)",09/11/2025
G9135,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)",09/11/2025
G9136,"Oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)",09/11/2025
G9137,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)",09/11/2025
G9138,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9139,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)",09/11/2025
G9140,"Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours",09/11/2025
G9143,"Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)",09/11/2025
G9147,"Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration",09/11/2025
G9148,National committee for quality assurance - level 1 medical home,09/11/2025
G9149,National committee for quality assurance - level 2 medical home,09/11/2025
G9150,National committee for quality assurance - level 3 medical home,09/11/2025
G9151,Mapcp demonstration - state provided services,09/11/2025
G9152,Mapcp demonstration - community health teams,09/11/2025
G9153,Mapcp demonstration - physician incentive pool,09/11/2025
G9156,Evaluation for wheelchair requiring face to face visit with physician,09/11/2025
G9157,"Transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes",09/11/2025
G9158,"Motor speech functional limitation, discharge status, at discharge from therapy or to end reporting",09/11/2025
G9159,"Spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals",09/11/2025
G9160,"Spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G9161,"Spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting",09/11/2025
G9162,"Spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals",09/11/2025
G9163,"Spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G9164,"Spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting",09/11/2025
G9165,"Attention functional limitation, current status at therapy episode outset and at reporting intervals",09/11/2025
G9166,"Attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G9167,"Attention functional limitation, discharge status at discharge from therapy or to end reporting",09/11/2025
G9168,"Memory functional limitation, current status at therapy episode outset and at reporting intervals",09/11/2025
G9169,"Memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G9170,"Memory functional limitation, discharge status at discharge from therapy or to end reporting",09/11/2025
G9171,"Voice functional limitation, current status at therapy episode outset and at reporting intervals",09/11/2025
G9172,"Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G9173,"Voice functional limitation, discharge status at discharge from therapy or to end reporting",09/11/2025
G9174,"Other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals",09/11/2025
G9175,"Other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G9176,"Other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting",09/11/2025
G9186,"Motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",09/11/2025
G9187,"Bundled payments for care improvement initiative home visit for patient assessment performed by a qualified health care professional for individuals not considered homebound including, but not limited to, assessment of safety, falls, clinical status, fluid status, medication reconciliation/management, patient compliance with orders/plan of care, performance of activities of daily living, appropriateness of care setting; (for use only in the meidcare-approved bundled payments for care improvement initiative); may not be billed for a 30-day period covered by a transitional care management code",09/11/2025
G9188,"Beta-blocker therapy not prescribed, reason not given",09/11/2025
G9189,Beta-blocker therapy prescribed or currently being taken,09/11/2025
G9190,"Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)",09/11/2025
G9191,"Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)",09/11/2025
G9192,"Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)",09/11/2025
G9193,Clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression,09/11/2025
G9194,Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase,09/11/2025
G9195,Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase,09/11/2025
G9196,"Documentation of medical reason(s) for not ordering a first or second generation cephalosporin for antimicrobial prophylaxis (e.g., patients enrolled in clinical trials, patients with documented infection prior to surgical procedure of interest, patients who were receiving antibiotics more than 24 hours prior to surgery [except colon surgery patients taking oral prophylactic antibiotics], patients who were receiving antibiotics within 24 hours prior to arrival [except colon surgery patients taking oral prophylactic antibiotics], other medical reason(s))",09/11/2025
G9197,Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis,09/11/2025
G9198,"Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given",09/11/2025
G9199,"Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))",09/11/2025
G9200,"Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given",09/11/2025
G9201,Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission,09/11/2025
G9202,Patients with a positive hepatitis c antibody test,09/11/2025
G9203,Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c,09/11/2025
G9204,"Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given",09/11/2025
G9205,Patient starting antiviral treatmentfor hepatitis c during the measurement period,09/11/2025
G9206,Patient starting antiviral treatment for hepatitis c during the measurement period,09/11/2025
G9207,Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c,09/11/2025
G9208,"Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given",09/11/2025
G9209,Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment,09/11/2025
G9210,"Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)",09/11/2025
G9211,"Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given",09/11/2025
G9212,Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation,09/11/2025
G9213,"Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified",09/11/2025
G9214,Cd4+ cell count or cd4+ cell percentage results documented,09/11/2025
G9215,"Cd4+ cell count or percentage not documented as performed, reason not given",09/11/2025
G9216,"Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not given",09/11/2025
G9217,"Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given",09/11/2025
G9218,"Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given",09/11/2025
G9219,"Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)",09/11/2025
G9220,"Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)",09/11/2025
G9221,Pneumocystis jiroveci pneumonia prophlaxis prescribed,09/11/2025
G9222,Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3,09/11/2025
G9223,Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%,09/11/2025
G9224,"Documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation)",09/11/2025
G9225,"Foot exam was not performed, reason not given",09/11/2025
G9226,"Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed)",09/11/2025
G9227,"Functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan at the time of the encounter",09/11/2025
G9228,"Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)",09/11/2025
G9229,"Chlamydia, gonorrhea, and syphilis screening results not documented (patient refusal is the only allowed exception)",09/11/2025
G9230,"Chlamydia, gonorrhea, and syphilis not screened, reason not given",09/11/2025
G9231,"Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period",09/11/2025
G9232,"Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason (e.g., patient is unable to communicate the diagnosis of a comorbid condition; the patient is unwilling to communicate the diagnosis of a comorbid condition; or the patient is unaware of the comorbid condition, or any other specified patient reason)",09/11/2025
G9233,All quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient,09/11/2025
G9234,I intend to report the total knee replacement measures group,09/11/2025
G9235,All quality actions for the applicable measures in the general surgery measures group have been performed for this patient,09/11/2025
G9236,All quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient,09/11/2025
G9237,I intend to report the general surgery measures group,09/11/2025
G9238,I intend to report the optimizing patient exposure to ionizing radiation measures group,09/11/2025
G9239,"Documentation of reasons for patient initiating maintenance hemodialysis with a catheter as the mode of vascular access (e.g., patient has a maturing arteriovenous fistula (avf)/arteriovenous graft (avg), time-limited trial of hemodialysis, other medical reasons, patient declined avf/avg, other patient reasons, patient followed by reporting nephrologist for fewer than 90 days, other system reasons)",09/11/2025
G9240,Patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated,09/11/2025
G9241,Patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated,09/11/2025
G9242,Documentation of viral load equal to or greater than 200 copies/ml or viral load not performed,09/11/2025
G9243,Documentation of viral load less than 200 copies/ml,09/11/2025
G9244,Antiretroviral thereapy not prescribed,09/11/2025
G9245,Antiretroviral therapy prescribed,09/11/2025
G9246,Patient did not have two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart,09/11/2025
G9247,Patient had two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart,09/11/2025
G9248,Patient did not have a medical visit in the last 6 months,09/11/2025
G9249,Patient had a medical visit in the last 6 months,09/11/2025
G9250,Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment,09/11/2025
G9251,Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment,09/11/2025
G9252,Adenoma(s) or other neoplasm detected during screening colonoscopy,09/11/2025
G9253,Adenoma(s) or other neoplasm not detected during screening colonoscopy,09/11/2025
G9254,Documentation of patient discharged to home later than post-operative day 2 following cea or cas,09/11/2025
G9255,Documentation of patient discharged to home no later than post operative day 2 following cea or cas,09/11/2025
G9256,Documentation of patient death following cas,09/11/2025
G9257,Documentation of patient stroke following cas,09/11/2025
G9258,Documentation of patient stroke following cea,09/11/2025
G9259,Documentation of patient survival and absence of stroke following cas,09/11/2025
G9260,Documentation of patient death following cea,09/11/2025
G9261,Documentation of patient survival and absence of stroke following cea,09/11/2025
G9262,Documentation of patient death in the hospital following endovascular aaa repair,09/11/2025
G9263,Documentation of patient discharged alive following endovascular aaa repair,09/11/2025
G9264,"Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (e.g., other medical reasons, patient declined arteriovenous fistula (avf)/arteriovenous graft (avg), other patient reasons)",09/11/2025
G9265,Patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access,09/11/2025
G9266,Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access,09/11/2025
G9267,Documentation of patient with one or more complications or mortality within 30 days,09/11/2025
G9268,Documentation of patient with one or more complications within 90 days,09/11/2025
G9269,Documentation of patient without one or more complications and without mortality within 30 days,09/11/2025
G9270,Documentation of patient without one or more complications within 90 days,09/11/2025
G9271,Ldl value < 100,09/11/2025
G9272,Ldl value >= 100,09/11/2025
G9273,Blood pressure has a systolic value of < 140 and a diastolic value of < 90,09/11/2025
G9274,Blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90,09/11/2025
G9275,Documentation that patient is a current non-tobacco user,09/11/2025
G9276,Documentation that patient is a current tobacco user,09/11/2025
G9277,"Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication or exception to aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use, allergy to aspirin or anti-platelets, history of gastrointestinal bleed and bleeding disorder; additionally, the following exceptions documented by the physician as a reason for not taking daily aspirin or anti-platelet are acceptable (use of non-steroidal anti-inflammatory agents, documented risk for drug interaction, uncontrolled hypertension defined as >180 systolic or >110 diastolic or gastroesophageal reflux)",09/11/2025
G9278,Documentation that the patient is not on daily aspirin or anti-platelet regimen,09/11/2025
G9279,Pneumococcal screening performed and documentation of vaccination received prior to discharge,09/11/2025
G9280,"Pneumococcal vaccination not administered prior to discharge, reason not specified",09/11/2025
G9281,Screening performed and documentation that vaccination not indicated/patient refusal,09/11/2025
G9282,"Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons)",09/11/2025
G9283,Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation,09/11/2025
G9284,Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation,09/11/2025
G9285,Specimen site other than anatomic location of lung or is not classified as non small cell lung cancer,09/11/2025
G9286,Antibiotic regimen prescribed within 10 days after onset of symptoms,09/11/2025
G9287,Antibiotic regimen not prescribed within 10 days after onset of symptoms,09/11/2025
G9288,"Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)",09/11/2025
G9289,Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation,09/11/2025
G9290,Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation,09/11/2025
G9291,"Specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos",09/11/2025
G9292,"Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)",09/11/2025
G9293,"Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate",09/11/2025
G9294,"Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate",09/11/2025
G9295,Specimen site other than anatomic cutaneous location,09/11/2025
G9296,"Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure",09/11/2025
G9297,"Shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given",09/11/2025
G9298,"Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)",09/11/2025
G9299,"Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)",09/11/2025
G9300,"Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)",09/11/2025
G9301,Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet,09/11/2025
G9302,"Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given",09/11/2025
G9303,"Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given",09/11/2025
G9304,"Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant",09/11/2025
G9305,Intervention for presence of leak of endoluminal contents through an anastomosis not required,09/11/2025
G9306,Intervention for presence of leak of endoluminal contents through an anastomosis required,09/11/2025
G9307,"No return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure",09/11/2025
G9308,"Unplanned return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure",09/11/2025
G9309,No unplanned hospital readmission within 30 days of principal procedure,09/11/2025
G9310,Unplanned hospital readmission within 30 days of principal procedure,09/11/2025
G9311,No surgical site infection,09/11/2025
G9312,Surgical site infection,09/11/2025
G9313,"Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason",09/11/2025
G9314,"Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given",09/11/2025
G9315,"Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis",09/11/2025
G9316,"Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family",09/11/2025
G9317,"Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed",09/11/2025
G9318,Imaging study named according to standardized nomenclature,09/11/2025
G9319,"Imaging study not named according to standardized nomenclature, reason not given",09/11/2025
G9320,"Documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",09/11/2025
G9321,Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies documented in the 12-month period prior to the current study,09/11/2025
G9322,"Count of previous ct and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies not documented in the 12-month period prior to the current study, reason not given",09/11/2025
G9323,"Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",09/11/2025
G9324,"All necessary data elements not included, reason not given",09/11/2025
G9325,"Ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",09/11/2025
G9326,"Ct studies performed not reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements, reason not given",09/11/2025
G9327,Ct studies performed reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements,09/11/2025
G9328,"Dicom format image data availability not documented in final report due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",09/11/2025
G9329,"Dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report, reason not given",09/11/2025
G9340,"Final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study",09/11/2025
G9341,"Search conducted for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performed",09/11/2025
G9342,"Search not conducted prior to an imaging study being performed for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive, reason not given",09/11/2025
G9343,"Due to medical reasons, search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",09/11/2025
G9344,"Due to system reasons search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., non-affiliated external healthcare facilities or entities does not have archival abilities through a shared archival system)",09/11/2025
G9345,"Follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors",09/11/2025
G9346,"Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules due to medical reasons (e.g., patients with known malignant disease, patients with unexplained fever, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",09/11/2025
G9347,"Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given",09/11/2025
G9348,Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons,09/11/2025
G9349,Ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis,09/11/2025
G9350,Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis,09/11/2025
G9351,More than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis,09/11/2025
G9352,"More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given",09/11/2025
G9353,"More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)",09/11/2025
G9354,One ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis,09/11/2025
G9355,Elective delivery (without medical indication) by cesarean birth or induction of labor not performed (<39 weeks of gestation),09/11/2025
G9356,Elective delivery (without medical indication) by cesarean birth or induction of labor performed (<39 weeks of gestation),09/11/2025
G9357,"Post-partum screenings, evaluations and education performed",09/11/2025
G9358,"Post-partum screenings, evaluations and education not performed",09/11/2025
G9359,Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier,09/11/2025
G9360,No documentation of negative or managed positive tb screen,09/11/2025
G9361,"Medical indication for delivery by cesarean birth or induction of labor (<39 weeks of gestation) [documentation of reason(s) for elective delivery (e.g., hemorrhage and placental complications, hypertension, preeclampsia and eclampsia, rupture of membranes (premature or prolonged), maternal conditions complicating pregnancy/delivery, fetal conditions complicating pregnancy/delivery, late pregnancy, prior uterine surgery, or participation in clinical trial)]",09/11/2025
G9362,"Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure 60 minutes or longer, as documented in the anesthesia record",09/11/2025
G9363,"Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record",09/11/2025
G9364,"Sinusitis caused by, or presumed to be caused by, bacterial infection",09/11/2025
G9365,One high-risk medication ordered,09/11/2025
G9366,One high-risk medication not ordered,09/11/2025
G9367,At least two orders for high-risk medications from the same drug class,09/11/2025
G9368,At least two orders for high-risk medications from the same drug class not ordered,09/11/2025
G9369,Individual filled at least two prescriptions for any antipsychotic medication and had a pdc of 0.8 or greater,09/11/2025
G9370,Individual who did not fill at least two prescriptions for any antipsychotic medication or did not have a pdc of 0.8 or greater,09/11/2025
G9376,Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery,09/11/2025
G9377,Patient did not have the retina attached after 6 months following only one surgery,09/11/2025
G9378,Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month),09/11/2025
G9379,Patient did not achieve flat retinas six months post surgery,09/11/2025
G9380,Patient offered assistance with end of life issues or existing end of life plan was reviewed or updated during the measurement period,09/11/2025
G9381,"Documentation of medical reason(s) for not offering assistance with end of life issues (e.g., patient in hospice care, patient in terminal phase) during the measurement period",09/11/2025
G9382,Patient not offered assistance with end of life issues or existing end of life plan was not reviewed or updated during the measurement period,09/11/2025
G9383,Patient received screening for hcv infection within the 12 month reporting period,09/11/2025
G9384,"Documentation of medical reason(s) for not receiving annual screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [i.e., ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist for organ transplant, limited life expectancy, other medical reasons)",09/11/2025
G9385,"Documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)",09/11/2025
G9386,"Screening for hcv infection not received within the 12 month reporting period, reason not given",09/11/2025
G9389,Unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery,09/11/2025
G9390,No unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery,09/11/2025
G9391,"Patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit",09/11/2025
G9392,"Patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit",09/11/2025
G9393,Patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five,09/11/2025
G9394,"Patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period",09/11/2025
G9395,Patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five,09/11/2025
G9396,Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days),09/11/2025
G9399,"Documentation in the patient record of a discussion between the physician/clinician and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward the outcome of the treatment",09/11/2025
G9400,Documentation of medical or patient reason(s) for not discussing treatment options; medical reasons: patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving antiviral treatment; successful antiviral treatment (with sustained virologic response) prior to reporting period; other documented medical reasons; patient reasons: patient unable or unwilling to participate in the discussion or other patient reasons,09/11/2025
G9401,"No documentation in the patient record of a discussion between the physician or other qualified healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment",09/11/2025
G9402,Patient received follow-up within 30 days after discharge,09/11/2025
G9403,"Clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)",09/11/2025
G9404,Patient did not receive follow-up within 30 days after discharge,09/11/2025
G9405,Patient received follow-up within 7 days after discharge,09/11/2025
G9406,"Clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)",09/11/2025
G9407,Patient did not receive follow-up within 7 days after discharge,09/11/2025
G9408,Patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days,09/11/2025
G9409,Patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days,09/11/2025
G9410,"Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision",09/11/2025
G9411,"Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision",09/11/2025
G9412,"Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision",09/11/2025
G9413,"Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision",09/11/2025
G9414,"Patient had one dose of meningococcal vaccine (serogroups a, c, w, y) on or between the patient's 11th and 13th birthdays",09/11/2025
G9415,"Patient did not have one dose of meningococcal vaccine (serogroups a, c, w, y) on or between the patient's 11th and 13th birthdays",09/11/2025
G9416,"Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays",09/11/2025
G9417,"Patient did not have one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays",09/11/2025
G9418,Primary non-small cell lung cancer lung biopsy and cytology specimen report documents classification into specific histologic type following iaslc guidance or classified as nsclc-nos with an explanation,09/11/2025
G9419,"Documentation of medical reason(s) for not including the histological type or nsclc-nos classification with an explanation (e.g. specimen insufficient or non-diagnostic, specimen does not contain cancer, or other documented medical reasons)",09/11/2025
G9420,Specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer,09/11/2025
G9421,Primary non-small cell lung cancer lung biopsy and cytology specimen report does not document classification into specific histologic type or histologic type does not follow iaslc guidance or is classified as nsclc-nos but without an explanation,09/11/2025
G9422,"Primary lung carcinoma resection report documents pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma and not nsclc-nos)",09/11/2025
G9423,"Documentation of medical reason for not including pt category, pn category and histologic type [for patient with appropriate exclusion criteria (e.g., metastatic disease, benign tumors, malignant tumors other than carcinomas, inadequate surgical specimens)]",09/11/2025
G9424,"Specimen site other than anatomic location of lung, or classified as nsclc-nos",09/11/2025
G9425,"Primary lung carcinoma resection report does not document pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma)",09/11/2025
G9426,Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients,09/11/2025
G9427,Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients,09/11/2025
G9428,"Pathology report includes the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors",09/11/2025
G9429,"Documentation of medical reason(s) for not including pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors (e.g., negative skin biopsies, insufficient tissue, or other documented medical reasons)",09/11/2025
G9430,Specimen site other than anatomic cutaneous location,09/11/2025
G9431,"Pathology report does not include the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors",09/11/2025
G9432,"Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented",09/11/2025
G9433,"Death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period",09/11/2025
G9434,"Asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given",09/11/2025
G9435,Aspirin prescribed at discharge,09/11/2025
G9436,"Aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)",09/11/2025
G9437,Aspirin not prescribed at discharge,09/11/2025
G9438,P2y inhibitor prescribed at discharge,09/11/2025
G9439,"P2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)",09/11/2025
G9440,P2y inhibitor not prescribed at discharge,09/11/2025
G9441,Statin prescribed at discharge,09/11/2025
G9442,"Statin not prescribed for documented reasons (e.g., allergy, medical intolerance)",09/11/2025
G9443,Statin not prescribed at discharge,09/11/2025
G9448,Patients who were born in the years 1945 to 1965,09/11/2025
G9449,History of receiving blood transfusions prior to 1992,09/11/2025
G9450,History of injection drug use,09/11/2025
G9451,Patient received one-time screening for hcv infection,09/11/2025
G9452,Documentation of medical reason(s) for not receiving hcv antibody test due to limited life expectancy,09/11/2025
G9453,"Documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)",09/11/2025
G9454,"One-time screening for hcv infection not received within 12-month reporting period and no documentation of prior screening for hcv infection, reason not given",09/11/2025
G9455,"Patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc",09/11/2025
G9456,"Documentation of medical or patient reason(s) for not ordering or performing screening for hcc. medical reason: comorbid medical conditions with expected survival < 5 years, hepatic decompensation and not a candidate for liver transplantation, or other medical reasons; patient reasons: patient declined or other patient reasons (e.g., cost of tests, time related to accessing testing equipment)",09/11/2025
G9457,Patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the submission period,09/11/2025
G9458,"Patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or referral to external smoking or tobacco cessation support programs, or current enrollment in smoking or tobacco use cessation program) if identified as a tobacco user",09/11/2025
G9459,Currently a tobacco non-user,09/11/2025
G9460,"Tobacco assessment or tobacco cessation intervention not performed, reason not given",09/11/2025
G9463,I intend to report the sinusitis measures group,09/11/2025
G9464,All quality actions for the applicable measures in the sinusitis measures group have been performed for this patient,09/11/2025
G9465,I intend to report the acute otitis externa (aoe) measures group,09/11/2025
G9466,All quality actions for the applicable measures in the aoe measures group have been performed for this patient,09/11/2025
G9467,Patient who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills within the last twelve months,09/11/2025
G9468,Patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills,09/11/2025
G9469,Patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 90 or greater consecutive days or a single prescription equating to 900 mg prednisone or greater for all fills,09/11/2025
G9470,Patients not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills,09/11/2025
G9471,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented",09/11/2025
G9472,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed",09/11/2025
G9473,"Services performed by chaplain in the hospice setting, each 15 minutes",09/11/2025
G9474,"Services performed by dietary counselor in the hospice setting, each 15 minutes",09/11/2025
G9475,"Services performed by other counselor in the hospice setting, each 15 minutes",09/11/2025
G9476,"Services performed by volunteer in the hospice setting, each 15 minutes",09/11/2025
G9477,"Services performed by care coordinator in the hospice setting, each 15 minutes",09/11/2025
G9478,"Services performed by other qualified therapist in the hospice setting, each 15 minutes",09/11/2025
G9479,"Services performed by qualified pharmacist in the hospice setting, each 15 minutes",09/11/2025
G9480,Admission to medicare care choice model program (mccm),09/11/2025
G9481,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a problem focused history;  a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor.  typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9482,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination;  straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of low to moderate severity.  typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9483,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate severity.  typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9484,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9485,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9486,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are self limited or minor.  typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9487,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of low to moderate severity.  typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9488,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a detailed history; a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9489,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved coms innovation center demonstration project, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9490,"Cms innovation center models, home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary connections to community and other services.  (for use only in medicare-approved cms innovation center models); may not be billed for a 30 day period covered by a transitional care management code",09/11/2025
G9496,"Documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g., neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma",09/11/2025
G9497,Received instruction from the anesthesiologist or proxy prior to the day of surgery to abstain from smoking on the day of surgery,09/11/2025
G9498,Antibiotic regimen prescribed,09/11/2025
G9499,Patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period,09/11/2025
G9500,Radiation exposure indices documented in final report for procedure using fluoroscopy,09/11/2025
G9501,"Radiation exposure indices not documented in final report for procedure using fluoroscopy, reason not given",09/11/2025
G9502,"Documentation of medical reason for not performing foot exam (i.e., patients who have had either a bilateral amputation above or below the knee, or both a left and right amputation above or below the knee before or during the measurement period)",09/11/2025
G9503,Patient taking tamsulosin hydrochloride,09/11/2025
G9504,"Documented reason for not assessing hepatitis b virus (hbv) status (e.g., patient not initiating anti-tnf therapy, patient declined) prior to initiating anti-tnf therapy",09/11/2025
G9505,Antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason,09/11/2025
G9506,Biologic immune response modifier prescribed,09/11/2025
G9507,"Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs)",09/11/2025
G9508,Documentation that the patient is not on a statin medication,09/11/2025
G9509,Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5,09/11/2025
G9510,Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve  month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5,09/11/2025
G9511,Index event date phq-9 or phq-9m score greater than 9 documented during the twelve month denominator identification period,09/11/2025
G9512,Individual had a pdc of 0.8 or greater,09/11/2025
G9513,Individual did not have a pdc of 0.8 or greater,09/11/2025
G9514,Patient required a return to the operating room within 90 days of surgery,09/11/2025
G9515,Patient did not require a return to the operating room within 90 days of surgery,09/11/2025
G9516,"Patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery",09/11/2025
G9517,"Patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given",09/11/2025
G9518,Documentation of active injection drug use,09/11/2025
G9519,Patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery,09/11/2025
G9520,Patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery,09/11/2025
G9521,Total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months,09/11/2025
G9522,"Total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given",09/11/2025
G9523,Patient discontinued from hemodialysis or peritoneal dialysis,09/11/2025
G9524,Patient was referred to hospice care,09/11/2025
G9525,"Documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)",09/11/2025
G9526,"Patient was not referred to hospice care, reason not given",09/11/2025
G9529,Patient with minor blunt head trauma had an appropriate indication(s) for a head ct,09/11/2025
G9530,Patient presented with a minor blunt head trauma  and had a head ct ordered for trauma by an emergency care provider,09/11/2025
G9531,"Patient has documentation of ventricular shunt, brain tumor, multisystem trauma, or is currently taking an antiplatelet medication including: abciximab, anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide, prasugrel, ticlopidine, ticagrelor, tirofiban, or vorapaxar",09/11/2025
G9532,Patient had a head ct for trauma ordered by someone other than an emergency care provider  or was ordered for a reason other than trauma,09/11/2025
G9533,Patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct,09/11/2025
G9534,"Advanced brain imaging (cta, ct, mra or mri) was not ordered",09/11/2025
G9535,Patients with a normal neurological examination,09/11/2025
G9536,"Documentation of medical reason(s) for ordering an advanced brain imaging study (i.e., patient has an abnormal neurological examination; patient has the coexistence of seizures, or both; recent onset of severe headache; change in the type of headache; signs of increased intracranial pressure (e.g., papilledema, absent venous pulsations on funduscopic examination, altered mental status, focal neurologic deficits, signs of meningeal irritation); hiv-positive patients with a new type of headache; immunocompromised patient with unexplained headache symptoms; patient on coagulopathy/anti-coagulation or anti-platelet therapy; very young patients with unexplained headache symptoms)",09/11/2025
G9537,Imaging needed as part of a clinical trial; or other clinician ordered the study,09/11/2025
G9538,"Advanced brain imaging (cta, ct, mra or mri) was ordered",09/11/2025
G9539,Intent for potential removal at time of placement,09/11/2025
G9540,Patient alive 3 months post procedure,09/11/2025
G9541,Filter removed within 3 months of placement,09/11/2025
G9542,Documented re-assessment for the appropriateness of filter removal within 3 months of placement,09/11/2025
G9543,Documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement,09/11/2025
G9544,"Patients that do not have the filter removed, documented re-assessment for the appropriateness of filter removal, or documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement",09/11/2025
G9547,"Cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal lesion  less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct, or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols",09/11/2025
G9548,Final reports for imaging studies stating no  follow-up imaging is recommended,09/11/2025
G9549,"Documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadenopathy, signs of metastasis or an active diagnosis or history of cancer, and other medical reason(s))",09/11/2025
G9550,"Final reports for imaging studies with follow-up imaging recommended, or final reports that do not include a specific recommendation of no follow-up",09/11/2025
G9551,Final reports for imaging studies without an incidentally found lesion noted,09/11/2025
G9552,Incidental thyroid nodule < 1.0 cm noted in report,09/11/2025
G9553,Prior thyroid disease diagnosis,09/11/2025
G9554,"Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging recommended",09/11/2025
G9555,"Documentation of medical reason(s) for recommending follow up imaging (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))",09/11/2025
G9556,"Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging not recommended",09/11/2025
G9557,"Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found",09/11/2025
G9558,Patient treated with a beta-lactam antibiotic as definitive therapy,09/11/2025
G9559,"Documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta-lactam antibiotics)",09/11/2025
G9560,"Patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given",09/11/2025
G9561,Patients prescribed opiates for longer than six weeks,09/11/2025
G9562,Patients who had a follow-up evaluation conducted at least every three months during opioid therapy,09/11/2025
G9563,Patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy,09/11/2025
G9572,Index date phq-score greater than 9 documented during the twelve month denominator identification period,09/11/2025
G9573,Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five,09/11/2025
G9574,Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five; either phq-9 or phq-9m score was not assessed or is greater than or equal to five,09/11/2025
G9577,Patients prescribed opiates for longer than six weeks,09/11/2025
G9578,Documentation of signed opioid treatment agreement at least once during opioid therapy,09/11/2025
G9579,No documentation of signed an opioid treatment agreement at least once during opioid therapy,09/11/2025
G9580,Door to puncture time of 90 minutes or less,09/11/2025
G9581,"Door to puncture time of greater than 2 hours for reasons documented by clinician (e.g., patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment; hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment)",09/11/2025
G9582,"Door to puncture time of greater than 90 minutes, no reason given",09/11/2025
G9583,Patients prescribed opiates for longer than six weeks,09/11/2025
G9584,"Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy",09/11/2025
G9585,"Patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at least once during opioid therapy",09/11/2025
G9593,Pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules,09/11/2025
G9594,Patient presented with a minor blunt head trauma and had a head ct ordered for trauma by an emergency care provider,09/11/2025
G9595,"Patient has documentation of ventricular shunt, brain tumor, or coagulopathy",09/11/2025
G9596,Pediatric patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than trauma,09/11/2025
G9597,Pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules,09/11/2025
G9598,Aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct,09/11/2025
G9599,Aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct,09/11/2025
G9600,Symptomatic aaas that required urgent/emergent (non-elective) repair,09/11/2025
G9601,Patient discharge to home no later than post-operative day #7,09/11/2025
G9602,Patient not discharged to home by post-operative day #7,09/11/2025
G9603,Patient survey score improved from baseline following treatment,09/11/2025
G9604,Patient survey results not available,09/11/2025
G9605,Patient survey score did not improve from baseline following treatment,09/11/2025
G9606,Intraoperative cystoscopy performed to evaluate for lower tract injury,09/11/2025
G9607,"Documented medical reasons for not performing intraoperative cystoscopy (e.g., urethral pathology precluding cystoscopy, any patient who has a congenital or acquired absence of the urethra) or in the case of patient death",09/11/2025
G9608,Intraoperative cystoscopy not performed to evaluate for lower tract injury,09/11/2025
G9609,Documentation of an order for anti-platelet agents,09/11/2025
G9610,Documentation of medical reason(s) in the patient's record for not ordering anti-platelet agents,09/11/2025
G9611,"Order for anti-platelet agents was not documented in the patient's record, reason not given",09/11/2025
G9612,Photodocumentation of two or more cecal landmarks to establish a complete examination,09/11/2025
G9613,"Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)",09/11/2025
G9614,"Photodocumentation of less than two cecal landmarks (i.e., no cecal landmarks or only one cecal landmark) to establish a complete examination",09/11/2025
G9615,Preoperative assessment documented,09/11/2025
G9616,"Documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)",09/11/2025
G9617,"Preoperative assessment not documented, reason not given",09/11/2025
G9618,Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind,09/11/2025
G9619,"Documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)",09/11/2025
G9620,"Patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given",09/11/2025
G9621,Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling,09/11/2025
G9622,Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method,09/11/2025
G9623,"Documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)",09/11/2025
G9624,Patient not screened for unhealthy alcohol use using a systematic screening method or patient did not receive brief counseling if identified as an unhealthy alcohol user,09/11/2025
G9625,Patient sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery,09/11/2025
G9626,"Documented medical reason for not reporting bladder injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bladder injury)",09/11/2025
G9627,Patient did not sustain bladder injury at the time of surgery nor discovered  subsequently up to 30 days post-surgery,09/11/2025
G9628,Patient sustained bowel injury at the time of surgery or discovered subsequently up to 30 days  post-surgery,09/11/2025
G9629,"Documented medical reasons for not reporting bowel injury (e.g., gynecologic or other pelvic malignancy documented, planned (e.g., not due to an unexpected bowel injury) resection and/or re-anastomosis of bowel, or patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bowel injury)",09/11/2025
G9630,Patient did not sustain a bowel injury at the time of surgery nor discovered subsequently up to 30 days post-surgery,09/11/2025
G9631,Patient sustained ureter injury at the time of surgery or discovered subsequently up to 30 days post-surgery,09/11/2025
G9632,"Documented medical reasons for not reporting ureter injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of ureter injury)",09/11/2025
G9633,Patient did not sustain ureter injury at the time of surgery nor discovered subsequently up to 30 days post-surgery,09/11/2025
G9634,Health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improved,09/11/2025
G9635,"Health-related quality of life not assessed with tool for documented reason(s) (e.g., patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the hrqol survey, patient has the inability to read and/or write in order to complete the hrqol questionnaire)",09/11/2025
G9636,Health-related quality of life not assessed with tool during at least two visits or quality of life score declined,09/11/2025
G9637,"Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)",09/11/2025
G9638,"Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)",09/11/2025
G9639,Major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure,09/11/2025
G9640,Documentation of planned hybrid or staged procedure,09/11/2025
G9641,Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure,09/11/2025
G9642,"Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)",09/11/2025
G9643,Elective surgery,09/11/2025
G9644,Patients who abstained from smoking prior to anesthesia on the day of surgery or procedure,09/11/2025
G9645,Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure,09/11/2025
G9646,Patients with 90 day mrs score of 0 to 2,09/11/2025
G9647,Patients in whom mrs score could not be obtained at 90 day follow-up,09/11/2025
G9648,Patients with 90 day mrs score greater than 2,09/11/2025
G9649,"Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))",09/11/2025
G9650,"Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi",09/11/2025
G9651,"Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented",09/11/2025
G9652,Patient has been treated with a systemic or biologic medication for psoriasis for at least six months,09/11/2025
G9653,Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months,09/11/2025
G9654,Monitored anesthesia care (mac),09/11/2025
G9655,A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used,09/11/2025
G9656,Patient transferred directly from anesthetizing location to pacu or other non-icu location,09/11/2025
G9657,Transfer of care during an anesthetic or to the intensive care unit,09/11/2025
G9658,A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used,09/11/2025
G9659,"Patients greater than or equal to 86 years of age who underwent a screening colonoscopy and did not have a history of colorectal cancer or other valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits",09/11/2025
G9660,"Documentation of medical reason(s) for a colonoscopy performed on a patient greater than or equal to 86 years of age (e.g., iron deficiency anemia, lower gastrointestinal bleeding, familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits)",09/11/2025
G9661,"Patients greater than or equal to 86 years of age who received a  colonoscopy for an assessment of signs/symptoms of gi tract illness, and/or because the patient meets high risk criteria, and/or to follow-up on previously diagnosed advanced lesions",09/11/2025
G9662,"Previously diagnosed or have a diagnosis of clinical ascvd, including ascvd procedure",09/11/2025
G9663,Any ldl-c laboratory result >= 190 mg/dl,09/11/2025
G9664,Patients who are currently statin therapy users or received an order (prescription) for statin therapy,09/11/2025
G9665,Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy,09/11/2025
G9666,Patient's highest fasting or direct ldl-c laboratory test result in the measurement period or two years prior to the beginning of the measurement period is 70-189 mg/dl,09/11/2025
G9667,"Documentation of medical reason(s) for not currently being a statin   therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy)",09/11/2025
G9669,I intend to report the multiple chronic conditions measures group,09/11/2025
G9670,All quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient,09/11/2025
G9671,I intend to report the diabetic retinopathy measures group,09/11/2025
G9672,All quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient,09/11/2025
G9673,I intend to report the cardiovascular prevention measures group,09/11/2025
G9674,Patients with clinical ascvd diagnosis,09/11/2025
G9675,Patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl,09/11/2025
G9676,Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period,09/11/2025
G9677,All quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient,09/11/2025
G9678,Oncology care model (ocm) monthly enhanced oncology services (meos) payment for  ocm enhanced services.  g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement,09/11/2025
G9679,This code is for onsite acute care treatment of a nursing facility resident with pneumonia; may only be billed once per day per beneficiary,09/11/2025
G9680,This code is for onsite acute care treatment of a nursing facility resident with chf; may only be billed once per day per beneficiary,09/11/2025
G9681,This code is for onsite acute care treatment of a resident with copd or asthma; may only be billed once per day per beneficiary,09/11/2025
G9682,This code is for the onsite acute care treatment a nursing facility resident with a skin infection; may only be billed once per day per beneficiary,09/11/2025
G9683,Facility service(s) for the onsite acute care treatment of a nursing facility resident with fluid or electrolyte disorder. (may only be billed once per day per beneficiary). this service is for a demonstration project,09/11/2025
G9684,This code is for the onsite acute care treatment of a nursing facility resident for a uti; may only be billed once per day per beneficiary,09/11/2025
G9685,Physician service or other qualified health care professional for the evaluation and management of a beneficiary's acute change in condition in a nursing facility. this service is for a demonstration project,09/11/2025
G9686,"Onsite nursing facility conference, that is separate and distinct from an evaluation and management visit, including qualified practitioner and at least one member of the nursing facility interdisciplinary care team",09/11/2025
G9687,Hospice services provided to patient any time during the measurement period,09/11/2025
G9688,Patients using hospice services any time during the measurement period,09/11/2025
G9689,Patient admitted for performance of elective carotid intervention,09/11/2025
G9690,Patient receiving hospice services any time during the measurement period,09/11/2025
G9691,Patient had hospice services any time during the measurement period,09/11/2025
G9692,Hospice services received by patient any time during the measurement period,09/11/2025
G9693,Patient use of hospice services any time during the measurement period,09/11/2025
G9694,Hospice services utilized by patient any time during the measurement period,09/11/2025
G9695,Long-acting inhaled bronchodilator prescribed,09/11/2025
G9696,"Documentation of medical reason(s) for not prescribing a long-acting inhaled bronchodilator (e.g., patient intolerance or history of side effects)",09/11/2025
G9697,Documentation of patient reason(s) for not prescribing a long-acting inhaled bronchodilator,09/11/2025
G9698,"Documentation of system reason(s) for not prescribing a long-acting inhaled bronchodilator (e.g., cost of treatment or lack of insurance)",09/11/2025
G9699,"Long-acting inhaled bronchodilator not prescribed, reason not otherwise specified",09/11/2025
G9700,Patients who use hospice services any time during the measurement period,09/11/2025
G9701,Children who are taking antibiotics in the 30 days prior to the date of the encounter during which the diagnosis was established,09/11/2025
G9702,Patients who use hospice services any time during the measurement period,09/11/2025
G9703,Episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date,09/11/2025
G9704,Ajcc breast cancer stage i: t1 mic or t1a documented,09/11/2025
G9705,Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented,09/11/2025
G9706,"Low (or very low) risk of recurrence, prostate cancer",09/11/2025
G9707,Patient received hospice services any time during the measurement period,09/11/2025
G9708,Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy,09/11/2025
G9709,Hospice services used by patient any time during the measurement period,09/11/2025
G9710,Patient was provided hospice services any time during the measurement period,09/11/2025
G9711,Patients with a diagnosis or past history of total colectomy or colorectal cancer,09/11/2025
G9712,"Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal   infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/uti, acne, hiv disease/asymptomatic hiv, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis",09/11/2025
G9713,Patients who use hospice services any time during the measurement period,09/11/2025
G9714,Patient is using hospice services any time during the measurement period,09/11/2025
G9715,Patients who use hospice services any time during the measurement period,09/11/2025
G9716,"Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason",09/11/2025
G9717,Documentation stating the patient has had a diagnosis of bipolar disorder,09/11/2025
G9718,Hospice services for patient provided any time during the measurement period,09/11/2025
G9719,"Patient is not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair",09/11/2025
G9720,Hospice services for patient occurred any time during the measurement period,09/11/2025
G9721,"Patient not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair",09/11/2025
G9722,"Documented history of renal failure or baseline serum creatinine >= 4.0 mg/dl; renal transplant recipients are not considered to have preoperative renal failure, unless, since transplantation the cr has been or is 4.0 or higher",09/11/2025
G9723,Hospice services for patient received any time during the measurement period,09/11/2025
G9724,Patients who had documentation of use of anticoagulant medications overlapping the measurement year,09/11/2025
G9725,Patients who use hospice services any time during the measurement period,09/11/2025
G9726,Patient refused to participate,09/11/2025
G9727,"Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",09/11/2025
G9728,Patient refused to participate,09/11/2025
G9729,"Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",09/11/2025
G9730,Patient refused to participate,09/11/2025
G9731,"Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",09/11/2025
G9732,Patient refused to participate,09/11/2025
G9733,"Patient unable to complete the low back fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",09/11/2025
G9734,Patient refused to participate,09/11/2025
G9735,"Patient unable to complete the shoulder fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",09/11/2025
G9736,Patient refused to participate,09/11/2025
G9737,"Patient unable to complete the elbow/wrist/hand fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",09/11/2025
G9738,Patient refused to participate,09/11/2025
G9739,"Patient unable to complete the general orthopedic fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",09/11/2025
G9740,Hospice services given to patient any time during the measurement period,09/11/2025
G9741,Patients who use hospice services any time during the measurement period,09/11/2025
G9742,Psychiatric symptoms assessed,09/11/2025
G9743,"Psychiatric symptoms not assessed, reason not otherwise specified",09/11/2025
G9744,Patient not eligible due to active diagnosis of hypertension,09/11/2025
G9745,Documented reason for not screening or recommending a follow-up for high blood pressure,09/11/2025
G9746,"Patient has mitral stenosis or prosthetic heart valves or patient has transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)",09/11/2025
G9747,Patient is undergoing palliative dialysis with a catheter,09/11/2025
G9748,Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant,09/11/2025
G9749,Patient is undergoing palliative dialysis with a catheter,09/11/2025
G9750,Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant,09/11/2025
G9751,Patient died at any time during the 24-month measurement period,09/11/2025
G9752,Emergency surgery,09/11/2025
G9753,"Documentation of medical reason for not conducting a search for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., trauma, acute myocardial infarction, stroke, aortic aneurysm where time is of the essence)",09/11/2025
G9754,A finding of an incidental pulmonary nodule,09/11/2025
G9755,"Documentation of medical reason(s) for not including a recommended interval and modality for follow-up or for no follow-up, and source of recommendations (e.g., patients with unexplained fever, immunocompromised patients who are at risk for infection)",09/11/2025
G9756,Surgical procedures that included the use of silicone oil,09/11/2025
G9757,Surgical procedures that included the use of silicone oil,09/11/2025
G9758,Patient in hospice at any time during the measurement period,09/11/2025
G9759,History of preoperative posterior capsule rupture,09/11/2025
G9760,Patients who use hospice services any time during the measurement period,09/11/2025
G9761,Patients who use hospice services any time during the measurement period,09/11/2025
G9762,Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays,09/11/2025
G9763,Patient did not have at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays,09/11/2025
G9764,Patient has been treated with a systemic medication for psoriasis vulgaris,09/11/2025
G9765,"Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi",09/11/2025
G9766,Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment,09/11/2025
G9767,Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment,09/11/2025
G9768,Patients who utilize hospice services any time during the measurement period,09/11/2025
G9769,Patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 months,09/11/2025
G9770,Peripheral nerve block (pnb),09/11/2025
G9771,At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time,09/11/2025
G9772,"Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time (e.g., emergency cases, intentional hypothermia, etc.)",09/11/2025
G9773,"At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time, reason not given",09/11/2025
G9774,Patients who have had a hysterectomy,09/11/2025
G9775,Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively,09/11/2025
G9776,"Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively  (e.g., intolerance or other medical reason)",09/11/2025
G9777,Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively,09/11/2025
G9778,Patients who have a diagnosis of pregnancy at any time during the measurement period,09/11/2025
G9779,Patients who are breastfeeding at any time during the performance period,09/11/2025
G9780,Patients who have a diagnosis of rhabdomyolysis at any time during the performance period,09/11/2025
G9781,"Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons)",09/11/2025
G9782,History of or active diagnosis of familial hypercholesterolemia,09/11/2025
G9783,Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy,09/11/2025
G9784,Pathologists/dermatopathologists providing a second opinion on a biopsy,09/11/2025
G9785,"Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist",09/11/2025
G9786,"Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist",09/11/2025
G9787,Patient alive as of the last day of the measurement year,09/11/2025
G9788,Most recent bp is less than or equal to 140/90 mm hg,09/11/2025
G9789,"Blood pressure recorded during inpatient stays, emergency room visits, or urgent care visits",09/11/2025
G9790,"Most recent bp is greater than 140/90 mm hg, or blood pressure not documented",09/11/2025
G9791,Most recent tobacco status is tobacco free,09/11/2025
G9792,Most recent tobacco status is not tobacco free,09/11/2025
G9793,Patient is currently on a daily aspirin or other antiplatelet,09/11/2025
G9794,"Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)",09/11/2025
G9795,Patient is not currently on a daily aspirin or other antiplatelet,09/11/2025
G9796,Patient is currently on a statin therapy,09/11/2025
G9797,Patient is not on a statin therapy,09/11/2025
G9798,Discharge(s) for ami between july 1 of the year prior measurement period to june 30 of the measurement period,09/11/2025
G9799,Patients with a medication dispensing event indicator of a history of asthma any time during the patient's history through the end of the measure period,09/11/2025
G9800,Patients who are identified as having an intolerance or allergy to beta-blocker therapy,09/11/2025
G9801,Hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosis,09/11/2025
G9802,Patients who use hospice services any time during the measurement period,09/11/2025
G9803,Patient prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami,09/11/2025
G9804,Patient was not prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami,09/11/2025
G9805,Patients who use hospice services any time during the measurement period,09/11/2025
G9806,Patients who received cervical cytology or an hpv test,09/11/2025
G9807,Patients who did not receive cervical cytology or an hpv test,09/11/2025
G9808,Any patients who had no asthma controller medications dispensed during the measurement year,09/11/2025
G9809,Patients who use hospice services any time during the measurement period,09/11/2025
G9810,Patient achieved a pdc of at least 75% for their asthma controller medication,09/11/2025
G9811,Patient did not achieve a pdc of at least 75% for their asthma controller medication,09/11/2025
G9812,"Patient died including all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and those deaths occurring after discharge from the hospital, but within 30 days of the procedure",09/11/2025
G9813,Patient did not die within 30 days of the procedure or during the index hospitalization,09/11/2025
G9814,Death occurring during the index acute care hospitalization,09/11/2025
G9815,Death did not occur during the index acute care hospitalization,09/11/2025
G9816,Death occurring after discharge from the hospital but within 30 days post procedure,09/11/2025
G9817,Death did not occur after discharge from the hospital within 30 days post procedure,09/11/2025
G9818,Documentation of sexual activity,09/11/2025
G9819,Patients who use hospice services any time during the measurement period,09/11/2025
G9820,Documentation of a chlamydia screening test with proper follow-up,09/11/2025
G9821,No documentation of a chlamydia screening test with proper follow-up,09/11/2025
G9822,Patients who had an endometrial ablation procedure during the 12 months prior to the index date (exclusive of the index date),09/11/2025
G9823,Endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation,09/11/2025
G9824,Endometrial sampling or hysteroscopy with biopsy and results not documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation,09/11/2025
G9825,Her-2/neu negative or undocumented/unknown,09/11/2025
G9826,Patient transferred to practice after initiation of chemotherapy,09/11/2025
G9827,Her2-targeted therapies not administered during the initial course of treatment,09/11/2025
G9828,Her2-targeted therapies administered during the initial course of treatment,09/11/2025
G9829,Breast adjuvant chemotherapy administered,09/11/2025
G9830,Her-2/neu positive,09/11/2025
G9831,Ajcc stage at breast cancer diagnosis = ii or iii,09/11/2025
G9832,"Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis does not equal = t1, t1a, t1b",09/11/2025
G9833,Patient transfer to practice after initiation of chemotherapy,09/11/2025
G9834,Patient has metastatic disease at diagnosis,09/11/2025
G9835,Trastuzumab administered within 12 months of diagnosis,09/11/2025
G9836,"Reason for not administering trastuzumab documented (e.g. patient declined, patient died, patient transferred, contraindication or other clinical exclusion, neoadjuvant chemotherapy or radiation not complete)",09/11/2025
G9837,Trastuzumab not administered within 12 months of diagnosis,09/11/2025
G9838,Patient has metastatic disease at diagnosis,09/11/2025
G9839,Anti-egfr monoclonal antibody therapy,09/11/2025
G9840,Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab,09/11/2025
G9841,Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab,09/11/2025
G9842,Patient has metastatic disease at diagnosis,09/11/2025
G9843,Ras (kras or nras) gene mutation,09/11/2025
G9844,Patient did not receive anti-egfr monoclonal antibody therapy,09/11/2025
G9845,Patient received anti-egfr monoclonal antibody therapy,09/11/2025
G9846,Patients who died from cancer,09/11/2025
G9847,Patient received systemic cancer-directed therapy in the last 14 days of life,09/11/2025
G9848,Patient did not receive systemic cancer-directed therapy in the last 14 days of life,09/11/2025
G9849,Patients who died from cancer,09/11/2025
G9850,Patient had more than one emergency department visit in the last 30 days of life,09/11/2025
G9851,Patient had one or less emergency department visits in the last 30 days of life,09/11/2025
G9852,Patients who died from cancer,09/11/2025
G9853,Patient admitted to the icu in the last 30 days of life,09/11/2025
G9854,Patient was not admitted to the icu in the last 30 days of life,09/11/2025
G9855,Patients who died from cancer,09/11/2025
G9856,Patient was not admitted to hospice,09/11/2025
G9857,Patient admitted to hospice,09/11/2025
G9858,Patient enrolled in hospice,09/11/2025
G9859,Patients who died from cancer,09/11/2025
G9860,Patient spent less than three days in hospice care,09/11/2025
G9861,Patient spent greater than or equal to three days in hospice care,09/11/2025
G9862,"Documentation of medical reason(s) for not recommending at least a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is = 66 years old, or life expectancy < 10 years old, other medical reasons)",09/11/2025
G9868,"Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, less than 10 minutes",09/11/2025
G9869,"Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, 10-20 minutes",09/11/2025
G9870,"Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, more than 20 minutes",09/11/2025
G9873,First medicare diabetes prevention program (mdpp) core session was attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions,09/11/2025
G9874,Four total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions,09/11/2025
G9875,Nine total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions,09/11/2025
G9876,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9",09/11/2025
G9877,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12",09/11/2025
G9878,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9",09/11/2025
G9879,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12",09/11/2025
G9880,The mdpp beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight in months 1-12 of the mdpp services period under the mdpp expanded model (em).  this is a one-time payment available when a beneficiary first achieves at least 5% weight loss from baseline as measured by an in-person weight measurement at a core session or core maintenance session,09/11/2025
G9881,"The mdpp beneficiary achieved at least 9% weight loss (wl) from his/her baseline weight in months 1-24 under the mdpp expanded model (em).  this is a one-time payment available when a beneficiary first achieves at least 9% weight loss from baseline as measured by an in-person weight measurement at a core session, core maintenance session, or ongoing maintenance session",09/11/2025
G9882,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 13-15 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 13-15",09/11/2025
G9883,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 16-18 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 16-18",09/11/2025
G9884,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 19-21 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 19-21",09/11/2025
G9885,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 22-24 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 22-24",09/11/2025
G9886,"Behavioral counseling for diabetes prevention, in-person, group, 60 minutes",09/11/2025
G9887,"Behavioral counseling for diabetes prevention, distance learning, 60 minutes",09/11/2025
G9888,Maintenance 5% wl from baseline weight in months 7-12,09/11/2025
G9890,"Bridge payment: a one-time payment for the first medicare diabetes prevention program (mdpp) core session, core maintenance session, or ongoing maintenance session furnished by an mdpp supplier to an mdpp beneficiary during months 1-24 of the mdpp expanded model (em) who has previously received mdpp services from a different mdpp supplier under the mdpp expanded model.  a supplier may only receive one bridge payment per mdpp beneficiary",09/11/2025
G9891,Mdpp session reported as a line-item on a claim for a payable mdpp expanded model (em)  hcpcs code for a session furnished by the billing supplier under the mdpp expanded model and counting toward achievement of the attendance performance goal for the payable mdpp expanded model hcpcs code (this code is for reporting purposes only),09/11/2025
G9892,Documentation of patient reason(s) for not performing a dilated macular examination,09/11/2025
G9893,"Dilated macular exam was not performed, reason not otherwise specified",09/11/2025
G9894,Androgen deprivation therapy prescribed/administered in combination with external beam radiotherapy to the prostate,09/11/2025
G9895,"Documentation of medical reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate (e.g., salvage therapy)",09/11/2025
G9896,Documentation of patient reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate,09/11/2025
G9897,"Patients who were not prescribed/administered androgen deprivation therapy in combination with external beam radiotherapy to the prostate, reason not given",09/11/2025
G9898,"Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period",09/11/2025
G9899,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed",09/11/2025
G9900,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified",09/11/2025
G9901,"Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period",09/11/2025
G9902,Patient screened for tobacco use and identified as a tobacco user,09/11/2025
G9903,Patient screened for tobacco use and identified as a tobacco non-user,09/11/2025
G9904,"Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)",09/11/2025
G9905,Patient not screened for tobacco use,09/11/2025
G9906,Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy),09/11/2025
G9907,"Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months (e.g., limited life expectancy, other medical reason)",09/11/2025
G9908,Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy),09/11/2025
G9909,"Documentation of medical reason(s) for not  providing tobacco cessation intervention on the date of the encounter or within the previous 12 months if identified as a tobacco user (e.g., limited life expectancy, other medical reason)",09/11/2025
G9910,"Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period",09/11/2025
G9911,Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant  systemic therapy,09/11/2025
G9912,Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy,09/11/2025
G9913,"Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified",09/11/2025
G9914,Patient initiated an anti-tnf agent,09/11/2025
G9915,No record of hbv results documented,09/11/2025
G9916,Functional status  performed once in the last 12 months,09/11/2025
G9917,Documentation of advanced stage dementia and caregiver knowledge is limited,09/11/2025
G9918,"Functional status not performed, reason not otherwise specified",09/11/2025
G9919,Screening performed and positive and provision of recommendations,09/11/2025
G9920,Screening performed and negative,09/11/2025
G9921,"No screening performed, partial screening performed or positive screen without recommendations and reason is not given or otherwise specified",09/11/2025
G9922,Safety concerns screen provided and if positive then documented mitigation recommendations,09/11/2025
G9923,Safety concerns screen provided and negative,09/11/2025
G9924,"Documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations, orders or referrals for positive screen (e.g., patient in palliative care, other medical reason)",09/11/2025
G9925,"Safety concerns screening not provided, reason not otherwise specified",09/11/2025
G9926,"Safety concerns screening positive screen is without provision of mitigation recommendations, including but not limited to referral to other resources",09/11/2025
G9927,Documentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment,09/11/2025
G9928,"Fda-approved anticoagulant not prescribed, reason not given",09/11/2025
G9929,"Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)",09/11/2025
G9930,Patients who are receiving comfort care only,09/11/2025
G9931,"Documentation of cha2ds2-vasc risk score of 0 or 1 for men; or 0, 1, or 2 for women",09/11/2025
G9932,"Documentation of patient reason(s) for not having records of negative or managed positive tb screen (e.g., patient does not return for mantoux (ppd) skin test evaluation)",09/11/2025
G9933,Adenoma(s) or colorectal cancer detected during screening colonoscopy,09/11/2025
G9934,"Documentation that neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma",09/11/2025
G9935,Adenoma(s) or colorectal cancer not detected during screening colonoscopy,09/11/2025
G9936,"Surveillance colonoscopy - personal history of colonic polyps, colon cancer, or other malignant neoplasm of rectum, rectosigmoid junction, and anus",09/11/2025
G9937,Diagnostic colonoscopy,09/11/2025
G9938,"Patients aged 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the six months prior to the measurement period through december 31 of the measurement period",09/11/2025
G9939,Pathologists/dermatopathologists is the same clinician who performed the biopsy,09/11/2025
G9940,"Documentation of medical reason(s) for not on a statin (e.g., pregnancy, in vitro fertilization, clomiphene rx, esrd, cirrhosis, muscular pain and disease during the measurement period or prior year)",09/11/2025
G9941,Back pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively,09/11/2025
G9942,Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy,09/11/2025
G9943,Back pain was not measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively,09/11/2025
G9944,Back pain was measured by the visual analog scale (vas) within three months preoperatively and at one year  (9 to 15 months) postoperatively,09/11/2025
G9945,"Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular,  idiopathic or congenital lumbar scoliosis",09/11/2025
G9946,Back pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively,09/11/2025
G9947,Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 to 20 weeks) postoperatively,09/11/2025
G9948,Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy,09/11/2025
G9949,Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively,09/11/2025
G9954,Patient exhibits 2 or more risk factors for post-operative vomiting,09/11/2025
G9955,Cases in which an inhalational anesthetic is used only for induction,09/11/2025
G9956,Patient received combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively,09/11/2025
G9957,"Documentation of medical reason for not receiving combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)",09/11/2025
G9958,Patient did not receive combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively,09/11/2025
G9959,Systemic antimicrobials not prescribed,09/11/2025
G9960,Documentation of medical reason(s) for prescribing systemic antimicrobials,09/11/2025
G9961,Systemic antimicrobials prescribed,09/11/2025
G9962,Embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy,09/11/2025
G9963,Embolization endpoints are not documented separately for each embolized vessel or ovarian artery angiography or embolization not performed in the presence of variant uterine artery anatomy,09/11/2025
G9964,Patient received at least one well-child visit with a pcp during the performance period,09/11/2025
G9965,Patient did not receive at least one well-child visit with a pcp during the performance period,09/11/2025
G9966,"Children who were screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report",09/11/2025
G9967,"Children who were not screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report",09/11/2025
G9968,Patient was referred to another clinician or specialist during the measurement period,09/11/2025
G9969,Clinician who referred the patient to another clinician received a report from the clinician to whom the patient was referred,09/11/2025
G9970,Clinician who referred the patient to another clinician did not receive a report from the clinician to whom the patient was referred,09/11/2025
G9974,"Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity",09/11/2025
G9975,Documentation of medical reason(s) for not performing a dilated macular examination,09/11/2025
G9978,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9979,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: an expanded problem focused history;  an expanded problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9980,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting  problem(s) are of moderate severity. typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9981,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9982,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9983,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9984,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9985,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a detailed history;  a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9986,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",09/11/2025
G9987,"Bundled payments for care improvement advanced (bpci advanced) model home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary  connections to community and other services; for use only for a bpci advanced model episode of care; may not be billed for a 30-day period covered by a transitional care management code",09/11/2025
G9988,Palliative care services provided to patient any time during the measurement period,09/11/2025
G9989,"Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., adverse reaction to vaccine)",09/11/2025
G9990,Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period,09/11/2025
G9991,Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period,09/11/2025
G9992,Palliative care services used by patient any time during the measurement period,09/11/2025
G9993,Patient was provided palliative care services any time during the measurement period,09/11/2025
G9994,Patient is using palliative care services any time during the measurement period,09/11/2025
G9995,Patients who use palliative care services any time during the measurement period,09/11/2025
G9996,Documentation stating the patient has received or is currently receiving palliative or hospice care,09/11/2025
G9997,Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter,09/11/2025
G9998,"Documentation of medical reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., last colonoscopy incomplete, last colonoscopy had inadequate prep, piecemeal removal of adenomas, or sessile serrated polyps >= 20 mm in size, last colonoscopy found greater than 10 adenomas, lower gastrointestinal bleeding, or patient at high risk for colon cancer due to underlying medical history ([i.e. crohn's disease, ulcerative colitis, personal or family history of colon cancer, hereditary colorectal cancer syndromes])",09/11/2025
G9999,"Documentation of system reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., unable to locate previous colonoscopy report, patient cannot provide precise date or details from previous colonoscopy, previous colonoscopy report was incomplete)",09/11/2025
H0001,Alcohol and/or drug assessment,09/11/2025
H0002,Behavioral health screening to determine eligibility for admission to treatment program,09/11/2025
H0003,Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs,09/11/2025
H0004,"Behavioral health counseling and therapy, per 15 minutes",09/11/2025
H0005,Alcohol and/or drug services; group counseling by a clinician,09/11/2025
H0006,Alcohol and/or drug services; case management,09/11/2025
H0007,Alcohol and/or drug services; crisis intervention (outpatient),09/11/2025
H0008,Alcohol and/or drug services; sub-acute detoxification (hospital inpatient),09/11/2025
H0009,Alcohol and/or drug services; acute detoxification (hospital inpatient),09/11/2025
H0010,Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient),09/11/2025
H0011,Alcohol and/or drug services; acute detoxification (residential addiction program inpatient),09/11/2025
H0012,Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient),09/11/2025
H0013,Alcohol and/or drug services; acute detoxification (residential addiction program outpatient),09/11/2025
H0014,Alcohol and/or drug services; ambulatory detoxification,09/11/2025
H0015,"Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education",09/11/2025
H0016,Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting),09/11/2025
H0017,"Behavioral health; residential (hospital residential treatment program), without room and board, per diem",09/11/2025
H0018,"Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem",09/11/2025
H0019,"Behavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem",09/11/2025
H0020,Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program),09/11/2025
H0021,Alcohol and/or drug training service (for staff and personnel not employed by providers),09/11/2025
H0022,Alcohol and/or drug intervention service (planned facilitation),09/11/2025
H0023,Behavioral health outreach service (planned approach to reach a targeted population),09/11/2025
H0024,Behavioral health prevention information dissemination service (one-way direct or non-direct contact with service audiences to affect knowledge and attitude),09/11/2025
H0025,"Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior)",09/11/2025
H0026,"Alcohol and/or drug prevention process service, community-based (delivery of services to develop skills of impactors)",09/11/2025
H0027,Alcohol and/or drug prevention environmental service (broad range of external activities geared toward modifying systems in order to mainstream prevention through policy and law),09/11/2025
H0028,"Alcohol and/or drug prevention problem identification and referral service (e.g., student assistance and employee assistance programs), does not include assessment",09/11/2025
H0029,"Alcohol and/or drug prevention alternatives service (services for populations that exclude alcohol and other drug use e.g., alcohol free social events)",09/11/2025
H0030,Behavioral health hotline service,09/11/2025
H0031,"Mental health assessment, by non-physician",09/11/2025
H0032,Mental health service plan development by non-physician,09/11/2025
H0033,"Oral medication administration, direct observation",09/11/2025
H0034,"Medication training and support, per 15 minutes",09/11/2025
H0035,"Mental health partial hospitalization, treatment, less than 24 hours",09/11/2025
H0036,"Community psychiatric supportive treatment, face-to-face, per 15 minutes",09/11/2025
H0037,"Community psychiatric supportive treatment program, per diem",09/11/2025
H0038,"Self-help/peer services, per 15 minutes",09/11/2025
H0039,"Assertive community treatment, face-to-face, per 15 minutes",09/11/2025
H0040,"Assertive community treatment program, per diem",09/11/2025
H0041,"Foster care, child, non-therapeutic, per diem",09/11/2025
H0042,"Foster care, child, non-therapeutic, per month",09/11/2025
H0043,"Supported housing, per diem",09/11/2025
H0044,"Supported housing, per month",09/11/2025
H0045,"Respite care services, not in the home, per diem",09/11/2025
H0046,"Mental health services, not otherwise specified",09/11/2025
H0047,"Alcohol and/or other drug abuse services, not otherwise specified",09/11/2025
H0048,"Alcohol and/or other drug testing: collection and handling only, specimens other than blood",09/11/2025
H0049,Alcohol and/or drug screening,09/11/2025
H0050,"Alcohol and/or drug services, brief intervention, per 15 minutes",09/11/2025
H0051,Traditional healing service,09/11/2025
H0052,Missing and murdered indigenous persons (mmip) mental health and clinical care,09/11/2025
H0053,Historical trauma (ht) mental health and clinical care for indigenous persons,09/11/2025
H1000,"Prenatal care, at-risk assessment",09/11/2025
H1001,"Prenatal care, at-risk enhanced service; antepartum management",09/11/2025
H1002,"Prenatal care, at risk enhanced service; care coordination",09/11/2025
H1003,"Prenatal care, at-risk enhanced service; education",09/11/2025
H1004,"Prenatal care, at-risk enhanced service; follow-up home visit",09/11/2025
H1005,"Prenatal care, at-risk enhanced service package (includes h1001-h1004)",09/11/2025
H1010,"Non-medical family planning education, per session",09/11/2025
H1011,Family assessment by licensed behavioral health professional for state defined purposes,09/11/2025
H2000,Comprehensive multidisciplinary evaluation,09/11/2025
H2001,"Rehabilitation program, per 1/2 day",09/11/2025
H2010,"Comprehensive medication services, per 15 minutes",09/11/2025
H2011,"Crisis intervention service, per 15 minutes",09/11/2025
H2012,"Behavioral health day treatment, per hour",09/11/2025
H2013,"Psychiatric health facility service, per diem",09/11/2025
H2014,"Skills training and development, per 15 minutes",09/11/2025
H2015,"Comprehensive community support services, per 15 minutes",09/11/2025
H2016,"Comprehensive community support services, per diem",09/11/2025
H2017,"Psychosocial rehabilitation services, per 15 minutes",09/11/2025
H2018,"Psychosocial rehabilitation services, per diem",09/11/2025
H2019,"Therapeutic behavioral services, per 15 minutes",09/11/2025
H2020,"Therapeutic behavioral services, per diem",09/11/2025
H2021,"Community-based wrap-around services, per 15 minutes",09/11/2025
H2022,"Community-based wrap-around services, per diem",09/11/2025
H2023,"Supported employment, per 15 minutes",09/11/2025
H2024,"Supported employment, per diem",09/11/2025
H2025,"Ongoing support to maintain employment, per 15 minutes",09/11/2025
H2026,"Ongoing support to maintain employment, per diem",09/11/2025
H2027,"Psychoeducational service, per 15 minutes",09/11/2025
H2028,"Sexual offender treatment service, per 15 minutes",09/11/2025
H2029,"Sexual offender treatment service, per diem",09/11/2025
H2030,"Mental health clubhouse services, per 15 minutes",09/11/2025
H2031,"Mental health clubhouse services, per diem",09/11/2025
H2032,"Activity therapy, per 15 minutes",09/11/2025
H2033,"Multisystemic therapy for juveniles, per 15 minutes",09/11/2025
H2034,"Alcohol and/or drug abuse halfway house services, per diem",09/11/2025
H2035,"Alcohol and/or other drug treatment program, per hour",09/11/2025
H2036,"Alcohol and/or other drug treatment program, per diem",09/11/2025
H2037,"Developmental delay prevention activities, dependent child of client, per 15 minutes",09/11/2025
H2038,"Skills training and development, per diem",09/11/2025
H2040,"Coordinated specialty care, team-based, for first episode psychosis, per month",09/11/2025
H2041,"Coordinated specialty care, team-based, for first episode psychosis, per encounter",09/11/2025
J0120,"Injection, tetracycline, up to 250 mg",09/11/2025
J0121,"Injection, omadacycline, 1 mg",09/11/2025
J0122,"Injection, eravacycline, 1 mg",09/11/2025
J0129,"Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",09/11/2025
J0130,"Injection abciximab, 10 mg",09/11/2025
J0131,"Injection, acetaminophen, not otherwise specified,10 mg",09/11/2025
J0132,"Injection, acetylcysteine, 100 mg",09/11/2025
J0133,"Injection, acyclovir, 5 mg",09/11/2025
J0134,"Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg",09/11/2025
J0135,"Injection, adalimumab, 20 mg",09/11/2025
J0136,"Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg",09/11/2025
J0137,"Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg",09/11/2025
J0138,"Injection, acetaminophen 10 mg and ibuprofen 3 mg",09/11/2025
J0139,"Injection, adalimumab, 1 mg",09/11/2025
J0150,"Injection, adenosine for therapeutic use,  6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)",09/11/2025
J0151,"Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)",09/11/2025
J0153,"Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)",09/11/2025
J0163,"Injection, epinephrine in sodium chloride (endo), 0.1 mg",09/11/2025
J0164,"Injection, epinephrine in sodium chloride (baxter), 0.1 mg",09/11/2025
J0165,"Injection, epinephrine, not otherwise specified, 0.1 mg",09/11/2025
J0166,"Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg",09/11/2025
J0167,"Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg",09/11/2025
J0168,"Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg",09/11/2025
J0169,"Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg",09/11/2025
J0171,"Injection, adrenalin, epinephrine, 0.1 mg",09/11/2025
J0172,"Injection, aducanumab-avwa, 2 mg",09/11/2025
J0173,"Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg",09/11/2025
J0174,"Injection, lecanemab-irmb, 1 mg",09/11/2025
J0175,"Injection, donanemab-azbt, 2 mg",09/11/2025
J0177,"Injection, aflibercept hd, 1 mg",09/11/2025
J0178,"Injection, aflibercept, 1 mg",09/11/2025
J0179,"Injection, brolucizumab-dbll, 1 mg",09/11/2025
J0180,"Injection, agalsidase beta, 1 mg",09/11/2025
J0184,"Injection, amisulpride, 1 mg",09/11/2025
J0185,"Injection, aprepitant, 1 mg",09/11/2025
J0190,"Injection, biperiden lactate, per 5 mg",09/11/2025
J0200,"Injection, alatrofloxacin mesylate, 100 mg",09/11/2025
J0202,"Injection, alemtuzumab, 1 mg",09/11/2025
J0205,"Injection, alglucerase, per 10 units",09/11/2025
J0206,"Injection, allopurinol sodium, 1 mg",09/11/2025
J0207,"Injection, amifostine, 500 mg",09/11/2025
J0208,"Injection, sodium thiosulfate (pedmark), 100 mg",09/11/2025
J0209,"Injection, sodium thiosulfate (hope), 100 mg",09/11/2025
J0210,"Injection, methyldopate hcl, up to 250 mg",09/11/2025
J0211,"Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)",09/11/2025
J0215,"Injection, alefacept, 0.5 mg",09/11/2025
J0216,"Injection, alfentanil hydrochloride, 500 micrograms",09/11/2025
J0217,"Injection, velmanase alfa-tycv, 1 mg",09/11/2025
J0218,"Injection, olipudase alfa-rpcp, 1 mg",09/11/2025
J0219,"Injection, avalglucosidase alfa-ngpt, 4 mg",09/11/2025
J0220,"Injection, alglucosidase alfa, 10 mg, not otherwise specified",09/11/2025
J0221,"Injection, alglucosidase alfa, (lumizyme), 10 mg",09/11/2025
J0222,"Injection, patisiran, 0.1 mg",09/11/2025
J0223,"Injection, givosiran, 0.5 mg",09/11/2025
J0224,"Injection, lumasiran, 0.5 mg",09/11/2025
J0225,"Injection, vutrisiran, 1 mg",09/11/2025
J0248,"Injection, remdesivir, 1 mg",09/11/2025
J0256,"Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg",09/11/2025
J0257,"Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg",09/11/2025
J0270,"Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",09/11/2025
J0275,"Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",09/11/2025
J0278,"Injection, amikacin sulfate, 100 mg",09/11/2025
J0280,"Injection, aminophyllin, up to 250 mg",09/11/2025
J0281,"Injection, aminocaproic acid, 1 gram",09/11/2025
J0282,"Injection, amiodarone hydrochloride, 30 mg",09/11/2025
J0283,"Injection, amiodarone hydrochloride (nexterone), 30 mg",09/11/2025
J0285,"Injection, amphotericin b, 50 mg",09/11/2025
J0287,"Injection, amphotericin b lipid complex, 10 mg",09/11/2025
J0288,"Injection, amphotericin b cholesteryl sulfate complex, 10 mg",09/11/2025
J0289,"Injection, amphotericin b liposome, 10 mg",09/11/2025
J0290,"Injection, ampicillin sodium, 500 mg",09/11/2025
J0291,"Injection, plazomicin, 5 mg",09/11/2025
J0295,"Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm",09/11/2025
J0300,"Injection, amobarbital, up to 125 mg",09/11/2025
J0330,"Injection, succinylcholine chloride, up to 20 mg",09/11/2025
J0348,"Injection, anidulafungin, 1 mg",09/11/2025
J0349,"Injection, rezafungin, 1 mg",09/11/2025
J0350,"Injection, anistreplase, per 30 units",09/11/2025
J0360,"Injection, hydralazine hcl, up to 20 mg",09/11/2025
J0364,"Injection, apomorphine hydrochloride, 1 mg",09/11/2025
J0365,"Injection, aprotonin, 10,000 kiu",09/11/2025
J0380,"Injection, metaraminol bitartrate, per 10 mg",09/11/2025
J0390,"Injection, chloroquine hydrochloride, up to 250 mg",09/11/2025
J0391,"Injection, artesunate, 1 mg",09/11/2025
J0395,"Injection, arbutamine hcl, 1 mg",09/11/2025
J0400,"Injection, aripiprazole, intramuscular, 0.25 mg",09/11/2025
J0401,"Injection, aripiprazole (abilify maintena), 1 mg",09/11/2025
J0402,"Injection, aripiprazole (abilify asimtufii), 1 mg",09/11/2025
J0456,"Injection, azithromycin, 500 mg",09/11/2025
J0457,"Injection, aztreonam, 100 mg",09/11/2025
J0458,"Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)",09/11/2025
J0461,"Injection, atropine sulfate, 0.01 mg",09/11/2025
J0462,"Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg",09/11/2025
J0470,"Injection, dimercaprol, per 100 mg",09/11/2025
J0475,"Injection, baclofen, 10 mg",09/11/2025
J0476,"Injection, baclofen, 50 mcg for intrathecal trial",09/11/2025
J0480,"Injection, basiliximab, 20 mg",09/11/2025
J0485,"Injection, belatacept, 1 mg",09/11/2025
J0490,"Injection, belimumab, 10 mg",09/11/2025
J0491,"Injection, anifrolumab-fnia, 1 mg",09/11/2025
J0500,"Injection, dicyclomine hcl, up to 20 mg",09/11/2025
J0515,"Injection, benztropine mesylate, per 1 mg",09/11/2025
J0517,"Injection, benralizumab, 1 mg",09/11/2025
J0520,"Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg",09/11/2025
J0525,"Injection, cefotetan disodium, 10 mg",09/11/2025
J0558,"Injection, penicillin g benzathine and penicillin g procaine, 100,000 units",09/11/2025
J0561,"Injection, penicillin g benzathine, 100,000 units",09/11/2025
J0565,"Injection, bezlotoxumab, 10 mg",09/11/2025
J0567,"Injection, cerliponase alfa, 1 mg",09/11/2025
J0570,"Buprenorphine implant, 74.2 mg",09/11/2025
J0571,"Buprenorphine, oral, 1 mg",09/11/2025
J0572,"Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine",09/11/2025
J0573,"Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine",09/11/2025
J0574,"Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine",09/11/2025
J0575,"Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine",09/11/2025
J0576,"Injection, buprenorphine extended-release (brixadi), 1 mg",09/11/2025
J0577,"Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy",09/11/2025
J0578,"Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy",09/11/2025
J0582,"Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg",09/11/2025
J0583,"Injection, bivalirudin, 1 mg",09/11/2025
J0584,"Injection, burosumab-twza 1 mg",09/11/2025
J0585,"Injection, onabotulinumtoxina, 1 unit",09/11/2025
J0586,"Injection, abobotulinumtoxina, 5 units",09/11/2025
J0587,"Injection, rimabotulinumtoxinb, 100 units",09/11/2025
J0588,"Injection, incobotulinumtoxin a, 1 unit",09/11/2025
J0589,"Injection, daxibotulinumtoxina-lanm, 1 unit",09/11/2025
J0591,"Injection, deoxycholic acid, 1 mg",09/11/2025
J0592,"Injection, buprenorphine hydrochloride, 0.1 mg",09/11/2025
J0593,"Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)",09/11/2025
J0594,"injection, busulfan, 1 mg",09/11/2025
J0595,"Injection, butorphanol tartrate, 1 mg",09/11/2025
J0596,"Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units",09/11/2025
J0597,"Injection, c-1 esterase inhibitor (human), berinert, 10 units",09/11/2025
J0598,"Injection, c-1 esterase inhibitor (human), cinryze, 10 units",09/11/2025
J0599,"Injection, c-1 esterase inhibitor (human), (haegarda), 10 units",09/11/2025
J0600,"Injection, edetate calcium disodium, up to 1000 mg",09/11/2025
J0601,"Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)",09/11/2025
J0602,"Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)",09/11/2025
J0603,"Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)",09/11/2025
J0604,"Cinacalcet, oral, 1 mg, (for esrd on dialysis)",09/11/2025
J0605,"Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)",09/11/2025
J0606,"Injection, etelcalcetide, 0.1 mg",09/11/2025
J0607,"Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)",09/11/2025
J0608,"Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)",09/11/2025
J0609,"Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)",09/11/2025
J0610,"Injection, calcium gluconate (fresenius kabi), per 10 ml",09/11/2025
J0611,"Injection, calcium gluconate (wg critical care), per 10 ml",09/11/2025
J0612,"Injection, calcium gluconate, not otherwise specified, 10 mg",09/11/2025
J0613,"Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg",09/11/2025
J0614,"Injection, treosulfan, 50 mg",09/11/2025
J0615,"Calcium acetate, oral, 23 mg (for esrd on dialysis)",09/11/2025
J0616,"Injection, metoprolol tartrate, 1 mg",09/11/2025
J0618,"Injection, calcium chloride, 2 mg",09/11/2025
J0620,"Injection, calcium glycerophosphate and calcium lactate, per 10 ml",09/11/2025
J0630,"Injection, calcitonin salmon, up to 400 units",09/11/2025
J0636,"Injection, calcitriol, 0.1 mcg",09/11/2025
J0637,"Injection, caspofungin acetate, 5 mg",09/11/2025
J0638,"Injection, canakinumab, 1 mg",09/11/2025
J0640,"Injection, leucovorin calcium, per 50 mg",09/11/2025
J0641,"Injection, levoleucovorin, not otherwise specified, 0.5 mg",09/11/2025
J0642,"Injection, levoleucovorin (khapzory), 0.5 mg",09/11/2025
J0650,"Injection, levothyroxine sodium, not otherwise specified, 10 mcg",09/11/2025
J0651,"Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg",09/11/2025
J0652,"Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg",09/11/2025
J0665,"Injection, bupivicaine, not otherwise specified, 0.5 mg",09/11/2025
J0666,"Injection, bupivacaine liposome, 1 mg",09/11/2025
J0668,"Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg",09/11/2025
J0670,"Injection, mepivacaine hydrochloride, per 10 ml",09/11/2025
J0675,"Injection, carboprost tromethamine, 0.1 mg",09/11/2025
J0681,"Injection, ceftobiprole medocaril sodium, 3 mg",09/11/2025
J0687,"Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg",09/11/2025
J0688,"Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg",09/11/2025
J0689,"Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg",09/11/2025
J0690,"Injection, cefazolin sodium, 500 mg",09/11/2025
J0691,"Injection, lefamulin, 1 mg",09/11/2025
J0692,"Injection, cefepime hydrochloride, 500 mg",09/11/2025
J0693,"Injection, cefiderocol, 5 mg",09/11/2025
J0694,"Injection, cefoxitin sodium, 1 gm",09/11/2025
J0695,"Injection, ceftolozane 50 mg and tazobactam 25 mg",09/11/2025
J0696,"Injection, ceftriaxone sodium, per 250 mg",09/11/2025
J0697,"Injection, sterile cefuroxime sodium, per 750 mg",09/11/2025
J0698,"Injection, cefotaxime sodium, per gm",09/11/2025
J0699,"Injection, cefiderocol, 10 mg",09/11/2025
J0701,"Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg",09/11/2025
J0702,"Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg",09/11/2025
J0703,"Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg",09/11/2025
J0706,"Injection, caffeine citrate, 5 mg",09/11/2025
J0710,"Injection, cephapirin sodium, up to 1 gm",09/11/2025
J0712,"Injection, ceftaroline fosamil, 10 mg",09/11/2025
J0713,"Injection, ceftazidime, per 500 mg",09/11/2025
J0714,"Injection, ceftazidime and avibactam, 0.5 g/0.125 g",09/11/2025
J0715,"Injection, ceftizoxime sodium, per 500 mg",09/11/2025
J0716,"Injection, centruroides immune f(ab)2, up to 120 milligrams",09/11/2025
J0717,"Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",09/11/2025
J0720,"Injection, chloramphenicol sodium succinate, up to 1 gm",09/11/2025
J0725,"Injection, chorionic gonadotropin, per 1,000 usp units",09/11/2025
J0735,"Injection, clonidine hydrochloride, 1 mg",09/11/2025
J0736,"Injection, clindamycin phosphate, 300 mg",09/11/2025
J0737,"Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg",09/11/2025
J0738,"Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)",09/11/2025
J0739,"Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)",09/11/2025
J0740,"Injection, cidofovir, 375 mg",09/11/2025
J0741,"Injection, cabotegravir and rilpivirine, 2mg/3mg",09/11/2025
J0742,"Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg",09/11/2025
J0743,"Injection, cilastatin sodium; imipenem, per 250 mg",09/11/2025
J0744,"Injection, ciprofloxacin for intravenous infusion, 200 mg",09/11/2025
J0745,"Injection, codeine phosphate, per 30 mg",09/11/2025
J0750,"Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)",09/11/2025
J0751,"Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)",09/11/2025
J0752,"Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)",09/11/2025
J0759,"Injection, clevidipine butyrate, 1 mg",09/11/2025
J0760,"Injection, colchicine, per 1 mg",09/11/2025
J0770,"Injection, colistimethate sodium, up to 150 mg",09/11/2025
J0775,"Injection, collagenase, clostridium histolyticum, 0.01 mg",09/11/2025
J0780,"Injection, prochlorperazine, up to 10 mg",09/11/2025
J0791,"Injection, crizanlizumab-tmca, 5 mg",09/11/2025
J0795,"Injection, corticorelin ovine triflutate, 1 microgram",09/11/2025
J0799,"Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified",09/11/2025
J0800,"Injection, corticotropin, up to 40 units",09/11/2025
J0801,"Injection, corticotropin (acthar gel), up to 40 units",09/11/2025
J0802,"Injection, corticotropin (ani), up to 40 units",09/11/2025
J0833,"Injection, cosyntropin, not otherwise specified, 0.25 mg",09/11/2025
J0834,"Injection, cosyntropin, 0.25 mg",09/11/2025
J0840,"Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram",09/11/2025
J0841,"Injection, crotalidae immune f(ab')2 (equine), 120 mg",09/11/2025
J0850,"Injection, cytomegalovirus immune globulin intravenous (human), per vial",09/11/2025
J0870,"Injection, imetelstat, 1 mg",09/11/2025
J0872,"Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg",09/11/2025
J0873,"Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg",09/11/2025
J0874,"Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg",09/11/2025
J0875,"Injection, dalbavancin, 5 mg",09/11/2025
J0877,"Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg",09/11/2025
J0878,"Injection, daptomycin, 1 mg",09/11/2025
J0879,"Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)",09/11/2025
J0881,"Injection, darbepoetin alfa, 1 microgram (non-esrd use)",09/11/2025
J0882,"Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)",09/11/2025
J0883,"Injection, argatroban, 1 mg (for non-esrd use)",09/11/2025
J0884,"Injection, argatroban, 1 mg (for esrd on dialysis)",09/11/2025
J0885,"Injection, epoetin alfa, (for non-esrd use), 1000 units",09/11/2025
J0886,"Injection, epoetin alfa, 1000 units (for esrd on dialysis)",09/11/2025
J0887,"Injection, epoetin beta, 1 microgram, (for esrd on dialysis)",09/11/2025
J0888,"Injection, epoetin beta, 1 microgram, (for non esrd use)",09/11/2025
J0889,"Daprodustat, oral, 1 mg, (for esrd on dialysis)",09/11/2025
J0890,"Injection, peginesatide, 0.1 mg (for esrd on dialysis)",09/11/2025
J0891,"Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)",09/11/2025
J0892,"Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)",09/11/2025
J0893,"Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg",09/11/2025
J0894,"Injection, decitabine, 1 mg",09/11/2025
J0895,"Injection, deferoxamine mesylate, 500 mg",09/11/2025
J0896,"Injection, luspatercept-aamt, 0.25 mg",09/11/2025
J0897,"Injection, denosumab, 1 mg",09/11/2025
J0898,"Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)",09/11/2025
J0899,"Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)",09/11/2025
J0900,"Injection, testosterone enanthate and estradiol valerate, up to 1 cc",09/11/2025
J0901,"Vadadustat, oral, 1 mg (for esrd on dialysis)",09/11/2025
J0911,"Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)",09/11/2025
J0945,"Injection, brompheniramine maleate, per 10 mg",09/11/2025
J1000,"Injection, depo-estradiol cypionate, up to 5 mg",09/11/2025
J1010,"Injection, methylprednisolone acetate, 1 mg",09/11/2025
J1020,"Injection, methylprednisolone acetate, 20 mg",09/11/2025
J1030,"Injection, methylprednisolone acetate, 40 mg",09/11/2025
J1040,"Injection, methylprednisolone acetate, 80 mg",09/11/2025
J1050,"Injection, medroxyprogesterone acetate, 1 mg",09/11/2025
J1060,"Injection, testosterone cypionate and estradiol cypionate, up to 1 ml",09/11/2025
J1070,"Injection, testosterone cypionate, up to 100 mg",09/11/2025
J1071,"Injection, testosterone cypionate, 1 mg",09/11/2025
J1072,"Injection, testosterone cypionate (azmiro), 1 mg",09/11/2025
J1080,"Injection, testosterone cypionate, 1 cc, 200 mg",09/11/2025
J1094,"Injection, dexamethasone acetate, 1 mg",09/11/2025
J1095,"Injection, dexamethasone 9 percent, intraocular, 1 microgram",09/11/2025
J1096,"Dexamethasone, lacrimal ophthalmic insert, 0.1 mg",09/11/2025
J1097,"Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml",09/11/2025
J1100,"Injection, dexamethasone sodium phosphate, 1 mg",09/11/2025
J1105,"Dexmedetomidine, oral, 1 mcg",09/11/2025
J1110,"Injection, dihydroergotamine mesylate, per 1 mg",09/11/2025
J1120,"Injection, acetazolamide sodium, up to 500 mg",09/11/2025
J1130,"Injection, diclofenac sodium, 0.5 mg",09/11/2025
J1160,"Injection, digoxin, up to 0.5 mg",09/11/2025
J1162,"Injection, digoxin immune fab (ovine), per vial",09/11/2025
J1163,"Injection, diltiazem hydrochloride, 0.5 mg",09/11/2025
J1165,"Injection, phenytoin sodium, per 50 mg",09/11/2025
J1170,"Injection, hydromorphone, up to 4 mg",09/11/2025
J1171,"Injection, hydromorphone, 0.1 mg",09/11/2025
J1180,"Injection, dyphylline, up to 500 mg",09/11/2025
J1190,"Injection, dexrazoxane hydrochloride, per 250 mg",09/11/2025
J1200,"Injection, diphenhydramine hcl, up to 50 mg",09/11/2025
J1201,"Injection, cetirizine hydrochloride, 0.5 mg",09/11/2025
J1202,"Miglustat, oral, 65 mg",09/11/2025
J1203,"Injection, cipaglucosidase alfa-atga, 5 mg",09/11/2025
J1205,"Injection, chlorothiazide sodium, per 500 mg",09/11/2025
J1212,"Injection, dmso, dimethyl sulfoxide, 50%, 50 ml",09/11/2025
J1230,"Injection, methadone hcl, up to 10 mg",09/11/2025
J1240,"Injection, dimenhydrinate, up to 50 mg",09/11/2025
J1245,"Injection, dipyridamole, per 10 mg",09/11/2025
J1250,"Injection, dobutamine hydrochloride, per 250 mg",09/11/2025
J1260,"Injection, dolasetron mesylate, 10 mg",09/11/2025
J1265,"Injection, dopamine hcl, 40 mg",09/11/2025
J1267,"Injection, doripenem, 10 mg",09/11/2025
J1270,"Injection, doxercalciferol, 1 mcg",09/11/2025
J1271,"Injection, doxycycline hyclate, 1 mg",09/11/2025
J1290,"Injection, ecallantide, 1 mg",09/11/2025
J1299,"Injection, eculizumab, 2 mg",09/11/2025
J1300,"Injection, eculizumab, 10 mg",09/11/2025
J1301,"Injection, edaravone, 1 mg",09/11/2025
J1302,"Injection, sutimlimab-jome, 10 mg",09/11/2025
J1303,"Injection, ravulizumab-cwvz, 10 mg",09/11/2025
J1304,"Injection, tofersen, 1 mg",09/11/2025
J1305,"Injection, evinacumab-dgnb, 5mg",09/11/2025
J1306,"Injection, inclisiran, 1 mg",09/11/2025
J1307,"Injection, crovalimab-akkz, 10 mg",09/11/2025
J1308,"Injection, famotidine, 0.25 mg",09/11/2025
J1320,"Injection, amitriptyline hcl, up to 20 mg",09/11/2025
J1322,"Injection, elosulfase alfa, 1 mg",09/11/2025
J1323,"Injection, elranatamab-bcmm, 1 mg",09/11/2025
J1324,"Injection, enfuvirtide, 1 mg",09/11/2025
J1325,"Injection, epoprostenol, 0.5 mg",09/11/2025
J1326,"Injection, zolbetuximab-clzb, 2 mg",09/11/2025
J1327,"Injection, eptifibatide, 5 mg",09/11/2025
J1330,"Injection, ergonovine maleate, up to 0.2 mg",09/11/2025
J1335,"Injection, ertapenem sodium, 500 mg",09/11/2025
J1364,"Injection, erythromycin lactobionate, per 500 mg",09/11/2025
J1370,"Injection, esomeprazole sodium, 1 mg",09/11/2025
J1380,"Injection, estradiol valerate, up to 10 mg",09/11/2025
J1410,"Injection, estrogen conjugated, per 25 mg",09/11/2025
J1411,"Injection, etranacogene dezaparvovec-drlb, per therapeutic dose",09/11/2025
J1412,"Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes",09/11/2025
J1413,"Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose",09/11/2025
J1414,"Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose",09/11/2025
J1426,"Injection, casimersen, 10 mg",09/11/2025
J1427,"Injection, viltolarsen, 10 mg",09/11/2025
J1428,"Injection, eteplirsen, 10 mg",09/11/2025
J1429,"Injection, golodirsen, 10 mg",09/11/2025
J1430,"Injection, ethanolamine oleate, 100 mg",09/11/2025
J1434,"Injection, fosaprepitant (focinvez), 1 mg",09/11/2025
J1435,"Injection, estrone, per 1 mg",09/11/2025
J1436,"Injection, etidronate disodium, per 300 mg",09/11/2025
J1437,"Injection, ferric derisomaltose, 10 mg",09/11/2025
J1438,"Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",09/11/2025
J1439,"Injection, ferric carboxymaltose, 1 mg",09/11/2025
J1440,"Fecal microbiota, live - jslm, 1 ml",09/11/2025
J1442,"Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram",09/11/2025
J1443,"Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron",09/11/2025
J1444,"Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron",09/11/2025
J1445,"Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron",09/11/2025
J1446,"Injection, tbo-filgrastim, 5 micrograms",09/11/2025
J1447,"Injection, tbo-filgrastim, 1 microgram",09/11/2025
J1448,"Injection, trilaciclib, 1mg",09/11/2025
J1449,"Injection, eflapegrastim-xnst, 0.1 mg",09/11/2025
J1450,"Injection fluconazole, 200 mg",09/11/2025
J1451,"Injection, fomepizole, 15 mg",09/11/2025
J1452,"Injection, fomivirsen sodium, intraocular, 1.65 mg",09/11/2025
J1453,"Injection, fosaprepitant, 1 mg",09/11/2025
J1454,"Injection, fosnetupitant 235 mg and palonosetron 0.25 mg",09/11/2025
J1455,"Injection, foscarnet sodium, per 1000 mg",09/11/2025
J1456,"Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg",09/11/2025
J1457,"Injection, gallium nitrate, 1 mg",09/11/2025
J1458,"Injection, galsulfase, 1 mg",09/11/2025
J1459,"Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg",09/11/2025
J1460,"Injection, gamma globulin, intramuscular, 1 cc",09/11/2025
J1551,"Injection, immune globulin (cutaquig), 100 mg",09/11/2025
J1552,"Injection, immune globulin (alyglo), 500 mg",09/11/2025
J1554,"Injection, immune globulin (asceniv), 500 mg",09/11/2025
J1555,"Injection, immune globulin (cuvitru), 100 mg",09/11/2025
J1556,"Injection, immune globulin (bivigam), 500 mg",09/11/2025
J1557,"Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg",09/11/2025
J1558,"Injection, immune globulin (xembify), 100 mg",09/11/2025
J1559,"Injection, immune globulin (hizentra), 100 mg",09/11/2025
J1560,"Injection, gamma globulin, intramuscular, over 10 cc",09/11/2025
J1561,"Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg",09/11/2025
J1562,"Injection, immune globulin (vivaglobin), 100 mg",09/11/2025
J1566,"Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg",09/11/2025
J1568,"Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg",09/11/2025
J1569,"Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg",09/11/2025
J1570,"Injection, ganciclovir sodium, 500 mg",09/11/2025
J1571,"Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml",09/11/2025
J1572,"Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg",09/11/2025
J1573,"Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml",09/11/2025
J1574,"Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg",09/11/2025
J1575,"Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin",09/11/2025
J1576,"Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg",09/11/2025
J1580,"Injection, garamycin, gentamicin, up to 80 mg",09/11/2025
J1590,"Injection, gatifloxacin, 10 mg",09/11/2025
J1595,"Injection, glatiramer acetate, 20 mg",09/11/2025
J1596,"Injection, glycopyrrolate, 0.1 mg",09/11/2025
J1597,"Injection, glycopyrrolate (glyrx-pf), 0.1 mg",09/11/2025
J1598,"Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg",09/11/2025
J1599,"Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg",09/11/2025
J1600,"Injection, gold sodium thiomalate, up to 50 mg",09/11/2025
J1602,"Injection, golimumab, 1 mg, for intravenous use",09/11/2025
J1610,"Injection, glucagon hydrochloride, per 1 mg",09/11/2025
J1611,"Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg",09/11/2025
J1612,"Injection, glucagon (gvoke), 0.01 mg",09/11/2025
J1620,"Injection, gonadorelin hydrochloride, per 100 mcg",09/11/2025
J1626,"Injection, granisetron hydrochloride, 100 mcg",09/11/2025
J1627,"Injection, granisetron, extended-release, 0.1 mg",09/11/2025
J1628,"Injection, guselkumab, 1 mg",09/11/2025
J1630,"Injection, haloperidol, up to 5 mg",09/11/2025
J1631,"Injection, haloperidol decanoate, per 50 mg",09/11/2025
J1632,"Injection, brexanolone, 1 mg",09/11/2025
J1640,"Injection, hemin, 1 mg",09/11/2025
J1642,"Injection, heparin sodium, (heparin lock flush), per 10 units",09/11/2025
J1643,"Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units",09/11/2025
J1644,"Injection, heparin sodium, per 1000 units",09/11/2025
J1645,"Injection, dalteparin sodium, per 2500 iu",09/11/2025
J1650,"Injection, enoxaparin sodium, 10 mg",09/11/2025
J1652,"Injection, fondaparinux sodium, 0.5 mg",09/11/2025
J1655,"Injection, tinzaparin sodium, 1000 iu",09/11/2025
J1670,"Injection, tetanus immune globulin, human, up to 250 units",09/11/2025
J1675,"Injection, histrelin acetate, 10 micrograms",09/11/2025
J1700,"Injection, hydrocortisone acetate, up to 25 mg",09/11/2025
J1710,"Injection, hydrocortisone sodium phosphate, up to 50 mg",09/11/2025
J1720,"Injection, hydrocortisone sodium succinate, up to 100 mg",09/11/2025
J1725,"Injection, hydroxyprogesterone caproate, 1 mg",09/11/2025
J1726,"Injection, hydroxyprogesterone caproate, (makena), 10 mg",09/11/2025
J1729,"Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg",09/11/2025
J1730,"Injection, diazoxide, up to 300 mg",09/11/2025
J1738,"Injection, meloxicam, 1 mg",09/11/2025
J1740,"Injection, ibandronate sodium, 1 mg",09/11/2025
J1741,"Injection, ibuprofen, 100 mg",09/11/2025
J1742,"Injection, ibutilide fumarate, 1 mg",09/11/2025
J1743,"Injection, idursulfase, 1 mg",09/11/2025
J1744,"Injection, icatibant, 1 mg",09/11/2025
J1745,"Injection, infliximab, excludes biosimilar, 10 mg",09/11/2025
J1746,"Injection, ibalizumab-uiyk, 10 mg",09/11/2025
J1747,"Injection, spesolimab-sbzo, 1 mg",09/11/2025
J1748,"Injection, infliximab-dyyb (zymfentra), 10 mg",09/11/2025
J1749,"Injection, iloprost, 0.1 mcg",09/11/2025
J1750,"Injection, iron dextran, 50 mg",09/11/2025
J1756,"Injection, iron sucrose, 1 mg",09/11/2025
J1786,"Injection, imiglucerase, 10 units",09/11/2025
J1790,"Injection, droperidol, up to 5 mg",09/11/2025
J1800,"Injection, propranolol hcl, up to 1 mg",09/11/2025
J1805,"Injection, esmolol hydrochloride, 10 mg",09/11/2025
J1806,"Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg",09/11/2025
J1807,"Injection, ethacrynate sodium, 1 mg",09/11/2025
J1808,"Injection, folic acid, 0.1 mg",09/11/2025
J1809,"Injection, fosdenopterin, 0.1 mg",09/11/2025
J1810,"Injection, droperidol and fentanyl citrate, up to 2 ml ampule",09/11/2025
J1811,"Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units",09/11/2025
J1812,"Insulin (fiasp), per 5 units",09/11/2025
J1813,"Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units",09/11/2025
J1814,"Insulin (lyumjev), per 5 units",09/11/2025
J1815,"Injection, insulin, per 5 units",09/11/2025
J1817,"Insulin for administration through dme (i.e., insulin pump) per 50 units",09/11/2025
J1823,"Injection, inebilizumab-cdon, 1 mg",09/11/2025
J1826,"Injection, interferon beta-1a, 30 mcg",09/11/2025
J1830,"Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",09/11/2025
J1833,"Injection, isavuconazonium, 1 mg",09/11/2025
J1834,"Injection, isoniazid, 1 mg",09/11/2025
J1835,"Injection, itraconazole, 50 mg",09/11/2025
J1836,"Injection, metronidazole, 10 mg",09/11/2025
J1840,"Injection, kanamycin sulfate, up to 500 mg",09/11/2025
J1850,"Injection, kanamycin sulfate, up to 75 mg",09/11/2025
J1885,"Injection, ketorolac tromethamine, per 15 mg",09/11/2025
J1890,"Injection, cephalothin sodium, up to 1 gram",09/11/2025
J1920,"Injection, labetalol hydrochloride, 5 mg",09/11/2025
J1921,"Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg",09/11/2025
J1930,"Injection, lanreotide, 1 mg",09/11/2025
J1931,"Injection, laronidase, 0.1 mg",09/11/2025
J1932,"Injection, lanreotide, (cipla), 1 mg",09/11/2025
J1938,"Injection, furosemide, 1 mg",09/11/2025
J1939,"Injection, bumetanide, 0.5 mg",09/11/2025
J1940,"Injection, furosemide, up to 20 mg",09/11/2025
J1941,"Injection, furosemide (furoscix), 20 mg",09/11/2025
J1942,"Injection, aripiprazole lauroxil, 1 mg",09/11/2025
J1943,"Injection, aripiprazole lauroxil, (aristada initio), 1 mg",09/11/2025
J1944,"Injection, aripiprazole lauroxil, (aristada), 1 mg",09/11/2025
J1945,"Injection, lepirudin, 50 mg",09/11/2025
J1950,"Injection, leuprolide acetate (for depot suspension), per 3.75 mg",09/11/2025
J1951,"Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg",09/11/2025
J1952,"Leuprolide injectable, camcevi, 1 mg",09/11/2025
J1953,"Injection, levetiracetam, 10 mg",09/11/2025
J1954,"Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg",09/11/2025
J1955,"Injection, levocarnitine, per 1 gm",09/11/2025
J1956,"Injection, levofloxacin, 250 mg",09/11/2025
J1960,"Injection, levorphanol tartrate, up to 2 mg",09/11/2025
J1961,"Injection, lenacapavir (only for use as hiv treatment), 1 mg",09/11/2025
J1980,"Injection, hyoscyamine sulfate, up to 0.25 mg",09/11/2025
J1990,"Injection, chlordiazepoxide hcl, up to 100 mg",09/11/2025
J2001,"Injection, lidocaine hcl for intravenous infusion, 10 mg",09/11/2025
J2002,"Injection, lidocaine hcl in 5% dextrose, 1 mg",09/11/2025
J2003,"Injection, lidocaine hydrochloride, 1 mg",09/11/2025
J2004,"Injection, lidocaine hcl with epinephrine, 1 mg",09/11/2025
J2010,"Injection, lincomycin hcl, up to 300 mg",09/11/2025
J2020,"Injection, linezolid, 200 mg",09/11/2025
J2021,"Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg",09/11/2025
J2060,"Injection, lorazepam, 2 mg",09/11/2025
J2062,"Loxapine for inhalation, 1 mg",09/11/2025
J2150,"Injection, mannitol, 25% in 50 ml",09/11/2025
J2151,"Injection, mannitol, 250 mg",09/11/2025
J2170,"Injection, mecasermin, 1 mg",09/11/2025
J2175,"Injection, meperidine hydrochloride, per 100 mg",09/11/2025
J2180,"Injection, meperidine and promethazine hcl, up to 50 mg",09/11/2025
J2182,"Injection, mepolizumab, 1 mg",09/11/2025
J2183,"Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg",09/11/2025
J2184,"Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg",09/11/2025
J2185,"Injection, meropenem, 100 mg",09/11/2025
J2186,"Injection, meropenem and vaborbactam, 10mg/10mg (20mg)",09/11/2025
J2210,"Injection, methylergonovine maleate, up to 0.2 mg",09/11/2025
J2212,"Injection, methylnaltrexone, 0.1 mg",09/11/2025
J2246,"Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg",09/11/2025
J2247,"Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg",09/11/2025
J2248,"Injection, micafungin sodium, 1 mg",09/11/2025
J2249,"Injection, remimazolam, 1 mg",09/11/2025
J2250,"Injection, midazolam hydrochloride, per 1 mg",09/11/2025
J2251,"Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg",09/11/2025
J2252,"Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg",09/11/2025
J2253,"Injection, midazolam (seizalam), 1 mg",09/11/2025
J2260,"Injection, milrinone lactate, 5 mg",09/11/2025
J2265,"Injection, minocycline hydrochloride, 1 mg",09/11/2025
J2267,"Injection, mirikizumab-mrkz, 1 mg",09/11/2025
J2270,"Injection, morphine sulfate, up to 10 mg",09/11/2025
J2271,"Injection, morphine sulfate, 100mg",09/11/2025
J2272,"Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg",09/11/2025
J2274,"Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg",09/11/2025
J2275,"Injection, morphine sulfate (preservative-free sterile solution), per 10 mg",09/11/2025
J2277,"Injection, motixafortide, 0.25 mg",09/11/2025
J2278,"Injection, ziconotide, 1 microgram",09/11/2025
J2280,"Injection, moxifloxacin, 100 mg",09/11/2025
J2281,"Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg",09/11/2025
J2290,"Injection, nafcillin sodium, 20 mg",09/11/2025
J2291,"Injection, nafcillin sodium (baxter), 20 mg",09/11/2025
J2300,"Injection, nalbuphine hydrochloride, per 10 mg",09/11/2025
J2305,"Injection, nitroglycerin, 5 mg",09/11/2025
J2310,"Injection, naloxone hydrochloride, per 1 mg",09/11/2025
J2311,"Injection, naloxone hydrochloride (zimhi), 1 mg",09/11/2025
J2312,"Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg",09/11/2025
J2313,"Injection, naloxone hydrochloride (zimhi), 0.01 mg",09/11/2025
J2315,"Injection, naltrexone, depot form, 1 mg",09/11/2025
J2320,"Injection, nandrolone decanoate, up to 50 mg",09/11/2025
J2323,"Injection, natalizumab, 1 mg",09/11/2025
J2325,"Injection, nesiritide, 0.1 mg",09/11/2025
J2326,"Injection, nusinersen, 0.1 mg",09/11/2025
J2327,"Injection, risankizumab-rzaa, intravenous, 1 mg",09/11/2025
J2329,"Injection, ublituximab-xiiy, 1mg",09/11/2025
J2350,"Injection, ocrelizumab, 1 mg",09/11/2025
J2351,"Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq",09/11/2025
J2353,"Injection, octreotide, depot form for intramuscular injection, 1 mg",09/11/2025
J2354,"Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg",09/11/2025
J2355,"Injection, oprelvekin, 5 mg",09/11/2025
J2356,"Injection, tezepelumab-ekko, 1 mg",09/11/2025
J2357,"Injection, omalizumab, 5 mg",09/11/2025
J2358,"Injection, olanzapine, long-acting, 1 mg",09/11/2025
J2359,"Injection, olanzapine, 0.5 mg",09/11/2025
J2360,"Injection, orphenadrine citrate, up to 60 mg",09/11/2025
J2370,"Injection, phenylephrine hcl, up to 1 ml",09/11/2025
J2371,"Injection, phenylephrine hydrochloride, 20 micrograms",09/11/2025
J2372,"Injection, phenylephrine hydrochloride (biorphen), 20 micrograms",09/11/2025
J2373,"Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms",09/11/2025
J2400,"Injection, chloroprocaine hydrochloride, per 30 ml",09/11/2025
J2401,"Injection, chloroprocaine hydrochloride, per 1 mg",09/11/2025
J2402,"Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg",09/11/2025
J2403,"Chloroprocaine hcl ophthalmic, 3% gel, 1 mg",09/11/2025
J2404,"Injection, nicardipine, 0.1 mg",09/11/2025
J2405,"Injection, ondansetron hydrochloride, per 1 mg",09/11/2025
J2406,"Injection, oritavancin (kimyrsa), 10 mg",09/11/2025
J2407,"Injection, oritavancin (orbactiv), 10 mg",09/11/2025
J2410,"Injection, oxymorphone hcl, up to 1 mg",09/11/2025
J2425,"Injection, palifermin, 50 micrograms",09/11/2025
J2426,"Injection, paliperidone palmitate extended release (invega sustenna), 1 mg",09/11/2025
J2427,"Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg",09/11/2025
J2428,"Injection, paliperidone palmitate extended release (erzofri), 1 mg",09/11/2025
J2430,"Injection, pamidronate disodium, per 30 mg",09/11/2025
J2440,"Injection, papaverine hcl, up to 60 mg",09/11/2025
J2460,"Injection, oxytetracycline hcl, up to 50 mg",09/11/2025
J2468,"Injection, palonosetron hydrochloride (posfrea), 25 micrograms",09/11/2025
J2469,"Injection, palonosetron hcl, 25 mcg",09/11/2025
J2470,"Injection, pantoprazole sodium, 40 mg",09/11/2025
J2471,"Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg",09/11/2025
J2472,"Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg",09/11/2025
J2501,"Injection, paricalcitol, 1 mcg",09/11/2025
J2502,"Injection, pasireotide long acting, 1 mg",09/11/2025
J2503,"Injection, pegaptanib sodium, 0.3 mg",09/11/2025
J2504,"Injection, pegademase bovine, 25 iu",09/11/2025
J2505,"Injection, pegfilgrastim, 6 mg",09/11/2025
J2506,"Injection, pegfilgrastim, excludes biosimilar, 0.5 mg",09/11/2025
J2507,"Injection, pegloticase, 1 mg",09/11/2025
J2508,"Injection, pegunigalsidase alfa-iwxj, 1 mg",09/11/2025
J2510,"Injection, penicillin g procaine, aqueous, up to 600,000 units",09/11/2025
J2513,"Injection, pentastarch, 10% solution, 100 ml",09/11/2025
J2515,"Injection, pentobarbital sodium, per 50 mg",09/11/2025
J2540,"Injection, penicillin g potassium, up to 600,000 units",09/11/2025
J2543,"Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)",09/11/2025
J2545,"Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg",09/11/2025
J2547,"Injection, peramivir, 1 mg",09/11/2025
J2550,"Injection, promethazine hcl, up to 50 mg",09/11/2025
J2560,"Injection, phenobarbital sodium, up to 120 mg",09/11/2025
J2561,"Injection, phenobarbital sodium (sezaby), 1 mg",09/11/2025
J2562,"Injection, plerixafor, 1 mg",09/11/2025
J2590,"Injection, oxytocin, up to 10 units",09/11/2025
J2597,"Injection, desmopressin acetate, per 1 mcg",09/11/2025
J2598,"Injection, vasopressin, 1 unit",09/11/2025
J2599,"Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit",09/11/2025
J2601,"Injection, vasopressin (baxter), 1 unit",09/11/2025
J2650,"Injection, prednisolone acetate, up to 1 ml",09/11/2025
J2670,"Injection, tolazoline hcl, up to 25 mg",09/11/2025
J2675,"Injection, progesterone, per 50 mg",09/11/2025
J2679,"Injection, fluphenazine hcl, 1.25 mg",09/11/2025
J2680,"Injection, fluphenazine decanoate, up to 25 mg",09/11/2025
J2690,"Injection, procainamide hcl, up to 1 gm",09/11/2025
J2700,"Injection, oxacillin sodium, up to 250 mg",09/11/2025
J2704,"Injection, propofol, 10 mg",09/11/2025
J2710,"Injection, neostigmine methylsulfate, up to 0.5 mg",09/11/2025
J2720,"Injection, protamine sulfate, per 10 mg",09/11/2025
J2724,"Injection, protein c concentrate, intravenous, human, 10 iu",09/11/2025
J2725,"Injection, protirelin, per 250 mcg",09/11/2025
J2730,"Injection, pralidoxime chloride, up to 1 gm",09/11/2025
J2760,"Injection, phentolamine mesylate, up to 5 mg",09/11/2025
J2765,"Injection, metoclopramide hcl, up to 10 mg",09/11/2025
J2770,"Injection, quinupristin/dalfopristin, 500 mg (150/350)",09/11/2025
J2777,"Injection, faricimab-svoa, 0.1 mg",09/11/2025
J2778,"Injection, ranibizumab, 0.1 mg",09/11/2025
J2779,"Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg",09/11/2025
J2780,"Injection, ranitidine hydrochloride, 25 mg",09/11/2025
J2781,"Injection, pegcetacoplan, intravitreal, 1 mg",09/11/2025
J2782,"Injection, avacincaptad pegol, 0.1 mg",09/11/2025
J2783,"Injection, rasburicase, 0.5 mg",09/11/2025
J2785,"Injection, regadenoson, 0.1 mg",09/11/2025
J2786,"Injection, reslizumab, 1 mg",09/11/2025
J2787,"Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml",09/11/2025
J2788,"Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)",09/11/2025
J2790,"Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)",09/11/2025
J2791,"Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu",09/11/2025
J2792,"Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu",09/11/2025
J2793,"Injection, rilonacept, 1 mg",09/11/2025
J2794,"Injection, risperidone (risperdal consta), 0.5 mg",09/11/2025
J2795,"Injection, ropivacaine hydrochloride, 1 mg",09/11/2025
J2796,"Injection, romiplostim, 10 micrograms",09/11/2025
J2797,"Injection, rolapitant, 0.5 mg",09/11/2025
J2798,"Injection, risperidone, (perseris), 0.5 mg",09/11/2025
J2799,"Injection, risperidone (uzedy), 1 mg",09/11/2025
J2800,"Injection, methocarbamol, up to 10 ml",09/11/2025
J2801,"Injection, risperidone (rykindo), 0.5 mg",09/11/2025
J2802,"Injection, romiplostim, 1 microgram",09/11/2025
J2804,"Injection, rifampin, 1 mg",09/11/2025
J2805,"Injection, sincalide, 5 micrograms",09/11/2025
J2806,"Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms",09/11/2025
J2810,"Injection, theophylline, per 40 mg",09/11/2025
J2820,"Injection, sargramostim (gm-csf), 50 mcg",09/11/2025
J2840,"Injection, sebelipase alfa, 1 mg",09/11/2025
J2850,"Injection, secretin, synthetic, human, 1 microgram",09/11/2025
J2860,"Injection, siltuximab, 10 mg",09/11/2025
J2865,"Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg",09/11/2025
J2910,"Injection, aurothioglucose, up to 50 mg",09/11/2025
J2916,"Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg",09/11/2025
J2919,"Injection, methylprednisolone sodium succinate, 5 mg",09/11/2025
J2920,"Injection, methylprednisolone sodium succinate, up to 40 mg",09/11/2025
J2930,"Injection, methylprednisolone sodium succinate, up to 125 mg",09/11/2025
J2940,"Injection, somatrem, 1 mg",09/11/2025
J2941,"Injection, somatropin, 1 mg",09/11/2025
J2950,"Injection, promazine hcl, up to 25 mg",09/11/2025
J2993,"Injection, reteplase, 18.1 mg",09/11/2025
J2995,"Injection, streptokinase, per 250,000 iu",09/11/2025
J2997,"Injection, alteplase recombinant, 1 mg",09/11/2025
J2998,"Injection, plasminogen, human-tvmh, 1 mg",09/11/2025
J3000,"Injection, streptomycin, up to 1 gm",09/11/2025
J3010,"Injection, fentanyl citrate, 0.1 mg",09/11/2025
J3030,"Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",09/11/2025
J3031,"Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)",09/11/2025
J3032,"Injection, eptinezumab-jjmr, 1 mg",09/11/2025
J3055,"Injection, talquetamab-tgvs, 0.25 mg",09/11/2025
J3060,"Injection, taliglucerase alfa, 10 units",09/11/2025
J3070,"Injection, pentazocine, 30 mg",09/11/2025
J3090,"Injection, tedizolid phosphate, 1 mg",09/11/2025
J3095,"Injection, telavancin, 10 mg",09/11/2025
J3101,"Injection, tenecteplase, 1 mg",09/11/2025
J3105,"Injection, terbutaline sulfate, up to 1 mg",09/11/2025
J3110,"Injection, teriparatide, 10 mcg",09/11/2025
J3111,"Injection, romosozumab-aqqg, 1 mg",09/11/2025
J3120,"Injection, testosterone enanthate, up to 100 mg",09/11/2025
J3121,"Injection, testosterone enanthate, 1 mg",09/11/2025
J3130,"Injection, testosterone enanthate, up to 200 mg",09/11/2025
J3140,"Injection, testosterone suspension, up to 50 mg",09/11/2025
J3145,"Injection, testosterone undecanoate, 1 mg",09/11/2025
J3150,"Injection, testosterone propionate, up to 100 mg",09/11/2025
J3230,"Injection, chlorpromazine hcl, up to 50 mg",09/11/2025
J3240,"Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial",09/11/2025
J3241,"Injection, teprotumumab-trbw, 10 mg",09/11/2025
J3243,"Injection, tigecycline, 1 mg",09/11/2025
J3244,"Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg",09/11/2025
J3245,"Injection, tildrakizumab, 1 mg",09/11/2025
J3246,"Injection, tirofiban hcl, 0.25 mg",09/11/2025
J3247,"Injection, secukinumab, intravenous, 1 mg",09/11/2025
J3250,"Injection, trimethobenzamide hcl, up to 200 mg",09/11/2025
J3260,"Injection, tobramycin sulfate, up to 80 mg",09/11/2025
J3262,"Injection, tocilizumab, 1 mg",09/11/2025
J3263,"Injection, toripalimab-tpzi, 1 mg",09/11/2025
J3265,"Injection, torsemide, 10 mg/ml",09/11/2025
J3280,"Injection, thiethylperazine maleate, up to 10 mg",09/11/2025
J3285,"Injection, treprostinil, 1 mg",09/11/2025
J3290,"Injection, tranexamic acid, 5 mg",09/11/2025
J3299,"Injection, triamcinolone acetonide (xipere), 1 mg",09/11/2025
J3300,"Injection, triamcinolone acetonide, preservative free, 1 mg",09/11/2025
J3301,"Injection, triamcinolone acetonide, not otherwise specified, 10 mg",09/11/2025
J3302,"Injection, triamcinolone diacetate, per 5 mg",09/11/2025
J3303,"Injection, triamcinolone hexacetonide, per 5 mg",09/11/2025
J3304,"Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg",09/11/2025
J3305,"Injection, trimetrexate glucuronate, per 25 mg",09/11/2025
J3310,"Injection, perphenazine, up to 5 mg",09/11/2025
J3315,"Injection, triptorelin pamoate, 3.75 mg",09/11/2025
J3316,"Injection, triptorelin, extended-release, 3.75 mg",09/11/2025
J3320,"Injection, spectinomycin dihydrochloride, up to 2 gm",09/11/2025
J3350,"Injection, urea, up to 40 gm",09/11/2025
J3355,"Injection, urofollitropin, 75 iu",09/11/2025
J3357,"Ustekinumab, for subcutaneous injection, 1 mg",09/11/2025
J3358,"Ustekinumab, for intravenous injection, 1 mg",09/11/2025
J3360,"Injection, diazepam, up to 5 mg",09/11/2025
J3364,"Injection, urokinase, 5000 iu vial",09/11/2025
J3365,"Injection, iv, urokinase, 250,000 i.u. vial",09/11/2025
J3370,"Injection, vancomycin hcl, 500 mg",09/11/2025
J3371,"Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg",09/11/2025
J3372,"Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg",09/11/2025
J3373,"Injection, vancomycin hydrochloride, 10 mg",09/11/2025
J3374,"Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg",09/11/2025
J3375,"Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to j3373, 10 mg",09/11/2025
J3380,"Injection, vedolizumab, intravenous, 1 mg",09/11/2025
J3385,"Injection, velaglucerase alfa, 100 units",09/11/2025
J3391,"Injection, atidarsagene autotemcel, per treatment",09/11/2025
J3392,"Injection, exagamglogene autotemcel, per treatment",09/11/2025
J3393,"Injection, betibeglogene autotemcel, per treatment",09/11/2025
J3394,"Injection, lovotibeglogene autotemcel, per treatment",09/11/2025
J3396,"Injection, verteporfin, 0.1 mg",09/11/2025
J3397,"Injection, vestronidase alfa-vjbk, 1 mg",09/11/2025
J3398,"Injection, voretigene neparvovec-rzyl, 1 billion vector genomes",09/11/2025
J3399,"Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes",09/11/2025
J3400,"Injection, triflupromazine hcl, up to 20 mg",09/11/2025
J3401,"Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml",09/11/2025
J3402,"Injection, remestemcel-l-rknd, per therapeutic dose",09/11/2025
J3403,"Revakinagene taroretcel-lwey, per implant",09/11/2025
J3410,"Injection, hydroxyzine hcl, up to 25 mg",09/11/2025
J3411,"Injection, thiamine hcl, 100 mg",09/11/2025
J3415,"Injection, pyridoxine hcl, 100 mg",09/11/2025
J3420,"Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg",09/11/2025
J3424,"Injection, hydroxocobalamin, intravenous, 25 mg",09/11/2025
J3425,"Injection, hydroxocobalamin, intramuscular, 10 mcg",09/11/2025
J3430,"Injection, phytonadione (vitamin k), per 1 mg",09/11/2025
J3465,"Injection, voriconazole, 10 mg",09/11/2025
J3470,"Injection, hyaluronidase, up to 150 units",09/11/2025
J3471,"Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)",09/11/2025
J3472,"Injection, hyaluronidase, ovine, preservative free, per 1000 usp units",09/11/2025
J3473,"Injection, hyaluronidase, recombinant, 1 usp unit",09/11/2025
J3475,"Injection, magnesium sulfate, per 500 mg",09/11/2025
J3480,"Injection, potassium chloride, per 2 meq",09/11/2025
J3485,"Injection, zidovudine, 10 mg",09/11/2025
J3486,"Injection, ziprasidone mesylate, 10 mg",09/11/2025
J3489,"Injection, zoledronic acid, 1 mg",09/11/2025
J3490,Unclassified drugs,09/11/2025
J3520,"Edetate disodium, per 150 mg",09/11/2025
J3530,Nasal vaccine inhalation,09/11/2025
J3535,Drug administered through a metered dose inhaler,09/11/2025
J3570,"Laetrile, amygdalin, vitamin b17",09/11/2025
J3590,Unclassified biologics,09/11/2025
J3591,Unclassified drug or biological used for esrd on dialysis,09/11/2025
J7030,"Infusion, normal saline solution , 1000 cc",09/11/2025
J7040,"Infusion, normal saline solution, sterile (500 ml = 1 unit)",09/11/2025
J7042,5% dextrose/normal saline (500 ml = 1 unit),09/11/2025
J7050,"Infusion, normal saline solution, 250 cc",09/11/2025
J7060,5% dextrose/water (500 ml = 1 unit),09/11/2025
J7070,"Infusion, d5w, 1000 cc",09/11/2025
J7100,"Infusion, dextran 40, 500 ml",09/11/2025
J7110,"Infusion, dextran 75, 500 ml",09/11/2025
J7120,"Ringers lactate infusion, up to 1000 cc",09/11/2025
J7121,"5% dextrose in lactated ringers infusion, up to 1000 cc",09/11/2025
J7131,"Hypertonic saline solution, 1 ml",09/11/2025
J7165,"Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity",09/11/2025
J7168,"Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity",09/11/2025
J7169,"Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg",09/11/2025
J7170,"Injection, emicizumab-kxwh, 0.5 mg",09/11/2025
J7171,"Injection, adamts13, recombinant-krhn, 10 iu",09/11/2025
J7172,"Injection, marstacimab-hncq, 0.5 mg",09/11/2025
J7173,"Injection, concizumab-mtci, 0.5 mg",09/11/2025
J7174,"Injection, fitusiran, 0.04 mg",09/11/2025
J7175,"Injection, factor x, (human), 1 i.u.",09/11/2025
J7177,"Injection, human fibrinogen concentrate (fibryga), 1 mg",09/11/2025
J7178,"Injection, human fibrinogen concentrate, not otherwise specified, 1 mg",09/11/2025
J7179,"Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco",09/11/2025
J7180,"Injection, factor xiii (antihemophilic factor, human), 1 i.u.",09/11/2025
J7181,"Injection, factor xiii a-subunit, (recombinant), per iu",09/11/2025
J7182,"Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu",09/11/2025
J7183,"Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco",09/11/2025
J7185,"Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.",09/11/2025
J7186,"Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.",09/11/2025
J7187,"Injection, von willebrand factor complex (humate-p), per iu vwf:rco",09/11/2025
J7188,"Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.",09/11/2025
J7189,"Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram",09/11/2025
J7190,"Factor viii (antihemophilic factor, human) per i.u.",09/11/2025
J7191,"Factor viii (antihemophilic factor (porcine)), per i.u.",09/11/2025
J7192,"Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified",09/11/2025
J7193,"Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.",09/11/2025
J7194,"Factor ix, complex, per i.u.",09/11/2025
J7195,"Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified",09/11/2025
J7196,"Injection, antithrombin recombinant, 50 i.u.",09/11/2025
J7197,"Antithrombin iii (human), per i.u.",09/11/2025
J7198,"Anti-inhibitor, per i.u.",09/11/2025
J7199,"Hemophilia clotting factor, not otherwise classified",09/11/2025
J7200,"Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu",09/11/2025
J7201,"Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.",09/11/2025
J7202,"Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.",09/11/2025
J7203,"Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu",09/11/2025
J7204,"Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu",09/11/2025
J7205,"Injection, factor viii fc fusion protein (recombinant), per iu",09/11/2025
J7207,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.",09/11/2025
J7208,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.",09/11/2025
J7209,"Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.",09/11/2025
J7210,"Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.",09/11/2025
J7211,"Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.",09/11/2025
J7212,"Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram",09/11/2025
J7213,"Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.",09/11/2025
J7214,"Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.",09/11/2025
J7294,"Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each",09/11/2025
J7295,"Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each",09/11/2025
J7296,"Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg",09/11/2025
J7297,"Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg",09/11/2025
J7298,"Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg",09/11/2025
J7300,Intrauterine copper contraceptive (paragard),09/11/2025
J7301,"Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg",09/11/2025
J7302,"Levonorgestrel-releasing intrauterine contraceptive system, 52 mg",09/11/2025
J7303,"Contraceptive supply, hormone containing vaginal ring, each",09/11/2025
J7304,"Contraceptive supply, hormone containing patch, each",09/11/2025
J7306,"Levonorgestrel (contraceptive) implant system, including implants and supplies",09/11/2025
J7307,"Etonogestrel (contraceptive) implant system, including implant and supplies",09/11/2025
J7308,"Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)",09/11/2025
J7309,"Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram",09/11/2025
J7310,"Ganciclovir, 4.5 mg, long-acting implant",09/11/2025
J7311,"Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg",09/11/2025
J7312,"Injection, dexamethasone, intravitreal implant, 0.1 mg",09/11/2025
J7313,"Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg",09/11/2025
J7314,"Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg",09/11/2025
J7315,"Mitomycin, ophthalmic, 0.2 mg",09/11/2025
J7316,"Injection, ocriplasmin, 0.125 mg",09/11/2025
J7318,"Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg",09/11/2025
J7320,"Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg",09/11/2025
J7321,"Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose",09/11/2025
J7322,"Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg",09/11/2025
J7323,"Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose",09/11/2025
J7324,"Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose",09/11/2025
J7325,"Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg",09/11/2025
J7326,"Hyaluronan or derivative, gel-one, for intra-articular injection, per dose",09/11/2025
J7327,"Hyaluronan or derivative, monovisc, for intra-articular injection, per dose",09/11/2025
J7328,"Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg",09/11/2025
J7329,"Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg",09/11/2025
J7330,"Autologous cultured chondrocytes, implant",09/11/2025
J7331,"Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg",09/11/2025
J7332,"Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg",09/11/2025
J7333,"Hyaluronan or derivative, visco-3, for intra-articular injection, per dose",09/11/2025
J7335,"Capsaicin 8% patch, per 10 square centimeters",09/11/2025
J7336,"Capsaicin 8% patch, per square centimeter",09/11/2025
J7340,"Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml",09/11/2025
J7342,"Instillation, ciprofloxacin otic suspension, 6 mg",09/11/2025
J7345,"Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg",09/11/2025
J7351,"Injection, bimatoprost, intracameral implant, 1 microgram",09/11/2025
J7352,"Afamelanotide implant, 1 mg",09/11/2025
J7353,"Anacaulase-bcdb, 8.8% gel, 1 gram",09/11/2025
J7354,"Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)",09/11/2025
J7355,"Injection, travoprost, intracameral implant, 1 microgram",09/11/2025
J7356,"Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg",09/11/2025
J7401,"Mometasone furoate sinus implant, 10 micrograms",09/11/2025
J7402,"Mometasone furoate sinus implant, (sinuva), 10 micrograms",09/11/2025
J7500,"Azathioprine, oral, 50 mg",09/11/2025
J7501,"Azathioprine, parenteral, 100 mg",09/11/2025
J7502,"Cyclosporine, oral, 100 mg",09/11/2025
J7503,"Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg",09/11/2025
J7504,"Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg",09/11/2025
J7505,"Muromonab-cd3, parenteral, 5 mg",09/11/2025
J7506,"Prednisone, oral, per 5 mg",09/11/2025
J7507,"Tacrolimus, immediate release, oral, 1 mg",09/11/2025
J7508,"Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg",09/11/2025
J7509,"Methylprednisolone oral, per 4 mg",09/11/2025
J7510,"Prednisolone oral, per 5 mg",09/11/2025
J7511,"Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg",09/11/2025
J7512,"Prednisone, immediate release or delayed release, oral, 1 mg",09/11/2025
J7513,"Daclizumab, parenteral, 25 mg",09/11/2025
J7514,"Mycophenolate mofetil (myhibbin), oral suspension, 100 mg",09/11/2025
J7515,"Cyclosporine, oral, 25 mg",09/11/2025
J7516,"Injection, cyclosporine, 250 mg",09/11/2025
J7517,"Mycophenolate mofetil, oral, 250 mg",09/11/2025
J7518,"Mycophenolic acid, oral, 180 mg",09/11/2025
J7519,"Injection, mycophenolate mofetil, 10 mg",09/11/2025
J7520,"Sirolimus, oral, 1 mg",09/11/2025
J7521,"Tacrolimus, granules, oral suspension, 0.1 mg",09/11/2025
J7525,"Tacrolimus, parenteral, 5 mg",09/11/2025
J7527,"Everolimus, oral, 0.25 mg",09/11/2025
J7599,"Immunosuppressive drug, not otherwise classified",09/11/2025
J7601,"Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg",09/11/2025
J7604,"Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram",09/11/2025
J7605,"Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms",09/11/2025
J7606,"Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms",09/11/2025
J7607,"Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg",09/11/2025
J7608,"Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram",09/11/2025
J7609,"Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg",09/11/2025
J7610,"Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg",09/11/2025
J7611,"Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg",09/11/2025
J7612,"Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg",09/11/2025
J7613,"Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg",09/11/2025
J7614,"Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg",09/11/2025
J7615,"Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg",09/11/2025
J7620,"Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme",09/11/2025
J7622,"Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",09/11/2025
J7624,"Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",09/11/2025
J7626,"Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg",09/11/2025
J7627,"Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg",09/11/2025
J7628,"Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",09/11/2025
J7629,"Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",09/11/2025
J7631,"Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams",09/11/2025
J7632,"Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams",09/11/2025
J7633,"Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram",09/11/2025
J7634,"Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram",09/11/2025
J7635,"Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",09/11/2025
J7636,"Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",09/11/2025
J7637,"Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",09/11/2025
J7638,"Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",09/11/2025
J7639,"Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",09/11/2025
J7640,"Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms",09/11/2025
J7641,"Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram",09/11/2025
J7642,"Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",09/11/2025
J7643,"Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",09/11/2025
J7644,"Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",09/11/2025
J7645,"Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",09/11/2025
J7647,"Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",09/11/2025
J7648,"Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram",09/11/2025
J7649,"Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",09/11/2025
J7650,"Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",09/11/2025
J7657,"Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",09/11/2025
J7658,"Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram",09/11/2025
J7659,"Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",09/11/2025
J7660,"Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",09/11/2025
J7665,"Mannitol, administered through an inhaler, 5 mg",09/11/2025
J7667,"Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams",09/11/2025
J7668,"Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams",09/11/2025
J7669,"Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams",09/11/2025
J7670,"Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams",09/11/2025
J7674,"Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg",09/11/2025
J7676,"Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg",09/11/2025
J7677,"Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram",09/11/2025
J7680,"Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",09/11/2025
J7681,"Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",09/11/2025
J7682,"Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams",09/11/2025
J7683,"Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",09/11/2025
J7684,"Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",09/11/2025
J7685,"Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams",09/11/2025
J7686,"Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg",09/11/2025
J7699,"Noc drugs, inhalation solution administered through dme",09/11/2025
J7799,"Noc drugs, other than inhalation drugs, administered through dme",09/11/2025
J7999,"Compounded drug, not otherwise classified",09/11/2025
J8498,"Antiemetic drug, rectal/suppository, not otherwise specified",09/11/2025
J8499,"Prescription drug, oral, non chemotherapeutic, nos",09/11/2025
J8501,"Aprepitant, oral, 5 mg",09/11/2025
J8510,"Busulfan; oral, 2 mg",09/11/2025
J8515,"Cabergoline, oral, 0.25 mg",09/11/2025
J8520,"Capecitabine, oral, 150 mg",09/11/2025
J8521,"Capecitabine, oral, 500 mg",09/11/2025
J8522,"Capecitabine, oral, 50 mg",09/11/2025
J8530,"Cyclophosphamide; oral, 25 mg",09/11/2025
J8540,"Dexamethasone, oral, 0.25 mg",09/11/2025
J8541,"Dexamethasone (hemady), oral, 0.25 mg",09/11/2025
J8560,"Etoposide; oral, 50 mg",09/11/2025
J8562,"Fludarabine phosphate, oral, 10 mg",09/11/2025
J8565,"Gefitinib, oral, 250 mg",09/11/2025
J8597,"Antiemetic drug, oral, not otherwise specified",09/11/2025
J8600,"Melphalan; oral, 2 mg",09/11/2025
J8610,"Methotrexate; oral, 2.5 mg",09/11/2025
J8611,"Methotrexate (jylamvo), oral, 2.5 mg",09/11/2025
J8612,"Methotrexate (xatmep), oral, 2.5 mg",09/11/2025
J8650,"Nabilone, oral, 1 mg",09/11/2025
J8655,"Netupitant 300 mg and palonosetron 0.5 mg, oral",09/11/2025
J8670,"Rolapitant, oral, 1 mg",09/11/2025
J8700,"Temozolomide, oral, 5 mg",09/11/2025
J8705,"Topotecan, oral, 0.25 mg",09/11/2025
J8999,"Prescription drug, oral, chemotherapeutic, nos",09/11/2025
J9000,"Injection, doxorubicin hydrochloride, 10 mg",09/11/2025
J9010,"Injection, alemtuzumab, 10 mg",09/11/2025
J9011,"Injection, datopotamab deruxtecan-dlnk, 1 mg",09/11/2025
J9015,"Injection, aldesleukin, per single use vial",09/11/2025
J9017,"Injection, arsenic trioxide, 1 mg",09/11/2025
J9019,"Injection, asparaginase (erwinaze), 1,000 iu",09/11/2025
J9020,"Injection, asparaginase, not otherwise specified, 10,000 units",09/11/2025
J9021,"Injection, asparaginase, recombinant, (rylaze), 0.1 mg",09/11/2025
J9022,"Injection, atezolizumab, 10 mg",09/11/2025
J9023,"Injection, avelumab, 10 mg",09/11/2025
J9024,"Injection, atezolizumab, 5 mg and hyaluronidase-tqjs",09/11/2025
J9025,"Injection, azacitidine, 1 mg",09/11/2025
J9026,"Injection, tarlatamab-dlle, 1 mg",09/11/2025
J9027,"Injection, clofarabine, 1 mg",09/11/2025
J9028,"Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram",09/11/2025
J9029,"Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose",09/11/2025
J9030,"Bcg live intravesical instillation, 1 mg",09/11/2025
J9031,Bcg (intravesical) per instillation,09/11/2025
J9032,"Injection, belinostat, 10 mg",09/11/2025
J9033,"Injection, bendamustine hydrochloride, 1 mg",09/11/2025
J9034,"Injection, bendamustine hcl (bendeka), 1 mg",09/11/2025
J9035,"Injection, bevacizumab, 10 mg",09/11/2025
J9036,"Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg",09/11/2025
J9037,"Injection, belantamab mafodotin-blmf, 0.5 mg",09/11/2025
J9038,"Injection, axatilimab-csfr, 0.1 mg",09/11/2025
J9039,"Injection, blinatumomab, 1 microgram",09/11/2025
J9040,"Injection, bleomycin sulfate, 15 units",09/11/2025
J9041,"Injection, bortezomib, 0.1 mg",09/11/2025
J9042,"Injection, brentuximab vedotin, 1 mg",09/11/2025
J9043,"Injection, cabazitaxel, 1 mg",09/11/2025
J9044,"Injection, bortezomib, not otherwise specified, 0.1 mg",09/11/2025
J9045,"Injection, carboplatin, 50 mg",09/11/2025
J9046,"Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg",09/11/2025
J9047,"Injection, carfilzomib, 1 mg",09/11/2025
J9048,"Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg",09/11/2025
J9049,"Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg",09/11/2025
J9050,"Injection, carmustine, 100 mg",09/11/2025
J9051,"Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg",09/11/2025
J9052,"Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg",09/11/2025
J9054,"Injection, bortezomib (boruzu), 0.1 mg",09/11/2025
J9055,"Injection, cetuximab, 10 mg",09/11/2025
J9056,"Injection, bendamustine hydrochloride (vivimusta), 1 mg",09/11/2025
J9057,"Injection, copanlisib, 1 mg",09/11/2025
J9058,"Injection, bendamustine hydrochloride (apotex), 1 mg",09/11/2025
J9059,"Injection, bendamustine hydrochloride (baxter), 1 mg",09/11/2025
J9060,"Injection, cisplatin, powder or solution, 10 mg",09/11/2025
J9061,"Injection, amivantamab-vmjw, 2 mg",09/11/2025
J9063,"Injection, mirvetuximab soravtansine-gynx, 1 mg",09/11/2025
J9064,"Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg",09/11/2025
J9065,"Injection, cladribine, per 1 mg",09/11/2025
J9070,"Cyclophosphamide, 100 mg",09/11/2025
J9071,"Injection, cyclophosphamide (auromedics), 5 mg",09/11/2025
J9072,"Injection, cyclophosphamide (frindovyx), 5 mg",09/11/2025
J9073,"Injection, cyclophosphamide (dr. reddy's), 5 mg",09/11/2025
J9074,"Injection, cyclophosphamide (sandoz), 5 mg",09/11/2025
J9075,"Injection, cyclophosphamide, not otherwise specified, 5 mg",09/11/2025
J9076,"Injection, cyclophosphamide (baxter), 5 mg",09/11/2025
J9098,"Injection, cytarabine liposome, 10 mg",09/11/2025
J9100,"Injection, cytarabine, 100 mg",09/11/2025
J9118,"Injection, calaspargase pegol-mknl, 10 units",09/11/2025
J9119,"Injection, cemiplimab-rwlc, 1 mg",09/11/2025
J9120,"Injection, dactinomycin, 0.5 mg",09/11/2025
J9130,"Dacarbazine, 100 mg",09/11/2025
J9144,"Injection, daratumumab, 10 mg and hyaluronidase-fihj",09/11/2025
J9145,"Injection, daratumumab, 10 mg",09/11/2025
J9150,"Injection, daunorubicin, 10 mg",09/11/2025
J9151,"Injection, daunorubicin citrate, liposomal formulation, 10 mg",09/11/2025
J9153,"Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine",09/11/2025
J9155,"Injection, degarelix, 1 mg",09/11/2025
J9160,"Injection, denileukin diftitox, 300 micrograms",09/11/2025
J9161,"Injection, denileukin diftitox-cxdl, 1 mcg",09/11/2025
J9165,"Injection, diethylstilbestrol diphosphate, 250 mg",09/11/2025
J9171,"Injection, docetaxel, 1 mg",09/11/2025
J9172,"Injection, docetaxel (docivyx), 1 mg",09/11/2025
J9173,"Injection, durvalumab, 10 mg",09/11/2025
J9174,"Injection, docetaxel (beizray), 1 mg",09/11/2025
J9175,"Injection, elliotts' b solution, 1 ml",09/11/2025
J9176,"Injection, elotuzumab, 1 mg",09/11/2025
J9177,"Injection, enfortumab vedotin-ejfv, 0.25 mg",09/11/2025
J9178,"Injection, epirubicin hcl, 2 mg",09/11/2025
J9179,"Injection, eribulin mesylate, 0.1 mg",09/11/2025
J9181,"Injection, etoposide, 10 mg",09/11/2025
J9185,"Injection, fludarabine phosphate, 50 mg",09/11/2025
J9190,"Injection, fluorouracil, 500 mg",09/11/2025
J9196,"Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg",09/11/2025
J9198,"Injection, gemcitabine hydrochloride, (infugem), 100 mg",09/11/2025
J9199,"Injection, gemcitabine hydrochloride (infugem), 200 mg",09/11/2025
J9200,"Injection, floxuridine, 500 mg",09/11/2025
J9201,"Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg",09/11/2025
J9202,"Goserelin acetate implant, per 3.6 mg",09/11/2025
J9203,"Injection, gemtuzumab ozogamicin, 0.1 mg",09/11/2025
J9204,"Injection, mogamulizumab-kpkc, 1 mg",09/11/2025
J9205,"Injection, irinotecan liposome, 1 mg",09/11/2025
J9206,"Injection, irinotecan, 20 mg",09/11/2025
J9207,"Injection, ixabepilone, 1 mg",09/11/2025
J9208,"Injection, ifosfamide, 1 gram",09/11/2025
J9209,"Injection, mesna, 200 mg",09/11/2025
J9210,"Injection, emapalumab-lzsg, 1 mg",09/11/2025
J9211,"Injection, idarubicin hydrochloride, 5 mg",09/11/2025
J9212,"Injection, interferon alfacon-1, recombinant, 1 microgram",09/11/2025
J9213,"Injection, interferon, alfa-2a, recombinant, 3 million units",09/11/2025
J9214,"Injection, interferon, alfa-2b, recombinant, 1 million units",09/11/2025
J9215,"Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu",09/11/2025
J9216,"Injection, interferon, gamma 1-b, 3 million units",09/11/2025
J9217,"Leuprolide acetate (for depot suspension), 7.5 mg",09/11/2025
J9218,"Leuprolide acetate, per 1 mg",09/11/2025
J9219,"Leuprolide acetate implant, 65 mg",09/11/2025
J9220,"Injection, indigotindisulfonate sodium, 1 mg",09/11/2025
J9223,"Injection, lurbinectedin, 0.1 mg",09/11/2025
J9225,"Histrelin implant (vantas), 50 mg",09/11/2025
J9226,"Histrelin implant (supprelin la), 50 mg",09/11/2025
J9227,"Injection, isatuximab-irfc, 10 mg",09/11/2025
J9228,"Injection, ipilimumab, 1 mg",09/11/2025
J9229,"Injection, inotuzumab ozogamicin, 0.1 mg",09/11/2025
J9230,"Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg",09/11/2025
J9245,"Injection, melphalan hydrochloride, not otherwise specified, 50 mg",09/11/2025
J9246,"Injection, melphalan (evomela), 1 mg",09/11/2025
J9247,"Injection, melphalan flufenamide, 1mg",09/11/2025
J9248,"Injection, melphalan (hepzato), 1 mg",09/11/2025
J9249,"Injection, melphalan (apotex), 1 mg",09/11/2025
J9250,"Methotrexate sodium, 5 mg",09/11/2025
J9255,"Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg",09/11/2025
J9258,"Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg",09/11/2025
J9259,"Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg",09/11/2025
J9260,"Injection, methotrexate sodium, 50 mg",09/11/2025
J9261,"Injection, nelarabine, 50 mg",09/11/2025
J9262,"Injection, omacetaxine mepesuccinate, 0.01 mg",09/11/2025
J9263,"Injection, oxaliplatin, 0.5 mg",09/11/2025
J9264,"Injection, paclitaxel protein-bound particles, 1 mg",09/11/2025
J9265,"Injection, paclitaxel, 30 mg",09/11/2025
J9266,"Injection, pegaspargase, per single dose vial",09/11/2025
J9267,"Injection, paclitaxel, 1 mg",09/11/2025
J9268,"Injection, pentostatin, 10 mg",09/11/2025
J9269,"Injection, tagraxofusp-erzs, 10 micrograms",09/11/2025
J9270,"Injection, plicamycin, 2.5 mg",09/11/2025
J9271,"Injection, pembrolizumab, 1 mg",09/11/2025
J9272,"Injection, dostarlimab-gxly, 10 mg",09/11/2025
J9273,"Injection, tisotumab vedotin-tftv, 1 mg",09/11/2025
J9274,"Injection, tebentafusp-tebn, 1 microgram",09/11/2025
J9275,"Injection, cosibelimab-ipdl, 2 mg",09/11/2025
J9276,"Injection, zanidatamab-hrii, 2 mg",09/11/2025
J9280,"Injection, mitomycin, 5 mg",09/11/2025
J9281,"Mitomycin pyelocalyceal instillation, 1 mg",09/11/2025
J9285,"Injection, olaratumab, 10 mg",09/11/2025
J9286,"Injection, glofitamab-gxbm, 2.5 mg",09/11/2025
J9289,"Injection, nivolumab, 2 mg and hyaluronidase-nvhy",09/11/2025
J9292,"Injection, pemetrexed dipotassium, 10 mg",09/11/2025
J9293,"Injection, mitoxantrone hydrochloride, per 5 mg",09/11/2025
J9294,"Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg",09/11/2025
J9295,"Injection, necitumumab, 1 mg",09/11/2025
J9296,"Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg",09/11/2025
J9297,"Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg",09/11/2025
J9298,"Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg",09/11/2025
J9299,"Injection, nivolumab, 1 mg",09/11/2025
J9300,"Injection, gemtuzumab ozogamicin, 5 mg",09/11/2025
J9301,"Injection, obinutuzumab, 10 mg",09/11/2025
J9302,"Injection, ofatumumab, 10 mg",09/11/2025
J9303,"Injection, panitumumab, 10 mg",09/11/2025
J9304,"Injection, pemetrexed (pemfexy), 10 mg",09/11/2025
J9305,"Injection, pemetrexed, not otherwise specified, 10 mg",09/11/2025
J9306,"Injection, pertuzumab, 1 mg",09/11/2025
J9307,"Injection, pralatrexate, 1 mg",09/11/2025
J9308,"Injection, ramucirumab, 5 mg",09/11/2025
J9309,"Injection, polatuzumab vedotin-piiq, 1 mg",09/11/2025
J9310,"Injection, rituximab, 100 mg",09/11/2025
J9311,"Injection, rituximab 10 mg and hyaluronidase",09/11/2025
J9312,"Injection, rituximab, 10 mg",09/11/2025
J9313,"Injection, moxetumomab pasudotox-tdfk, 0.01 mg",09/11/2025
J9314,"Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg",09/11/2025
J9315,"Injection, romidepsin, 1 mg",09/11/2025
J9316,"Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg",09/11/2025
J9317,"Injection, sacituzumab govitecan-hziy, 2.5 mg",09/11/2025
J9318,"Injection, romidepsin, non-lyophilized, 0.1 mg",09/11/2025
J9319,"Injection, romidepsin, lyophilized, 0.1 mg",09/11/2025
J9320,"Injection, streptozocin, 1 gram",09/11/2025
J9321,"Injection, epcoritamab-bysp, 0.16 mg",09/11/2025
J9322,"Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg",09/11/2025
J9323,"Injection, pemetrexed ditromethamine, 10 mg",09/11/2025
J9324,"Injection, pemetrexed (pemrydi rtu), 10 mg",09/11/2025
J9325,"Injection, talimogene laherparepvec, per 1 million plaque forming units",09/11/2025
J9328,"Injection, temozolomide, 1 mg",09/11/2025
J9329,"Injection, tislelizumab-jsgr, 1mg",09/11/2025
J9330,"Injection, temsirolimus, 1 mg",09/11/2025
J9331,"Injection, sirolimus protein-bound particles, 1 mg",09/11/2025
J9332,"Injection, efgartigimod alfa-fcab, 2mg",09/11/2025
J9333,"Injection, rozanolixizumab-noli, 1 mg",09/11/2025
J9334,"Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc",09/11/2025
J9340,"Injection, thiotepa, 15 mg",09/11/2025
J9341,"Injection, thiotepa (tepylute), 1 mg",09/11/2025
J9342,"Injection, thiotepa, not otherwise specified, 1 mg",09/11/2025
J9345,"Injection, retifanlimab-dlwr, 1 mg",09/11/2025
J9347,"Injection, tremelimumab-actl, 1 mg",09/11/2025
J9348,"Injection, naxitamab-gqgk, 1 mg",09/11/2025
J9349,"Injection, tafasitamab-cxix, 2 mg",09/11/2025
J9350,"Injection, mosunetuzumab-axgb, 1 mg",09/11/2025
J9351,"Injection, topotecan, 0.1 mg",09/11/2025
J9352,"Injection, trabectedin, 0.1 mg",09/11/2025
J9353,"Injection, margetuximab-cmkb, 5 mg",09/11/2025
J9354,"Injection, ado-trastuzumab emtansine, 1 mg",09/11/2025
J9355,"Injection, trastuzumab, excludes biosimilar, 10 mg",09/11/2025
J9356,"Injection, trastuzumab, 10 mg and hyaluronidase-oysk",09/11/2025
J9357,"Injection, valrubicin, intravesical, 200 mg",09/11/2025
J9358,"Injection, fam-trastuzumab deruxtecan-nxki, 1 mg",09/11/2025
J9359,"Injection, loncastuximab tesirine-lpyl, 0.075 mg",09/11/2025
J9360,"Injection, vinblastine sulfate, 1 mg",09/11/2025
J9361,"Injection, efbemalenograstim alfa-vuxw, 0.5 mg",09/11/2025
J9370,"Vincristine sulfate, 1 mg",09/11/2025
J9371,"Injection, vincristine sulfate liposome, 1 mg",09/11/2025
J9376,"Injection, pozelimab-bbfg, 1 mg",09/11/2025
J9380,"Injection, teclistamab-cqyv, 0.5 mg",09/11/2025
J9381,"Injection, teplizumab-mzwv, 5 mcg",09/11/2025
J9382,"Injection, zenocutuzumab-zbco, 1 mg",09/11/2025
J9390,"Injection, vinorelbine tartrate, 10 mg",09/11/2025
J9393,"Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg",09/11/2025
J9394,"Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg",09/11/2025
J9395,"Injection, fulvestrant, 25 mg",09/11/2025
J9400,"Injection, ziv-aflibercept, 1 mg",09/11/2025
J9600,"Injection, porfimer sodium, 75 mg",09/11/2025
J9999,"Not otherwise classified, antineoplastic drugs",09/11/2025
K0001,Standard wheelchair,09/11/2025
K0002,Standard hemi (low seat) wheelchair,09/11/2025
K0003,Lightweight wheelchair,09/11/2025
K0004,"High strength, lightweight wheelchair",09/11/2025
K0005,Ultralightweight wheelchair,09/11/2025
K0006,Heavy duty wheelchair,09/11/2025
K0007,Extra heavy duty wheelchair,09/11/2025
K0008,Custom manual wheelchair/base,09/11/2025
K0009,Other manual wheelchair/base,09/11/2025
K0010,Standard - weight frame motorized/power wheelchair,09/11/2025
K0011,"Standard - weight frame motorized/power wheelchair with programmable control parameters for speed adjustment, tremor dampening, acceleration control and braking",09/11/2025
K0012,Lightweight portable motorized/power wheelchair,09/11/2025
K0013,Custom motorized/power wheelchair base,09/11/2025
K0014,Other motorized/power wheelchair base,09/11/2025
K0015,"Detachable, non-adjustable height armrest, replacement only, each",09/11/2025
K0017,"Detachable, adjustable height armrest, base, replacement only, each",09/11/2025
K0018,"Detachable, adjustable height armrest, upper portion, replacement only, each",09/11/2025
K0019,"Arm pad, replacement only, each",09/11/2025
K0020,"Fixed, adjustable height armrest, pair",09/11/2025
K0037,"High mount flip-up footrest, each",09/11/2025
K0038,"Leg strap, each",09/11/2025
K0039,"Leg strap, h style, each",09/11/2025
K0040,"Adjustable angle footplate, each",09/11/2025
K0041,"Large size footplate, each",09/11/2025
K0042,"Standard size footplate, replacement only, each",09/11/2025
K0043,"Footrest, lower extension tube, replacement only, each",09/11/2025
K0044,"Footrest, upper hanger bracket, replacement only, each",09/11/2025
K0045,"Footrest, complete assembly, replacement only, each",09/11/2025
K0046,"Elevating legrest, lower extension tube, replacement only, each",09/11/2025
K0047,"Elevating legrest, upper hanger bracket, replacement only, each",09/11/2025
K0050,"Ratchet assembly, replacement only",09/11/2025
K0051,"Cam release assembly, footrest or legrest, replacement only, each",09/11/2025
K0052,"Swingaway, detachable footrests, replacement only, each",09/11/2025
K0053,"Elevating footrests, articulating (telescoping), each",09/11/2025
K0056,"Seat height less than 17"" or equal to or greater than 21"" for a high strength, lightweight, or ultralightweight wheelchair",09/11/2025
K0065,"Spoke protectors, each",09/11/2025
K0069,"Rear wheel assembly, complete, with solid tire, spokes or molded, replacement only, each",09/11/2025
K0070,"Rear wheel assembly, complete, with pneumatic tire, spokes or molded, replacement only, each",09/11/2025
K0071,"Front caster assembly, complete, with pneumatic tire, replacement only, each",09/11/2025
K0072,"Front caster assembly, complete, with semi-pneumatic tire, replacement only, each",09/11/2025
K0073,"Caster pin lock, each",09/11/2025
K0077,"Front caster assembly, complete, with solid tire, replacement only, each",09/11/2025
K0098,"Drive belt for power wheelchair, replacement only",09/11/2025
K0105,"Iv hanger, each",09/11/2025
K0108,"Wheelchair component or accessory, not otherwise specified",09/11/2025
K0195,"Elevating leg rests, pair (for use with capped rental wheelchair base)",09/11/2025
K0455,"Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol)",09/11/2025
K0462,"Temporary replacement for patient owned equipment being repaired, any type",09/11/2025
K0552,"Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each",09/11/2025
K0553,"Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service",09/11/2025
K0554,"Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system",09/11/2025
K0601,"Replacement battery for external infusion pump owned by patient, silver oxide, 1.5 volt, each",09/11/2025
K0602,"Replacement battery for external infusion pump owned by patient, silver oxide, 3 volt, each",09/11/2025
K0603,"Replacement battery for external infusion pump owned by patient, alkaline, 1.5 volt, each",09/11/2025
K0604,"Replacement battery for external infusion pump owned by patient, lithium, 3.6 volt, each",09/11/2025
K0605,"Replacement battery for external infusion pump owned by patient, lithium, 4.5 volt, each",09/11/2025
K0606,"Automatic external defibrillator, with integrated electrocardiogram analysis, garment type",09/11/2025
K0607,"Replacement battery for automated external defibrillator, garment type only, each",09/11/2025
K0608,"Replacement garment for use with automated external defibrillator, each",09/11/2025
K0609,"Replacement electrodes for use with automated external defibrillator, garment type only, each",09/11/2025
K0669,"Wheelchair accessory, wheelchair seat or back cushion, does not meet specific code criteria or no written coding verification from dme pdac",09/11/2025
K0672,"Addition to lower extremity orthosis, removable soft interface, all components, replacement only, each",09/11/2025
K0730,Controlled dose inhalation drug delivery system,09/11/2025
K0733,"Power wheelchair accessory, 12 to 24 amp hour sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)",09/11/2025
K0738,"Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing",09/11/2025
K0739,"Repair or nonroutine service for durable medical equipment other than oxygen equipment requiring the skill of a technician, labor component, per 15 minutes",09/11/2025
K0740,"Repair or nonroutine service for oxygen equipment requiring the skill of a technician, labor component, per 15 minutes",09/11/2025
K0743,"Suction pump, home model, portable, for use on wounds",09/11/2025
K0744,"Absorptive wound dressing for use with suction pump, home model, portable, pad size 16 square inches or less",09/11/2025
K0745,"Absorptive wound dressing for use with suction pump, home model, portable, pad size more than 16 square inches but less than or equal to 48 square inches",09/11/2025
K0746,"Absorptive wound dressing for use with suction pump, home model, portable, pad size greater than 48 square inches",09/11/2025
K0800,"Power operated vehicle, group 1 standard, patient weight capacity up to and including 300 pounds",09/11/2025
K0801,"Power operated vehicle, group 1 heavy duty, patient weight capacity 301 to 450 pounds",09/11/2025
K0802,"Power operated vehicle, group 1 very heavy duty, patient weight capacity 451 to 600 pounds",09/11/2025
K0806,"Power operated vehicle, group 2 standard, patient weight capacity up to and including 300 pounds",09/11/2025
K0807,"Power operated vehicle, group 2 heavy duty, patient weight capacity 301 to 450 pounds",09/11/2025
K0808,"Power operated vehicle, group 2 very heavy duty, patient weight capacity 451 to 600 pounds",09/11/2025
K0812,"Power operated vehicle, not otherwise classified",09/11/2025
K0813,"Power wheelchair, group 1 standard, portable, sling/solid seat and back, patient weight capacity up to and including 300 pounds",09/11/2025
K0814,"Power wheelchair, group 1 standard, portable, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0815,"Power wheelchair, group 1 standard, sling/solid seat and back, patient weight capacity up to and including 300 pounds",09/11/2025
K0816,"Power wheelchair, group 1 standard, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0820,"Power wheelchair, group 2 standard, portable, sling/solid seat/back, patient weight capacity up to and including 300 pounds",09/11/2025
K0821,"Power wheelchair, group 2 standard, portable, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0822,"Power wheelchair, group 2 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds",09/11/2025
K0823,"Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0824,"Power wheelchair, group 2 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds",09/11/2025
K0825,"Power wheelchair, group 2 heavy duty, captains chair, patient weight capacity 301 to 450 pounds",09/11/2025
K0826,"Power wheelchair, group 2 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds",09/11/2025
K0827,"Power wheelchair, group 2 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds",09/11/2025
K0828,"Power wheelchair, group 2 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more",09/11/2025
K0829,"Power wheelchair, group 2 extra heavy duty, captains chair, patient weight 601 pounds or more",09/11/2025
K0830,"Power wheelchair, group 2 standard, seat elevator, sling/solid seat/back, patient weight capacity up to and including 300 pounds",09/11/2025
K0831,"Power wheelchair, group 2 standard, seat elevator, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0835,"Power wheelchair, group 2 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",09/11/2025
K0836,"Power wheelchair, group 2 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0837,"Power wheelchair, group 2 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds",09/11/2025
K0838,"Power wheelchair, group 2 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds",09/11/2025
K0839,"Power wheelchair, group 2 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds",09/11/2025
K0840,"Power wheelchair, group 2 extra heavy duty, single power option, sling/solid seat/back, patient weight capacity 601 pounds or more",09/11/2025
K0841,"Power wheelchair, group 2 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",09/11/2025
K0842,"Power wheelchair, group 2 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0843,"Power wheelchair, group 2 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds",09/11/2025
K0848,"Power wheelchair, group 3 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds",09/11/2025
K0849,"Power wheelchair, group 3 standard, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0850,"Power wheelchair, group 3 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds",09/11/2025
K0851,"Power wheelchair, group 3 heavy duty, captains chair, patient weight capacity 301 to 450 pounds",09/11/2025
K0852,"Power wheelchair, group 3 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds",09/11/2025
K0853,"Power wheelchair, group 3 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds",09/11/2025
K0854,"Power wheelchair, group 3 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more",09/11/2025
K0855,"Power wheelchair, group 3 extra heavy duty, captains chair, patient weight capacity 601 pounds or more",09/11/2025
K0856,"Power wheelchair, group 3 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",09/11/2025
K0857,"Power wheelchair, group 3 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0858,"Power wheelchair, group 3 heavy duty, single power option, sling/solid seat/back, patient weight 301 to 450 pounds",09/11/2025
K0859,"Power wheelchair, group 3 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds",09/11/2025
K0860,"Power wheelchair, group 3 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds",09/11/2025
K0861,"Power wheelchair, group 3 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",09/11/2025
K0862,"Power wheelchair, group 3 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds",09/11/2025
K0863,"Power wheelchair, group 3 very heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds",09/11/2025
K0864,"Power wheelchair, group 3 extra heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 601 pounds or more",09/11/2025
K0868,"Power wheelchair, group 4 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds",09/11/2025
K0869,"Power wheelchair, group 4 standard, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0870,"Power wheelchair, group 4 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds",09/11/2025
K0871,"Power wheelchair, group 4 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds",09/11/2025
K0877,"Power wheelchair, group 4 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",09/11/2025
K0878,"Power wheelchair, group 4 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0879,"Power wheelchair, group 4 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds",09/11/2025
K0880,"Power wheelchair, group 4 very heavy duty, single power option, sling/solid seat/back, patient weight 451 to 600 pounds",09/11/2025
K0884,"Power wheelchair, group 4 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",09/11/2025
K0885,"Power wheelchair, group 4 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds",09/11/2025
K0886,"Power wheelchair, group 4 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds",09/11/2025
K0890,"Power wheelchair, group 5 pediatric, single power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds",09/11/2025
K0891,"Power wheelchair, group 5 pediatric, multiple power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds",09/11/2025
K0898,"Power wheelchair, not otherwise classified",09/11/2025
K0899,"Power mobility device, not coded by dme pdac or does not meet criteria",09/11/2025
K0900,"Customized durable medical equipment, other than wheelchair",09/11/2025
K0901,"Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",09/11/2025
K0902,"Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",09/11/2025
K0903,"For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each",09/11/2025
K1001,"Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type",09/11/2025
K1002,"Cranial electrotherapy stimulation (ces) system, any type",09/11/2025
K1003,"Whirlpool tub, walk-in, portable",09/11/2025
K1004,Low frequency ultrasonic diathermy treatment device for home use,09/11/2025
K1005,"Disposable collection and storage bag for breast milk, any size, any type, each",09/11/2025
K1006,"Suction pump, home model, portable or stationary, electric, any type, for use with external urine management system",09/11/2025
K1007,"Bilateral hip, knee, ankle, foot device, powered, includes pelvic component, single or double upright(s), knee joints any type, with or without ankle joints any type, includes all components and accessories, motors, microprocessors, sensors",09/11/2025
K1009,"Speech volume modulation system, any type, including all components and accessories",09/11/2025
K1010,"Indwelling intraurethral drainage device with valve, patient inserted, replacement only, each",09/11/2025
K1011,"Activation device for intraurethral drainage device with valve, replacement only, each",09/11/2025
K1012,"Charger and base station for intraurethral activation device, replacement only",09/11/2025
K1013,"Enema tube, with or without adapter, any type, replacement only, each",09/11/2025
K1014,"Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control",09/11/2025
K1015,"Foot, adductus positioning device, adjustable",09/11/2025
K1016,Transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerve,09/11/2025
K1017,Monthly supplies for use of device coded at k1016,09/11/2025
K1018,External upper limb tremor stimulator of the peripheral nerves of the wrist,09/11/2025
K1019,Supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist,09/11/2025
K1020,Non-invasive vagus nerve stimulator,09/11/2025
K1021,"Exsufflation belt, includes all supplies and accessories",09/11/2025
K1022,"Addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any type",09/11/2025
K1023,"Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves of the upper arm",09/11/2025
K1024,Non-pneumatic compression controller with sequential calibrated gradient pressure,09/11/2025
K1025,"Non-pneumatic sequential compression garment, full arm",09/11/2025
K1026,"Mechanical allergen particle barrier/inhalation filter, cream, nasal, topical",09/11/2025
K1027,"Oral device/appliance used to reduce upper airway collapsibility, without fixed mechanical hinge, custom fabricated, includes fitting and adjustment",09/11/2025
K1028,"Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application",09/11/2025
K1029,"Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply",09/11/2025
K1030,"External recharging system for battery (internal) for use with implanted cardiac contractility modulation generator, replacement only",09/11/2025
K1031,Non-pneumatic compression controller without calibrated gradient pressure,09/11/2025
K1032,"Non-pneumatic sequential compression garment, full leg",09/11/2025
K1033,"Non-pneumatic sequential compression garment, half leg",09/11/2025
K1034,"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count",09/11/2025
K1035,"Molecular diagnostic test reader, nonprescription self-administered and self-collected use, fda approved, authorized or cleared",09/11/2025
K1036,"Supplies and accessories (e.g., transducer) for low frequency ultrasonic diathermy treatment device, per month",09/11/2025
K1037,Docking station for use with oral device/appliance used to reduce upper airway collapsibility,09/11/2025
L0112,"Cranial cervical orthosis, congenital torticollis type, with or without soft interface material, adjustable range of motion joint, custom fabricated",09/11/2025
L0113,"Cranial cervical orthosis, torticollis type, with or without joint, with or without soft interface material, prefabricated, includes fitting and adjustment",09/11/2025
L0120,"Cervical, flexible, non-adjustable, prefabricated, off-the-shelf (foam collar)",09/11/2025
L0130,"Cervical, flexible, thermoplastic collar, molded to patient",09/11/2025
L0140,"Cervical, semi-rigid, adjustable (plastic collar)",09/11/2025
L0150,"Cervical, semi-rigid, adjustable molded chin cup (plastic collar with mandibular/occipital piece)",09/11/2025
L0160,"Cervical, semi-rigid, wire frame occipital/mandibular support, prefabricated, off-the-shelf",09/11/2025
L0170,"Cervical, collar, molded to patient model",09/11/2025
L0172,"Cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated, off-the-shelf",09/11/2025
L0174,"Cervical, collar, semi-rigid, thermoplastic foam, two piece with thoracic extension, prefabricated, off-the-shelf",09/11/2025
L0180,"Cervical, multiple post collar, occipital/mandibular supports, adjustable",09/11/2025
L0190,"Cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars (somi, guilford, taylor types)",09/11/2025
L0200,"Cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars, and thoracic extension",09/11/2025
L0220,"Thoracic, rib belt, custom fabricated",09/11/2025
L0450,"Tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf",09/11/2025
L0452,"Tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, custom fabricated",09/11/2025
L0454,"Tlso flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0455,"Tlso, flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf",09/11/2025
L0456,"Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0457,"Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated, off-the-shelf",09/11/2025
L0458,"Tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment",09/11/2025
L0460,"Tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0462,"Tlso, triplanar control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment",09/11/2025
L0464,"Tlso, triplanar control, modular segmented spinal system, four rigid plastic shells, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment",09/11/2025
L0466,"Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0467,"Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf",09/11/2025
L0468,"Tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal, and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0469,"Tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf",09/11/2025
L0470,"Tlso, triplanar control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction to scapula, lateral strength provided by pelvic, thoracic, and lateral frame pieces, rotational strength provided by subclavicular extensions, restricts gross trunk motion in sagittal, coronal, and transverse planes, provides intracavitary pressure to reduce load on the intervertebral disks, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment",09/11/2025
L0472,"Tlso, triplanar control, hyperextension, rigid anterior and lateral frame extends from symphysis pubis to sternal notch with two anterior components (one pubic and one sternal), posterior and lateral pads with straps and closures, limits spinal flexion, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment",09/11/2025
L0480,"Tlso, triplanar control, one piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated",09/11/2025
L0482,"Tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated",09/11/2025
L0484,"Tlso, triplanar control, two piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated",09/11/2025
L0486,"Tlso, triplanar control, two piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated",09/11/2025
L0488,"Tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, prefabricated, includes fitting and adjustment",09/11/2025
L0490,"Tlso, sagittal-coronal control, one piece rigid plastic shell, with overlapping reinforced anterior, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates at or before the t-9 vertebra, anterior extends from symphysis pubis to xiphoid, anterior opening, restricts gross trunk motion in sagittal and coronal planes, prefabricated, includes fitting and adjustment",09/11/2025
L0491,"Tlso, sagittal-coronal control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment",09/11/2025
L0492,"Tlso, sagittal-coronal control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment",09/11/2025
L0621,"Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf",09/11/2025
L0622,"Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated",09/11/2025
L0623,"Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf",09/11/2025
L0624,"Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels placed over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated",09/11/2025
L0625,"Lumbar orthosis, flexible, provides lumbar support, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include pendulous abdomen design, shoulder straps, stays, prefabricated, off-the-shelf",09/11/2025
L0626,"Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0627,"Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0628,"Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",09/11/2025
L0629,"Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, custom fabricated",09/11/2025
L0630,"Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0631,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0632,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated",09/11/2025
L0633,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0634,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, custom fabricated",09/11/2025
L0635,"Lumbar-sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panel(s), lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, prefabricated, includes fitting and adjustment",09/11/2025
L0636,"Lumbar sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panels, lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, custom fabricated",09/11/2025
L0637,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0638,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated",09/11/2025
L0639,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0640,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, custom fabricated",09/11/2025
L0641,"Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",09/11/2025
L0642,"Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",09/11/2025
L0643,"Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",09/11/2025
L0648,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",09/11/2025
L0649,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",09/11/2025
L0650,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",09/11/2025
L0651,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelf",09/11/2025
L0700,"Cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral control, molded to patient model, (minerva type)",09/11/2025
L0710,"Ctlso, anterior-posterior-lateral-control, molded to patient model, with interface material, (minerva type)",09/11/2025
L0720,"Cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L0810,"Halo procedure, cervical halo incorporated into jacket vest",09/11/2025
L0820,"Halo procedure, cervical halo incorporated into plaster body jacket",09/11/2025
L0830,"Halo procedure, cervical halo incorporated into milwaukee type orthosis",09/11/2025
L0859,"Addition to halo procedure, magnetic resonance image compatible systems, rings and pins, any material",09/11/2025
L0861,"Addition to halo procedure, replacement liner/interface material",09/11/2025
L0970,"Tlso, corset front",09/11/2025
L0972,"Lso, corset front",09/11/2025
L0974,"Tlso, full corset",09/11/2025
L0976,"Lso, full corset",09/11/2025
L0978,Axillary crutch extension,09/11/2025
L0980,"Peroneal straps, prefabricated, off-the-shelf, pair",09/11/2025
L0982,"Stocking supporter grips, prefabricated, off-the-shelf, set of four (4)",09/11/2025
L0984,"Protective body sock, prefabricated, off-the-shelf, each",09/11/2025
L0999,"Addition to spinal orthosis, not otherwise specified",09/11/2025
L1000,"Cervical-thoracic-lumbar-sacral orthosis (ctlso) (milwaukee), inclusive of furnishing initial orthosis, including model",09/11/2025
L1001,"Cervical thoracic lumbar sacral orthosis, immobilizer, infant size, prefabricated, includes fitting and adjustment",09/11/2025
L1005,"Tension based scoliosis orthosis and accessory pads, includes fitting and adjustment",09/11/2025
L1006,"Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla to trochanter, includes all accessory pads, straps and interface, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1007,"Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla, to trochanter, includes all accessory pads, straps, and interface, custom fabricated",09/11/2025
L1010,"Addition to cervical-thoracic-lumbar-sacral orthosis (ctlso) or scoliosis orthosis, axilla sling",09/11/2025
L1020,"Addition to ctlso or scoliosis orthosis, kyphosis pad",09/11/2025
L1025,"Addition to ctlso or scoliosis orthosis, kyphosis pad, floating",09/11/2025
L1030,"Addition to ctlso or scoliosis orthosis, lumbar bolster pad",09/11/2025
L1040,"Addition to ctlso or scoliosis orthosis, lumbar or lumbar rib pad",09/11/2025
L1050,"Addition to ctlso or scoliosis orthosis, sternal pad",09/11/2025
L1060,"Addition to ctlso or scoliosis orthosis, thoracic pad",09/11/2025
L1070,"Addition to ctlso or scoliosis orthosis, trapezius sling",09/11/2025
L1080,"Addition to ctlso or scoliosis orthosis, outrigger",09/11/2025
L1085,"Addition to ctlso or scoliosis orthosis, outrigger, bilateral with vertical extensions",09/11/2025
L1090,"Addition to ctlso or scoliosis orthosis, lumbar sling",09/11/2025
L1100,"Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather",09/11/2025
L1110,"Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather, molded to patient model",09/11/2025
L1120,"Addition to ctlso, scoliosis orthosis, cover for upright, each",09/11/2025
L1200,"Thoracic-lumbar-sacral-orthosis (tlso), inclusive of furnishing initial orthosis only",09/11/2025
L1210,"Addition to tlso, (low profile), lateral thoracic extension",09/11/2025
L1220,"Addition to tlso, (low profile), anterior thoracic extension",09/11/2025
L1230,"Addition to tlso, (low profile), milwaukee type superstructure",09/11/2025
L1240,"Addition to tlso, (low profile), lumbar derotation pad",09/11/2025
L1250,"Addition to tlso, (low profile), anterior asis pad",09/11/2025
L1260,"Addition to tlso, (low profile), anterior thoracic derotation pad",09/11/2025
L1270,"Addition to tlso, (low profile), abdominal pad",09/11/2025
L1280,"Addition to tlso, (low profile), rib gusset (elastic), each",09/11/2025
L1290,"Addition to tlso, (low profile), lateral trochanteric pad",09/11/2025
L1300,"Other scoliosis procedure, body jacket molded to patient model",09/11/2025
L1310,"Other scoliosis procedure, post-operative body jacket",09/11/2025
L1320,"Thoracic, pectus carinatum orthosis, sternal compression, rigid circumferential frame with anterior and posterior rigid pads, custom fabricated",09/11/2025
L1499,"Spinal orthosis, not otherwise specified",09/11/2025
L1600,"Hip orthosis, abduction control of hip joints, flexible, frejka type with cover, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an inidividual with expertise",09/11/2025
L1610,"Hip orthosis, abduction control of hip joints, flexible, (frejka cover only), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1620,"Hip orthosis, abduction control of hip joints, flexible, (pavlik harness), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1630,"Hip orthosis, abduction control of hip joints, semi-flexible (von rosen type), custom fabricated",09/11/2025
L1640,"Hip orthosis, abduction control of hip joints, static, pelvic band or spreader bar, thigh cuffs, custom fabricated",09/11/2025
L1650,"Hip orthosis, abduction control of hip joints, static, adjustable, (ilfled type), prefabricated, includes fitting and adjustment",09/11/2025
L1652,"Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, includes fitting and adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1653,"Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, off the shelf",09/11/2025
L1660,"Hip orthosis, abduction control of hip joints, static, plastic, prefabricated, includes fitting and adjustment",09/11/2025
L1680,"Hip orthosis, abduction control of hip joints, dynamic, pelvic control, adjustable hip motion control, thigh cuffs (rancho hip action type), custom fabricated",09/11/2025
L1681,"Hip orthosis, bilateral hip joints and thigh cuffs, adjustable flexion, extension, abduction control of hip joint, postoperative hip abduction type, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1685,"Hip orthosis, abduction control of hip joint, postoperative hip abduction type, custom fabricated",09/11/2025
L1686,"Hip orthosis, abduction control of hip joint, postoperative hip abduction type, prefabricated, includes fitting and adjustment",09/11/2025
L1690,"Combination, bilateral, lumbo-sacral, hip, femur orthosis providing adduction and internal rotation control, prefabricated, includes fitting and adjustment",09/11/2025
L1700,"Legg perthes orthosis, (toronto type), custom fabricated",09/11/2025
L1710,"Legg perthes orthosis, (newington type), custom fabricated",09/11/2025
L1720,"Legg perthes orthosis, trilateral, (tachdijan type), custom fabricated",09/11/2025
L1730,"Legg perthes orthosis, (scottish rite type), custom fabricated",09/11/2025
L1755,"Legg perthes orthosis, (patten bottom type), custom fabricated",09/11/2025
L1810,"Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1812,"Knee orthosis, elastic with joints, prefabricated, off-the-shelf",09/11/2025
L1820,"Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1821,"Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated, off the shelf",09/11/2025
L1830,"Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf",09/11/2025
L1831,"Knee orthosis, locking knee joint(s), positional orthosis, prefabricated, includes fitting and adjustment",09/11/2025
L1832,"Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1833,"Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf",09/11/2025
L1834,"Knee orthosis, without knee joint, rigid, custom fabricated",09/11/2025
L1836,"Knee orthosis, rigid, without joint(s), includes soft interface material, prefabricated, off-the-shelf",09/11/2025
L1840,"Knee orthosis, derotation, medial-lateral, anterior cruciate ligament, custom fabricated",09/11/2025
L1843,"Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1844,"Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated",09/11/2025
L1845,"Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1846,"Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated",09/11/2025
L1847,"Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1848,"Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated, off-the-shelf",09/11/2025
L1850,"Knee orthosis, swedish type, prefabricated, off-the-shelf",09/11/2025
L1851,"Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",09/11/2025
L1852,"Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",09/11/2025
L1860,"Knee orthosis, modification of supracondylar prosthetic socket, custom fabricated (sk)",09/11/2025
L1900,"Ankle foot orthosis, spring wire, dorsiflexion assist calf band, custom fabricated",09/11/2025
L1902,"Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf",09/11/2025
L1904,"Ankle orthosis, ankle gauntlet or similar, with or without joints, custom fabricated",09/11/2025
L1906,"Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf",09/11/2025
L1907,"Ankle orthosis, supramalleolar with straps, with or without interface/pads, custom fabricated",09/11/2025
L1910,"Ankle foot orthosis, posterior, single bar, clasp attachment to shoe counter, prefabricated, includes fitting and adjustment",09/11/2025
L1920,"Ankle foot orthosis, single upright with static or adjustable stop (phelps or perlstein type), custom fabricated",09/11/2025
L1930,"Ankle foot orthosis, plastic or other material, prefabricated, includes fitting and adjustment",09/11/2025
L1932,"Ankle foot orthosis, rigid anterior tibial section, total carbon fiber or equal material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1933,"Ankle foot orthosis, rigid anterior tibial section, total carbon fiber or equal material, prefabricated, off-the-shelf",09/11/2025
L1940,"Ankle foot orthosis, plastic or other material, custom fabricated",09/11/2025
L1945,"Ankle foot orthosis, plastic, rigid anterior tibial section (floor reaction), custom fabricated",09/11/2025
L1950,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic, custom fabricated",09/11/2025
L1951,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic or other material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L1952,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic or other material, prefabricated, off-the-shelf",09/11/2025
L1960,"Ankle foot orthosis, posterior solid ankle, plastic, custom fabricated",09/11/2025
L1970,"Ankle foot orthosis, plastic with ankle joint, custom fabricated",09/11/2025
L1971,"Ankle foot orthosis, plastic or other material with ankle joint, with or without dorsiflexion assist, prefabricated, includes fitting and adjustment",09/11/2025
L1980,"Ankle foot orthosis, single upright free plantar dorsiflexion, solid stirrup, calf band/cuff (single bar 'bk' orthosis), custom fabricated",09/11/2025
L1990,"Ankle foot orthosis, double upright free plantar dorsiflexion, solid stirrup, calf band/cuff (double bar 'bk' orthosis), custom fabricated",09/11/2025
L2000,"Knee ankle foot orthosis, single upright, free knee, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar 'ak' orthosis), custom fabricated",09/11/2025
L2005,"Knee ankle foot orthosis, any material, single or double upright, stance control, automatic lock and swing phase release, any type activation, includes ankle joint, any type, custom fabricated",09/11/2025
L2006,"Knee ankle foot device, any material, single or double upright, swing and stance phase microprocessor control with adjustability, includes all components (e.g., sensors, batteries, charger), any type activation, with or without ankle joint(s), custom fabricated",09/11/2025
L2010,"Knee ankle foot orthosis, single upright, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar 'ak' orthosis), without knee joint, custom fabricated",09/11/2025
L2020,"Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs (double bar 'ak' orthosis), custom fabricated",09/11/2025
L2030,"Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs, (double bar 'ak' orthosis), without knee joint, custom fabricated",09/11/2025
L2034,"Knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, medial lateral rotation control, with or without free motion ankle, custom fabricated",09/11/2025
L2035,"Knee ankle foot orthosis, full plastic, static (pediatric size), without free motion ankle, prefabricated, includes fitting and adjustment",09/11/2025
L2036,"Knee ankle foot orthosis, full plastic, double upright, with or without free motion knee, with or without free motion ankle, custom fabricated",09/11/2025
L2037,"Knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, with or without free motion ankle, custom fabricated",09/11/2025
L2038,"Knee ankle foot orthosis, full plastic, with or without free motion knee, multi-axis ankle, custom fabricated",09/11/2025
L2040,"Hip knee ankle foot orthosis, torsion control, bilateral rotation straps, pelvic band/belt, custom fabricated",09/11/2025
L2050,"Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, hip joint, pelvic band/belt, custom fabricated",09/11/2025
L2060,"Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, ball bearing hip joint, pelvic band/ belt, custom fabricated",09/11/2025
L2070,"Hip knee ankle foot orthosis, torsion control, unilateral rotation straps, pelvic band/belt, custom fabricated",09/11/2025
L2080,"Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, hip joint, pelvic band/belt, custom fabricated",09/11/2025
L2090,"Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, ball bearing hip joint, pelvic band/ belt, custom fabricated",09/11/2025
L2106,"Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, thermoplastic type casting material, custom fabricated",09/11/2025
L2108,"Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, custom fabricated",09/11/2025
L2112,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, soft, prefabricated, includes fitting and adjustment",09/11/2025
L2114,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, semi-rigid, prefabricated, includes fitting and adjustment",09/11/2025
L2116,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, rigid, prefabricated, includes fitting and adjustment",09/11/2025
L2126,"Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, thermoplastic type casting material, custom fabricated",09/11/2025
L2128,"Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, custom fabricated",09/11/2025
L2132,"Kafo, fracture orthosis, femoral fracture cast orthosis, soft, prefabricated, includes fitting and adjustment",09/11/2025
L2134,"Kafo, fracture orthosis, femoral fracture cast orthosis, semi-rigid, prefabricated, includes fitting and adjustment",09/11/2025
L2136,"Kafo, fracture orthosis, femoral fracture cast orthosis, rigid, prefabricated, includes fitting and adjustment",09/11/2025
L2180,"Addition to lower extremity fracture orthosis, plastic shoe insert with ankle joints",09/11/2025
L2182,"Addition to lower extremity fracture orthosis, drop lock knee joint",09/11/2025
L2184,"Addition to lower extremity fracture orthosis, limited motion knee joint",09/11/2025
L2186,"Addition to lower extremity fracture orthosis, adjustable motion knee joint, lerman type",09/11/2025
L2188,"Addition to lower extremity fracture orthosis, quadrilateral brim",09/11/2025
L2190,"Addition to lower extremity fracture orthosis, waist belt",09/11/2025
L2192,"Addition to lower extremity fracture orthosis, hip joint, pelvic band, thigh flange, and pelvic belt",09/11/2025
L2200,"Addition to lower extremity, limited ankle motion, each joint",09/11/2025
L2210,"Addition to lower extremity, dorsiflexion assist (plantar flexion resist), each joint",09/11/2025
L2220,"Addition to lower extremity, dorsiflexion and plantar flexion assist/resist, each joint",09/11/2025
L2230,"Addition to lower extremity, split flat caliper stirrups and plate attachment",09/11/2025
L2232,"Addition to lower extremity orthosis, rocker bottom for total contact ankle foot orthosis, for custom fabricated orthosis only",09/11/2025
L2240,"Addition to lower extremity, round caliper and plate attachment",09/11/2025
L2250,"Addition to lower extremity, foot plate, molded to patient model, stirrup attachment",09/11/2025
L2260,"Addition to lower extremity, reinforced solid stirrup (scott-craig type)",09/11/2025
L2265,"Addition to lower extremity, long tongue stirrup",09/11/2025
L2270,"Addition to lower extremity, varus/valgus correction ('t') strap, padded/lined or malleolus pad",09/11/2025
L2275,"Addition to lower extremity, varus/valgus correction, plastic modification, padded/lined",09/11/2025
L2280,"Addition to lower extremity, molded inner boot",09/11/2025
L2300,"Addition to lower extremity, abduction bar (bilateral hip involvement), jointed, adjustable",09/11/2025
L2310,"Addition to lower extremity, abduction bar-straight",09/11/2025
L2320,"Addition to lower extremity, non-molded lacer, for custom fabricated orthosis only",09/11/2025
L2330,"Addition to lower extremity, lacer molded to patient model, for custom fabricated orthosis only",09/11/2025
L2335,"Addition to lower extremity, anterior swing band",09/11/2025
L2340,"Addition to lower extremity, pre-tibial shell, molded to patient model",09/11/2025
L2350,"Addition to lower extremity, prosthetic type, (bk) socket, molded to patient model, (used for 'ptb' 'afo' orthoses)",09/11/2025
L2360,"Addition to lower extremity, extended steel shank",09/11/2025
L2370,"Addition to lower extremity, patten bottom",09/11/2025
L2375,"Addition to lower extremity, torsion control, ankle joint and half solid stirrup",09/11/2025
L2380,"Addition to lower extremity, torsion control, straight knee joint, each joint",09/11/2025
L2385,"Addition to lower extremity, straight knee joint, heavy duty, each joint",09/11/2025
L2387,"Addition to lower extremity, polycentric knee joint, for custom fabricated knee ankle foot orthosis, each joint",09/11/2025
L2390,"Addition to lower extremity, offset knee joint, each joint",09/11/2025
L2395,"Addition to lower extremity, offset knee joint, heavy duty, each joint",09/11/2025
L2397,"Addition to lower extremity orthosis, suspension sleeve",09/11/2025
L2405,"Addition to knee joint, drop lock, each",09/11/2025
L2415,"Addition to knee lock with integrated release mechanism (bail, cable, or equal), any material, each joint",09/11/2025
L2425,"Addition to knee joint, disc or dial lock for adjustable knee flexion, each joint",09/11/2025
L2430,"Addition to knee joint, ratchet lock for active and progressive knee extension, each joint",09/11/2025
L2492,"Addition to knee joint, lift loop for drop lock ring",09/11/2025
L2500,"Addition to lower extremity, thigh/weight bearing, gluteal/ ischial weight bearing, ring",09/11/2025
L2510,"Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, molded to patient model",09/11/2025
L2520,"Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, custom fitted",09/11/2025
L2525,"Addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim molded to patient model",09/11/2025
L2526,"Addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim, custom fitted",09/11/2025
L2530,"Addition to lower extremity, thigh-weight bearing, lacer, non-molded",09/11/2025
L2540,"Addition to lower extremity, thigh/weight bearing, lacer, molded to patient model",09/11/2025
L2550,"Addition to lower extremity, thigh/weight bearing, high roll cuff",09/11/2025
L2570,"Addition to lower extremity, pelvic control, hip joint, clevis type two position joint, each",09/11/2025
L2580,"Addition to lower extremity, pelvic control, pelvic sling",09/11/2025
L2600,"Addition to lower extremity, pelvic control, hip joint, clevis type, or thrust bearing, free, each",09/11/2025
L2610,"Addition to lower extremity, pelvic control, hip joint, clevis or thrust bearing, lock, each",09/11/2025
L2620,"Addition to lower extremity, pelvic control, hip joint, heavy duty, each",09/11/2025
L2622,"Addition to lower extremity, pelvic control, hip joint, adjustable flexion, each",09/11/2025
L2624,"Addition to lower extremity, pelvic control, hip joint, adjustable flexion, extension, abduction control, each",09/11/2025
L2627,"Addition to lower extremity, pelvic control, plastic, molded to patient model, reciprocating hip joint and cables",09/11/2025
L2628,"Addition to lower extremity, pelvic control, metal frame, reciprocating hip joint and cables",09/11/2025
L2630,"Addition to lower extremity, pelvic control, band and belt, unilateral",09/11/2025
L2640,"Addition to lower extremity, pelvic control, band and belt, bilateral",09/11/2025
L2650,"Addition to lower extremity, pelvic and thoracic control, gluteal pad, each",09/11/2025
L2660,"Addition to lower extremity, thoracic control, thoracic band",09/11/2025
L2670,"Addition to lower extremity, thoracic control, paraspinal uprights",09/11/2025
L2680,"Addition to lower extremity, thoracic control, lateral support uprights",09/11/2025
L2750,"Addition to lower extremity orthosis, plating chrome or nickel, per bar",09/11/2025
L2755,"Addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, per segment, for custom fabricated orthosis only",09/11/2025
L2760,"Addition to lower extremity orthosis, extension, per extension, per bar (for lineal adjustment for growth)",09/11/2025
L2768,"Orthotic side bar disconnect device, per bar",09/11/2025
L2780,"Addition to lower extremity orthosis, non-corrosive finish, per bar",09/11/2025
L2785,"Addition to lower extremity orthosis, drop lock retainer, each",09/11/2025
L2795,"Addition to lower extremity orthosis, knee control, full kneecap",09/11/2025
L2800,"Addition to lower extremity orthosis, knee control, knee cap, medial or lateral pull, for use with custom fabricated orthosis only",09/11/2025
L2810,"Addition to lower extremity orthosis, knee control, condylar pad",09/11/2025
L2820,"Addition to lower extremity orthosis, soft interface for molded plastic, below knee section",09/11/2025
L2830,"Addition to lower extremity orthosis, soft interface for molded plastic, above knee section",09/11/2025
L2840,"Addition to lower extremity orthosis, tibial length sock, fracture or equal, each",09/11/2025
L2850,"Addition to lower extremity orthosis, femoral length sock, fracture or equal, each",09/11/2025
L2861,"Addition to lower extremity joint, knee or ankle, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each",09/11/2025
L2999,"Lower extremity orthoses, not otherwise specified",09/11/2025
L3000,"Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each",09/11/2025
L3001,"Foot, insert, removable, molded to patient model, spenco, each",09/11/2025
L3002,"Foot, insert, removable, molded to patient model, plastazote or equal, each",09/11/2025
L3003,"Foot, insert, removable, molded to patient model, silicone gel, each",09/11/2025
L3010,"Foot, insert, removable, molded to patient model, longitudinal arch support, each",09/11/2025
L3020,"Foot, insert, removable, molded to patient model, longitudinal/ metatarsal support, each",09/11/2025
L3030,"Foot, insert, removable, formed to patient foot, each",09/11/2025
L3031,"Foot, insert/plate, removable, addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, each",09/11/2025
L3040,"Foot, arch support, removable, premolded, longitudinal, each",09/11/2025
L3050,"Foot, arch support, removable, premolded, metatarsal, each",09/11/2025
L3060,"Foot, arch support, removable, premolded, longitudinal/ metatarsal, each",09/11/2025
L3070,"Foot, arch support, non-removable attached to shoe, longitudinal, each",09/11/2025
L3080,"Foot, arch support, non-removable attached to shoe, metatarsal, each",09/11/2025
L3090,"Foot, arch support, non-removable attached to shoe, longitudinal/metatarsal, each",09/11/2025
L3100,"Hallus-valgus night dynamic splint, prefabricated, off-the-shelf",09/11/2025
L3140,"Foot, abduction rotation bar, including shoes",09/11/2025
L3150,"Foot, abduction rotation bar, without shoes",09/11/2025
L3160,"Foot, adjustable shoe-styled positioning device",09/11/2025
L3161,"Foot, adductus positioning device, adjustable",09/11/2025
L3170,"Foot, plastic, silicone or equal, heel stabilizer, prefabricated, off-the-shelf, each",09/11/2025
L3201,"Orthopedic shoe, oxford with supinator or pronator, infant",09/11/2025
L3202,"Orthopedic shoe, oxford with supinator or pronator, child",09/11/2025
L3203,"Orthopedic shoe, oxford with supinator or pronator, junior",09/11/2025
L3204,"Orthopedic shoe, hightop with supinator or pronator, infant",09/11/2025
L3206,"Orthopedic shoe, hightop with supinator or pronator, child",09/11/2025
L3207,"Orthopedic shoe, hightop with supinator or pronator, junior",09/11/2025
L3208,"Surgical boot, each, infant",09/11/2025
L3209,"Surgical boot, each, child",09/11/2025
L3211,"Surgical boot, each, junior",09/11/2025
L3212,"Benesch boot, pair, infant",09/11/2025
L3213,"Benesch boot, pair, child",09/11/2025
L3214,"Benesch boot, pair, junior",09/11/2025
L3215,"Orthopedic footwear, ladies shoe, oxford, each",09/11/2025
L3216,"Orthopedic footwear, ladies shoe, depth inlay, each",09/11/2025
L3217,"Orthopedic footwear, ladies shoe, hightop, depth inlay, each",09/11/2025
L3219,"Orthopedic footwear, mens shoe, oxford, each",09/11/2025
L3221,"Orthopedic footwear, mens shoe, depth inlay, each",09/11/2025
L3222,"Orthopedic footwear, mens shoe, hightop, depth inlay, each",09/11/2025
L3224,"Orthopedic footwear, woman's shoe, oxford, used as an integral part of a brace (orthosis)",09/11/2025
L3225,"Orthopedic footwear, man's shoe, oxford, used as an integral part of a brace (orthosis)",09/11/2025
L3230,"Orthopedic footwear, custom shoe, depth inlay, each",09/11/2025
L3250,"Orthopedic footwear, custom molded shoe, removable inner mold, prosthetic shoe, each",09/11/2025
L3251,"Foot, shoe molded to patient model, silicone shoe, each",09/11/2025
L3252,"Foot, shoe molded to patient model, plastazote (or similar), custom fabricated, each",09/11/2025
L3253,"Foot, molded shoe plastazote (or similar) custom fitted, each",09/11/2025
L3254,Non-standard size or width,09/11/2025
L3255,Non-standard size or length,09/11/2025
L3257,"Orthopedic footwear, additional charge for split size",09/11/2025
L3260,"Surgical boot/shoe, each",09/11/2025
L3265,"Plastazote sandal, each",09/11/2025
L3300,"Lift, elevation, heel, tapered to metatarsals, per inch",09/11/2025
L3310,"Lift, elevation, heel and sole, neoprene, per inch",09/11/2025
L3320,"Lift, elevation, heel and sole, cork, per inch",09/11/2025
L3330,"Lift, elevation, metal extension (skate)",09/11/2025
L3332,"Lift, elevation, inside shoe, tapered, up to one-half inch",09/11/2025
L3334,"Lift, elevation, heel, per inch",09/11/2025
L3340,"Heel wedge, sach",09/11/2025
L3350,Heel wedge,09/11/2025
L3360,"Sole wedge, outside sole",09/11/2025
L3370,"Sole wedge, between sole",09/11/2025
L3380,Clubfoot wedge,09/11/2025
L3390,Outflare wedge,09/11/2025
L3400,"Metatarsal bar wedge, rocker",09/11/2025
L3410,"Metatarsal bar wedge, between sole",09/11/2025
L3420,"Full sole and heel wedge, between sole",09/11/2025
L3430,"Heel, counter, plastic reinforced",09/11/2025
L3440,"Heel, counter, leather reinforced",09/11/2025
L3450,"Heel, sach cushion type",09/11/2025
L3455,"Heel, new leather, standard",09/11/2025
L3460,"Heel, new rubber, standard",09/11/2025
L3465,"Heel, thomas with wedge",09/11/2025
L3470,"Heel, thomas extended to ball",09/11/2025
L3480,"Heel, pad and depression for spur",09/11/2025
L3485,"Heel, pad, removable for spur",09/11/2025
L3500,"Orthopedic shoe addition, insole, leather",09/11/2025
L3510,"Orthopedic shoe addition, insole, rubber",09/11/2025
L3520,"Orthopedic shoe addition, insole, felt covered with leather",09/11/2025
L3530,"Orthopedic shoe addition, sole, half",09/11/2025
L3540,"Orthopedic shoe addition, sole, full",09/11/2025
L3550,"Orthopedic shoe addition, toe tap standard",09/11/2025
L3560,"Orthopedic shoe addition, toe tap, horseshoe",09/11/2025
L3570,"Orthopedic shoe addition, special extension to instep (leather with eyelets)",09/11/2025
L3580,"Orthopedic shoe addition, convert instep to velcro closure",09/11/2025
L3590,"Orthopedic shoe addition, convert firm shoe counter to soft counter",09/11/2025
L3595,"Orthopedic shoe addition, march bar",09/11/2025
L3600,"Transfer of an orthosis from one shoe to another, caliper plate, existing",09/11/2025
L3610,"Transfer of an orthosis from one shoe to another, caliper plate, new",09/11/2025
L3620,"Transfer of an orthosis from one shoe to another, solid stirrup, existing",09/11/2025
L3630,"Transfer of an orthosis from one shoe to another, solid stirrup, new",09/11/2025
L3640,"Transfer of an orthosis from one shoe to another, dennis browne splint (riveton), both shoes",09/11/2025
L3649,"Orthopedic shoe, modification, addition or transfer, not otherwise specified",09/11/2025
L3650,"Shoulder orthosis, figure of eight design abduction restrainer, prefabricated, off-the-shelf",09/11/2025
L3660,"Shoulder orthosis, figure of eight design abduction restrainer, canvas and webbing, prefabricated, off-the-shelf",09/11/2025
L3670,"Shoulder orthosis, acromio/clavicular (canvas and webbing type), prefabricated, off-the-shelf",09/11/2025
L3671,"Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3674,"Shoulder orthosis, abduction positioning (airplane design), thoracic component and support bar, with or without nontorsion joint/turnbuckle, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3675,"Shoulder orthosis, vest type abduction restrainer, canvas webbing type or equal, prefabricated, off-the-shelf",09/11/2025
L3677,"Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L3678,"Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated, off-the-shelf",09/11/2025
L3702,"Elbow orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3710,"Elbow orthosis, elastic with metal joints, prefabricated, off-the-shelf",09/11/2025
L3720,"Elbow orthosis, double upright with forearm/arm cuffs, free motion, custom fabricated",09/11/2025
L3730,"Elbow orthosis, double upright with forearm/arm cuffs, extension/ flexion assist, custom fabricated",09/11/2025
L3740,"Elbow orthosis, double upright with forearm/arm cuffs, adjustable position lock with active control, custom fabricated",09/11/2025
L3760,"Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific  patient by an individual with expertise",09/11/2025
L3761,"Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, off-the-shelf",09/11/2025
L3762,"Elbow orthosis, rigid, without joints, includes soft interface material, prefabricated, off-the-shelf",09/11/2025
L3763,"Elbow wrist hand orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3764,"Elbow wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3765,"Elbow wrist hand finger orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3766,"Elbow wrist hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3806,"Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3807,"Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L3808,"Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3809,"Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type",09/11/2025
L3891,"Addition to upper extremity joint, wrist or elbow, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each",09/11/2025
L3900,"Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, wrist or finger driven, custom fabricated",09/11/2025
L3901,"Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, cable driven, custom fabricated",09/11/2025
L3904,"Wrist hand finger orthosis, external powered, electric, custom fabricated",09/11/2025
L3905,"Wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3906,"Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3908,"Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf",09/11/2025
L3912,"Hand finger orthosis (hfo), flexion glove with elastic finger control, prefabricated, off-the-shelf",09/11/2025
L3913,"Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3915,"Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L3916,"Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated, off-the-shelf",09/11/2025
L3917,"Hand orthosis, metacarpal fracture orthosis, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L3918,"Hand orthosis, metacarpal fracture orthosis, prefabricated, off-the-shelf",09/11/2025
L3919,"Hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3921,"Hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3923,"Hand finger orthosis, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L3924,"Hand finger orthosis, without joints, may include soft interface, straps, prefabricated, off-the-shelf",09/11/2025
L3925,"Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), non torsion joint/spring, extension/flexion, may include soft interface material, prefabricated, off-the-shelf",09/11/2025
L3927,"Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), without joint/spring, extension/flexion (e.g., static or ring type), may include soft interface material, prefabricated, off-the-shelf",09/11/2025
L3929,"Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L3930,"Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, off-the-shelf",09/11/2025
L3931,"Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, includes fitting and adjustment",09/11/2025
L3933,"Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment",09/11/2025
L3935,"Finger orthosis, nontorsion joint, may include soft interface, custom fabricated, includes fitting and adjustment",09/11/2025
L3956,"Addition of joint to upper extremity orthosis, any material; per joint",09/11/2025
L3960,"Shoulder elbow wrist hand orthosis, abduction positioning, airplane design, prefabricated, includes fitting and adjustment",09/11/2025
L3961,"Shoulder elbow wrist hand orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3962,"Shoulder elbow wrist hand orthosis, abduction positioning, erb's palsey design, prefabricated, includes fitting and adjustment",09/11/2025
L3967,"Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3971,"Shoulder elbow wrist hand orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3973,"Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3975,"Shoulder elbow wrist hand finger orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3976,"Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3977,"Shoulder elbow wrist hand finger orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3978,"Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",09/11/2025
L3980,"Upper extremity fracture orthosis, humeral, prefabricated, includes fitting and adjustment",09/11/2025
L3981,"Upper extremity fracture orthosis, humeral, prefabricated, includes shoulder cap design, with or without joints, forearm section, may include soft interface, straps, includes fitting and adjustments",09/11/2025
L3982,"Upper extremity fracture orthosis, radius/ulnar, prefabricated, includes fitting and adjustment",09/11/2025
L3984,"Upper extremity fracture orthosis, wrist, prefabricated, includes fitting and adjustment",09/11/2025
L3995,"Addition to upper extremity orthosis, sock, fracture or equal, each",09/11/2025
L3999,"Upper limb orthosis, not otherwise specified",09/11/2025
L4000,Replace girdle for spinal orthosis (ctlso or so),09/11/2025
L4002,"Replacement strap, any orthosis, includes all components, any length, any type",09/11/2025
L4010,Replace trilateral socket brim,09/11/2025
L4020,"Replace quadrilateral socket brim, molded to patient model",09/11/2025
L4030,"Replace quadrilateral socket brim, custom fitted",09/11/2025
L4040,"Replace molded thigh lacer, for custom fabricated orthosis only",09/11/2025
L4045,"Replace non-molded thigh lacer, for custom fabricated orthosis only",09/11/2025
L4050,"Replace molded calf lacer, for custom fabricated orthosis only",09/11/2025
L4055,"Replace non-molded calf lacer, for custom fabricated orthosis only",09/11/2025
L4060,Replace high roll cuff,09/11/2025
L4070,Replace proximal and distal upright for kafo,09/11/2025
L4080,"Replace metal bands kafo, proximal thigh",09/11/2025
L4090,"Replace metal bands kafo-afo, calf or distal thigh",09/11/2025
L4100,"Replace leather cuff kafo, proximal thigh",09/11/2025
L4110,"Replace leather cuff kafo-afo, calf or distal thigh",09/11/2025
L4130,Replace pretibial shell,09/11/2025
L4205,"Repair of orthotic device, labor component, per 15 minutes",09/11/2025
L4210,"Repair of orthotic device, repair or replace minor parts",09/11/2025
L4350,"Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf",09/11/2025
L4360,"Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L4361,"Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf",09/11/2025
L4370,"Pneumatic full leg splint, prefabricated, off-the-shelf",09/11/2025
L4386,"Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L4387,"Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf",09/11/2025
L4392,"Replacement, soft interface material, static afo",09/11/2025
L4394,"Replace soft interface material, foot drop splint",09/11/2025
L4396,"Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",09/11/2025
L4397,"Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated, off-the-shelf",09/11/2025
L4398,"Foot drop splint, recumbent positioning device, prefabricated, off-the-shelf",09/11/2025
L4631,"Ankle foot orthosis, walking boot type, varus/valgus correction, rocker bottom, anterior tibial shell, soft interface, custom arch support, plastic or other material, includes straps and closures, custom fabricated",09/11/2025
L5000,"Partial foot, shoe insert with longitudinal arch, toe filler",09/11/2025
L5010,"Partial foot, molded socket, ankle height, with toe filler",09/11/2025
L5020,"Partial foot, molded socket, tibial tubercle height, with toe filler",09/11/2025
L5050,"Ankle, symes, molded socket, sach foot",09/11/2025
L5060,"Ankle, symes, metal frame, molded leather socket, articulated ankle/foot",09/11/2025
L5100,"Below knee, molded socket, shin, sach foot",09/11/2025
L5105,"Below knee, plastic socket, joints and thigh lacer, sach foot",09/11/2025
L5150,"Knee disarticulation (or through knee), molded socket, external knee joints, shin, sach foot",09/11/2025
L5160,"Knee disarticulation (or through knee), molded socket, bent knee configuration, external knee joints, shin, sach foot",09/11/2025
L5200,"Above knee, molded socket, single axis constant friction knee, shin, sach foot",09/11/2025
L5210,"Above knee, short prosthesis, no knee joint ('stubbies'), with foot blocks, no ankle joints, each",09/11/2025
L5220,"Above knee, short prosthesis, no knee joint ('stubbies'), with articulated ankle/foot, dynamically aligned, each",09/11/2025
L5230,"Above knee, for proximal femoral focal deficiency, constant friction knee, shin, sach foot",09/11/2025
L5250,"Hip disarticulation, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot",09/11/2025
L5270,"Hip disarticulation, tilt table type; molded socket, locking hip joint, single axis constant friction knee, shin, sach foot",09/11/2025
L5280,"Hemipelvectomy, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot",09/11/2025
L5301,"Below knee, molded socket, shin, sach foot, endoskeletal system",09/11/2025
L5312,"Knee disarticulation (or through knee), molded socket, single axis knee, pylon, sach foot, endoskeletal system",09/11/2025
L5321,"Above knee, molded socket, open end, sach foot, endoskeletal system, single axis knee",09/11/2025
L5331,"Hip disarticulation, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot",09/11/2025
L5341,"Hemipelvectomy, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot",09/11/2025
L5400,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment, suspension, and one cast change, below knee",09/11/2025
L5410,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, below knee, each additional cast change and realignment",09/11/2025
L5420,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension and one cast change 'ak' or knee disarticulation",09/11/2025
L5430,"Immediate post surgical or early fitting, application of initial rigid dressing, incl. fitting, alignment and supension, 'ak' or knee disarticulation, each additional cast change and realignment",09/11/2025
L5450,"Immediate post surgical or early fitting, application of non-weight bearing rigid dressing, below knee",09/11/2025
L5460,"Immediate post surgical or early fitting, application of non-weight bearing rigid dressing, above knee",09/11/2025
L5500,"Initial, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed",09/11/2025
L5505,"Initial, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed",09/11/2025
L5510,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model",09/11/2025
L5520,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed",09/11/2025
L5530,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model",09/11/2025
L5535,"Preparatory, below knee 'ptb' type socket, non-alignable system, no cover, sach foot, prefabricated, adjustable open end socket",09/11/2025
L5540,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, laminated socket, molded to model",09/11/2025
L5560,"Preparatory, above knee- knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model",09/11/2025
L5570,"Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed",09/11/2025
L5580,"Preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model",09/11/2025
L5585,"Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, prefabricated adjustable open end socket",09/11/2025
L5590,"Preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon no cover, sach foot, laminated socket, molded to model",09/11/2025
L5595,"Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, thermoplastic or equal, molded to patient model",09/11/2025
L5600,"Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, laminated socket, molded to patient model",09/11/2025
L5610,"Addition to lower extremity, endoskeletal system, above knee, hydracadence system",09/11/2025
L5611,"Addition to lower extremity, endoskeletal system, above knee - knee disarticulation, 4 bar linkage, with friction swing phase control",09/11/2025
L5613,"Addition to lower extremity, endoskeletal system, above knee-knee disarticulation, 4 bar linkage, with hydraulic swing phase control",09/11/2025
L5614,"Addition to lower extremity, exoskeletal system, above knee-knee disarticulation, 4 bar linkage, with pneumatic swing phase control",09/11/2025
L5615,"Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control",09/11/2025
L5616,"Addition to lower extremity, endoskeletal system, above knee, universal multiplex system, friction swing phase control",09/11/2025
L5617,"Addition to lower extremity, quick change self-aligning unit, above knee or below knee, each",09/11/2025
L5618,"Addition to lower extremity, test socket, symes",09/11/2025
L5620,"Addition to lower extremity, test socket, below knee",09/11/2025
L5622,"Addition to lower extremity, test socket, knee disarticulation",09/11/2025
L5624,"Addition to lower extremity, test socket, above knee",09/11/2025
L5626,"Addition to lower extremity, test socket, hip disarticulation",09/11/2025
L5628,"Addition to lower extremity, test socket, hemipelvectomy",09/11/2025
L5629,"Addition to lower extremity, below knee, acrylic socket",09/11/2025
L5630,"Addition to lower extremity, symes type, expandable wall socket",09/11/2025
L5631,"Addition to lower extremity, above knee or knee disarticulation, acrylic socket",09/11/2025
L5632,"Addition to lower extremity, symes type, 'ptb' brim design socket",09/11/2025
L5634,"Addition to lower extremity, symes type, posterior opening (canadian) socket",09/11/2025
L5636,"Addition to lower extremity, symes type, medial opening socket",09/11/2025
L5637,"Addition to lower extremity, below knee, total contact",09/11/2025
L5638,"Addition to lower extremity, below knee, leather socket",09/11/2025
L5639,"Addition to lower extremity, below knee, wood socket",09/11/2025
L5640,"Addition to lower extremity, knee disarticulation, leather socket",09/11/2025
L5642,"Addition to lower extremity, above knee, leather socket",09/11/2025
L5643,"Addition to lower extremity, hip disarticulation, flexible inner socket, external frame",09/11/2025
L5644,"Addition to lower extremity, above knee, wood socket",09/11/2025
L5645,"Addition to lower extremity, below knee, flexible inner socket, external frame",09/11/2025
L5646,"Addition to lower extremity, below knee, air, fluid, gel or equal, cushion socket",09/11/2025
L5647,"Addition to lower extremity, below knee suction socket",09/11/2025
L5648,"Addition to lower extremity, above knee, air, fluid, gel or equal, cushion socket",09/11/2025
L5649,"Addition to lower extremity, ischial containment/narrow m-l socket",09/11/2025
L5650,"Additions to lower extremity, total contact, above knee or knee disarticulation socket",09/11/2025
L5651,"Addition to lower extremity, above knee, flexible inner socket, external frame",09/11/2025
L5652,"Addition to lower extremity, suction suspension, above knee or knee disarticulation socket",09/11/2025
L5653,"Addition to lower extremity, knee disarticulation, expandable wall socket",09/11/2025
L5654,"Addition to lower extremity, socket insert, symes, (kemblo, pelite, aliplast, plastazote or equal)",09/11/2025
L5655,"Addition to lower extremity, socket insert, below knee (kemblo, pelite, aliplast, plastazote or equal)",09/11/2025
L5656,"Addition to lower extremity, socket insert, knee disarticulation (kemblo, pelite, aliplast, plastazote or equal)",09/11/2025
L5657,"Addition to lower extremity prosthesis, manual/automated adjustable air, fluid, gel or equal socket insert for limb volume management, any materials",09/11/2025
L5658,"Addition to lower extremity, socket insert, above knee (kemblo, pelite, aliplast, plastazote or equal)",09/11/2025
L5661,"Addition to lower extremity, socket insert, multi-durometer symes",09/11/2025
L5665,"Addition to lower extremity, socket insert, multi-durometer, below knee",09/11/2025
L5666,"Addition to lower extremity, below knee, cuff suspension",09/11/2025
L5668,"Addition  to lower extremity, below knee, molded distal cushion",09/11/2025
L5670,"Addition to lower extremity, below knee, molded supracondylar suspension ('pts' or similar)",09/11/2025
L5671,"Addition to lower extremity, below knee / above knee suspension locking mechanism (shuttle, lanyard or equal), excludes socket insert",09/11/2025
L5672,"Addition to lower extremity, below knee, removable medial brim suspension",09/11/2025
L5673,"Addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric, or equal, with or without perforations, with or without breathable material, for use with locking mechanism",09/11/2025
L5676,"Additions to lower extremity, below knee, knee joints, single axis, pair",09/11/2025
L5677,"Additions to lower extremity, below knee, knee joints, polycentric, pair",09/11/2025
L5678,"Additions to lower extremity, below knee, joint covers, pair",09/11/2025
L5679,"Addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric, or equal, with or without perforations, with or without breathable material, not for use with locking mechanism",09/11/2025
L5680,"Addition to lower extremity, below knee, thigh lacer, nonmolded",09/11/2025
L5681,"Addition to lower extremity, below knee/above knee, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)",09/11/2025
L5682,"Addition to lower extremity, below knee, thigh lacer, gluteal/ischial, molded",09/11/2025
L5683,"Addition to lower extremity, below knee/above knee, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)",09/11/2025
L5684,"Addition to lower extremity, below knee, fork strap",09/11/2025
L5685,"Addition to lower extremity prosthesis, below knee, suspension/sealing sleeve, with or without valve, any material, each",09/11/2025
L5686,"Addition to lower extremity, below knee, back check (extension control)",09/11/2025
L5688,"Addition to lower extremity, below knee, waist belt, webbing",09/11/2025
L5690,"Addition to lower extremity, below knee, waist belt, padded and lined",09/11/2025
L5692,"Addition to lower extremity, above knee, pelvic control belt, light",09/11/2025
L5694,"Addition to lower extremity, above knee, pelvic control belt, padded and lined",09/11/2025
L5695,"Addition to lower extremity, above knee, pelvic control, sleeve suspension, neoprene or equal, each",09/11/2025
L5696,"Addition to lower extremity, above knee or knee disarticulation, pelvic joint",09/11/2025
L5697,"Addition to lower extremity, above knee or knee disarticulation, pelvic band",09/11/2025
L5698,"Addition to lower extremity, above knee or knee disarticulation, silesian bandage",09/11/2025
L5699,"All lower extremity prostheses, shoulder harness",09/11/2025
L5700,"Replacement, socket, below knee, molded to patient model",09/11/2025
L5701,"Replacement, socket, above knee/knee disarticulation, including attachment plate, molded to patient model",09/11/2025
L5702,"Replacement, socket, hip disarticulation, including hip joint, molded to patient model",09/11/2025
L5703,"Ankle, symes, molded to patient model, socket without solid ankle cushion heel (sach) foot, replacement only",09/11/2025
L5704,"Custom shaped protective cover, below knee",09/11/2025
L5705,"Custom shaped protective cover, above knee",09/11/2025
L5706,"Custom shaped protective cover, knee disarticulation",09/11/2025
L5707,"Custom shaped protective cover, hip disarticulation",09/11/2025
L5710,"Addition, exoskeletal knee-shin system, single axis, manual lock",09/11/2025
L5711,"Additions exoskeletal knee-shin system, single axis, manual lock, ultra-light material",09/11/2025
L5712,"Addition, exoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)",09/11/2025
L5714,"Addition, exoskeletal knee-shin system, single axis, variable friction swing phase control",09/11/2025
L5716,"Addition, exoskeletal knee-shin system, polycentric, mechanical stance phase lock",09/11/2025
L5718,"Addition, exoskeletal knee-shin system, polycentric, friction swing and stance phase control",09/11/2025
L5722,"Addition, exoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control",09/11/2025
L5724,"Addition, exoskeletal knee-shin system, single axis, fluid swing phase control",09/11/2025
L5726,"Addition, exoskeletal knee-shin system, single axis, external joints fluid swing phase control",09/11/2025
L5728,"Addition, exoskeletal knee-shin system, single axis, fluid swing and stance phase control",09/11/2025
L5780,"Addition, exoskeletal knee-shin system, single axis, pneumatic/hydra pneumatic swing phase control",09/11/2025
L5781,"Addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system",09/11/2025
L5782,"Addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system, heavy duty",09/11/2025
L5783,"Addition to lower extremity, user adjustable, mechanical, residual limb volume management system (with or without lamination kit)",09/11/2025
L5785,"Addition, exoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)",09/11/2025
L5790,"Addition, exoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)",09/11/2025
L5795,"Addition, exoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)",09/11/2025
L5810,"Addition, endoskeletal knee-shin system, single axis, manual lock",09/11/2025
L5811,"Addition, endoskeletal knee-shin system, single axis, manual lock, ultra-light material",09/11/2025
L5812,"Addition, endoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)",09/11/2025
L5814,"Addition, endoskeletal knee-shin system, polycentric, hydraulic swing phase control, mechanical stance phase lock",09/11/2025
L5816,"Addition, endoskeletal knee-shin system, polycentric, mechanical stance phase lock",09/11/2025
L5818,"Addition, endoskeletal knee-shin system, polycentric, friction swing, and stance phase control",09/11/2025
L5822,"Addition, endoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control",09/11/2025
L5824,"Addition, endoskeletal knee-shin system, single axis, fluid swing phase control",09/11/2025
L5826,"Addition, endoskeletal knee-shin system, single axis, hydraulic swing phase control, with miniature high activity frame",09/11/2025
L5827,"Endoskeletal knee-shin system, single axis, electromechanical swing and stance phase control, with or without shock absorption and stance extension damping",09/11/2025
L5828,"Addition, endoskeletal knee-shin system, single axis, fluid swing and stance phase control",09/11/2025
L5830,"Addition, endoskeletal knee-shin system, single axis, pneumatic/ swing phase control",09/11/2025
L5840,"Addition, endoskeletal knee/shin system, 4-bar linkage or multiaxial, pneumatic swing phase control",09/11/2025
L5841,"Addition, endoskeletal knee-shin system, polycentric, pneumatic swing, and stance phase control",09/11/2025
L5845,"Addition, endoskeletal, knee-shin system, stance flexion feature, adjustable",09/11/2025
L5848,"Addition to endoskeletal knee-shin system, fluid stance extension, dampening feature, with or without adjustability",09/11/2025
L5850,"Addition, endoskeletal system, above knee or hip disarticulation, knee extension assist",09/11/2025
L5855,"Addition, endoskeletal system, hip disarticulation, mechanical hip extension assist",09/11/2025
L5856,"Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing and stance phase, includes electronic sensor(s), any type",09/11/2025
L5857,"Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing phase only, includes electronic sensor(s), any type",09/11/2025
L5858,"Addition to lower extremity prosthesis, endoskeletal knee shin system, microprocessor control feature, stance phase only, includes electronic sensor(s), any type",09/11/2025
L5859,"Addition to lower extremity prosthesis, endoskeletal knee-shin system, powered and programmable flexion/extension assist control, includes any type motor(s)",09/11/2025
L5910,"Addition, endoskeletal system, below knee, alignable system",09/11/2025
L5920,"Addition, endoskeletal system, above knee or hip disarticulation, alignable system",09/11/2025
L5925,"Addition, endoskeletal system, above knee, knee disarticulation or hip disarticulation, manual lock",09/11/2025
L5926,"Addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any type",09/11/2025
L5930,"Addition, endoskeletal system, high activity knee control frame",09/11/2025
L5940,"Addition, endoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)",09/11/2025
L5950,"Addition, endoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)",09/11/2025
L5960,"Addition, endoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)",09/11/2025
L5961,"Addition, endoskeletal system, polycentric hip joint, pneumatic or hydraulic control, rotation control, with or without flexion and/or extension control",09/11/2025
L5962,"Addition, endoskeletal system, below knee, flexible protective outer surface covering system",09/11/2025
L5964,"Addition, endoskeletal system, above knee, flexible protective outer surface covering system",09/11/2025
L5966,"Addition, endoskeletal system, hip disarticulation, flexible protective outer surface covering system",09/11/2025
L5968,"Addition to lower limb prosthesis, multiaxial ankle with swing phase active dorsiflexion feature",09/11/2025
L5969,"Addition, endoskeletal ankle-foot or ankle system, power assist, includes any type motor(s)",09/11/2025
L5970,"All lower extremity prostheses, foot, external keel, sach foot",09/11/2025
L5971,"All lower extremity prosthesis, solid ankle cushion heel (sach) foot, replacement only",09/11/2025
L5972,"All lower extremity prostheses, foot, flexible keel",09/11/2025
L5973,"Endoskeletal ankle foot system, microprocessor controlled feature, dorsiflexion and/or plantar flexion control, includes power source",09/11/2025
L5974,"All lower extremity prostheses, foot, single axis ankle/foot",09/11/2025
L5975,"All lower extremity prosthesis, combination single axis ankle and flexible keel foot",09/11/2025
L5976,"All lower extremity prostheses, energy storing foot (seattle carbon copy ii or equal)",09/11/2025
L5978,"All lower extremity prostheses, foot, multiaxial ankle/foot",09/11/2025
L5979,"All lower extremity prosthesis, multi-axial ankle, dynamic response foot, one piece system",09/11/2025
L5980,"All lower extremity prostheses, flex foot system",09/11/2025
L5981,"All lower extremity prostheses, flex-walk system or equal",09/11/2025
L5982,"All exoskeletal lower extremity prostheses, axial rotation unit",09/11/2025
L5984,"All endoskeletal lower extremity prosthesis, axial rotation unit, with or without adjustability",09/11/2025
L5985,"All endoskeletal lower extremity prostheses, dynamic prosthetic pylon",09/11/2025
L5986,"All lower extremity prostheses, multi-axial rotation unit ('mcp' or equal)",09/11/2025
L5987,"All lower extremity prosthesis, shank foot system with vertical loading pylon",09/11/2025
L5988,"Addition to lower limb prosthesis, vertical shock reducing pylon feature",09/11/2025
L5990,"Addition to lower extremity prosthesis, user adjustable heel height",09/11/2025
L5991,"Addition to lower extremity prostheses, osseointegrated external prosthetic connector",09/11/2025
L5999,"Lower extremity prosthesis, not otherwise specified",09/11/2025
L6000,"Partial hand, thumb remaining",09/11/2025
L6010,"Partial hand, little and/or ring finger remaining",09/11/2025
L6020,"Partial hand, no finger remaining",09/11/2025
L6025,"Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device",09/11/2025
L6026,"Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device, excludes terminal device(s)",09/11/2025
L6028,"Partial hand, finger, and thumb prosthesis without prosthetic digit(s)/thumb, amputation at metacarpal level, including flexible or non-flexible interface, molded to patient model, including palm, for use without external power and/or passive prosthetic digit/thumb, not including inserts described by l6692",09/11/2025
L6029,"Upper extremity addition, test socket/interface, partial hand including fingers",09/11/2025
L6030,"Upper extremity addition, external frame, partial hand including fingers",09/11/2025
L6031,"Replacement socket/interface, partial hand including fingers, molded to patient model, for use with or without external power",09/11/2025
L6032,"Addition to upper extremity prosthesis, partial hand including fingers, ultralight material (titanium, carbon fiber or equal)",09/11/2025
L6033,"Addition to upper extremity prosthesis, partial hand including fingers, acrylic material",09/11/2025
L6034,"Partial hand, finger, and thumb prosthesis without prosthetic digit(s)/thumb, amputation at transmetacarpal level, including flexible or non-flexible interface, molded to patient model, for use without external power and/or passive prosthetic digit/thumb, not including inserts described by l6692",09/11/2025
L6035,"Single prosthetic digit, mechanical, can include metacarpophalangeal (mcp), proximal interphalangeal (pip), and/or distal interphalangeal (dip) joint(s), with or without locking mechanism, can include flexion or extension assist, any material, attachment, initial issue or replacement",09/11/2025
L6036,"Prosthetic thumb, mechanical, can include metacarpophalangeal (mcp), interphalangeal (ip) joint(s), with or without locking mechanism, can include flexion or extension assist, any material, attachment, initial issue or replacement",09/11/2025
L6037,"Immediate post-surgical or early fitting, application of initial rigid dressing, including fitting alignment and suspension of components, and one cast change, partial hand including fingers",09/11/2025
L6038,"Addition to single prosthetic digit or thumb, mechanical, attachment, multiaxial and/or internal/external rotation/abduction/adduction mechanism, with or without locking feature, any material",09/11/2025
L6039,"Passive prosthetic digit or thumb prosthesis not including hand restoration partial hand, full or partial, custom made, any material, initial or replacement, per single passive prosthetic digit or thumb",09/11/2025
L6050,"Wrist disarticulation, molded socket, flexible elbow hinges, triceps pad",09/11/2025
L6055,"Wrist disarticulation, molded socket with expandable interface, flexible elbow hinges, triceps pad",09/11/2025
L6100,"Below elbow, molded socket, flexible elbow hinge, triceps pad",09/11/2025
L6110,"Below elbow, molded socket, (muenster or northwestern suspension types)",09/11/2025
L6120,"Below elbow, molded double wall split socket, step-up hinges, half cuff",09/11/2025
L6130,"Below elbow, molded double wall split socket, stump activated locking hinge, half cuff",09/11/2025
L6200,"Elbow disarticulation, molded socket, outside locking hinge, forearm",09/11/2025
L6205,"Elbow disarticulation, molded socket with expandable interface, outside locking hinges, forearm",09/11/2025
L6250,"Above elbow, molded double wall socket, internal locking elbow, forearm",09/11/2025
L6300,"Shoulder disarticulation, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm",09/11/2025
L6310,"Shoulder disarticulation, passive restoration (complete prosthesis)",09/11/2025
L6320,"Shoulder disarticulation, passive restoration (shoulder cap only)",09/11/2025
L6350,"Interscapular thoracic, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm",09/11/2025
L6360,"Interscapular thoracic, passive restoration (complete prosthesis)",09/11/2025
L6370,"Interscapular thoracic, passive restoration (shoulder cap only)",09/11/2025
L6380,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting alignment and suspension of components, and one cast change, wrist disarticulation or below elbow",09/11/2025
L6382,"Immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, elbow disarticulation or above elbow",09/11/2025
L6384,"Immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, shoulder disarticulation or interscapular thoracic",09/11/2025
L6386,"Immediate post surgical or early fitting, each additional cast change and realignment",09/11/2025
L6388,"Immediate post surgical or early fitting, application of rigid dressing only",09/11/2025
L6400,"Below elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping",09/11/2025
L6450,"Elbow disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping",09/11/2025
L6500,"Above elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping",09/11/2025
L6550,"Shoulder disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping",09/11/2025
L6570,"Interscapular thoracic, molded socket, endoskeletal system, including soft prosthetic tissue shaping",09/11/2025
L6580,"Preparatory, wrist disarticulation or below elbow, single wall plastic socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, molded to patient model",09/11/2025
L6582,"Preparatory, wrist disarticulation or below elbow, single wall socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, direct formed",09/11/2025
L6584,"Preparatory, elbow disarticulation or above elbow, single wall plastic socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, molded to patient model",09/11/2025
L6586,"Preparatory, elbow disarticulation or above elbow, single wall socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, direct formed",09/11/2025
L6588,"Preparatory, shoulder disarticulation or interscapular thoracic, single wall plastic socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, molded to patient model",09/11/2025
L6590,"Preparatory, shoulder disarticulation or interscapular thoracic, single wall socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, direct formed",09/11/2025
L6600,"Upper extremity additions, polycentric hinge, pair",09/11/2025
L6605,"Upper extremity additions, single pivot hinge, pair",09/11/2025
L6610,"Upper extremity additions, flexible metal hinge, pair",09/11/2025
L6611,"Addition to upper extremity prosthesis, external powered, additional switch, any type",09/11/2025
L6615,"Upper extremity addition, disconnect locking wrist unit",09/11/2025
L6616,"Upper extremity addition, additional disconnect insert for locking wrist unit, each",09/11/2025
L6620,"Upper extremity addition, flexion/extension wrist unit, with or without friction",09/11/2025
L6621,"Upper extremity prosthesis addition, flexion/extension wrist with or without friction, for use with external powered terminal device",09/11/2025
L6623,"Upper extremity addition, spring assisted rotational wrist unit with latch release",09/11/2025
L6624,"Upper extremity addition, flexion/extension and rotation wrist unit",09/11/2025
L6625,"Upper extremity addition, rotation wrist unit with cable lock",09/11/2025
L6628,"Upper extremity addition, quick disconnect hook adapter, otto bock or equal",09/11/2025
L6629,"Upper extremity addition, quick disconnect lamination collar with coupling piece, otto bock or equal",09/11/2025
L6630,"Upper extremity addition, stainless steel, any wrist",09/11/2025
L6632,"Upper extremity addition, latex suspension sleeve, each",09/11/2025
L6635,"Upper extremity addition, lift assist for elbow",09/11/2025
L6637,"Upper extremity addition, nudge control elbow lock",09/11/2025
L6638,"Upper extremity addition to prosthesis, electric locking feature, only for use with manually powered elbow",09/11/2025
L6640,"Upper extremity additions, shoulder abduction joint, pair",09/11/2025
L6641,"Upper extremity addition, excursion amplifier, pulley type",09/11/2025
L6642,"Upper extremity addition, excursion amplifier, lever type",09/11/2025
L6645,"Upper extremity addition, shoulder flexion-abduction joint, each",09/11/2025
L6646,"Upper extremity addition, shoulder joint, multipositional locking, flexion, adjustable abduction friction control, for use with body powered or external powered system",09/11/2025
L6647,"Upper extremity addition, shoulder lock mechanism, body powered actuator",09/11/2025
L6648,"Upper extremity addition, shoulder lock mechanism, external powered actuator",09/11/2025
L6650,"Upper extremity addition, shoulder universal joint, each",09/11/2025
L6655,"Upper extremity addition, standard control cable, extra",09/11/2025
L6660,"Upper extremity addition, heavy duty control cable",09/11/2025
L6665,"Upper extremity addition, teflon, or equal, cable lining",09/11/2025
L6670,"Upper extremity addition, hook to hand, cable adapter",09/11/2025
L6672,"Upper extremity addition, harness, chest or shoulder, saddle type",09/11/2025
L6675,"Upper extremity addition, harness, (e.g., figure of eight type), single cable design",09/11/2025
L6676,"Upper extremity addition, harness, (e.g., figure of eight type), dual cable design",09/11/2025
L6677,"Upper extremity addition, harness, triple control, simultaneous operation of terminal device and elbow",09/11/2025
L6680,"Upper extremity addition, test socket, wrist disarticulation or below elbow",09/11/2025
L6682,"Upper extremity addition, test socket, elbow disarticulation or above elbow",09/11/2025
L6684,"Upper extremity addition, test socket, shoulder disarticulation or interscapular thoracic",09/11/2025
L6686,"Upper extremity addition, suction socket",09/11/2025
L6687,"Upper extremity addition, frame type socket, below elbow or wrist disarticulation",09/11/2025
L6688,"Upper extremity addition, frame type socket, above elbow or elbow disarticulation",09/11/2025
L6689,"Upper extremity addition, frame type socket, shoulder disarticulation",09/11/2025
L6690,"Upper extremity addition, frame type socket, interscapular-thoracic",09/11/2025
L6691,"Upper extremity addition, removable insert, each",09/11/2025
L6692,"Upper extremity addition, silicone gel insert or equal, with or without locking mechanism, each",09/11/2025
L6693,"Upper extremity addition, locking elbow, forearm counterbalance",09/11/2025
L6694,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, for use with locking mechanism",09/11/2025
L6695,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, not for use with locking mechanism",09/11/2025
L6696,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)",09/11/2025
L6697,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)",09/11/2025
L6698,"Addition to upper extremity prosthesis, lock mechanism, excludes socket insert",09/11/2025
L6700,"Upper extremity addition, external powered feature, myoelectronic control module, additional emg inputs, pattern-recognition decoding intent movement",09/11/2025
L6703,"Terminal device, passive hand/mitt, any material, any size",09/11/2025
L6704,"Terminal device, sport/recreational/work attachment, any material, any size",09/11/2025
L6706,"Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined",09/11/2025
L6707,"Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined",09/11/2025
L6708,"Terminal device, hand, mechanical, voluntary opening, any material, any size",09/11/2025
L6709,"Terminal device, hand, mechanical, voluntary closing, any material, any size",09/11/2025
L6711,"Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined, pediatric",09/11/2025
L6712,"Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined, pediatric",09/11/2025
L6713,"Terminal device, hand, mechanical, voluntary opening, any material, any size, pediatric",09/11/2025
L6714,"Terminal device, hand, mechanical, voluntary closing, any material, any size, pediatric",09/11/2025
L6715,"Terminal device, multiple articulating digit, includes motor(s), initial issue or replacement",09/11/2025
L6721,"Terminal device, hook or hand, heavy duty, mechanical, voluntary opening, any material, any size, lined or unlined",09/11/2025
L6722,"Terminal device, hook or hand, heavy duty, mechanical, voluntary closing, any material, any size, lined or unlined",09/11/2025
L6805,"Addition to terminal device, modifier wrist unit",09/11/2025
L6810,"Addition to terminal device, precision pinch device",09/11/2025
L6880,"Electric hand, switch or myoelectric controlled, independently articulating digits, any grasp pattern or combination of grasp patterns, includes motor(s)",09/11/2025
L6881,"Automatic grasp feature, addition to upper limb electric prosthetic terminal device",09/11/2025
L6882,"Microprocessor control feature, addition to upper limb prosthetic terminal device",09/11/2025
L6883,"Replacement socket, below elbow/wrist disarticulation, molded to patient model, for use with or without external power",09/11/2025
L6884,"Replacement socket, above elbow/elbow disarticulation, molded to patient model, for use with or without external power",09/11/2025
L6885,"Replacement socket, shoulder disarticulation/interscapular thoracic, molded to patient model, for use with or without external power",09/11/2025
L6890,"Addition to upper extremity prosthesis, glove for terminal device, any material, prefabricated, includes fitting and adjustment",09/11/2025
L6895,"Addition to upper extremity prosthesis, glove for terminal device, any material, custom fabricated",09/11/2025
L6900,"Hand restoration (casts, shading and measurements included), partial hand, with glove, thumb or one finger remaining",09/11/2025
L6905,"Hand restoration (casts, shading and measurements included), partial hand, with glove, multiple fingers remaining",09/11/2025
L6910,"Hand restoration (casts, shading and measurements included), partial hand, with glove, no fingers remaining",09/11/2025
L6915,"Hand restoration (shading, and measurements included), replacement glove for above",09/11/2025
L6920,"Wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal, switch, cables, two batteries and one charger, switch control of terminal device",09/11/2025
L6925,"Wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",09/11/2025
L6930,"Below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device",09/11/2025
L6935,"Below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",09/11/2025
L6940,"Elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device",09/11/2025
L6945,"Elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",09/11/2025
L6950,"Above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device",09/11/2025
L6955,"Above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",09/11/2025
L6960,"Shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device",09/11/2025
L6965,"Shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",09/11/2025
L6970,"Interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device",09/11/2025
L6975,"Interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",09/11/2025
L7007,"Electric hand, switch or myoelectric controlled, adult",09/11/2025
L7008,"Electric hand, switch or myoelectric, controlled, pediatric",09/11/2025
L7009,"Electric hook, switch or myoelectric controlled, adult",09/11/2025
L7040,"Prehensile actuator, switch controlled",09/11/2025
L7045,"Electric hook, switch or myoelectric controlled, pediatric",09/11/2025
L7170,"Electronic elbow, hosmer or equal, switch controlled",09/11/2025
L7180,"Electronic elbow, microprocessor sequential control of elbow and terminal device",09/11/2025
L7181,"Electronic elbow, microprocessor simultaneous control of elbow and terminal device",09/11/2025
L7185,"Electronic elbow, adolescent, variety village or equal, switch controlled",09/11/2025
L7186,"Electronic elbow, child, variety village or equal, switch controlled",09/11/2025
L7190,"Electronic elbow, adolescent, variety village or equal, myoelectronically controlled",09/11/2025
L7191,"Electronic elbow, child, variety village or equal, myoelectronically controlled",09/11/2025
L7259,"Electronic wrist rotator, any type",09/11/2025
L7260,"Electronic wrist rotator, otto bock or equal",09/11/2025
L7261,"Electronic wrist rotator, for utah arm",09/11/2025
L7360,"Six volt battery, each",09/11/2025
L7362,"Battery charger, six volt, each",09/11/2025
L7364,"Twelve volt battery, each",09/11/2025
L7366,"Battery charger, twelve volt, each",09/11/2025
L7367,"Lithium ion battery, rechargeable, replacement",09/11/2025
L7368,"Lithium ion battery charger, replacement only",09/11/2025
L7400,"Addition to upper extremity prosthesis, below elbow/wrist disarticulation, ultralight material (titanium, carbon fiber or equal)",09/11/2025
L7401,"Addition to upper extremity prosthesis, above elbow disarticulation, ultralight material (titanium, carbon fiber or equal)",09/11/2025
L7402,"Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, ultralight material (titanium, carbon fiber or equal)",09/11/2025
L7403,"Addition to upper extremity prosthesis, below elbow/wrist disarticulation, acrylic material",09/11/2025
L7404,"Addition to upper extremity prosthesis, above elbow disarticulation, acrylic material",09/11/2025
L7405,"Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, acrylic material",09/11/2025
L7406,"Addition to upper extremity prosthesis, user adjustable, mechanical, residual limb volume management system (with or without lamination kit)",09/11/2025
L7499,"Upper extremity prosthesis, not otherwise specified",09/11/2025
L7510,"Repair of prosthetic device, repair or replace minor parts",09/11/2025
L7520,"Repair prosthetic device, labor component, per 15 minutes",09/11/2025
L7600,"Prosthetic donning sleeve, any material, each",09/11/2025
L7700,"Gasket or seal, for use with prosthetic socket insert, any type, each",09/11/2025
L7900,Male vacuum erection system,09/11/2025
L7902,"Tension ring, for vacuum erection device, any type, replacement only, each",09/11/2025
L8000,"Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type",09/11/2025
L8001,"Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, unilateral, any size, any type",09/11/2025
L8002,"Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, bilateral, any size, any type",09/11/2025
L8010,"Breast prosthesis, mastectomy sleeve",09/11/2025
L8015,"External breast prosthesis garment, with mastectomy form, post mastectomy",09/11/2025
L8020,"Breast prosthesis, mastectomy form",09/11/2025
L8030,"Breast prosthesis, silicone or equal, without integral adhesive",09/11/2025
L8031,"Breast prosthesis, silicone or equal, with integral adhesive",09/11/2025
L8032,"Nipple prosthesis, prefabricated, reusable, any type, each",09/11/2025
L8033,"Nipple prosthesis, custom fabricated, reusable, any material, any type, each",09/11/2025
L8035,"Custom breast prosthesis, post mastectomy, molded to patient model",09/11/2025
L8039,"Breast prosthesis, not otherwise specified",09/11/2025
L8040,"Nasal prosthesis, provided by a non-physician",09/11/2025
L8041,"Midfacial prosthesis, provided by a non-physician",09/11/2025
L8042,"Orbital prosthesis, provided by a non-physician",09/11/2025
L8043,"Upper facial prosthesis, provided by a non-physician",09/11/2025
L8044,"Hemi-facial prosthesis, provided by a non-physician",09/11/2025
L8045,"Auricular prosthesis, provided by a non-physician",09/11/2025
L8046,"Partial facial prosthesis, provided by a non-physician",09/11/2025
L8047,"Nasal septal prosthesis, provided by a non-physician",09/11/2025
L8048,"Unspecified maxillofacial prosthesis, by report, provided by a non-physician",09/11/2025
L8049,"Repair or modification of maxillofacial prosthesis, labor component, 15 minute increments, provided by a non-physician",09/11/2025
L8300,"Truss, single with standard pad",09/11/2025
L8310,"Truss, double with standard pads",09/11/2025
L8320,"Truss, addition to standard pad, water pad",09/11/2025
L8330,"Truss, addition to standard pad, scrotal pad",09/11/2025
L8400,"Prosthetic sheath, below knee, each",09/11/2025
L8410,"Prosthetic sheath, above knee, each",09/11/2025
L8415,"Prosthetic sheath, upper limb, each",09/11/2025
L8417,"Prosthetic sheath/sock, including a gel cushion layer, below knee or above knee, each",09/11/2025
L8420,"Prosthetic sock, multiple ply, below knee, each",09/11/2025
L8430,"Prosthetic sock, multiple ply, above knee, each",09/11/2025
L8435,"Prosthetic sock, multiple ply, upper limb, each",09/11/2025
L8440,"Prosthetic shrinker, below knee, each",09/11/2025
L8460,"Prosthetic shrinker, above knee, each",09/11/2025
L8465,"Prosthetic shrinker, upper limb, each",09/11/2025
L8470,"Prosthetic sock, single ply, fitting, below knee, each",09/11/2025
L8480,"Prosthetic sock, single ply, fitting, above knee, each",09/11/2025
L8485,"Prosthetic sock, single ply, fitting, upper limb, each",09/11/2025
L8499,Unlisted procedure for miscellaneous prosthetic services,09/11/2025
L8500,"Artificial larynx, any type",09/11/2025
L8501,Tracheostomy speaking valve,09/11/2025
L8505,"Artificial larynx replacement battery / accessory, any type",09/11/2025
L8507,"Tracheo-esophageal voice prosthesis, patient inserted, any type, each",09/11/2025
L8509,"Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type",09/11/2025
L8510,Voice amplifier,09/11/2025
L8511,"Insert for indwelling tracheoesophageal prosthesis, with or without valve, replacement only, each",09/11/2025
L8512,"Gelatin capsules or equivalent, for use with tracheoesophageal voice prosthesis, replacement only, per 10",09/11/2025
L8513,"Cleaning device used with tracheoesophageal voice prosthesis, pipet, brush, or equal, replacement only, each",09/11/2025
L8514,"Tracheoesophageal puncture dilator, replacement only, each",09/11/2025
L8515,"Gelatin capsule, application device for use with tracheoesophageal voice prosthesis, each",09/11/2025
L8600,"Implantable breast prosthesis, silicone or equal",09/11/2025
L8603,"Injectable bulking agent, collagen implant, urinary tract, 2.5 ml syringe, includes shipping and necessary supplies",09/11/2025
L8604,"Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, urinary tract, 1 ml, includes shipping and necessary supplies",09/11/2025
L8605,"Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, anal canal, 1 ml, includes shipping and necessary supplies",09/11/2025
L8606,"Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies",09/11/2025
L8607,"Injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies",09/11/2025
L8608,"Miscellaneous external component, supply or accessory for use with the argus ii retinal prosthesis system",09/11/2025
L8609,Artificial cornea,09/11/2025
L8610,Ocular implant,09/11/2025
L8612,Aqueous shunt,09/11/2025
L8613,Ossicula implant,09/11/2025
L8614,"Cochlear device, includes all internal and external components",09/11/2025
L8615,"Headset/headpiece for use with cochlear implant device, replacement",09/11/2025
L8616,"Microphone for use with cochlear implant device, replacement",09/11/2025
L8617,"Transmitting coil for use with cochlear implant device, replacement",09/11/2025
L8618,"Transmitter cable for use with cochlear implant device or auditory osseointegrated device, replacement",09/11/2025
L8619,"Cochlear implant, external speech processor and controller, integrated system, replacement",09/11/2025
L8621,"Zinc air battery for use with cochlear implant device and auditory osseointegrated sound processors, replacement, each",09/11/2025
L8622,"Alkaline battery for use with cochlear implant device, any size, replacement, each",09/11/2025
L8623,"Lithium ion battery for use with cochlear implant device speech processor, other than ear level, replacement, each",09/11/2025
L8624,"Lithium ion battery for use with cochlear implant or auditory osseointegrated device speech processor, ear level, replacement, each",09/11/2025
L8625,"External recharging system for battery for use with cochlear implant or auditory osseointegrated device, replacement only, each",09/11/2025
L8627,"Cochlear implant, external speech processor, component, replacement",09/11/2025
L8628,"Cochlear implant, external controller component, replacement",09/11/2025
L8629,"Transmitting coil and cable, integrated, for use with cochlear implant device, replacement",09/11/2025
L8630,Metacarpophalangeal joint implant,09/11/2025
L8631,"Metacarpal phalangeal joint replacement, two or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon), for surgical implantation (all sizes, includes entire system)",09/11/2025
L8641,Metatarsal joint implant,09/11/2025
L8642,Hallux implant,09/11/2025
L8658,"Interphalangeal joint spacer, silicone or equal, each",09/11/2025
L8659,"Interphalangeal finger joint replacement, 2 or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon) for surgical implantation, any size",09/11/2025
L8670,"Vascular graft material, synthetic, implant",09/11/2025
L8678,"Electrical stimulator supplies (external) for use with implantable neurostimulator, per month",09/11/2025
L8679,"Implantable neurostimulator, pulse generator, any type",09/11/2025
L8680,"Implantable neurostimulator electrode, each",09/11/2025
L8681,"Patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only",09/11/2025
L8682,Implantable neurostimulator radiofrequency receiver,09/11/2025
L8683,Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver,09/11/2025
L8684,"Radiofrequency transmitter (external) for use with implantable sacral root neurostimulator receiver for bowel and bladder management, replacement",09/11/2025
L8685,"Implantable neurostimulator pulse generator, single array, rechargeable, includes extension",09/11/2025
L8686,"Implantable neurostimulator pulse generator, single array, non-rechargeable, includes extension",09/11/2025
L8687,"Implantable neurostimulator pulse generator, dual array, rechargeable, includes extension",09/11/2025
L8688,"Implantable neurostimulator pulse generator, dual array, non-rechargeable, includes extension",09/11/2025
L8689,"External recharging system for battery (internal) for use with implantable neurostimulator, replacement only",09/11/2025
L8690,"Auditory osseointegrated device, includes all internal and external components",09/11/2025
L8691,"Auditory osseointegrated device, external sound processor, excludes transducer/actuator, replacement only, each",09/11/2025
L8692,"Auditory osseointegrated device, external sound processor, used without osseointegration, body worn, includes headband or other means of external attachment",09/11/2025
L8693,"Auditory osseointegrated device abutment, any length, replacement only",09/11/2025
L8694,"Auditory osseointegrated device, transducer/actuator, replacement only, each",09/11/2025
L8695,"External recharging system for battery (external) for use with implantable neurostimulator, replacement only",09/11/2025
L8696,"Antenna (external) for use with implantable diaphragmatic/phrenic nerve stimulation device, replacement, each",09/11/2025
L8698,"Miscellaneous component, supply or accessory for use with total artificial heart system",09/11/2025
L8699,"Prosthetic implant, not otherwise specified",09/11/2025
L8701,"Powered upper extremity range of motion assist device, elbow, wrist, hand with single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated",09/11/2025
L8702,"Powered upper extremity range of motion assist device, elbow, wrist, hand, finger, single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated",09/11/2025
L8720,"External lower extremity sensory prosthetic device, cutaneous stimulation of mechanoreceptors proximal to the ankle, per leg",09/11/2025
L8721,"Receptor sole for use with l8720, replacement, each",09/11/2025
L9900,"Orthotic and prosthetic supply, accessory, and/or service component of another hcpcs ""l"" code",09/11/2025
M0001,Advancing cancer care mips value pathways,09/11/2025
M0002,Optimal care for kidney health mips value pathways,09/11/2025
M0003,Optimal care for patients with episodic neurological conditions mips value pathways,09/11/2025
M0004,Quality care for patients with neurological conditions mips value pathway,09/11/2025
M0005,Value in primary care mips value pathway,09/11/2025
M0010,Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services,09/11/2025
M0064,Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders,09/11/2025
M0075,Cellular therapy,09/11/2025
M0076,Prolotherapy,09/11/2025
M0100,Intragastric hypothermia using gastric freezing,09/11/2025
M0201,"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's home",09/11/2025
M0220,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring",09/11/2025
M0221,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency",09/11/2025
M0222,"Intravenous injection, bebtelovimab, includes injection and post administration monitoring",09/11/2025
M0223,"Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency",09/11/2025
M0224,"Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring",09/11/2025
M0235,"Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose",09/11/2025
M0236,"Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose",09/11/2025
M0237,"Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose",09/11/2025
M0238,"Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose",09/11/2025
M0239,"Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring",09/11/2025
M0240,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses",09/11/2025
M0241,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses",09/11/2025
M0243,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring",09/11/2025
M0244,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency",09/11/2025
M0245,"Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring",09/11/2025
M0246,"Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency",09/11/2025
M0247,"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring",09/11/2025
M0248,"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency",09/11/2025
M0249,"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose",09/11/2025
M0250,"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose",09/11/2025
M0300,Iv chelation therapy (chemical endarterectomy),09/11/2025
M0301,Fabric wrapping of abdominal aneurysm,09/11/2025
M1000,Pain screened as moderate to severe,09/11/2025
M1001,Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician,09/11/2025
M1002,"Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given",09/11/2025
M1003,Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy,09/11/2025
M1004,"Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)",09/11/2025
M1005,"Tb screening not performed or results not interpreted, reason not given",09/11/2025
M1006,"Disease activity not assessed, reason not given",09/11/2025
M1007,>=50% of total number of a patient's outpatient ra encounters assessed,09/11/2025
M1008,<50% of total number of a patient's outpatient ra encounters assessed,09/11/2025
M1009,Discharge/discontinuation of the episode of care documented in the medical record,09/11/2025
M1010,Discharge/discontinuation of the episode of care documented in the medical record,09/11/2025
M1011,Discharge/discontinuation of the episode of care documented in the medical record,09/11/2025
M1012,Discharge/discontinuation of the episode of care documented in the medical record,09/11/2025
M1013,Discharge/discontinuation of the episode of care documented in the medical record,09/11/2025
M1014,Discharge/discontinuation of the episode of care documented in the medical record,09/11/2025
M1015,Discharge/discontinuation of the episode of care documented in the medical record,09/11/2025
M1016,Female patients unable to bear children,09/11/2025
M1017,Patient admitted to palliative care services,09/11/2025
M1018,"Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients",09/11/2025
M1019,Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5,09/11/2025
M1020,Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5,09/11/2025
M1021,Patient had only urgent care visits during the performance period,09/11/2025
M1022,Patients who were in hospice at any time during the performance period,09/11/2025
M1023,Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five,09/11/2025
M1024,Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five,09/11/2025
M1025,Patients who were in hospice at any time during the performance period,09/11/2025
M1026,Patients who were in hospice at any time during the performance period,09/11/2025
M1027,Imaging of the head (ct or mri) was obtained,09/11/2025
M1028,Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained,09/11/2025
M1029,"Imaging of the head (ct or mri) was not obtained, reason not given",09/11/2025
M1030,Patients with clinical indications for imaging of the head,09/11/2025
M1031,Patients with no clinical indications for imaging of the head,09/11/2025
M1032,Adults currently taking pharmacotherapy for oud,09/11/2025
M1033,Pharmacotherapy for oud initiated after june 30th of performance period,09/11/2025
M1034,Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days,09/11/2025
M1035,Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment,09/11/2025
M1036,Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days,09/11/2025
M1037,Patients with a diagnosis of lumbar spine region cancer at the time of the procedure,09/11/2025
M1038,Patients with a diagnosis of lumbar spine region fracture at the time of the procedure,09/11/2025
M1039,Patients with a diagnosis of lumbar spine region infection at the time of the procedure,09/11/2025
M1040,Patients with a diagnosis of lumbar idiopathic or congenital scoliosis,09/11/2025
M1041,"Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis",09/11/2025
M1042,Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively,09/11/2025
M1043,Functional status was not measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively,09/11/2025
M1044,Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively,09/11/2025
M1045,"Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was greater than or equal to 37 or knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was greater than or equal to 71",09/11/2025
M1046,"Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was less than 37 or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was less than 71 postoperatively",09/11/2025
M1047,Functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively,09/11/2025
M1048,Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively,09/11/2025
M1049,Functional status was not measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively,09/11/2025
M1050,Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively,09/11/2025
M1051,"Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis",09/11/2025
M1052,Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively,09/11/2025
M1053,Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively,09/11/2025
M1054,Patient had only urgent care visits during the performance period,09/11/2025
M1055,Aspirin or another antiplatelet therapy used,09/11/2025
M1056,"Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease",09/11/2025
M1057,"Aspirin or another antiplatelet therapy not used, reason not given",09/11/2025
M1058,Patient was a permanent nursing home resident at any time during the performance period,09/11/2025
M1059,Patient was in hospice or receiving palliative care at any time during the performance period,09/11/2025
M1060,Patient died prior to the end of the performance period,09/11/2025
M1061,Patient pregnancy,09/11/2025
M1062,Patient immunocompromised,09/11/2025
M1063,Patients receiving high doses of immunosuppressive therapy,09/11/2025
M1064,Shingrix vaccine documented as administered or previously received,09/11/2025
M1065,"Shingrix vaccine was not administered for reasons documented by clinician (e.g. patient administered vaccine other than shingrix, patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)",09/11/2025
M1066,"Shingrix vaccine not documented as administered, reason not given",09/11/2025
M1067,Hospice services for patient provided any time during the measurement period,09/11/2025
M1068,Adults who are not ambulatory,09/11/2025
M1069,Patient screened for future fall risk,09/11/2025
M1070,"Patient not screened for future fall risk, reason not given",09/11/2025
M1071,Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminotomy,09/11/2025
M1106,The start of an episode of care documented in the medical record,09/11/2025
M1107,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",09/11/2025
M1108,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",09/11/2025
M1109,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",09/11/2025
M1110,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",09/11/2025
M1111,The start of an episode of care documented in the medical record,09/11/2025
M1112,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",09/11/2025
M1113,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",09/11/2025
M1114,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",09/11/2025
M1115,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",09/11/2025
M1116,The start of an episode of care documented in the medical record,09/11/2025
M1117,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",09/11/2025
M1118,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",09/11/2025
M1119,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",09/11/2025
M1120,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",09/11/2025
M1121,The start of an episode of care documented in the medical record,09/11/2025
M1122,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",09/11/2025
M1123,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",09/11/2025
M1124,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",09/11/2025
M1125,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",09/11/2025
M1126,The start of an episode of care documented in the medical record,09/11/2025
M1127,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",09/11/2025
M1128,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",09/11/2025
M1129,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",09/11/2025
M1130,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",09/11/2025
M1131,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",09/11/2025
M1132,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",09/11/2025
M1133,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",09/11/2025
M1134,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",09/11/2025
M1135,The start of an episode of care documented in the medical record,09/11/2025
M1136,The start of an episode of care documented in the medical record,09/11/2025
M1137,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",09/11/2025
M1138,"Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)",09/11/2025
M1139,"Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)",09/11/2025
M1140,"Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery for surgery or hospitalized",09/11/2025
M1141,"Functional status was not measured by the oxford knee score (oks) or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) at one year (9 to 15 months) postoperatively",09/11/2025
M1142,Emergent cases,09/11/2025
M1143,"Initiated episode of rehabilitation therapy, medical, or chiropractic care for neck impairment",09/11/2025
M1144,"Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only",09/11/2025
M1145,"Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier)",09/11/2025
M1146,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",09/11/2025
M1147,"Ongoing care not medically possible because the patient was  discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",09/11/2025
M1148,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",09/11/2025
M1149,"Patient unable to complete the neck fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility, and an adequate proxy is not available",09/11/2025
M1150,Current or prior left ventricular ejection fraction (lvef) less than or equal to 40% or documentation of moderately or severely depressed left ventricular systolic function,09/11/2025
M1151,Patients with a history of heart transplant or with a left ventricular assist device (lvad),09/11/2025
M1152,Patients with a history of heart transplant or with a left ventricular assist device (lvad),09/11/2025
M1153,Patient with diagnosis of osteoporosis on date of encounter,09/11/2025
M1154,Hospice services provided to patient any time during the measurement period,09/11/2025
M1155,Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period,09/11/2025
M1156,Patient received active chemotherapy any time during the measurement period,09/11/2025
M1157,Patient received bone marrow transplant any time during the measurement period,09/11/2025
M1158,Patient had history of immunocompromising conditions prior to or during the measurement period,09/11/2025
M1159,Hospice services provided to patient any time during the measurement period,09/11/2025
M1160,Patient had anaphylaxis due to the meningococcal vaccine any time on or before the patient's 13th birthday,09/11/2025
M1161,"Patient had anaphylaxis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday",09/11/2025
M1162,"Patient had encephalitis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday",09/11/2025
M1163,Patient had anaphylaxis due to the hpv vaccine any time on or before the patient's 13th birthday,09/11/2025
M1164,Patients with dementia any time during the patient's history through the end of the measurement period,09/11/2025
M1165,Patients who use hospice services any time during the measurement period,09/11/2025
M1166,Pathology report for tissue specimens produced from wide local excisions or re-excisions,09/11/2025
M1167,In hospice or using hospice services during the measurement period,09/11/2025
M1168,Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period,09/11/2025
M1169,"Documentation of medical reason(s) for not administering influenza vaccine (e.g., prior anaphylaxis due to the influenza vaccine)",09/11/2025
M1170,Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period,09/11/2025
M1171,Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period,09/11/2025
M1172,"Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine)",09/11/2025
M1173,Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period,09/11/2025
M1174,Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period,09/11/2025
M1175,"Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine)",09/11/2025
M1176,Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period,09/11/2025
M1177,Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period,09/11/2025
M1178,"Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., prior anaphylaxis due to the pneumococcal vaccine)",09/11/2025
M1179,"Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 19th birthday and before or during measurement period",09/11/2025
M1180,Patients on immune checkpoint inhibitor therapy,09/11/2025
M1181,Grade 2 or above diarrhea and/or grade 2 or above colitis,09/11/2025
M1182,"Patients not eligible due to pre-existing inflammatory bowel disease (ibd) (e.g., ulcerative colitis, crohn's disease)",09/11/2025
M1183,Documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered,09/11/2025
M1184,"Documentation of medical reason(s) for not prescribing or administering corticosteroid or immunosuppressant treatment (e.g., allergy, intolerance, infectious etiology, pancreatic insufficiency, hyperthyroidism, prior bowel surgical interventions, celiac disease, receiving other medication, awaiting diagnostic workup results for alternative etiologies, other medical reasons/contraindication)",09/11/2025
M1185,"Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given",09/11/2025
M1186,Patients who have an order for or are receiving hospice or palliative care,09/11/2025
M1187,Patients with a diagnosis of end stage renal disease (esrd),09/11/2025
M1188,Patients with a diagnosis of chronic kidney disease (ckd) stage 5,09/11/2025
M1189,Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed,09/11/2025
M1190,Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr),09/11/2025
M1191,Hospice services provided to patient any time during the measurement period,09/11/2025
M1192,Patients with an existing diagnosis of squamous cell carcinoma of the esophagus,09/11/2025
M1193,"Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both",09/11/2025
M1194,"Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)",09/11/2025
M1195,"Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given",09/11/2025
M1196,"Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4",09/11/2025
M1197,Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score,09/11/2025
M1198,Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter,09/11/2025
M1199,Patients receiving rrt,09/11/2025
M1200,Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period,09/11/2025
M1201,"Documentation of medical reason(s) for not prescribing ace inhibitor (ace-i) or arb therapy during the measurement period (e.g., pregnancy, history of angioedema to ace-i, other allergy to ace-i and arb, hyperkalemia or history of hyperkalemia while on ace-i or arb therapy, acute kidney injury due to ace-i or arb therapy), other medical reasons)",09/11/2025
M1202,"Documentation of patient reason(s) for not prescribing ace inhibitor or arb therapy during the measurement period, (e.g., patient declined, other patient reasons)",09/11/2025
M1203,"Ace inhibitor or arb therapy not prescribed during the measurement period, reason not given",09/11/2025
M1204,"Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4",09/11/2025
M1205,Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score,09/11/2025
M1206,Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter,09/11/2025
M1207,"Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety",09/11/2025
M1208,"Patient is not screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety",09/11/2025
M1209,"At least two orders for high-risk medications from the same drug class, (table 4), without appropriate diagnoses",09/11/2025
M1210,"At least two orders for high-risk medications from the same drug class, (table 4), not ordered",09/11/2025
M1211,Most recent glycemic status assessment (hba1c or gmi) level > 9.0%,09/11/2025
M1212,"Glycemic status assessment (hba1c or gmi) level is missing, or was not performed during the measurement period",09/11/2025
M1213,No history of spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) and present spirometry is >= 70%,09/11/2025
M1214,Spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and reviewed,09/11/2025
M1215,"Documentation of medical reason(s) for not documenting and reviewing spirometry results (e.g., patients with dementia or tracheostomy)",09/11/2025
M1216,No spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and/or no spirometry performed with results documented during the encounter,09/11/2025
M1217,"Documentation of system reason(s) for not documenting and reviewing spirometry results (e.g., spirometry equipment not available at the time of the encounter)",09/11/2025
M1218,"Patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)",09/11/2025
M1219,Anaphylaxis due to the vaccine on or before the date of the encounter,09/11/2025
M1220,Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; with evidence of retinopathy,09/11/2025
M1221,Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; without evidence of retinopathy,09/11/2025
M1222,"Glaucoma plan of care not documented, reason not otherwise specified",09/11/2025
M1223,Glaucoma plan of care documented,09/11/2025
M1224,Intraocular pressure (iop) reduced by a value less than 20% from the pre-intervention level,09/11/2025
M1225,Intraocular pressure (iop) reduced by a value of greater than or equal to 20% from the pre-intervention level,09/11/2025
M1226,"Iop measurement not documented, reason not otherwise specified",09/11/2025
M1227,Evidence-based therapy was prescribed,09/11/2025
M1228,"Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test",09/11/2025
M1229,"Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection",09/11/2025
M1230,"Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given",09/11/2025
M1231,Patient receives hcv antibody test with nonreactive result,09/11/2025
M1232,Patient receives hcv antibody test with reactive result,09/11/2025
M1233,"Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given",09/11/2025
M1234,"Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia",09/11/2025
M1235,Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period,09/11/2025
M1236,Baseline mrs > 2,09/11/2025
M1237,"Patient reason for not screening for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety (e.g., patient declined or other patient reasons)",09/11/2025
M1238,"Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)",09/11/2025
M1239,Patient did not respond to the question of patient felt heard and understood by this provider and team,09/11/2025
M1240,Patient did not respond to the question of patient felt this provider and team put my best interests first when making recommendations about my care,09/11/2025
M1241,"Patient did not respond to the question of patient felt this provider and team saw me as a person, not just someone with a medical problem",09/11/2025
M1242,Patient did not respond to the question of patient felt this provider and team understood what is important to me in my life,09/11/2025
M1243,"Patient provided a response other than ""completely true"" for the question of patient felt heard and understood by this provider and team",09/11/2025
M1244,"Patient provided a response other than ""completely true"" for the question of patient felt this provider and team put my best interests first when making recommendations about my care",09/11/2025
M1245,"Patient provided a response other than ""completely true"" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem",09/11/2025
M1246,"Patient provided a response other than ""completely true"" for the question of patient felt this provider and team understood what is important to me in my life",09/11/2025
M1247,"Patient responded ""completely true"" for the question of patient felt this provider and team put my best interests first when making recommendations about my care",09/11/2025
M1248,"Patient responded ""completely true"" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem",09/11/2025
M1249,"Patient responded ""completely true"" for the question of patient felt this provider and team understood what is important to me in my life",09/11/2025
M1250,"Patient responded as ""completely true"" for the question of patient felt heard and understood by this provider and team",09/11/2025
M1251,Patients for whom a proxy completed the entire hu survey on their behalf for any reason (no patient involvement),09/11/2025
M1252,Patients who did not complete at least one of the four patient experience hu survey items and return the hu survey within 60 days of the ambulatory palliative care visit,09/11/2025
M1253,Patients who respond on the patient experience hu survey that they did not receive care by the listed ambulatory palliative care provider in the last 60 days (disavowal),09/11/2025
M1254,Patients who were deceased when the hu survey reached them,09/11/2025
M1255,"Patients who have another reason for visiting the clinic [not prenatal or postpartum care] and have a positive pregnancy test but have not established the clinic as an ob provider (e.g., plan to terminate the pregnancy or seek prenatal services elsewhere)",09/11/2025
M1256,Prior history of known cvd,09/11/2025
M1257,"Cvd risk assessment not performed or incomplete (e.g., cvd risk assessment was not documented), reason not otherwise specified",09/11/2025
M1258,"Cvd risk assessment performed, have a documented calculated risk score",09/11/2025
M1259,Patient status documented within the first year of initiating dialysis,09/11/2025
M1260,Patient status not documented within the first year of initiating dialysis,09/11/2025
M1261,Patients that were on the kidney or kidney-pancreas waitlist prior to initiation of dialysis,09/11/2025
M1262,Patients who had a transplant prior to initiation of dialysis,09/11/2025
M1263,Patients in hospice on their initiation of dialysis date or during the month of evaluation,09/11/2025
M1264,Patients age 75 or older on their initiation of dialysis date,09/11/2025
M1265,Cms medical evidence form 2728 for dialysis patients: initial form completed,09/11/2025
M1266,Patients admitted to a skilled nursing facility (snf),09/11/2025
M1267,Patients not observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period,09/11/2025
M1268,Patients observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period,09/11/2025
M1269,Receiving esrd mcp dialysis services by the provider on the last day of the reporting month,09/11/2025
M1270,Patients not on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period,09/11/2025
M1271,Patients with dementia at any time prior to or during the month,09/11/2025
M1272,Patients observed on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period,09/11/2025
M1273,Patients who were admitted to a skilled nursing facility (snf) within one year of dialysis initiation according to the cms-2728 form,09/11/2025
M1274,Patients who were admitted to a skilled nursing facility (snf) during the month of evaluation were excluded from that month,09/11/2025
M1275,Patients determined to be in hospice were excluded from month of evaluation and the remainder of reporting period,09/11/2025
M1276,"Bmi documented outside normal parameters, no follow-up plan documented, no reason given",09/11/2025
M1277,Colorectal cancer screening results documented and reviewed,09/11/2025
M1278,"Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented",09/11/2025
M1279,"Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given",09/11/2025
M1280,Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy,09/11/2025
M1281,"Blood pressure reading not documented, reason not given",09/11/2025
M1282,Patient screened for tobacco use and identified as a tobacco non-user,09/11/2025
M1283,Patient screened for tobacco use and identified as a tobacco user,09/11/2025
M1284,"Patients age 66 or older in institutional special needs plans (snp) or residing in long term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period",09/11/2025
M1285,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified",09/11/2025
M1286,"Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason",09/11/2025
M1287,Bmi is documented below normal parameters and a follow-up plan is documented,09/11/2025
M1288,Documented reason for not screening or recommending a follow-up for high blood pressure,09/11/2025
M1289,Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy),09/11/2025
M1290,Patient not eligible due to active diagnosis of hypertension,09/11/2025
M1291,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,09/11/2025
M1292,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,09/11/2025
M1293,Bmi is documented above normal parameters and a follow-up plan is documented,09/11/2025
M1294,"Normal blood pressure reading documented, follow-up not required",09/11/2025
M1295,Patients with a diagnosis or past history of total colectomy or colorectal cancer,09/11/2025
M1296,Bmi is documented within normal parameters and no follow-up plan is required,09/11/2025
M1297,Bmi not documented due to medical reason or patient refusal of height or weight measurement,09/11/2025
M1298,Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter,09/11/2025
M1299,Influenza immunization administered or previously received,09/11/2025
M1300,"Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)",09/11/2025
M1301,Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy),09/11/2025
M1302,"Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed",09/11/2025
M1303,Hospice services provided to patient any time during the measurement period,09/11/2025
M1304,Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period,09/11/2025
M1305,Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period,09/11/2025
M1306,Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period,09/11/2025
M1307,Documentation stating the patient has received or is currently receiving palliative or hospice care,09/11/2025
M1308,"Influenza immunization was not administered, reason not given",09/11/2025
M1309,Palliative care services provided to patient any time during the measurement period,09/11/2025
M1310,"Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user",09/11/2025
M1311,Anaphylaxis due to the vaccine on or before the date of the encounter,09/11/2025
M1312,Patient not screened for tobacco use,09/11/2025
M1313,Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period,09/11/2025
M1314,Bmi not documented and no reason is given,09/11/2025
M1315,Colorectal cancer screening results were not documented and reviewed; reason not otherwise specified,09/11/2025
M1316,Current tobacco non-user,09/11/2025
M1317,Patients who are counseled on connection with a csp and explicitly opt out,09/11/2025
M1318,Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp,09/11/2025
M1319,Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening,09/11/2025
M1320,Patients who screened positive for at least 1 of the 5 hrsns,09/11/2025
M1321,Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hg,09/11/2025
M1322,Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye,09/11/2025
M1323,Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented,09/11/2025
M1324,"Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)",09/11/2025
M1325,"Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)",09/11/2025
M1326,Patients with a diagnosis of hypotony,09/11/2025
M1327,Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks,09/11/2025
M1328,Patients with a diagnosis of acute vitreous hemorrhage,09/11/2025
M1329,Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter,09/11/2025
M1330,"Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)",09/11/2025
M1331,Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam,09/11/2025
M1332,Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks,09/11/2025
M1333,Acute vitreous hemorrhage,09/11/2025
M1334,Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter,09/11/2025
M1335,"Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)",09/11/2025
M1336,Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks,09/11/2025
M1337,Acute pvd,09/11/2025
M1338,Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period,09/11/2025
M1339,Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period,09/11/2025
M1340,Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period,09/11/2025
M1341,Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period,09/11/2025
M1342,Patients who died during the performance period,09/11/2025
M1343,Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam or with excessive missing responses,09/11/2025
M1344,Patients who did not have a baseline pam score and/or a second score within 4 to 12 months of baseline pam score,09/11/2025
M1345,Patients who had a baseline pam score and a second score within 4 to 12 month of baseline pam score,09/11/2025
M1346,Patients who did not have a net increase in pam score of at least 6 points within a 4 to 12 month period,09/11/2025
M1347,Patients who achieved a net increase in pam score of at least 3 points in a 4 to 12 month period (passing),09/11/2025
M1348,Patients who achieved a net increase in pam score of at least 6-points in a 4 to 12 month period (excellent),09/11/2025
M1349,Patients who did not have a net increase in pam score of at least 3 points within a 4 to 12 month period,09/11/2025
M1350,"Patients who had a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter",09/11/2025
M1351,"Patients who had a suicide safety plan initiated, reviewed, or updated and reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation",09/11/2025
M1352,Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessment,09/11/2025
M1353,"Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter",09/11/2025
M1354,"Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation",09/11/2025
M1355,Suicide risk based on their clinician's evaluation or a clinician-rated tool,09/11/2025
M1356,Patients who died during the measurement period,09/11/2025
M1357,Patients who had a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment,09/11/2025
M1358,Patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment,09/11/2025
M1359,Index assessment during the denominator period when the suicidal ideation and/or behavior symptoms or increased suicide risk by clinician determination occurs and a non-zero c-ssrs score is obtained,09/11/2025
M1360,Suicidal ideation and/or behavior symptoms based on the c-ssrs,09/11/2025
M1361,Suicide risk based on their clinician's evaluation or a clinician-rated tool,09/11/2025
M1362,Patients who died during the measurement period,09/11/2025
M1363,Patients who did not have a follow-up assessment within 120 days of the index assessment,09/11/2025
M1364,Calculated 10-year ascvd risk score of >= 20 percent during the performance period,09/11/2025
M1365,Patient encounter during the performance period with hospice and palliative care specialty code 17,09/11/2025
M1366,Focusing on women's health mips value pathway,09/11/2025
M1367,"Quality care for the treatment of ear, nose, and throat disorders mips value pathway",09/11/2025
M1368,Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway,09/11/2025
M1369,Quality care in mental health and substance use disorders mips value pathway,09/11/2025
M1370,Rehabilitative support for musculoskeletal care mips value pathway,09/11/2025
M1371,Most recent glycemic status assessment (hba1c or gmi) level < 7.0%,09/11/2025
M1372,Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%,09/11/2025
M1373,Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0%,09/11/2025
M1374,An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period,09/11/2025
M1375,An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period,09/11/2025
M1376,An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period,09/11/2025
M1377,Recommended follow-up interval for repeat colonoscopy of 10 years documented  in colonoscopy report and communicated with patient,09/11/2025
M1378,"Documentation of medical reason(s) for not recommending a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is >= 66 years old, or life expectancy < 10 years, other medical reasons)",09/11/2025
M1379,"A 10 year follow-up interval for colonoscopy not recommended, reason not otherwise specified",09/11/2025
M1380,"Filled at least two prescriptions during the performance period for any combination of the qualifying oral antipsychotic medications listed under ""denominator note"" or the long-acting injectable antipsychotic medications listed under ""denominator note""",09/11/2025
M1381,"Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedure",09/11/2025
M1382,Patient encounter during the performance period with place of service code 11,09/11/2025
M1383,Acute pvd,09/11/2025
M1384,Patients who died during the performance period,09/11/2025
M1385,"Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up",09/11/2025
M1386,"Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period",09/11/2025
M1387,Patients who died during the performance period,09/11/2025
M1388,Patients with documentation of an exam performed for recurrence of melanoma,09/11/2025
M1390,Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period,09/11/2025
M1391,All patients who were diagnosed with recurrent melanoma during the current performance period,09/11/2025
M1392,"Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)",09/11/2025
M1393,Patients who were not diagnosed with recurrent melanoma during the current performance period,09/11/2025
M1394,Stages i-iii breast cancer,09/11/2025
M1395,Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group,09/11/2025
M1396,Patients on a therapeutic clinical trial,09/11/2025
M1397,Patients with recurrence/disease progression,09/11/2025
M1398,Patients with baseline and follow-up promis surveys documented in the medical record,09/11/2025
M1399,Patients who leave the practice during the follow-up period,09/11/2025
M1400,Patients who died during the follow-up period,09/11/2025
M1401,Stages i-iii breast cancer,09/11/2025
M1402,Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group,09/11/2025
M1403,Patients with baseline and follow-up promis surveys documented in the medical record,09/11/2025
M1404,Patients on a therapeutic clinical trial,09/11/2025
M1405,Patients with recurrence/disease progression,09/11/2025
M1406,Patients who leave the practice during the follow-up period,09/11/2025
M1407,Patients who died during the follow-up period,09/11/2025
M1408,"Patients who have germline brca testing completed before diagnosis of epithelial ovarian, fallopian tube, or primary peritoneal cancer",09/11/2025
M1409,Patients who received germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis,09/11/2025
M1410,Patients who did not have germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis,09/11/2025
M1411,Currently on first-line immune checkpoint inhibitors without chemotherapy,09/11/2025
M1412,"Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement",09/11/2025
M1413,Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy,09/11/2025
M1414,"Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication)",09/11/2025
M1415,Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy,09/11/2025
M1416,Patient received hospice services any time during the performance period,09/11/2025
M1417,Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination,09/11/2025
M1418,Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by clinician,09/11/2025
M1419,Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination,09/11/2025
M1420,Complete ophthalmologic care mips value pathway,09/11/2025
M1421,Dermatological care mips value pathway,09/11/2025
M1422,Gastroenterology care mips value pathway,09/11/2025
M1423,Optimal care for patients with urologic conditions mips value pathway,09/11/2025
M1424,Pulmonology care mips value pathway,09/11/2025
M1425,Surgical care mips value pathway,09/11/2025
P2028,"Cephalin floculation, blood",09/11/2025
P2029,"Congo red, blood",09/11/2025
P2031,Hair analysis (excluding arsenic),09/11/2025
P2033,"Thymol turbidity, blood",09/11/2025
P2038,"Mucoprotein, blood (seromucoid) (medical necessity procedure)",09/11/2025
P3000,"Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision",09/11/2025
P3001,"Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician",09/11/2025
P7001,"Culture, bacterial, urine; quantitative, sensitivity study",09/11/2025
P9010,"Blood (whole), for transfusion, per unit",09/11/2025
P9011,"Blood, split unit",09/11/2025
P9012,"Cryoprecipitate, each unit",09/11/2025
P9016,"Red blood cells, leukocytes reduced, each unit",09/11/2025
P9017,"Fresh frozen plasma (single donor), frozen within 8 hours of collection, each unit",09/11/2025
P9019,"Platelets, each unit",09/11/2025
P9020,"Platelet rich plasma, each unit",09/11/2025
P9021,"Red blood cells, each unit",09/11/2025
P9022,"Red blood cells, washed, each unit",09/11/2025
P9023,"Plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit",09/11/2025
P9025,"Plasma, cryoprecipitate reduced, pathogen reduced, each unit",09/11/2025
P9026,"Cryoprecipitated fibrinogen complex, pathogen reduced, each unit",09/11/2025
P9027,"Red blood cells, leukocytes reduced, oxygen/ carbon dioxide reduced, each unit",09/11/2025
P9031,"Platelets, leukocytes reduced, each unit",09/11/2025
P9032,"Platelets, irradiated, each unit",09/11/2025
P9033,"Platelets, leukocytes reduced, irradiated, each unit",09/11/2025
P9034,"Platelets, pheresis, each unit",09/11/2025
P9035,"Platelets, pheresis, leukocytes reduced, each unit",09/11/2025
P9036,"Platelets, pheresis, irradiated, each unit",09/11/2025
P9037,"Platelets, pheresis, leukocytes reduced, irradiated, each unit",09/11/2025
P9038,"Red blood cells, irradiated, each unit",09/11/2025
P9039,"Red blood cells, deglycerolized, each unit",09/11/2025
P9040,"Red blood cells, leukocytes reduced, irradiated, each unit",09/11/2025
P9041,"Infusion, albumin (human), 5%, 50 ml",09/11/2025
P9043,"Infusion, plasma protein fraction (human), 5%, 50 ml",09/11/2025
P9044,"Plasma, cryoprecipitate reduced, each unit",09/11/2025
P9045,"Infusion, albumin (human), 5%, 250 ml",09/11/2025
P9046,"Infusion, albumin (human), 25%, 20 ml",09/11/2025
P9047,"Infusion, albumin (human), 25%, 50 ml",09/11/2025
P9048,"Infusion, plasma protein fraction (human), 5%, 250 ml",09/11/2025
P9050,"Granulocytes, pheresis, each unit",09/11/2025
P9051,"Whole blood or red blood cells, leukocytes reduced, cmv-negative, each unit",09/11/2025
P9052,"Platelets, hla-matched leukocytes reduced, apheresis/pheresis, each unit",09/11/2025
P9053,"Platelets, pheresis, leukocytes reduced, cmv-negative, irradiated, each unit",09/11/2025
P9054,"Whole blood or red blood cells, leukocytes reduced, frozen, deglycerol, washed, each unit",09/11/2025
P9055,"Platelets, leukocytes reduced, cmv-negative, apheresis/pheresis, each unit",09/11/2025
P9056,"Whole blood, leukocytes reduced, irradiated, each unit",09/11/2025
P9057,"Red blood cells, frozen/deglycerolized/washed, leukocytes reduced, irradiated, each unit",09/11/2025
P9058,"Red blood cells, leukocytes reduced, cmv-negative, irradiated, each unit",09/11/2025
P9059,"Fresh frozen plasma between 8-24 hours of collection, each unit",09/11/2025
P9060,"Fresh frozen plasma, donor retested, each unit",09/11/2025
P9070,"Plasma, pooled multiple donor, pathogen reduced, frozen, each unit",09/11/2025
P9071,"Plasma (single donor), pathogen reduced, frozen, each unit",09/11/2025
P9072,"Platelets, pheresis, pathogen reduced or rapid bacterial tested, each unit",09/11/2025
P9073,"Platelets, pheresis, pathogen-reduced, each unit",09/11/2025
P9099,Blood component or product not otherwise classified,09/11/2025
P9100,Pathogen(s) test for platelets,09/11/2025
P9603,Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled,09/11/2025
P9604,Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge,09/11/2025
P9612,"Catheterization for collection of specimen, single patient, all places of service",09/11/2025
P9615,Catheterization for collection of specimen(s) (multiple patients),09/11/2025
Q0035,Cardiokymography,09/11/2025
Q0081,"Infusion therapy, using other than chemotherapeutic drugs, per visit",09/11/2025
Q0083,"Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit",09/11/2025
Q0084,"Chemotherapy administration by infusion technique only, per visit",09/11/2025
Q0085,"Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit",09/11/2025
Q0091,"Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory",09/11/2025
Q0092,Set-up portable x-ray equipment,09/11/2025
Q0111,"Wet mounts, including preparations of vaginal, cervical or skin specimens",09/11/2025
Q0112,All potassium hydroxide (koh) preparations,09/11/2025
Q0113,Pinworm examinations,09/11/2025
Q0114,Fern test,09/11/2025
Q0115,"Post-coital direct, qualitative examinations of vaginal or cervical mucous",09/11/2025
Q0138,"Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)",09/11/2025
Q0139,"Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)",09/11/2025
Q0144,"Azithromycin dihydrate, oral, capsules/powder, 1 gram",09/11/2025
Q0155,"Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09/11/2025
Q0161,"Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09/11/2025
Q0162,"Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09/11/2025
Q0163,"Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen",09/11/2025
Q0164,"Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09/11/2025
Q0166,"Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen",09/11/2025
Q0167,"Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09/11/2025
Q0169,"Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09/11/2025
Q0173,"Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09/11/2025
Q0174,"Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09/11/2025
Q0175,"Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09/11/2025
Q0177,"Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09/11/2025
Q0180,"Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen",09/11/2025
Q0181,"Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",09/11/2025
Q0220,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg",09/11/2025
Q0221,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg",09/11/2025
Q0222,"Injection, bebtelovimab, 175 mg",09/11/2025
Q0224,"Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg",09/11/2025
Q0235,"Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg",09/11/2025
Q0237,"Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg",09/11/2025
Q0239,"Injection, bamlanivimab-xxxx, 700 mg",09/11/2025
Q0240,"Injection, casirivimab and imdevimab, 600 mg",09/11/2025
Q0243,"Injection, casirivimab and imdevimab, 2400 mg",09/11/2025
Q0244,"Injection, casirivimab and imdevimab, 1200 mg",09/11/2025
Q0245,"Injection, bamlanivimab and etesevimab, 2100 mg",09/11/2025
Q0247,"Injection, sotrovimab, 500 mg",09/11/2025
Q0249,"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg",09/11/2025
Q0477,"Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0478,"Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type",09/11/2025
Q0479,"Power module for use with electric or electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0480,"Driver for use with pneumatic ventricular assist device, replacement only",09/11/2025
Q0481,"Microprocessor control unit for use with electric ventricular assist device, replacement only",09/11/2025
Q0482,"Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only",09/11/2025
Q0483,"Monitor/display module for use with electric ventricular assist device, replacement only",09/11/2025
Q0484,"Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0485,"Monitor control cable for use with electric ventricular assist device, replacement only",09/11/2025
Q0486,"Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0487,"Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0488,"Power pack base for use with electric ventricular assist device, replacement only",09/11/2025
Q0489,"Power pack base for use with electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0490,"Emergency power source for use with electric ventricular assist device, replacement only",09/11/2025
Q0491,"Emergency power source for use with electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0492,"Emergency power supply cable for use with electric ventricular assist device, replacement only",09/11/2025
Q0493,"Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0494,"Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0495,"Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0496,"Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0497,"Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0498,"Holster for use with electric or electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0499,"Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only",09/11/2025
Q0500,"Filters for use with electric or electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0501,"Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0502,"Mobility cart for pneumatic ventricular assist device, replacement only",09/11/2025
Q0503,"Battery for pneumatic ventricular assist device, replacement only, each",09/11/2025
Q0504,"Power adapter for pneumatic ventricular assist device, replacement only, vehicle type",09/11/2025
Q0506,"Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only",09/11/2025
Q0507,Miscellaneous supply or accessory for use with an external ventricular assist device,09/11/2025
Q0508,Miscellaneous supply or accessory for use with an implanted ventricular assist device,09/11/2025
Q0509,Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a,09/11/2025
Q0510,"Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant",09/11/2025
Q0511,"Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period",09/11/2025
Q0512,"Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period",09/11/2025
Q0513,Pharmacy dispensing fee for inhalation drug(s); per 30 days,09/11/2025
Q0514,Pharmacy dispensing fee for inhalation drug(s); per 90 days,09/11/2025
Q0515,"Injection, sermorelin acetate, 1 microgram",09/11/2025
Q0516,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days",09/11/2025
Q0517,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days",09/11/2025
Q0518,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days",09/11/2025
Q0519,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days",09/11/2025
Q0520,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days",09/11/2025
Q0521,Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription,09/11/2025
Q1004,New technology intraocular lens category 4 as defined in federal register notice,09/11/2025
Q1005,New technology intraocular lens category 5 as defined in federal register notice,09/11/2025
Q2004,"Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml",09/11/2025
Q2009,"Injection, fosphenytoin, 50 mg phenytoin equivalent",09/11/2025
Q2017,"Injection, teniposide, 50 mg",09/11/2025
Q2026,"Injection, radiesse, 0.1 ml",09/11/2025
Q2028,"Injection, sculptra, 0.5 mg",09/11/2025
Q2034,"Influenza virus vaccine, split virus, for intramuscular use (agriflu)",09/11/2025
Q2035,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)",09/11/2025
Q2036,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)",09/11/2025
Q2037,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)",09/11/2025
Q2038,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)",09/11/2025
Q2039,"Influenza virus vaccine, not otherwise specified",09/11/2025
Q2040,"Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion",09/11/2025
Q2041,"Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
Q2042,"Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
Q2043,"Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion",09/11/2025
Q2049,"Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg",09/11/2025
Q2050,"Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg",09/11/2025
Q2052,"Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)",09/11/2025
Q2053,"Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
Q2054,"Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
Q2055,"Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
Q2056,"Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
Q2057,"Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose",09/11/2025
Q2058,"Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion",09/11/2025
Q3001,"Radioelements for brachytherapy, any type, each",09/11/2025
Q3014,Telehealth originating site facility fee,09/11/2025
Q3027,"Injection, interferon beta-1a, 1 mcg for intramuscular use",09/11/2025
Q3028,"Injection, interferon beta-1a, 1 mcg for subcutaneous use",09/11/2025
Q3031,Collagen skin test,09/11/2025
Q4001,"Casting supplies, body cast adult, with or without head, plaster",09/11/2025
Q4002,"Cast supplies, body cast adult, with or without head, fiberglass",09/11/2025
Q4003,"Cast supplies, shoulder cast, adult (11 years +), plaster",09/11/2025
Q4004,"Cast supplies, shoulder cast, adult (11 years +), fiberglass",09/11/2025
Q4005,"Cast supplies, long arm cast, adult (11 years +), plaster",09/11/2025
Q4006,"Cast supplies, long arm cast, adult (11 years +), fiberglass",09/11/2025
Q4007,"Cast supplies, long arm cast, pediatric (0-10 years), plaster",09/11/2025
Q4008,"Cast supplies, long arm cast, pediatric (0-10 years), fiberglass",09/11/2025
Q4009,"Cast supplies, short arm cast, adult (11 years +), plaster",09/11/2025
Q4010,"Cast supplies, short arm cast, adult (11 years +), fiberglass",09/11/2025
Q4011,"Cast supplies, short arm cast, pediatric (0-10 years), plaster",09/11/2025
Q4012,"Cast supplies, short arm cast, pediatric (0-10 years), fiberglass",09/11/2025
Q4013,"Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster",09/11/2025
Q4014,"Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass",09/11/2025
Q4015,"Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster",09/11/2025
Q4016,"Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass",09/11/2025
Q4017,"Cast supplies, long arm splint, adult (11 years +), plaster",09/11/2025
Q4018,"Cast supplies, long arm splint, adult (11 years +), fiberglass",09/11/2025
Q4019,"Cast supplies, long arm splint, pediatric (0-10 years), plaster",09/11/2025
Q4020,"Cast supplies, long arm splint, pediatric (0-10 years), fiberglass",09/11/2025
Q4021,"Cast supplies, short arm splint, adult (11 years +), plaster",09/11/2025
Q4022,"Cast supplies, short arm splint, adult (11 years +), fiberglass",09/11/2025
Q4023,"Cast supplies, short arm splint, pediatric (0-10 years), plaster",09/11/2025
Q4024,"Cast supplies, short arm splint, pediatric (0-10 years), fiberglass",09/11/2025
Q4025,"Cast supplies, hip spica (one or both legs), adult (11 years +), plaster",09/11/2025
Q4026,"Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass",09/11/2025
Q4027,"Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster",09/11/2025
Q4028,"Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass",09/11/2025
Q4029,"Cast supplies, long leg cast, adult (11 years +), plaster",09/11/2025
Q4030,"Cast supplies, long leg cast, adult (11 years +), fiberglass",09/11/2025
Q4031,"Cast supplies, long leg cast, pediatric (0-10 years), plaster",09/11/2025
Q4032,"Cast supplies, long leg cast, pediatric (0-10 years), fiberglass",09/11/2025
Q4033,"Cast supplies, long leg cylinder cast, adult (11 years +), plaster",09/11/2025
Q4034,"Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass",09/11/2025
Q4035,"Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster",09/11/2025
Q4036,"Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass",09/11/2025
Q4037,"Cast supplies, short leg cast, adult (11 years +), plaster",09/11/2025
Q4038,"Cast supplies, short leg cast, adult (11 years +), fiberglass",09/11/2025
Q4039,"Cast supplies, short leg cast, pediatric (0-10 years), plaster",09/11/2025
Q4040,"Cast supplies, short leg cast, pediatric (0-10 years), fiberglass",09/11/2025
Q4041,"Cast supplies, long leg splint, adult (11 years +), plaster",09/11/2025
Q4042,"Cast supplies, long leg splint, adult (11 years +), fiberglass",09/11/2025
Q4043,"Cast supplies, long leg splint, pediatric (0-10 years), plaster",09/11/2025
Q4044,"Cast supplies, long leg splint, pediatric (0-10 years), fiberglass",09/11/2025
Q4045,"Cast supplies, short leg splint, adult (11 years +), plaster",09/11/2025
Q4046,"Cast supplies, short leg splint, adult (11 years +), fiberglass",09/11/2025
Q4047,"Cast supplies, short leg splint, pediatric (0-10 years), plaster",09/11/2025
Q4048,"Cast supplies, short leg splint, pediatric (0-10 years), fiberglass",09/11/2025
Q4049,"Finger splint, static",09/11/2025
Q4050,"Cast supplies, for unlisted types and materials of casts",09/11/2025
Q4051,"Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)",09/11/2025
Q4074,"Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms",09/11/2025
Q4081,"Injection, epoetin alfa, 100 units (for esrd on dialysis)",09/11/2025
Q4082,"Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)",09/11/2025
Q4100,"Skin substitute, not otherwise specified",09/11/2025
Q4101,"Apligraf, per square centimeter",09/11/2025
Q4102,"Oasis wound matrix, per square centimeter",09/11/2025
Q4103,"Oasis burn matrix, per square centimeter",09/11/2025
Q4104,"Integra bilayer matrix wound dressing (bmwd), per square centimeter",09/11/2025
Q4105,"Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter",09/11/2025
Q4106,"Dermagraft, per square centimeter",09/11/2025
Q4107,"Graftjacket, per square centimeter",09/11/2025
Q4108,"Integra matrix, per square centimeter",09/11/2025
Q4110,"Primatrix, per square centimeter",09/11/2025
Q4111,"Gammagraft, per square centimeter",09/11/2025
Q4112,"Cymetra, injectable, 1 cc",09/11/2025
Q4113,"Graftjacket xpress, injectable, 1 cc",09/11/2025
Q4114,"Integra flowable wound matrix, injectable, 1 cc",09/11/2025
Q4115,"Alloskin, per square centimeter",09/11/2025
Q4116,"Alloderm, per square centimeter",09/11/2025
Q4117,"Hyalomatrix, per square centimeter",09/11/2025
Q4118,"Matristem micromatrix, 1 mg",09/11/2025
Q4119,"Matristem wound matrix, per square centimeter",09/11/2025
Q4120,"Matristem burn matrix, per square centimeter",09/11/2025
Q4121,"Theraskin, per square centimeter",09/11/2025
Q4122,"Dermacell, dermacell awm or dermacell awm porous, per square centimeter",09/11/2025
Q4123,"Alloskin rt, per square centimeter",09/11/2025
Q4124,"Oasis ultra tri-layer wound matrix, per square centimeter",09/11/2025
Q4125,"Arthroflex, per square centimeter",09/11/2025
Q4126,"Memoderm, dermaspan, tranzgraft or integuply, per square centimeter",09/11/2025
Q4127,"Talymed, per square centimeter",09/11/2025
Q4128,"Flex hd, or allopatch hd, per square centimeter",09/11/2025
Q4129,"Unite biomatrix, per square centimeter",09/11/2025
Q4130,"Strattice tm, per square centimeter",09/11/2025
Q4131,"Epifix or epicord, per square centimeter",09/11/2025
Q4132,"Grafix core and grafixpl core, per square centimeter",09/11/2025
Q4133,"Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter",09/11/2025
Q4134,"Hmatrix, per square centimeter",09/11/2025
Q4135,"Mediskin, per square centimeter",09/11/2025
Q4136,"Ez-derm, per square centimeter",09/11/2025
Q4137,"Amnioexcel, amnioexcel plus or biodexcel, per square centimeter",09/11/2025
Q4138,"Biodfence dryflex, per square centimeter",09/11/2025
Q4139,"Amniomatrix or biodmatrix, injectable, 1 cc",09/11/2025
Q4140,"Biodfence, per square centimeter",09/11/2025
Q4141,"Alloskin ac, per square centimeter",09/11/2025
Q4142,"Xcm biologic tissue matrix, per square centimeter",09/11/2025
Q4143,"Repriza, per square centimeter",09/11/2025
Q4145,"Epifix, injectable, 1 mg",09/11/2025
Q4146,"Tensix, per square centimeter",09/11/2025
Q4147,"Architect, architect px, or architect fx, extracellular matrix, per square centimeter",09/11/2025
Q4148,"Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter",09/11/2025
Q4149,"Excellagen, 0.1 cc",09/11/2025
Q4150,"Allowrap ds or dry, per square centimeter",09/11/2025
Q4151,"Amnioband or guardian, per square centimeter",09/11/2025
Q4152,"Dermapure, per square centimeter",09/11/2025
Q4153,"Dermavest and plurivest, per square centimeter",09/11/2025
Q4154,"Biovance, per square centimeter",09/11/2025
Q4155,"Neoxflo or clarixflo, 1 mg",09/11/2025
Q4156,"Neox 100 or clarix 100, per square centimeter",09/11/2025
Q4157,"Revitalon, per square centimeter",09/11/2025
Q4158,"Kerecis omega3, per square centimeter",09/11/2025
Q4159,"Affinity, per square centimeter",09/11/2025
Q4160,"Nushield, per square centimeter",09/11/2025
Q4161,"Bio-connekt wound matrix, per square centimeter",09/11/2025
Q4162,"Woundex flow, bioskin flow, 0.5 cc",09/11/2025
Q4163,"Woundex, bioskin, per square centimeter",09/11/2025
Q4164,"Helicoll, per square centimeter",09/11/2025
Q4165,"Keramatrix or kerasorb, per square centimeter",09/11/2025
Q4166,"Cytal, per square centimeter",09/11/2025
Q4167,"Truskin, per square centimeter",09/11/2025
Q4168,"Amnioband, 1 mg",09/11/2025
Q4169,"Artacent wound, per square centimeter",09/11/2025
Q4170,"Cygnus, per square centimeter",09/11/2025
Q4171,"Interfyl, 1 mg",09/11/2025
Q4172,"Puraply or puraply am, per square centimeter",09/11/2025
Q4173,"Palingen or palingen xplus, per square centimeter",09/11/2025
Q4174,"Palingen or promatrx, 0.36 mg per 0.25 cc",09/11/2025
Q4175,"Miroderm, per square centimeter",09/11/2025
Q4176,"Neopatch or therion, per square centimeter",09/11/2025
Q4177,"Floweramnioflo, 0.1 cc",09/11/2025
Q4178,"Floweramniopatch, per square centimeter",09/11/2025
Q4179,"Flowerderm, per square centimeter",09/11/2025
Q4180,"Revita, per square centimeter",09/11/2025
Q4181,"Amnio wound, per square centimeter",09/11/2025
Q4182,"Transcyte, per square centimeter",09/11/2025
Q4183,"Surgigraft, per square centimeter",09/11/2025
Q4184,"Cellesta or cellesta duo, per square centimeter",09/11/2025
Q4185,Cellesta flowable amnion (25 mg per cc); per 0.5 cc,09/11/2025
Q4186,"Epifix, per square centimeter",09/11/2025
Q4187,"Epicord, per square centimeter",09/11/2025
Q4188,"Amnioarmor, per square centimeter",09/11/2025
Q4189,"Artacent ac, 1 mg",09/11/2025
Q4190,"Artacent ac, per square centimeter",09/11/2025
Q4191,"Restorigin, per square centimeter",09/11/2025
Q4192,"Restorigin, 1 cc",09/11/2025
Q4193,"Coll-e-derm, per square centimeter",09/11/2025
Q4194,"Novachor, per square centimeter",09/11/2025
Q4195,"Puraply, per square centimeter",09/11/2025
Q4196,"Puraply am, per square centimeter",09/11/2025
Q4197,"Puraply xt, per square centimeter",09/11/2025
Q4198,"Genesis amniotic membrane, per square centimeter",09/11/2025
Q4199,"Cygnus matrix, per square centimeter",09/11/2025
Q4200,"Skin te, per square centimeter",09/11/2025
Q4201,"Matrion, per square centimeter",09/11/2025
Q4202,"Keroxx (2.5g/cc), 1cc",09/11/2025
Q4203,"Derma-gide, per square centimeter",09/11/2025
Q4204,"Xwrap, per square centimeter",09/11/2025
Q4205,"Membrane graft or membrane wrap, per square centimeter",09/11/2025
Q4206,"Fluid flow or fluid gf, 1 cc",09/11/2025
Q4208,"Novafix, per square cenitmeter",09/11/2025
Q4209,"Surgraft, per square centimeter",09/11/2025
Q4210,"Axolotl graft or axolotl dualgraft, per square centimeter",09/11/2025
Q4211,"Amnion bio or axobiomembrane, per square centimeter",09/11/2025
Q4212,"Allogen, per cc",09/11/2025
Q4213,"Ascent, 0.5 mg",09/11/2025
Q4214,"Cellesta cord, per square centimeter",09/11/2025
Q4215,"Axolotl ambient or axolotl cryo, 0.1 mg",09/11/2025
Q4216,"Artacent cord, per square centimeter",09/11/2025
Q4217,"Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter",09/11/2025
Q4218,"Surgicord, per square centimeter",09/11/2025
Q4219,"Surgigraft-dual, per square centimeter",09/11/2025
Q4220,"Bellacell hd or surederm, per square centimeter",09/11/2025
Q4221,"Amniowrap2, per square centimeter",09/11/2025
Q4222,"Progenamatrix, per square centimeter",09/11/2025
Q4224,"Human health factor 10 amniotic patch (hhf10-p), per square centimeter",09/11/2025
Q4225,"Amniobind or dermabind tl, per square centimeter",09/11/2025
Q4226,"Myown skin, includes harvesting and preparation procedures, per square centimeter",09/11/2025
Q4227,"Amniocore, per square centimeter",09/11/2025
Q4228,"Bionextpatch, per square centimeter",09/11/2025
Q4229,"Cogenex amniotic membrane, per square centimeter",09/11/2025
Q4230,"Cogenex flowable amnion, per 0.5 cc",09/11/2025
Q4231,"Corplex p, per cc",09/11/2025
Q4232,"Corplex, per square centimeter",09/11/2025
Q4233,"Surfactor or nudyn, per 0.5 cc",09/11/2025
Q4234,"Xcellerate, per square centimeter",09/11/2025
Q4235,"Amniorepair or altiply, per square centimeter",09/11/2025
Q4236,"Carepatch, per square centimeter",09/11/2025
Q4237,"Cryo-cord, per square centimeter",09/11/2025
Q4238,"Derm-maxx, per square centimeter",09/11/2025
Q4239,"Amnio-maxx or amnio-maxx lite, per square centimeter",09/11/2025
Q4240,"Corecyte, for topical use only, per 0.5 cc",09/11/2025
Q4241,"Polycyte, for topical use only, per 0.5 cc",09/11/2025
Q4242,"Amniocyte plus, per 0.5 cc",09/11/2025
Q4244,"Procenta, per 200 mg",09/11/2025
Q4245,"Amniotext, per cc",09/11/2025
Q4246,"Coretext or protext, per cc",09/11/2025
Q4247,"Amniotext patch, per square centimeter",09/11/2025
Q4248,"Dermacyte amniotic membrane allograft, per square centimeter",09/11/2025
Q4249,"Amniply, for topical use only, per square centimeter",09/11/2025
Q4250,"Amnioamp-mp, per square centimeter",09/11/2025
Q4251,"Vim, per square centimeter",09/11/2025
Q4252,"Vendaje, per square centimeter",09/11/2025
Q4253,"Zenith amniotic membrane, per square centimeter",09/11/2025
Q4254,"Novafix dl, per square centimeter",09/11/2025
Q4255,"Reguard, for topical use only, per square centimeter",09/11/2025
Q4256,"Mlg-complete, per square centimeter",09/11/2025
Q4257,"Relese, per square centimeter",09/11/2025
Q4258,"Enverse, per square centimeter",09/11/2025
Q4259,"Celera dual layer or celera dual membrane, per square centimeter",09/11/2025
Q4260,"Signature apatch, per square centimeter",09/11/2025
Q4261,"Tag, per square centimeter",09/11/2025
Q4262,"Dual layer impax membrane, per square centimeter",09/11/2025
Q4263,"Surgraft tl, per square centimeter",09/11/2025
Q4264,"Cocoon membrane, per square centimeter",09/11/2025
Q4265,"Neostim tl, per square centimeter",09/11/2025
Q4266,"Neostim membrane, per square centimeter",09/11/2025
Q4267,"Neostim dl, per square centimeter",09/11/2025
Q4268,"Surgraft ft, per square centimeter",09/11/2025
Q4269,"Surgraft xt, per square centimeter",09/11/2025
Q4270,"Complete sl, per square centimeter",09/11/2025
Q4271,"Complete ft, per square centimeter",09/11/2025
Q4272,"Esano a, per square centimeter",09/11/2025
Q4273,"Esano aaa, per square centimeter",09/11/2025
Q4274,"Esano ac, per square centimeter",09/11/2025
Q4275,"Esano aca, per square centimeter",09/11/2025
Q4276,"Orion, per square centimeter",09/11/2025
Q4277,"Woundplus membrane or e-graft, per square centimeter",09/11/2025
Q4278,"Epieffect, per square centimeter",09/11/2025
Q4279,"Vendaje ac, per square centimeter",09/11/2025
Q4280,"Xcell amnio matrix, per square centimeter",09/11/2025
Q4281,"Barrera sl or barrera dl, per square centimeter",09/11/2025
Q4282,"Cygnus dual, per square centimeter",09/11/2025
Q4283,"Biovance tri-layer or biovance 3l, per square centimeter",09/11/2025
Q4284,"Dermabind sl, per square centimeter",09/11/2025
Q4285,"Nudyn dl or nudyn dl mesh, per square centimeter",09/11/2025
Q4286,"Nudyn sl or nudyn slw, per square centimeter",09/11/2025
Q4287,"Dermabind dl, per square centimeter",09/11/2025
Q4288,"Dermabind ch, per square centimeter",09/11/2025
Q4289,"Revoshield + amniotic barrier, per square centimeter",09/11/2025
Q4290,"Membrane wrap-hydro, per square centimeter",09/11/2025
Q4291,"Lamellas xt, per square centimeter",09/11/2025
Q4292,"Lamellas, per square centimeter",09/11/2025
Q4293,"Acesso dl, per square centimeter",09/11/2025
Q4294,"Amnio quad-core, per square centimeter",09/11/2025
Q4295,"Amnio tri-core amniotic, per square centimeter",09/11/2025
Q4296,"Rebound matrix, per square centimeter",09/11/2025
Q4297,"Emerge matrix, per square centimeter",09/11/2025
Q4298,"Amnicore pro, per square centimeter",09/11/2025
Q4299,"Amnicore pro+, per square centimeter",09/11/2025
Q4300,"Acesso tl, per square centimeter",09/11/2025
Q4301,"Activate matrix, per square centimeter",09/11/2025
Q4302,"Complete aca, per square centimeter",09/11/2025
Q4303,"Complete aa, per square centimeter",09/11/2025
Q4304,"Grafix plus, per square centimeter",09/11/2025
Q4305,"American amnion ac tri-layer, per square centimeter",09/11/2025
Q4306,"American amnion ac, per square centimeter",09/11/2025
Q4307,"American amnion, per square centimeter",09/11/2025
Q4308,"Sanopellis, per square centimeter",09/11/2025
Q4309,"Via matrix, per square centimeter",09/11/2025
Q4310,"Procenta, per 100 mg",09/11/2025
Q4311,"Acesso, per square centimeter",09/11/2025
Q4312,"Acesso ac, per square centimeter",09/11/2025
Q4313,"Dermabind fm, per square centimeter",09/11/2025
Q4314,"Reeva ft, per square cenitmeter",09/11/2025
Q4315,"Regenelink amniotic membrane allograft, per square centimeter",09/11/2025
Q4316,"Amchoplast, per square centimeter",09/11/2025
Q4317,"Vitograft, per square centimeter",09/11/2025
Q4318,"E-graft, per square centimeter",09/11/2025
Q4319,"Sanograft, per square centimeter",09/11/2025
Q4320,"Pellograft, per square centimeter",09/11/2025
Q4321,"Renograft, per square centimeter",09/11/2025
Q4322,"Caregraft, per square centimeter",09/11/2025
Q4323,"Alloply, per square centimeter",09/11/2025
Q4324,"Amniotx, per square centimeter",09/11/2025
Q4325,"Acapatch, per square centimeter",09/11/2025
Q4326,"Woundplus, per square centimeter",09/11/2025
Q4327,"Duoamnion, per square centimeter",09/11/2025
Q4328,"Most, per square centimeter",09/11/2025
Q4329,"Singlay, per square centimeter",09/11/2025
Q4330,"Total, per square centimeter",09/11/2025
Q4331,"Axolotl graft, per square centimeter",09/11/2025
Q4332,"Axolotl dualgraft, per square centimeter",09/11/2025
Q4333,"Ardeograft, per square centimeter",09/11/2025
Q4334,"Amnioplast 1, per square centimeter",09/11/2025
Q4335,"Amnioplast 2, per square centimeter",09/11/2025
Q4336,"Artacent c, per square centimeter",09/11/2025
Q4337,"Artacent trident, per square centimeter",09/11/2025
Q4338,"Artacent velos, per square centimeter",09/11/2025
Q4339,"Artacent vericlen, per square centimeter",09/11/2025
Q4340,"Simpligraft, per square centimeter",09/11/2025
Q4341,"Simplimax, per square centimeter",09/11/2025
Q4342,"Theramend, per square centimeter",09/11/2025
Q4343,"Dermacyte ac matrix amniotic membrane allograft, per square centimeter",09/11/2025
Q4344,"Tri-membrane wrap, per square centimeter",09/11/2025
Q4345,"Matrix hd allograft dermis, per square centimeter",09/11/2025
Q4346,"Shelter dm matrix, per square centimeter",09/11/2025
Q4347,"Rampart dl matrix, per square centimeter",09/11/2025
Q4348,"Sentry sl matrix, per square centimeter",09/11/2025
Q4349,"Mantle dl matrix, per square centimeter",09/11/2025
Q4350,"Palisade dm matrix, per square centimeter",09/11/2025
Q4351,"Enclose tl matrix, per square centimeter",09/11/2025
Q4352,"Overlay sl matrix, per square centimeter",09/11/2025
Q4353,"Xceed tl matrix, per square centimeter",09/11/2025
Q4354,"Palingen dual-layer membrane, per square centimeter",09/11/2025
Q4355,"Abiomend xplus membrane and abiomend xplus hydromembrane, per square centimeter",09/11/2025
Q4356,"Abiomend membrane and abiomend hydromembrane, per square centimeter",09/11/2025
Q4357,"Xwrap plus, per square  centimeter",09/11/2025
Q4358,"Xwrap dual, per square  centimeter",09/11/2025
Q4359,"Choriply, per square centimeter",09/11/2025
Q4360,"Amchoplast fd, per square centimeter",09/11/2025
Q4361,"Epixpress, per square centimeter",09/11/2025
Q4362,"Cygnus disk, per square centimeter",09/11/2025
Q4363,"Amnio burgeon membrane and hydromembrane, per square centimeter",09/11/2025
Q4364,"Amnio burgeon xplus membrane and xplus hydromembrane, per square centimeter",09/11/2025
Q4365,"Amnio burgeon dual-layer membrane, per square centimeter",09/11/2025
Q4366,"Dual layer amnio burgeon x-membrane, per square centimeter",09/11/2025
Q4367,"Amniocore sl, per square centimeter",09/11/2025
Q4368,"Amchothick, per square centimeter",09/11/2025
Q4369,"Amnioplast 3, per square centimeter",09/11/2025
Q4370,"Aeroguard, per square centimeter",09/11/2025
Q4371,"Neoguard, per square centimeter",09/11/2025
Q4372,"Amchoplast excel, per square centimeter",09/11/2025
Q4373,"Membrane wrap lite, per square centimeter",09/11/2025
Q4375,"Duograft ac, per square centimeter",09/11/2025
Q4376,"Duograft aa, per square centimeter",09/11/2025
Q4377,"Trigraft ft, per square centimeter",09/11/2025
Q4378,"Renew ft matrix, per square centimeter",09/11/2025
Q4379,"Amniodefend ft matrix, per square centimeter",09/11/2025
Q4380,"Advograft one, per square centimeter",09/11/2025
Q4382,"Advograft dual, per square centimeter",09/11/2025
Q4383,"Axolotl graft ultra, per square centimeter",09/11/2025
Q4384,"Axolotl dualgraft ultra, per square centimeter",09/11/2025
Q4385,"Apollo ft, per square centimeter",09/11/2025
Q4386,"Acesso trifaca, per square centimeter",09/11/2025
Q4387,"Neothelium ft, per square centimeter",09/11/2025
Q4388,"Neothelium 4l, per square centimeter",09/11/2025
Q4389,"Neothelium 4l+, per square centimeter",09/11/2025
Q4390,"Ascendion, per square centimeter",09/11/2025
Q4391,"Amnioplast double, per square centimeter",09/11/2025
Q4392,"Grafix duo, per square centimeter",09/11/2025
Q4393,"Surgraft ac, per square centimeter",09/11/2025
Q4394,"Surgraft aca, per square centimeter",09/11/2025
Q4395,"Acelagraft, per square centimeter",09/11/2025
Q4396,"Natalin, per square centimeter",09/11/2025
Q4397,"Summit aaa, per square centimeter",09/11/2025
Q5001,Hospice or home health care provided in patient's home/residence,09/11/2025
Q5002,Hospice or home health care provided in assisted living facility,09/11/2025
Q5003,Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf),09/11/2025
Q5004,Hospice care provided in skilled nursing facility (snf),09/11/2025
Q5005,Hospice care provided in inpatient hospital,09/11/2025
Q5006,Hospice care provided in inpatient hospice facility,09/11/2025
Q5007,Hospice care provided in long term care facility,09/11/2025
Q5008,Hospice care provided in inpatient psychiatric facility,09/11/2025
Q5009,Hospice or home health care provided in place not otherwise specified (nos),09/11/2025
Q5010,Hospice home care provided in a hospice facility,09/11/2025
Q5098,"Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg",09/11/2025
Q5099,"Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg",09/11/2025
Q5100,"Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg",09/11/2025
Q5101,"Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram",09/11/2025
Q5102,"Injection, infliximab, biosimilar, 10 mg",09/11/2025
Q5103,"Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg",09/11/2025
Q5104,"Injection, infliximab-abda, biosimilar, (renflexis), 10 mg",09/11/2025
Q5105,"Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units",09/11/2025
Q5106,"Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units",09/11/2025
Q5107,"Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg",09/11/2025
Q5108,"Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg",09/11/2025
Q5109,"Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg",09/11/2025
Q5110,"Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram",09/11/2025
Q5111,"Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg",09/11/2025
Q5112,"Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg",09/11/2025
Q5113,"Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg",09/11/2025
Q5114,"Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg",09/11/2025
Q5115,"Injection, rituximab-abbs, biosimilar, (truxima), 10 mg",09/11/2025
Q5116,"Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg",09/11/2025
Q5117,"Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg",09/11/2025
Q5118,"Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg",09/11/2025
Q5119,"Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg",09/11/2025
Q5120,"Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg",09/11/2025
Q5121,"Injection, infliximab-axxq, biosimilar, (avsola), 10 mg",09/11/2025
Q5122,"Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg",09/11/2025
Q5123,"Injection, rituximab-arrx, biosimilar, (riabni), 10 mg",09/11/2025
Q5124,"Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg",09/11/2025
Q5125,"Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram",09/11/2025
Q5126,"Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg",09/11/2025
Q5127,"Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg",09/11/2025
Q5128,"Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg",09/11/2025
Q5129,"Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg",09/11/2025
Q5130,"Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg",09/11/2025
Q5131,"Injection, adalimumab-aacf (idacio), biosimilar, 20 mg",09/11/2025
Q5132,"Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg",09/11/2025
Q5133,"Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg",09/11/2025
Q5134,"Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg",09/11/2025
Q5135,"Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg",09/11/2025
Q5136,"Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg",09/11/2025
Q5137,"Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg",09/11/2025
Q5138,"Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg",09/11/2025
Q5139,"Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg",09/11/2025
Q5140,"Injection, adalimumab-fkjp, biosimilar, 1 mg",09/11/2025
Q5141,"Injection, adalimumab-aaty, biosimilar, 1 mg",09/11/2025
Q5142,"Injection, adalimumab-ryvk biosimilar, 1 mg",09/11/2025
Q5143,"Injection, adalimumab-adbm, biosimilar, 1 mg",09/11/2025
Q5144,"Injection, adalimumab-aacf (idacio), biosimilar, 1 mg",09/11/2025
Q5145,"Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg",09/11/2025
Q5146,"Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg",09/11/2025
Q5147,"Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg",09/11/2025
Q5148,"Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram",09/11/2025
Q5149,"Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg",09/11/2025
Q5150,"Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg",09/11/2025
Q5151,"Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg",09/11/2025
Q5152,"Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg",09/11/2025
Q5153,"Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg",09/11/2025
Q5154,"Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg",09/11/2025
Q5155,"Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg",09/11/2025
Q5156,"Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg",09/11/2025
Q5157,"Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg",09/11/2025
Q5158,"Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg",09/11/2025
Q5159,"Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg",09/11/2025
Q9001,Assessment by chaplain services,09/11/2025
Q9002,"Counseling, individual, by chaplain services",09/11/2025
Q9003,"Counseling, group, by chaplain services",09/11/2025
Q9004,Department of veterans affairs whole health partner services,09/11/2025
Q9950,"Injection, sulfur hexafluoride lipid microspheres, per ml",09/11/2025
Q9951,"Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml",09/11/2025
Q9953,"Injection, iron-based magnetic resonance contrast agent, per ml",09/11/2025
Q9954,"Oral magnetic resonance contrast agent, per 100 ml",09/11/2025
Q9955,"Injection, perflexane lipid microspheres, per ml",09/11/2025
Q9956,"Injection, octafluoropropane microspheres, per ml",09/11/2025
Q9957,"Injection, perflutren lipid microspheres, per ml",09/11/2025
Q9958,"High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml",09/11/2025
Q9959,"High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml",09/11/2025
Q9960,"High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml",09/11/2025
Q9961,"High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml",09/11/2025
Q9962,"High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml",09/11/2025
Q9963,"High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml",09/11/2025
Q9964,"High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml",09/11/2025
Q9965,"Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml",09/11/2025
Q9966,"Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml",09/11/2025
Q9967,"Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml",09/11/2025
Q9968,"Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg",09/11/2025
Q9969,"Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose",09/11/2025
Q9970,"Injection, ferric carboxymaltose, 1mg",09/11/2025
Q9972,"Injection, epoetin beta, 1 microgram, (for esrd on dialysis)",09/11/2025
Q9973,"Injection, epoetin beta, 1 microgram, (non-esrd use)",09/11/2025
Q9974,"Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg",09/11/2025
Q9975,"Injection, factor viii fc fusion protein (recombinant), per iu",09/11/2025
Q9976,"Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron",09/11/2025
Q9977,"Compounded drug, not otherwise classified",09/11/2025
Q9978,Netupitant 300 mg and palonosetron 0.5 mg,09/11/2025
Q9979,"Injection, alemtuzumab, 1 mg",09/11/2025
Q9980,"Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg",09/11/2025
Q9981,"Rolapitant, oral, 1 mg",09/11/2025
Q9982,"Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries",09/11/2025
Q9983,"Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries",09/11/2025
Q9984,"Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg",09/11/2025
Q9985,"Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg",09/11/2025
Q9986,"Injection, hydroxyprogesterone caproate, (makena), 10 mg",09/11/2025
Q9987,Pathogen(s) test for platelets,09/11/2025
Q9988,"Platelets, pheresis, pathogen-reduced, each unit",09/11/2025
Q9989,"Ustekinumab, for intravenous injection, 1 mg",09/11/2025
Q9991,"Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg",09/11/2025
Q9992,"Injection, buprenorphine extended-release (sublocade), greater than 100 mg",09/11/2025
Q9993,"Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg",09/11/2025
Q9994,"In-line cartridge containing digestive enzyme(s) for enteral feeding, each",09/11/2025
Q9995,"Injection, emicizumab-kxwh, 0.5 mg",09/11/2025
Q9996,"Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg",09/11/2025
Q9997,"Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg",09/11/2025
Q9998,"Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg",09/11/2025
Q9999,"Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg",09/11/2025
R0070,"Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, one patient seen",09/11/2025
R0075,"Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, more than one patient seen",09/11/2025
R0076,"Transportation of portable ekg to facility or location, per patient",09/11/2025
S0012,"Butorphanol tartrate, nasal spray, 25 mg",09/11/2025
S0013,"Esketamine, nasal spray, 1 mg",09/11/2025
S0014,"Tacrine hydrochloride, 10 mg",09/11/2025
S0017,"Injection, aminocaproic acid, 5 grams",09/11/2025
S0020,"Injection, bupivicaine hydrochloride, 30 ml",09/11/2025
S0021,"Injection, cefoperazone sodium, 1 gram",09/11/2025
S0023,"Injection, cimetidine hydrochloride, 300 mg",09/11/2025
S0028,"Injection, famotidine, 20 mg",09/11/2025
S0030,"Injection, metronidazole, 500 mg",09/11/2025
S0032,"Injection, nafcillin sodium, 2 grams",09/11/2025
S0034,"Injection, ofloxacin, 400 mg",09/11/2025
S0039,"Injection, sulfamethoxazole and trimethoprim, 10 ml",09/11/2025
S0040,"Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams",09/11/2025
S0073,"Injection, aztreonam, 500 mg",09/11/2025
S0074,"Injection, cefotetan disodium, 500 mg",09/11/2025
S0077,"Injection, clindamycin phosphate, 300 mg",09/11/2025
S0078,"Injection, fosphenytoin sodium, 750 mg",09/11/2025
S0080,"Injection, pentamidine isethionate, 300 mg",09/11/2025
S0081,"Injection, piperacillin sodium, 500 mg",09/11/2025
S0088,"Imatinib, 100 mg",09/11/2025
S0090,"Sildenafil citrate, 25 mg",09/11/2025
S0091,"Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166)",09/11/2025
S0092,"Injection, hydromorphone hydrochloride, 250 mg (loading dose for infusion pump)",09/11/2025
S0093,"Injection, morphine sulfate, 500 mg (loading dose for infusion pump)",09/11/2025
S0104,"Zidovudine, oral, 100 mg",09/11/2025
S0106,"Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets",09/11/2025
S0108,"Mercaptopurine, oral, 50 mg",09/11/2025
S0109,"Methadone, oral, 5 mg",09/11/2025
S0117,"Tretinoin, topical, 5 grams",09/11/2025
S0119,"Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)",09/11/2025
S0122,"Injection, menotropins, 75 iu",09/11/2025
S0126,"Injection, follitropin alfa, 75 iu",09/11/2025
S0128,"Injection, follitropin beta, 75 iu",09/11/2025
S0132,"Injection, ganirelix acetate, 250 mcg",09/11/2025
S0136,"Clozapine, 25 mg",09/11/2025
S0137,"Didanosine (ddi), 25 mg",09/11/2025
S0138,"Finasteride, 5 mg",09/11/2025
S0139,"Minoxidil, 10 mg",09/11/2025
S0140,"Saquinavir, 200 mg",09/11/2025
S0142,"Colistimethate sodium, inhalation solution administered through dme, concentrated form, per mg",09/11/2025
S0144,"Injection, propofol, 10 mg",09/11/2025
S0145,"Injection, pegylated interferon alfa-2a, 180 mcg per ml",09/11/2025
S0148,"Injection, pegylated interferon alfa-2b, 10 mcg",09/11/2025
S0155,"Sterile dilutant for epoprostenol, 50 ml",09/11/2025
S0156,"Exemestane, 25 mg",09/11/2025
S0157,"Becaplermin gel 0.01%, 0.5 gm",09/11/2025
S0160,"Dextroamphetamine sulfate, 5 mg",09/11/2025
S0164,"Injection, pantoprazole sodium, 40 mg",09/11/2025
S0166,"Injection, olanzapine, 2.5 mg",09/11/2025
S0169,"Calcitrol, 0.25 microgram",09/11/2025
S0170,"Anastrozole, oral, 1 mg",09/11/2025
S0171,"Injection, bumetanide, 0.5 mg",09/11/2025
S0172,"Chlorambucil, oral, 2 mg",09/11/2025
S0174,"Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)",09/11/2025
S0175,"Flutamide, oral, 125 mg",09/11/2025
S0176,"Hydroxyurea, oral, 500 mg",09/11/2025
S0177,"Levamisole hydrochloride, oral, 50 mg",09/11/2025
S0178,"Lomustine, oral, 10 mg",09/11/2025
S0179,"Megestrol acetate, oral, 20 mg",09/11/2025
S0182,"Procarbazine hydrochloride, oral, 50 mg",09/11/2025
S0183,"Prochlorperazine maleate, oral, 5 mg (for circumstances falling under the medicare statute, use q0164)",09/11/2025
S0187,"Tamoxifen citrate, oral, 10 mg",09/11/2025
S0189,"Testosterone pellet, 75 mg",09/11/2025
S0190,"Mifepristone, oral, 200 mg",09/11/2025
S0191,"Misoprostol, oral, 200 mcg",09/11/2025
S0194,"Dialysis/stress vitamin supplement, oral, 100 capsules",09/11/2025
S0195,"Pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine",09/11/2025
S0197,"Prenatal vitamins, 30-day supply",09/11/2025
S0199,"Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs",09/11/2025
S0201,"Partial hospitalization services, less than 24 hours, per diem",09/11/2025
S0207,"Paramedic intercept, non-hospital-based als service (non-voluntary), non-transport",09/11/2025
S0208,"Paramedic intercept, hospital-based als service (non-voluntary), non-transport",09/11/2025
S0209,"Wheelchair van, mileage, per mile",09/11/2025
S0215,"Non-emergency transportation; mileage, per mile",09/11/2025
S0220,Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 30 minutes,09/11/2025
S0221,Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 60 minutes,09/11/2025
S0250,Comprehensive geriatric assessment and treatment planning performed by assessment team,09/11/2025
S0255,"Hospice referral visit (advising patient and family of care options) performed by nurse, social worker, or other designated staff",09/11/2025
S0257,"Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service)",09/11/2025
S0260,History and physical (outpatient or office) related to surgical procedure (list separately in addition to code for appropriate evaluation and management service),09/11/2025
S0265,"Genetic counseling, under physician supervision, each 15 minutes",09/11/2025
S0270,"Physician management of patient home care, standard monthly case rate (per 30 days)",09/11/2025
S0271,"Physician management of patient home care, hospice monthly case rate (per 30 days)",09/11/2025
S0272,"Physician management of patient home care, episodic care monthly case rate (per 30 days)",09/11/2025
S0273,"Physician visit at member's home, outside of a capitation arrangement",09/11/2025
S0274,"Nurse practitioner visit at member's home, outside of a capitation arrangement",09/11/2025
S0280,"Medical home program, comprehensive care coordination and planning, initial plan",09/11/2025
S0281,"Medical home program, comprehensive care coordination and planning, maintenance of plan",09/11/2025
S0285,Colonoscopy consultation performed prior to a screening colonoscopy procedure,09/11/2025
S0302,Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service),09/11/2025
S0310,Hospitalist services (list separately in addition to code for appropriate evaluation and management service),09/11/2025
S0311,"Comprehensive management and care coordination for advanced illness, per calendar month",09/11/2025
S0315,Disease management program; initial assessment and initiation of the program,09/11/2025
S0316,"Disease management program, follow-up/reassessment",09/11/2025
S0317,Disease management program; per diem,09/11/2025
S0320,Telephone calls by a registered nurse to a disease management program member for monitoring purposes; per month,09/11/2025
S0340,"Lifestyle modification program for management of coronary artery disease, including all supportive services; first quarter / stage",09/11/2025
S0341,"Lifestyle modification program for management of coronary artery disease, including all supportive services; second or third quarter / stage",09/11/2025
S0342,"Lifestyle modification program for management of coronary artery disease, including all supportive services; fourth quarter / stage",09/11/2025
S0353,"Treatment planning and care coordination management for cancer, initial treatment",09/11/2025
S0354,"Treatment planning and care coordination management for cancer, established patient with a change of regimen",09/11/2025
S0390,"Routine foot care; removal and/or trimming of corns, calluses and/or nails and preventive maintenance in specific medical conditions (e.g., diabetes), per visit",09/11/2025
S0395,Impression casting of a foot performed by a practitioner other than the manufacturer of the orthotic,09/11/2025
S0400,Global fee for extracorporeal shock wave lithotripsy treatment of kidney stone(s),09/11/2025
S0500,"Disposable contact lens, per lens",09/11/2025
S0504,"Single vision prescription lens (safety, athletic, or sunglass), per lens",09/11/2025
S0506,"Bifocal vision prescription lens (safety, athletic, or sunglass), per lens",09/11/2025
S0508,"Trifocal vision prescription lens (safety, athletic, or sunglass), per lens",09/11/2025
S0510,"Non-prescription lens (safety, athletic, or sunglass), per lens",09/11/2025
S0512,"Daily wear specialty contact lens, per lens",09/11/2025
S0514,"Color contact lens, per lens",09/11/2025
S0515,"Scleral lens, liquid bandage device, per lens",09/11/2025
S0516,Safety eyeglass frames,09/11/2025
S0518,Sunglasses frames,09/11/2025
S0580,Polycarbonate lens (list this code in addition to the basic code for the lens),09/11/2025
S0581,Nonstandard lens (list this code in addition to the basic code for the lens),09/11/2025
S0590,"Integral lens service, miscellaneous services reported separately",09/11/2025
S0592,Comprehensive contact lens evaluation,09/11/2025
S0595,Dispensing new spectacle lenses for patient supplied frame,09/11/2025
S0596,Phakic intraocular lens for correction of refractive error,09/11/2025
S0601,Screening proctoscopy,09/11/2025
S0610,"Annual gynecological examination, new patient",09/11/2025
S0612,"Annual gynecological examination, established patient",09/11/2025
S0613,Annual gynecological examination; clinical breast examination without pelvic evaluation,09/11/2025
S0618,Audiometry for hearing aid evaluation to determine the level and degree of hearing loss,09/11/2025
S0620,Routine ophthalmological examination including refraction; new patient,09/11/2025
S0621,Routine ophthalmological examination including refraction; established patient,09/11/2025
S0622,"Physical exam for college, new or established patient (list separately in addition to appropriate evaluation and management code)",09/11/2025
S0630,Removal of sutures; by a physician other than the physician who originally closed the wound,09/11/2025
S0800,Laser in situ keratomileusis (lasik),09/11/2025
S0810,Photorefractive keratectomy (prk),09/11/2025
S0812,Phototherapeutic keratectomy (ptk),09/11/2025
S1001,"Deluxe item, patient aware (list in addition to code for basic item)",09/11/2025
S1002,Customized item (list in addition to code for basic item),09/11/2025
S1015,Iv tubing extension set,09/11/2025
S1016,"Non-pvc (polyvinyl chloride) intravenous administration set, for use with drugs that are not stable in pvc e.g., paclitaxel",09/11/2025
S1030,"Continuous noninvasive glucose monitoring device, purchase (for physician interpretation of data, use cpt code)",09/11/2025
S1031,"Continuous noninvasive glucose monitoring device, rental, including sensor, sensor replacement, and download to monitor (for physician interpretation of data, use cpt code)",09/11/2025
S1034,"Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices",09/11/2025
S1035,"Sensor; invasive (e.g., subcutaneous), disposable, for use with artificial pancreas device system",09/11/2025
S1036,"Transmitter; external, for use with artificial pancreas device system",09/11/2025
S1037,"Receiver (monitor); external, for use with artificial pancreas device system",09/11/2025
S1040,"Cranial remolding orthosis, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s)",09/11/2025
S1090,"Mometasone furoate sinus implant, 370 micrograms",09/11/2025
S1091,"Stent, non-coronary, temporary, with delivery system (propel)",09/11/2025
S2053,Transplantation of small intestine and liver allografts,09/11/2025
S2054,Transplantation of multivisceral organs,09/11/2025
S2055,"Harvesting of donor multivisceral organs, with preparation and maintenance of allografts; from cadaver donor",09/11/2025
S2060,Lobar lung transplantation,09/11/2025
S2061,"Donor lobectomy (lung) for transplantation, living donor",09/11/2025
S2065,Simultaneous pancreas kidney transplantation,09/11/2025
S2066,"Breast reconstruction with gluteal artery perforator (gap) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral",09/11/2025
S2067,"Breast reconstruction of a single breast with ""stacked"" deep inferior epigastric perforator (diep) flap(s) and/or gluteal artery perforator (gap) flap(s), including harvesting of the flap(s), microvascular transfer, closure of donor site(s) and shaping the flap into a breast, unilateral",09/11/2025
S2068,"Breast reconstruction with deep inferior epigastric perforator (diep) flap or superficial inferior epigastric artery (siea) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral",09/11/2025
S2070,"Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with endoscopic laser treatment of ureteral calculi (includes ureteral catheterization)",09/11/2025
S2079,Laparoscopic esophagomyotomy (heller type),09/11/2025
S2080,Laser-assisted uvulopalatoplasty (laup),09/11/2025
S2083,Adjustment of gastric band diameter via subcutaneous port by injection or aspiration of saline,09/11/2025
S2095,"Transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres",09/11/2025
S2102,Islet cell tissue transplant from pancreas; allogeneic,09/11/2025
S2103,Adrenal tissue transplant to brain,09/11/2025
S2107,"Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment",09/11/2025
S2112,"Arthroscopy, knee, surgical for harvesting of cartilage (chondrocyte cells)",09/11/2025
S2115,"Osteotomy, periacetabular, with internal fixation",09/11/2025
S2117,"Arthroereisis, subtalar",09/11/2025
S2118,"Metal-on-metal total hip resurfacing, including acetabular and femoral components",09/11/2025
S2120,Low density lipoprotein (ldl) apheresis using heparin-induced extracorporeal ldl precipitation,09/11/2025
S2140,"Cord blood harvesting for transplantation, allogeneic",09/11/2025
S2142,"Cord blood-derived stem-cell transplantation, allogeneic",09/11/2025
S2150,"Bone marrow or blood-derived stem cells (peripheral or umbilical), allogeneic or autologous, harvesting, transplantation, and related complications; including: pheresis and cell preparation/storage; marrow ablative therapy; drugs, supplies, hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services; and the number of days of pre-and post-transplant care in the global definition",09/11/2025
S2152,"Solid organ(s), complete or segmental, single organ or combination of organs; deceased or living donor(s), procurement, transplantation, and related complications; including: drugs; supplies; hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services, and the number of days of pre- and post-transplant care in the global definition",09/11/2025
S2202,Echosclerotherapy,09/11/2025
S2205,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), single coronary arterial graft",09/11/2025
S2206,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), two coronary arterial grafts",09/11/2025
S2207,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using venous graft only, single coronary venous graft",09/11/2025
S2208,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using single arterial and venous graft(s), single venous graft",09/11/2025
S2209,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using two arterial grafts and single venous graft",09/11/2025
S2225,"Myringotomy, laser-assisted",09/11/2025
S2230,Implantation of magnetic component of semi-implantable hearing device on ossicles in middle ear,09/11/2025
S2235,Implantation of auditory brain stem implant,09/11/2025
S2260,"Induced abortion, 17 to 24 weeks",09/11/2025
S2265,"Induced abortion, 25 to 28 weeks",09/11/2025
S2266,"Induced abortion, 29 to 31 weeks",09/11/2025
S2267,"Induced abortion, 32 weeks or greater",09/11/2025
S2300,"Arthroscopy, shoulder, surgical; with thermally-induced capsulorrhaphy",09/11/2025
S2325,Hip core decompression,09/11/2025
S2340,Chemodenervation of abductor muscle(s) of vocal cord,09/11/2025
S2341,Chemodenervation of adductor muscle(s) of vocal cord,09/11/2025
S2342,"Nasal endoscopy for post-operative debridement following functional endoscopic sinus surgery, nasal and/or sinus cavity(s), unilateral or bilateral",09/11/2025
S2348,"Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar",09/11/2025
S2350,"Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, single interspace",09/11/2025
S2351,"Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, each additional interspace (list separately in addition to code for primary procedure)",09/11/2025
S2360,"Percutaneous vertebroplasty, one vertebral body, unilateral or bilateral injection; cervical",09/11/2025
S2361,Each additional cervical vertebral body (list separately in addition to code for primary procedure),09/11/2025
S2400,"Repair, congenital diaphragmatic hernia in the fetus using temporary tracheal occlusion, procedure performed in utero",09/11/2025
S2401,"Repair, urinary tract obstruction in the fetus, procedure performed in utero",09/11/2025
S2402,"Repair, congenital cystic adenomatoid malformation in the fetus, procedure performed in utero",09/11/2025
S2403,"Repair, extralobar pulmonary sequestration in the fetus, procedure performed in utero",09/11/2025
S2404,"Repair, myelomeningocele in the fetus, procedure performed in utero",09/11/2025
S2405,"Repair of sacrococcygeal teratoma in the fetus, procedure performed in utero",09/11/2025
S2409,"Repair, congenital malformation of fetus, procedure performed in utero, not otherwise classified",09/11/2025
S2411,Fetoscopic laser therapy for treatment of twin-to-twin transfusion syndrome,09/11/2025
S2900,Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure),09/11/2025
S3000,"Diabetic indicator; retinal eye exam, dilated, bilateral",09/11/2025
S3005,"Performance measurement, evaluation of patient self assessment, depression",09/11/2025
S3600,Stat laboratory request (situations other than s3601),09/11/2025
S3601,Emergency stat laboratory charge for patient who is homebound or residing in a nursing facility,09/11/2025
S3620,"Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis;  hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)",09/11/2025
S3630,"Eosinophil count, blood, direct",09/11/2025
S3645,Hiv-1 antibody testing of oral mucosal transudate,09/11/2025
S3650,"Saliva test, hormone level; during menopause",09/11/2025
S3652,"Saliva test, hormone level; to assess preterm labor risk",09/11/2025
S3655,Antisperm antibodies test (immunobead),09/11/2025
S3708,Gastrointestinal fat absorption study,09/11/2025
S3721,Prostate cancer antigen 3 (pca3) testing,09/11/2025
S3722,"Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil",09/11/2025
S3800,Genetic testing for amyotrophic lateral sclerosis (als),09/11/2025
S3840,Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2,09/11/2025
S3841,Genetic testing for retinoblastoma,09/11/2025
S3842,Genetic testing for von hippel-lindau disease,09/11/2025
S3844,"Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness",09/11/2025
S3845,Genetic testing for alpha-thalassemia,09/11/2025
S3846,Genetic testing for hemoglobin e beta-thalassemia,09/11/2025
S3849,Genetic testing for niemann-pick disease,09/11/2025
S3850,Genetic testing for sickle cell anemia,09/11/2025
S3852,Dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer's disease,09/11/2025
S3853,Genetic testing for myotonic muscular dystrophy,09/11/2025
S3854,Gene expression profiling panel for use in the management of breast cancer treatment,09/11/2025
S3855,Genetic testing for detection of mutations in the presenilin - 1 gene,09/11/2025
S3861,"Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a) and variants for suspected brugada syndrome",09/11/2025
S3865,Comprehensive gene sequence analysis for hypertrophic cardiomyopathy,09/11/2025
S3866,Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family,09/11/2025
S3870,"Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability",09/11/2025
S3890,"Dna analysis, fecal, for colorectal cancer screening",09/11/2025
S3900,Surface electromyography (emg),09/11/2025
S3902,Ballistocardiogram,09/11/2025
S3904,Masters two step,09/11/2025
S4005,Interim labor facility global (labor occurring but not resulting in delivery),09/11/2025
S4011,"In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development",09/11/2025
S4013,"Complete cycle, gamete intrafallopian transfer (gift), case rate",09/11/2025
S4014,"Complete cycle, zygote intrafallopian transfer (zift), case rate",09/11/2025
S4015,"Complete in vitro fertilization cycle, not otherwise specified, case rate",09/11/2025
S4016,"Frozen in vitro fertilization cycle, case rate",09/11/2025
S4017,"Incomplete cycle, treatment cancelled prior to stimulation, case rate",09/11/2025
S4018,"Frozen embryo transfer procedure cancelled before transfer, case rate",09/11/2025
S4020,"In vitro fertilization procedure cancelled before aspiration, case rate",09/11/2025
S4021,"In vitro fertilization procedure cancelled after aspiration, case rate",09/11/2025
S4022,"Assisted oocyte fertilization, case rate",09/11/2025
S4023,"Donor egg cycle, incomplete, case rate",09/11/2025
S4024,"Air polymer-type a intrauterine foam, per study dose",09/11/2025
S4025,"Donor services for in vitro fertilization (sperm or embryo), case rate",09/11/2025
S4026,Procurement of donor sperm from sperm bank,09/11/2025
S4027,Storage of previously frozen embryos,09/11/2025
S4028,Microsurgical epididymal sperm aspiration (mesa),09/11/2025
S4030,Sperm procurement and cryopreservation services; initial visit,09/11/2025
S4031,Sperm procurement and cryopreservation services; subsequent visit,09/11/2025
S4035,"Stimulated intrauterine insemination (iui), case rate",09/11/2025
S4037,"Cryopreserved embryo transfer, case rate",09/11/2025
S4040,"Monitoring and storage of cryopreserved embryos, per 30 days",09/11/2025
S4042,"Management of ovulation induction (interpretation of diagnostic tests and studies, non-face-to-face medical management of the patient), per cycle",09/11/2025
S4981,Insertion of levonorgestrel-releasing intrauterine system,09/11/2025
S4988,"Penile contracture device, manual, greater than 3 lbs traction force",09/11/2025
S4989,"Contraceptive intrauterine device (e.g., progestacert iud), including implants and supplies",09/11/2025
S4990,"Nicotine patches, legend",09/11/2025
S4991,"Nicotine patches, non-legend",09/11/2025
S4993,Contraceptive pills for birth control,09/11/2025
S4995,Smoking cessation gum,09/11/2025
S5000,"Prescription drug, generic",09/11/2025
S5001,"Prescription drug, brand name",09/11/2025
S5010,"5% dextrose and 0.45% normal saline, 1000 ml",09/11/2025
S5011,"5% dextrose in lactated ringer's, 1000 ml",09/11/2025
S5012,"5% dextrose with potassium chloride, 1000 ml",09/11/2025
S5013,"5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1000 ml",09/11/2025
S5014,"5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1500 ml",09/11/2025
S5035,"Home infusion therapy, routine service of infusion device (e.g., pump maintenance)",09/11/2025
S5036,"Home infusion therapy, repair of infusion device (e.g., pump repair)",09/11/2025
S5100,"Day care services, adult; per 15 minutes",09/11/2025
S5101,"Day care services, adult; per half day",09/11/2025
S5102,"Day care services, adult; per diem",09/11/2025
S5105,"Day care services, center-based; services not included in program fee, per diem",09/11/2025
S5108,"Home care training to home care client, per 15 minutes",09/11/2025
S5109,"Home care training to home care client, per session",09/11/2025
S5110,"Home care training, family; per 15 minutes",09/11/2025
S5111,"Home care training, family; per session",09/11/2025
S5115,"Home care training, non-family; per 15 minutes",09/11/2025
S5116,"Home care training, non-family; per session",09/11/2025
S5120,Chore services; per 15 minutes,09/11/2025
S5121,Chore services; per diem,09/11/2025
S5125,Attendant care services; per 15 minutes,09/11/2025
S5126,Attendant care services; per diem,09/11/2025
S5130,"Homemaker service, nos; per 15 minutes",09/11/2025
S5131,"Homemaker service, nos; per diem",09/11/2025
S5135,"Companion care, adult (e.g., iadl/adl); per 15 minutes",09/11/2025
S5136,"Companion care, adult (e.g., iadl/adl); per diem",09/11/2025
S5140,"Foster care, adult; per diem",09/11/2025
S5141,"Foster care, adult; per month",09/11/2025
S5145,"Foster care, therapeutic, child; per diem",09/11/2025
S5146,"Foster care, therapeutic, child; per month",09/11/2025
S5150,"Unskilled respite care, not hospice; per 15 minutes",09/11/2025
S5151,"Unskilled respite care, not hospice; per diem",09/11/2025
S5160,Emergency response system; installation and testing,09/11/2025
S5161,"Emergency response system; service fee, per month (excludes installation and testing)",09/11/2025
S5162,Emergency response system; purchase only,09/11/2025
S5165,Home modifications; per service,09/11/2025
S5170,"Home delivered meals, including preparation; per meal",09/11/2025
S5175,"Laundry service, external, professional; per order",09/11/2025
S5180,"Home health respiratory therapy, initial evaluation",09/11/2025
S5181,"Home health respiratory therapy, nos, per diem",09/11/2025
S5185,"Medication reminder service, non-face-to-face; per month",09/11/2025
S5190,"Wellness assessment, performed by non-physician",09/11/2025
S5199,"Personal care item, nos, each",09/11/2025
S5497,"Home infusion therapy, catheter care / maintenance, not otherwise classified; includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S5498,"Home infusion therapy, catheter care / maintenance, simple (single lumen), includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem",09/11/2025
S5501,"Home infusion therapy, catheter care / maintenance, complex (more than one lumen), includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S5502,"Home infusion therapy, catheter care / maintenance, implanted access device, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (use this code for interim maintenance of vascular access not currently in use)",09/11/2025
S5517,"Home infusion therapy, all supplies necessary for restoration of catheter patency or declotting",09/11/2025
S5518,"Home infusion therapy, all supplies necessary for catheter repair",09/11/2025
S5520,"Home infusion therapy, all supplies (including catheter) necessary for a peripherally inserted central venous catheter (picc) line insertion",09/11/2025
S5521,"Home infusion therapy, all supplies (including catheter) necessary for a midline catheter insertion",09/11/2025
S5522,"Home infusion therapy, insertion of peripherally inserted central venous catheter (picc), nursing services only (no supplies or catheter included)",09/11/2025
S5523,"Home infusion therapy, insertion of midline venous catheter, nursing services only (no supplies or catheter included)",09/11/2025
S5550,"Insulin, rapid onset, 5 units",09/11/2025
S5551,"Insulin, most rapid onset (lispro or aspart); 5 units",09/11/2025
S5552,"Insulin, intermediate acting (nph or lente); 5 units",09/11/2025
S5553,"Insulin, long acting; 5 units",09/11/2025
S5560,"Insulin delivery device, reusable pen; 1.5 ml size",09/11/2025
S5561,"Insulin delivery device, reusable pen; 3 ml size",09/11/2025
S5565,Insulin cartridge for use in insulin delivery device other than pump; 150 units,09/11/2025
S5566,Insulin cartridge for use in insulin delivery device other than pump; 300 units,09/11/2025
S5570,"Insulin delivery device, disposable pen (including insulin); 1.5 ml size",09/11/2025
S5571,"Insulin delivery device, disposable pen (including insulin); 3 ml size",09/11/2025
S8030,Scleral application of tantalum ring(s) for localization of lesions for proton beam therapy,09/11/2025
S8032,Low-dose computed tomography for lung cancer screening,09/11/2025
S8035,Magnetic source imaging,09/11/2025
S8037,Magnetic resonance cholangiopancreatography (mrcp),09/11/2025
S8040,Topographic brain mapping,09/11/2025
S8042,"Magnetic resonance imaging (mri), low-field",09/11/2025
S8055,"Ultrasound guidance for multifetal pregnancy reduction(s), technical component (only to be used when the physician doing the reduction procedure does not perform the ultrasound, guidance is included in the cpt code for multifetal pregnancy reduction - 59866)",09/11/2025
S8080,"Scintimammography (radioimmunoscintigraphy of the breast), unilateral, including supply of radiopharmaceutical",09/11/2025
S8085,Fluorine-18 fluorodeoxyglucose (f-18 fdg) imaging using dual-head coincidence detection system (non-dedicated pet scan),09/11/2025
S8092,"Electron beam computed tomography (also known as ultrafast ct, cine ct)",09/11/2025
S8096,Portable peak flow meter,09/11/2025
S8097,"Asthma kit (including but not limited to portable peak expiratory flow meter, instructional video, brochure, and/or spacer)",09/11/2025
S8100,Holding chamber or spacer for use with an inhaler or nebulizer; without mask,09/11/2025
S8101,Holding chamber or spacer for use with an inhaler or nebulizer; with mask,09/11/2025
S8110,Peak expiratory flow rate (physician services),09/11/2025
S8120,"Oxygen contents, gaseous, 1 unit equals 1 cubic foot",09/11/2025
S8121,"Oxygen contents, liquid, 1 unit equals 1 pound",09/11/2025
S8130,"Interferential current stimulator, 2 channel",09/11/2025
S8131,"Interferential current stimulator, 4 channel",09/11/2025
S8185,Flutter device,09/11/2025
S8186,Swivel adapter,09/11/2025
S8189,"Tracheostomy supply, not otherwise classified",09/11/2025
S8210,Mucus trap,09/11/2025
S8262,"Mandibular orthopedic repositioning device, each",09/11/2025
S8265,Haberman feeder for cleft lip/palate,09/11/2025
S8270,"Enuresis alarm, using auditory buzzer and/or vibration device",09/11/2025
S8301,"Infection control supplies, not otherwise specified",09/11/2025
S8415,Supplies for home delivery of infant,09/11/2025
S8420,"Gradient pressure aid (sleeve and glove combination), custom made",09/11/2025
S8421,"Gradient pressure aid (sleeve and glove combination), ready made",09/11/2025
S8422,"Gradient pressure aid (sleeve), custom made, medium weight",09/11/2025
S8423,"Gradient pressure aid (sleeve), custom made, heavy weight",09/11/2025
S8424,"Gradient pressure aid (sleeve), ready made",09/11/2025
S8425,"Gradient pressure aid (glove), custom made, medium weight",09/11/2025
S8426,"Gradient pressure aid (glove), custom made, heavy weight",09/11/2025
S8427,"Gradient pressure aid (glove), ready made",09/11/2025
S8428,"Gradient pressure aid (gauntlet), ready made",09/11/2025
S8429,Gradient pressure exterior wrap,09/11/2025
S8430,"Padding for compression bandage, roll",09/11/2025
S8431,"Compression bandage, roll",09/11/2025
S8450,"Splint, prefabricated, digit (specify digit by use of modifier)",09/11/2025
S8451,"Splint, prefabricated, wrist or ankle",09/11/2025
S8452,"Splint, prefabricated, elbow",09/11/2025
S8460,"Camisole, post-mastectomy",09/11/2025
S8490,"Insulin syringes (100 syringes, any size)",09/11/2025
S8930,Electrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with the patient,09/11/2025
S8940,"Equestrian/hippotherapy, per session",09/11/2025
S8948,Application of a modality (requiring constant provider attendance) to one or more areas; low-level laser; each 15 minutes,09/11/2025
S8950,"Complex lymphedema therapy, each 15 minutes",09/11/2025
S8990,Physical or manipulative therapy performed for maintenance rather than restoration,09/11/2025
S8999,Resuscitation bag (for use by patient on artificial respiration during power failure or other catastrophic event),09/11/2025
S9001,Home uterine monitor with or without associated nursing services,09/11/2025
S9002,"Intra-vaginal motion sensor system, provides biofeedback for pelvic floor muscle rehabilitation device",09/11/2025
S9007,Ultrafiltration monitor,09/11/2025
S9015,Automated eeg monitoring,09/11/2025
S9024,Paranasal sinus ultrasound,09/11/2025
S9025,Omnicardiogram/cardiointegram,09/11/2025
S9034,"Extracorporeal shockwave lithotripsy for gall stones (if performed with ercp, use 43265)",09/11/2025
S9055,Procuren or other growth factor preparation to promote wound healing,09/11/2025
S9056,Coma stimulation per diem,09/11/2025
S9061,"Home administration of aerosolized drug therapy (e.g., pentamidine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9083,Global fee urgent care centers,09/11/2025
S9088,Services provided in an urgent care center (list in addition to code for service),09/11/2025
S9090,"Vertebral axial decompression, per session",09/11/2025
S9097,Home visit for wound care,09/11/2025
S9098,"Home visit, phototherapy services (e.g., bili-lite), including equipment rental, nursing services, blood draw, supplies, and other services, per diem",09/11/2025
S9110,"Telemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month",09/11/2025
S9117,"Back school, per visit",09/11/2025
S9122,"Home health aide or certified nurse assistant, providing care in the home; per hour",09/11/2025
S9123,"Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used)",09/11/2025
S9124,"Nursing care, in the home; by licensed practical nurse, per hour",09/11/2025
S9125,"Respite care, in the home, per diem",09/11/2025
S9126,"Hospice care, in the home, per diem",09/11/2025
S9127,"Social work visit, in the home, per diem",09/11/2025
S9128,"Speech therapy, in the home, per diem",09/11/2025
S9129,"Occupational therapy, in the home, per diem",09/11/2025
S9131,"Physical therapy; in the home, per diem",09/11/2025
S9140,"Diabetic management program, follow-up visit to non-md provider",09/11/2025
S9141,"Diabetic management program, follow-up visit to md provider",09/11/2025
S9145,"Insulin pump initiation, instruction in initial use of pump (pump not included)",09/11/2025
S9150,Evaluation by ocularist,09/11/2025
S9152,"Speech therapy, re-evaluation",09/11/2025
S9208,"Home management of preterm labor, including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)",09/11/2025
S9209,"Home management of preterm premature rupture of membranes (pprom), including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)",09/11/2025
S9211,"Home management of gestational hypertension, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)",09/11/2025
S9212,"Home management of postpartum hypertension, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)",09/11/2025
S9213,"Home management of preeclampsia, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately); per diem (do not use this code with any home infusion per diem code)",09/11/2025
S9214,"Home management of gestational diabetes, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)",09/11/2025
S9325,"Home infusion therapy, pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (do not use this code with s9326, s9327 or s9328)",09/11/2025
S9326,"Home infusion therapy, continuous (twenty-four hours or more) pain management infusion; administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9327,"Home infusion therapy, intermittent (less than twenty-four hours) pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9328,"Home infusion therapy, implanted pump pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9329,"Home infusion therapy, chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with s9330 or s9331)",09/11/2025
S9330,"Home infusion therapy, continuous (twenty-four hours or more) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9331,"Home infusion therapy, intermittent (less than twenty-four hours) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9335,"Home therapy, hemodialysis; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately), per diem",09/11/2025
S9336,"Home infusion therapy, continuous anticoagulant infusion therapy (e.g., heparin), administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9338,"Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9339,"Home therapy; peritoneal dialysis, administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9340,"Home therapy; enteral nutrition; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem",09/11/2025
S9341,"Home therapy; enteral nutrition via gravity; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem",09/11/2025
S9342,"Home therapy; enteral nutrition via pump; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem",09/11/2025
S9343,"Home therapy; enteral nutrition via bolus; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem",09/11/2025
S9345,"Home infusion therapy, anti-hemophilic agent infusion therapy (e.g., factor viii); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9346,"Home infusion therapy, alpha-1-proteinase inhibitor (e.g., prolastin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9347,"Home infusion therapy, uninterrupted, long-term, controlled rate intravenous or subcutaneous infusion therapy (e.g., epoprostenol); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9348,"Home infusion therapy, sympathomimetic/inotropic agent infusion therapy (e.g., dobutamine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9349,"Home infusion therapy, tocolytic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9351,"Home infusion therapy, continuous or intermittent anti-emetic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and visits coded separately), per diem",09/11/2025
S9353,"Home infusion therapy, continuous insulin infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9355,"Home infusion therapy, chelation therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9357,"Home infusion therapy, enzyme replacement intravenous therapy; (e.g., imiglucerase); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9359,"Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9361,"Home infusion therapy, diuretic intravenous therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9363,"Home infusion therapy, anti-spasmotic therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9364,"Home infusion therapy, total parenteral nutrition (tpn); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem (do not use with home infusion codes s9365-s9368 using daily volume scales)",09/11/2025
S9365,"Home infusion therapy, total parenteral nutrition (tpn); one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem",09/11/2025
S9366,"Home infusion therapy, total parenteral nutrition (tpn); more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem",09/11/2025
S9367,"Home infusion therapy, total parenteral nutrition (tpn); more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem",09/11/2025
S9368,"Home infusion therapy, total parenteral nutrition (tpn); more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem",09/11/2025
S9370,"Home therapy, intermittent anti-emetic injection therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9372,"Home therapy; intermittent anticoagulant injection therapy (e.g., heparin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code for flushing of infusion devices with heparin to maintain patency)",09/11/2025
S9373,"Home infusion therapy, hydration therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use with hydration therapy codes s9374-s9377 using daily volume scales)",09/11/2025
S9374,"Home infusion therapy, hydration therapy; one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9375,"Home infusion therapy, hydration therapy; more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9376,"Home infusion therapy, hydration therapy; more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9377,"Home infusion therapy, hydration therapy; more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies (drugs and nursing visits coded separately), per diem",09/11/2025
S9379,"Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9381,"Delivery or service to high risk areas requiring escort or extra protection, per visit",09/11/2025
S9401,"Anticoagulation clinic, inclusive of all services except laboratory tests, per session",09/11/2025
S9430,Pharmacy compounding and dispensing services,09/11/2025
S9432,Medical foods for non-inborn errors of metabolism,09/11/2025
S9433,"Medical food nutritionally complete, administered orally, providing 100% of nutritional intake",09/11/2025
S9434,Modified solid food supplements for inborn errors of metabolism,09/11/2025
S9435,Medical foods for inborn errors of metabolism,09/11/2025
S9436,"Childbirth preparation/lamaze classes, non-physician provider, per session",09/11/2025
S9437,"Childbirth refresher classes, non-physician provider, per session",09/11/2025
S9438,"Cesarean birth classes, non-physician provider, per session",09/11/2025
S9439,"Vbac (vaginal birth after cesarean) classes, non-physician provider, per session",09/11/2025
S9441,"Asthma education, non-physician provider, per session",09/11/2025
S9442,"Birthing classes, non-physician provider, per session",09/11/2025
S9443,"Lactation classes, non-physician provider, per session",09/11/2025
S9444,"Parenting classes, non-physician provider, per session",09/11/2025
S9445,"Patient education, not otherwise classified, non-physician provider, individual, per session",09/11/2025
S9446,"Patient education, not otherwise classified, non-physician provider, group, per session",09/11/2025
S9447,"Infant safety (including cpr) classes, non-physician provider, per session",09/11/2025
S9449,"Weight management classes, non-physician provider, per session",09/11/2025
S9451,"Exercise classes, non-physician provider, per session",09/11/2025
S9452,"Nutrition classes, non-physician provider, per session",09/11/2025
S9453,"Smoking cessation classes, non-physician provider, per session",09/11/2025
S9454,"Stress management classes, non-physician provider, per session",09/11/2025
S9455,"Diabetic management program, group session",09/11/2025
S9460,"Diabetic management program, nurse visit",09/11/2025
S9465,"Diabetic management program, dietitian visit",09/11/2025
S9470,"Nutritional counseling, dietitian visit",09/11/2025
S9472,"Cardiac rehabilitation program, non-physician provider, per diem",09/11/2025
S9473,"Pulmonary rehabilitation program, non-physician provider, per diem",09/11/2025
S9474,"Enterostomal therapy by a registered nurse certified in enterostomal therapy, per diem",09/11/2025
S9475,"Ambulatory setting substance abuse treatment or detoxification services, per diem",09/11/2025
S9476,"Vestibular rehabilitation program, non-physician provider, per diem",09/11/2025
S9480,"Intensive outpatient psychiatric services, per diem",09/11/2025
S9482,"Family stabilization services, per 15 minutes",09/11/2025
S9484,"Crisis intervention mental health services, per hour",09/11/2025
S9485,"Crisis intervention mental health services, per diem",09/11/2025
S9490,"Home infusion therapy, corticosteroid infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9494,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with home infusion codes for hourly dosing schedules s9497-s9504)",09/11/2025
S9497,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 3 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9500,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 24 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9501,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 12 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9502,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 8 hours, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9503,"Home infusion therapy, antibiotic, antiviral, or antifungal; once every 6 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9504,"Home infusion therapy, antibiotic, antiviral, or antifungal; once every 4 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9529,"Routine venipuncture for collection of specimen(s), single home bound, nursing home, or skilled nursing facility patient",09/11/2025
S9537,"Home therapy; hematopoietic hormone injection therapy (e.g., erythropoietin, g-csf, gm-csf); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9538,"Home transfusion of blood product(s); administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (blood products, drugs, and nursing visits coded separately), per diem",09/11/2025
S9542,"Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9558,"Home injectable therapy; growth hormone, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9559,"Home injectable therapy, interferon, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9560,"Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9562,"Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9563,"Home injectable therapy, immunotherapy, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9590,"Home therapy, irrigation therapy (e.g., sterile irrigation of an organ or anatomical cavity); including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",09/11/2025
S9810,"Home therapy; professional pharmacy services for provision of infusion, specialty drug administration, and/or disease state management, not otherwise classified, per hour (do not use this code with any per diem code)",09/11/2025
S9900,"Services by a journal-listed christian science practitioner for the purpose of healing, per diem",09/11/2025
S9901,"Services by a journal-listed christian science nurse, per hour",09/11/2025
S9960,"Ambulance service, conventional air service, nonemergency transport, one way (fixed wing)",09/11/2025
S9961,"Ambulance service, conventional air service, nonemergency transport, one way (rotary wing)",09/11/2025
S9970,"Health club membership, annual",09/11/2025
S9975,"Transplant related lodging, meals and transportation, per diem",09/11/2025
S9976,"Lodging, per diem, not otherwise classified",09/11/2025
S9977,"Meals, per diem, not otherwise specified",09/11/2025
S9981,"Medical records copying fee, administrative",09/11/2025
S9982,"Medical records copying fee, per page",09/11/2025
S9986,Not medically necessary service (patient is aware that service not medically necessary),09/11/2025
S9988,Services provided as part of a phase i clinical trial,09/11/2025
S9989,Services provided outside of the united states of america (list in addition to code(s) for service(s)),09/11/2025
S9990,Services provided as part of a phase ii clinical trial,09/11/2025
S9991,Services provided as part of a phase iii clinical trial,09/11/2025
S9992,"Transportation costs to and from trial location and local transportation costs (e.g., fares for taxicab or bus) for clinical trial participant and one caregiver/companion",09/11/2025
S9994,"Lodging costs (e.g., hotel charges) for clinical trial participant and one caregiver/companion",09/11/2025
S9996,Meals for clinical trial participant and one caregiver/companion,09/11/2025
S9999,Sales tax,09/11/2025
T1000,"Private duty / independent nursing service(s) - licensed, up to 15 minutes",09/11/2025
T1001,Nursing assessment / evaluation,09/11/2025
T1002,"Rn services, up to 15 minutes",09/11/2025
T1003,"Lpn/lvn services, up to 15 minutes",09/11/2025
T1004,"Services of a qualified nursing aide, up to 15 minutes",09/11/2025
T1005,"Respite care services, up to 15 minutes",09/11/2025
T1006,"Alcohol and/or substance abuse services, family/couple counseling",09/11/2025
T1007,"Alcohol and/or substance abuse services, treatment plan development and/or modification",09/11/2025
T1009,Child sitting services for children of the individual receiving alcohol and/or substance abuse services,09/11/2025
T1010,Meals for individuals receiving alcohol and/or substance abuse services (when meals not included in the program),09/11/2025
T1012,"Alcohol and/or substance abuse services, skills development",09/11/2025
T1013,"Sign language or oral interpretive services, per 15 minutes",09/11/2025
T1014,"Telehealth transmission, per minute, professional services bill separately",09/11/2025
T1015,"Clinic visit/encounter, all-inclusive",09/11/2025
T1016,"Case management, each 15 minutes",09/11/2025
T1017,"Targeted case management, each 15 minutes",09/11/2025
T1018,"School-based individualized education program (iep) services, bundled",09/11/2025
T1019,"Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)",09/11/2025
T1020,"Personal care services, per diem, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)",09/11/2025
T1021,"Home health aide or certified nurse assistant, per visit",09/11/2025
T1022,"Contracted home health agency services, all services provided under contract, per day",09/11/2025
T1023,"Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter",09/11/2025
T1024,"Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter",09/11/2025
T1025,"Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per diem",09/11/2025
T1026,"Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per hour",09/11/2025
T1027,"Family training and counseling for child development, per 15 minutes",09/11/2025
T1028,"Assessment of home, physical and family environment, to determine suitability to meet patient's medical needs",09/11/2025
T1029,"Comprehensive environmental lead investigation, not including laboratory analysis, per dwelling",09/11/2025
T1030,"Nursing care, in the home, by registered nurse, per diem",09/11/2025
T1031,"Nursing care, in the home, by licensed practical nurse, per diem",09/11/2025
T1032,"Services performed by a doula birth worker, per 15 minutes",09/11/2025
T1033,"Services performed by a doula birth worker, per diem",09/11/2025
T1040,"Medicaid certified community behavioral health clinic services, per diem",09/11/2025
T1041,"Medicaid certified community behavioral health clinic services, per month",09/11/2025
T1502,"Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit",09/11/2025
T1503,"Administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit",09/11/2025
T1505,"Electronic medication compliance management device, includes all components and accessories, not otherwise classified",09/11/2025
T1999,"Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in ""remarks""",09/11/2025
T2001,Non-emergency transportation; patient attendant/escort,09/11/2025
T2002,Non-emergency transportation; per diem,09/11/2025
T2003,Non-emergency transportation; encounter/trip,09/11/2025
T2004,"Non-emergency transport; commercial carrier, multi-pass",09/11/2025
T2005,Non-emergency transportation; stretcher van,09/11/2025
T2007,"Transportation waiting time, air ambulance and non-emergency vehicle, one-half (1/2) hour increments",09/11/2025
T2010,"Preadmission screening and resident review (pasrr) level i identification screening, per screen",09/11/2025
T2011,"Preadmission screening and resident review (pasrr) level ii evaluation, per evaluation",09/11/2025
T2012,"Habilitation, educational; waiver, per diem",09/11/2025
T2013,"Habilitation, educational, waiver; per hour",09/11/2025
T2014,"Habilitation, prevocational, waiver; per diem",09/11/2025
T2015,"Habilitation, prevocational, waiver; per hour",09/11/2025
T2016,"Habilitation, residential, waiver; per diem",09/11/2025
T2017,"Habilitation, residential, waiver; 15 minutes",09/11/2025
T2018,"Habilitation, supported employment, waiver; per diem",09/11/2025
T2019,"Habilitation, supported employment, waiver; per 15 minutes",09/11/2025
T2020,"Day habilitation, waiver; per diem",09/11/2025
T2021,"Day habilitation, waiver; per 15 minutes",09/11/2025
T2022,"Case management, per month",09/11/2025
T2023,Targeted case management; per month,09/11/2025
T2024,"Service assessment/plan of care development, waiver",09/11/2025
T2025,Waiver services; not otherwise specified (nos),09/11/2025
T2026,"Specialized childcare, waiver; per diem",09/11/2025
T2027,"Specialized childcare, waiver; per 15 minutes",09/11/2025
T2028,"Specialized supply, not otherwise specified, waiver",09/11/2025
T2029,"Specialized medical equipment, not otherwise specified, waiver",09/11/2025
T2030,"Assisted living, waiver; per month",09/11/2025
T2031,"Assisted living; waiver, per diem",09/11/2025
T2032,"Residential care, not otherwise specified (nos), waiver; per month",09/11/2025
T2033,"Residential care, not otherwise specified (nos), waiver; per diem",09/11/2025
T2034,"Crisis intervention, waiver; per diem",09/11/2025
T2035,"Utility services to support medical equipment and assistive technology/devices, waiver",09/11/2025
T2036,"Therapeutic camping, overnight, waiver; each session",09/11/2025
T2037,"Therapeutic camping, day, waiver; each session",09/11/2025
T2038,"Community transition, waiver; per service",09/11/2025
T2039,"Vehicle modifications, waiver; per service",09/11/2025
T2040,"Financial management, self-directed, waiver; per 15 minutes",09/11/2025
T2041,"Supports brokerage, self-directed, waiver; per 15 minutes",09/11/2025
T2042,Hospice routine home care; per diem,09/11/2025
T2043,Hospice continuous home care; per hour,09/11/2025
T2044,Hospice inpatient respite care; per diem,09/11/2025
T2045,Hospice general inpatient care; per diem,09/11/2025
T2046,"Hospice long term care, room and board only; per diem",09/11/2025
T2047,"Habilitation, prevocational, waiver; per 15 minutes",09/11/2025
T2048,"Behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem",09/11/2025
T2049,"Non-emergency transportation; stretcher van, mileage; per mile",09/11/2025
T2050,"Financial management, self-directed, waiver; per diem",09/11/2025
T2051,"Supports brokerage, self-directed, waiver; per diem",09/11/2025
T2101,"Human breast milk processing, storage and distribution only",09/11/2025
T4521,"Adult sized disposable incontinence product, brief/diaper, small, each",09/11/2025
T4522,"Adult sized disposable incontinence product, brief/diaper, medium, each",09/11/2025
T4523,"Adult sized disposable incontinence product, brief/diaper, large, each",09/11/2025
T4524,"Adult sized disposable incontinence product, brief/diaper, extra large, each",09/11/2025
T4525,"Adult sized disposable incontinence product, protective underwear/pull-on, small size, each",09/11/2025
T4526,"Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each",09/11/2025
T4527,"Adult sized disposable incontinence product, protective underwear/pull-on, large size, each",09/11/2025
T4528,"Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each",09/11/2025
T4529,"Pediatric sized disposable incontinence product, brief/diaper, small/medium size, each",09/11/2025
T4530,"Pediatric sized disposable incontinence product, brief/diaper, large size, each",09/11/2025
T4531,"Pediatric sized disposable incontinence product, protective underwear/pull-on, small/medium size, each",09/11/2025
T4532,"Pediatric sized disposable incontinence product, protective underwear/pull-on, large size, each",09/11/2025
T4533,"Youth sized disposable incontinence product, brief/diaper, each",09/11/2025
T4534,"Youth sized disposable incontinence product, protective underwear/pull-on, each",09/11/2025
T4535,"Disposable liner/shield/guard/pad/undergarment, for incontinence, each",09/11/2025
T4536,"Incontinence product, protective underwear/pull-on, reusable, any size, each",09/11/2025
T4537,"Incontinence product, protective underpad, reusable, bed size, each",09/11/2025
T4538,"Diaper service, reusable diaper, each diaper",09/11/2025
T4539,"Incontinence product, diaper/brief, reusable, any size, each",09/11/2025
T4540,"Incontinence product, protective underpad, reusable, chair size, each",09/11/2025
T4541,"Incontinence product, disposable underpad, large, each",09/11/2025
T4542,"Incontinence product, disposable underpad, small size, each",09/11/2025
T4543,"Adult sized disposable incontinence product, protective brief/diaper, above extra large, each",09/11/2025
T4544,"Adult sized disposable incontinence product, protective underwear/pull-on, above extra large, each",09/11/2025
T4545,"Incontinence product, disposable, penile wrap, each",09/11/2025
T5001,Positioning seat for persons with special orthopedic needs,09/11/2025
T5999,"Supply, not otherwise specified",09/11/2025
U0001,Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel,09/11/2025
U0002,"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc",09/11/2025
U0003,"Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by  cms-2020-01-r",09/11/2025
U0004,"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r",09/11/2025
U0005,"Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2",09/11/2025
V2020,"Frames, purchases",09/11/2025
V2025,Deluxe frame,09/11/2025
V2100,"Sphere, single vision, plano to plus or minus 4.00, per lens",09/11/2025
V2101,"Sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens",09/11/2025
V2102,"Sphere, single vision, plus or minus 7.12 to plus or minus 20.00d, per lens",09/11/2025
V2103,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens",09/11/2025
V2104,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens",09/11/2025
V2105,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens",09/11/2025
V2106,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens",09/11/2025
V2107,"Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens",09/11/2025
V2108,"Spherocylinder, single vision, plus or minus 4.25d to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens",09/11/2025
V2109,"Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens",09/11/2025
V2110,"Spherocylinder, single vision, plus or minus 4.25 to 7.00d sphere, over 6.00d cylinder, per lens",09/11/2025
V2111,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens",09/11/2025
V2112,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25d to 4.00d cylinder, per lens",09/11/2025
V2113,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens",09/11/2025
V2114,"Spherocylinder, single vision, sphere over plus or minus 12.00d, per lens",09/11/2025
V2115,"Lenticular, (myodisc), per lens, single vision",09/11/2025
V2118,"Aniseikonic lens, single vision",09/11/2025
V2121,"Lenticular lens, per lens, single",09/11/2025
V2199,"Not otherwise classified, single vision lens",09/11/2025
V2200,"Sphere, bifocal, plano to plus or minus 4.00d, per lens",09/11/2025
V2201,"Sphere, bifocal, plus or minus 4.12 to plus or minus 7.00d, per lens",09/11/2025
V2202,"Sphere, bifocal, plus or minus 7.12 to plus or minus 20.00d, per lens",09/11/2025
V2203,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens",09/11/2025
V2204,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens",09/11/2025
V2205,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens",09/11/2025
V2206,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens",09/11/2025
V2207,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere,.12 to 2.00d cylinder, per lens",09/11/2025
V2208,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens",09/11/2025
V2209,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens",09/11/2025
V2210,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens",09/11/2025
V2211,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens",09/11/2025
V2212,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens",09/11/2025
V2213,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens",09/11/2025
V2214,"Spherocylinder, bifocal, sphere over plus or minus 12.00d, per lens",09/11/2025
V2215,"Lenticular (myodisc), per lens, bifocal",09/11/2025
V2218,"Aniseikonic, per lens, bifocal",09/11/2025
V2219,Bifocal seg width over 28 mm,09/11/2025
V2220,Bifocal add over 3.25d,09/11/2025
V2221,"Lenticular lens, per lens, bifocal",09/11/2025
V2299,Specialty bifocal (by report),09/11/2025
V2300,"Sphere, trifocal, plano to plus or minus 4.00d, per lens",09/11/2025
V2301,"Sphere, trifocal, plus or minus 4.12 to plus or minus 7.00d, per lens",09/11/2025
V2302,"Sphere, trifocal, plus or minus 7.12 to plus or minus 20.00, per lens",09/11/2025
V2303,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens",09/11/2025
V2304,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 2.25-4.00d cylinder, per lens",09/11/2025
V2305,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00 cylinder, per lens",09/11/2025
V2306,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens",09/11/2025
V2307,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, .12 to 2.00d cylinder, per lens",09/11/2025
V2308,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens",09/11/2025
V2309,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens",09/11/2025
V2310,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens",09/11/2025
V2311,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens",09/11/2025
V2312,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens",09/11/2025
V2313,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens",09/11/2025
V2314,"Spherocylinder, trifocal, sphere over plus or minus 12.00d, per lens",09/11/2025
V2315,"Lenticular, (myodisc), per lens, trifocal",09/11/2025
V2318,"Aniseikonic lens, trifocal",09/11/2025
V2319,Trifocal seg width over 28 mm,09/11/2025
V2320,Trifocal add over 3.25d,09/11/2025
V2321,"Lenticular lens, per lens, trifocal",09/11/2025
V2399,Specialty trifocal (by report),09/11/2025
V2410,"Variable asphericity lens, single vision, full field, glass or plastic, per lens",09/11/2025
V2430,"Variable asphericity lens, bifocal, full field, glass or plastic, per lens",09/11/2025
V2499,"Variable sphericity lens, other type",09/11/2025
V2500,"Contact lens, pmma, spherical, per lens",09/11/2025
V2501,"Contact lens, pmma, toric or prism ballast, per lens",09/11/2025
V2502,"Contact lens, pmma, bifocal, per lens",09/11/2025
V2503,"Contact lens, pmma, color vision deficiency, per lens",09/11/2025
V2510,"Contact lens, gas permeable, spherical, per lens",09/11/2025
V2511,"Contact lens, gas permeable, toric, prism ballast, per lens",09/11/2025
V2512,"Contact lens, gas permeable, bifocal, per lens",09/11/2025
V2513,"Contact lens, gas permeable, extended wear, per lens",09/11/2025
V2520,"Contact lens, hydrophilic, spherical, per lens",09/11/2025
V2521,"Contact lens, hydrophilic, toric, or prism ballast, per lens",09/11/2025
V2522,"Contact lens, hydrophilic, bifocal, per lens",09/11/2025
V2523,"Contact lens, hydrophilic, extended wear, per lens",09/11/2025
V2524,"Contact lens, hydrophilic, spherical, photochromic additive, per lens",09/11/2025
V2525,"Contact lens, hydrophilic, dual focus, per lens",09/11/2025
V2526,"Contact lens, hydrophilic, with blue-violet filter, per lens",09/11/2025
V2530,"Contact lens, scleral, gas impermeable, per lens (for contact lens modification, see 92325)",09/11/2025
V2531,"Contact lens, scleral, gas permeable, per lens (for contact lens modification, see 92325)",09/11/2025
V2599,"Contact lens, other type",09/11/2025
V2600,Hand held low vision aids and other nonspectacle mounted aids,09/11/2025
V2610,Single lens spectacle mounted low vision aids,09/11/2025
V2615,"Telescopic and other compound lens system, including distance vision telescopic, near vision telescopes and compound microscopic lens system",09/11/2025
V2623,"Prosthetic eye, plastic, custom",09/11/2025
V2624,Polishing/resurfacing of ocular prosthesis,09/11/2025
V2625,Enlargement of ocular prosthesis,09/11/2025
V2626,Reduction of ocular prosthesis,09/11/2025
V2627,Scleral cover shell,09/11/2025
V2628,Fabrication and fitting of ocular conformer,09/11/2025
V2629,"Prosthetic eye, other type",09/11/2025
V2630,Anterior chamber intraocular lens,09/11/2025
V2631,Iris supported intraocular lens,09/11/2025
V2632,Posterior chamber intraocular lens,09/11/2025
V2700,"Balance lens, per lens",09/11/2025
V2702,Deluxe lens feature,09/11/2025
V2710,"Slab off prism, glass or plastic, per lens",09/11/2025
V2715,"Prism, per lens",09/11/2025
V2718,"Press-on lens, fresnell prism, per lens",09/11/2025
V2730,"Special base curve, glass or plastic, per lens",09/11/2025
V2744,"Tint, photochromatic, per lens",09/11/2025
V2745,"Addition to lens; tint, any color, solid, gradient or equal, excludes photochromatic, any lens material, per lens",09/11/2025
V2750,"Anti-reflective coating, per lens",09/11/2025
V2755,"U-v lens, per lens",09/11/2025
V2756,Eye glass case,09/11/2025
V2760,"Scratch resistant coating, per lens",09/11/2025
V2761,"Mirror coating, any type, solid, gradient or equal, any lens material, per lens",09/11/2025
V2762,"Polarization, any lens material, per lens",09/11/2025
V2770,"Occluder lens, per lens",09/11/2025
V2780,"Oversize lens, per lens",09/11/2025
V2781,"Progressive lens, per lens",09/11/2025
V2782,"Lens, index 1.54 to 1.65 plastic or 1.60 to 1.79 glass, excludes polycarbonate, per lens",09/11/2025
V2783,"Lens, index greater than or equal to 1.66 plastic or greater than or equal to 1.80 glass, excludes polycarbonate, per lens",09/11/2025
V2784,"Lens, polycarbonate or equal, any index, per lens",09/11/2025
V2785,"Processing, preserving and transporting corneal tissue",09/11/2025
V2786,"Specialty occupational multifocal lens, per lens",09/11/2025
V2787,Astigmatism correcting function of intraocular lens,09/11/2025
V2788,Presbyopia correcting function of intraocular lens,09/11/2025
V2790,"Amniotic membrane for surgical reconstruction, per procedure",09/11/2025
V2797,"Vision supply, accessory and/or service component of another hcpcs vision code",09/11/2025
V2799,"Vision item or service, miscellaneous",09/11/2025
V5008,Hearing screening,09/11/2025
V5010,Assessment for hearing aid,09/11/2025
V5011,Fitting/orientation/checking of hearing aid,09/11/2025
V5014,Repair/modification of a hearing aid,09/11/2025
V5020,Conformity evaluation,09/11/2025
V5030,"Hearing aid, monaural, body worn, air conduction",09/11/2025
V5040,"Hearing aid, monaural, body worn, bone conduction",09/11/2025
V5050,"Hearing aid, monaural, in the ear",09/11/2025
V5060,"Hearing aid, monaural, behind the ear",09/11/2025
V5070,"Glasses, air conduction",09/11/2025
V5080,"Glasses, bone conduction",09/11/2025
V5090,"Dispensing fee, unspecified hearing aid",09/11/2025
V5095,Semi-implantable middle ear hearing prosthesis,09/11/2025
V5100,"Hearing aid, bilateral, body worn",09/11/2025
V5110,"Dispensing fee, bilateral",09/11/2025
V5120,"Binaural, body",09/11/2025
V5130,"Binaural, in the ear",09/11/2025
V5140,"Binaural, behind the ear",09/11/2025
V5150,"Binaural, glasses",09/11/2025
V5160,"Dispensing fee, binaural",09/11/2025
V5170,"Hearing aid, cros, in the ear",09/11/2025
V5171,"Hearing aid, contralateral routing device, monaural, in the ear (ite)",09/11/2025
V5172,"Hearing aid, contralateral routing device, monaural, in the canal (itc)",09/11/2025
V5180,"Hearing aid, cros, behind the ear",09/11/2025
V5181,"Hearing aid, contralateral routing device, monaural, behind the ear (bte)",09/11/2025
V5190,"Hearing aid, contralateral routing, monaural, glasses",09/11/2025
V5200,"Dispensing fee, contralateral, monaural",09/11/2025
V5210,"Hearing aid, bicros, in the ear",09/11/2025
V5211,"Hearing aid, contralateral routing system, binaural, ite/ite",09/11/2025
V5212,"Hearing aid, contralateral routing system, binaural, ite/itc",09/11/2025
V5213,"Hearing aid, contralateral routing system, binaural, ite/bte",09/11/2025
V5214,"Hearing aid, contralateral routing system, binaural, itc/itc",09/11/2025
V5215,"Hearing aid, contralateral routing system, binaural, itc/bte",09/11/2025
V5220,"Hearing aid, bicros, behind the ear",09/11/2025
V5221,"Hearing aid, contralateral routing system, binaural, bte/bte",09/11/2025
V5230,"Hearing aid, contralateral routing system, binaural, glasses",09/11/2025
V5240,"Dispensing fee, contralateral routing system, binaural",09/11/2025
V5241,"Dispensing fee, monaural hearing aid, any type",09/11/2025
V5242,"Hearing aid, analog, monaural, cic (completely in the ear canal)",09/11/2025
V5243,"Hearing aid, analog, monaural, itc (in the canal)",09/11/2025
V5244,"Hearing aid, digitally programmable analog, monaural, cic",09/11/2025
V5245,"Hearing aid, digitally programmable, analog, monaural, itc",09/11/2025
V5246,"Hearing aid, digitally programmable analog, monaural, ite (in the ear)",09/11/2025
V5247,"Hearing aid, digitally programmable analog, monaural, bte (behind the ear)",09/11/2025
V5248,"Hearing aid, analog, binaural, cic",09/11/2025
V5249,"Hearing aid, analog, binaural, itc",09/11/2025
V5250,"Hearing aid, digitally programmable analog, binaural, cic",09/11/2025
V5251,"Hearing aid, digitally programmable analog, binaural, itc",09/11/2025
V5252,"Hearing aid, digitally programmable, binaural, ite",09/11/2025
V5253,"Hearing aid, digitally programmable, binaural, bte",09/11/2025
V5254,"Hearing aid, digital, monaural, cic",09/11/2025
V5255,"Hearing aid, digital, monaural, itc",09/11/2025
V5256,"Hearing aid, digital, monaural, ite",09/11/2025
V5257,"Hearing aid, digital, monaural, bte",09/11/2025
V5258,"Hearing aid, digital, binaural, cic",09/11/2025
V5259,"Hearing aid, digital, binaural, itc",09/11/2025
V5260,"Hearing aid, digital, binaural, ite",09/11/2025
V5261,"Hearing aid, digital, binaural, bte",09/11/2025
V5262,"Hearing aid, disposable, any type, monaural",09/11/2025
V5263,"Hearing aid, disposable, any type, binaural",09/11/2025
V5264,"Ear mold/insert, not disposable, any type",09/11/2025
V5265,"Ear mold/insert, disposable, any type",09/11/2025
V5266,Battery for use in hearing device,09/11/2025
V5267,"Hearing aid or assistive listening device/supplies/accessories, not otherwise specified",09/11/2025
V5268,"Assistive listening device, telephone amplifier, any type",09/11/2025
V5269,"Assistive listening device, alerting, any type",09/11/2025
V5270,"Assistive listening device, television amplifier, any type",09/11/2025
V5271,"Assistive listening device, television caption decoder",09/11/2025
V5272,"Assistive listening device, tdd",09/11/2025
V5273,"Assistive listening device, for use with cochlear implant",09/11/2025
V5274,"Assistive listening device, not otherwise specified",09/11/2025
V5275,"Ear impression, each",09/11/2025
V5281,"Assistive listening device, personal fm/dm system, monaural, (1 receiver, transmitter, microphone), any type",09/11/2025
V5282,"Assistive listening device, personal fm/dm system, binaural, (2 receivers, transmitter, microphone), any type",09/11/2025
V5283,"Assistive listening device, personal fm/dm neck, loop induction receiver",09/11/2025
V5284,"Assistive listening device, personal fm/dm, ear level receiver",09/11/2025
V5285,"Assistive listening device, personal fm/dm, direct audio input receiver",09/11/2025
V5286,"Assistive listening device, personal blue tooth fm/dm receiver",09/11/2025
V5287,"Assistive listening device, personal fm/dm receiver, not otherwise specified",09/11/2025
V5288,"Assistive listening device, personal fm/dm transmitter assistive listening device",09/11/2025
V5289,"Assistive listening device, personal fm/dm adapter/boot coupling device for receiver, any type",09/11/2025
V5290,"Assistive listening device, transmitter microphone, any type",09/11/2025
V5298,"Hearing aid, not otherwise classified",09/11/2025
V5299,"Hearing service, miscellaneous",09/11/2025
V5336,Repair/modification of augmentative communicative system or device (excludes adaptive hearing aid),09/11/2025
V5362,Speech screening,09/11/2025
V5363,Language screening,09/11/2025
V5364,Dysphagia screening,09/11/2025
